Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRP,Agouti-related protein,42296,0.226523745291189,0.00488268235053754,0.216953687884135,0.236093802698242,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN1,CCN family member 1,42047,0.317311425978908,0.00675917417816322,0.304063444589708,0.330559407368108,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLR,Low-density lipoprotein receptor,42170,0.366603505702255,0.00413814746064014,0.358492736679401,0.37471427472511,0
NMR metabolomics,X23428.Concentration of VLDL Particles,MFGE8,Lactadherin,42137,0.177299602138618,0.00435438958949956,0.168764998543199,0.185834205734037,0
NMR metabolomics,X23428.Concentration of VLDL Particles,NPY,Pro-neuropeptide Y,42262,0.274321907406029,0.00601666168260083,0.262529250508132,0.286114564303927,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.205714246951999,0.00275510716456892,0.200314236909444,0.211114256994554,0
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI,Tissue factor pathway inhibitor,42152,0.120942808200328,0.00299714134399115,0.115068411166106,0.126817205234551,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0770205592402571,0.00209440681740001,0.0729155218781531,0.0811255966023611,7.33951538550467e-280
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.116298427397485,0.0032273338606057,0.109972853030697,0.122624001764272,1.16412875289961e-271
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL27,C-C motif chemokine 27,42145,0.216991043447631,0.00607282111173687,0.205088314068627,0.228893772826636,2.6703688553904e-267
NMR metabolomics,X23428.Concentration of VLDL Particles,APCS,Serum amyloid P-component,39870,0.113076709505858,0.00316115202411635,0.106880851538589,0.119272567473126,1.56320824442092e-265
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.144942893090981,0.00417662312336386,0.136756711769188,0.153129074412774,6.15119564466176e-253
NMR metabolomics,X23428.Concentration of VLDL Particles,APOM,Apolipoprotein M,42199,0.0959078581565374,0.00276783203000059,0.0904829073777362,0.101332808935339,3.38302017535515e-252
NMR metabolomics,X23428.Concentration of VLDL Particles,PROC,Vitamin K-dependent protein C,42199,0.0863932099593923,0.00250533785040059,0.0814827477726072,0.0913036721461775,6.90398785821853e-250
NMR metabolomics,X23428.Concentration of VLDL Particles,F7,Coagulation factor VII,42194,0.101423519731656,0.00303455448553307,0.0954757929400116,0.107371246523301,1.88064293483055e-235
NMR metabolomics,X23428.Concentration of VLDL Particles,APOC1,Apolipoprotein C-I,39959,0.123790065560305,0.00377455537074298,0.116391937033649,0.131188194086961,1.79201170629973e-225
NMR metabolomics,X23428.Concentration of VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.242902991978382,0.00753190001310673,0.228140467952693,0.257665516004071,2.1870886180744e-218
NMR metabolomics,X23428.Concentration of VLDL Particles,GHR,Growth hormone receptor,39736,0.0889089459154856,0.00276979411375522,0.0834801494525254,0.0943377423784458,2.65880000625843e-216
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.17459398478682,0.00572799319306301,-0.185820851445224,-0.163367118128417,2.31017028569436e-197
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH,Parathyroid hormone,39649,0.2488101147653,0.00817018563983081,0.232796550911232,0.264823678619368,1.14104236258812e-195
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.0965055577914142,0.00318143698766993,0.0902699412955811,0.102741174287247,1.16661241402877e-195
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0571114529894977,0.00190846426259842,0.0533708630348048,0.0608520429441906,1.45674747900239e-190
NMR metabolomics,X23428.Concentration of VLDL Particles,FURIN,Furin,42181,0.0943361393687766,0.00326061224219251,0.0879453393740793,0.100726939363474,1.17148136552106e-178
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL23,C-C motif chemokine 23,42185,0.119890410282779,0.00417315460940093,0.111711027248354,0.128069793317205,2.92471839596704e-176
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,42230,0.135683107048266,0.00478030531760644,0.126313708625757,0.145052505470774,3.1167210410348e-172
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0932129253313594,0.0033045391480589,0.086736028601164,0.0996898220615548,3.39447483945935e-170
NMR metabolomics,X23428.Concentration of VLDL Particles,BCHE,Cholinesterase,39806,0.074910211756597,0.0026568896076675,0.0697027081255687,0.0801177153876253,4.94920474834797e-169
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.232710724433963,0.00830378789079436,0.216435300168006,0.24898614869992,6.1472971336896e-168
NMR metabolomics,X23428.Concentration of VLDL Particles,CES1,Liver carboxylesterase 1,42163,0.234784694894773,0.00840627400277059,0.218308397849343,0.251260991940203,5.88752823684723e-167
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA5,Plasma serine protease inhibitor,39835,0.0820035947955266,0.00299048917891022,0.0761422360048625,0.0878649535861906,2.68039950453025e-160
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0555112367851147,0.0020454731590191,0.0515021093934373,0.0595203641767921,7.47022710853879e-158
NMR metabolomics,X23428.Concentration of VLDL Particles,CFP,Properdin,39979,0.0637405727959761,0.0023495559549537,0.0591354431242668,0.0683457024676853,4.1998559263367e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP1,Neuropilin-1,42230,-0.0731469098554931,0.00270906571879606,-0.0784566786643334,-0.0678371410466528,1.82124377082448e-156
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.065159337416513,0.00241926996436529,0.060417568286357,0.069901106546669,1.05683536335747e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,CD4,T-cell surface glycoprotein CD4,42100,0.0768517855066812,0.00287557029822798,0.0712156677221544,0.082487903291208,2.23141620643149e-153
NMR metabolomics,X23428.Concentration of VLDL Particles,PAMR1,Inactive serine protease PAMR1,42137,0.069678829531859,0.00262256832380392,0.0645385956172033,0.0748190634465147,1.16134949580289e-151
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.223949616935623,0.0084695430705329,0.207349312517378,0.240549921353867,2.99818422362978e-150
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCA,Alpha-synuclein,39736,0.309228362421335,0.0117099186365557,0.286276921893686,0.332179802948984,4.14311823477702e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.381743077835918,0.0145191848071055,0.353285475613992,0.410200680057845,1.40224237039764e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.065855961202689,0.00253620877574197,0.0608849920022348,0.0708269304031433,3.76579685751104e-145
NMR metabolomics,X23428.Concentration of VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.176076972646404,0.00681997891346751,0.162709813976008,0.189444131316801,1.68102310791457e-143
NMR metabolomics,X23428.Concentration of VLDL Particles,LPL,Lipoprotein lipase,42145,-0.123198569710176,0.00477444308601245,-0.132556478158761,-0.113840661261592,2.27704667147725e-143
NMR metabolomics,X23428.Concentration of VLDL Particles,PROS1,Vitamin K-dependent protein S,39979,0.0648062751895034,0.00252808435182619,0.0598512298599241,0.0697613205190828,6.01098867103956e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.081426289394649,0.0032034980821142,0.0751474331537051,0.0877051456355928,2.7549404839811e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,P4HB,Protein disulfide-isomerase,42073,0.0971835926911757,0.00383589224646122,0.0896652438881118,0.10470194149424,2.20696682163461e-138
NMR metabolomics,X23428.Concentration of VLDL Particles,KLKB1,Plasma kallikrein,39759,0.061960951218606,0.00244024170686735,0.057178077473146,0.066743824964066,2.53961771978168e-138
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA4,Kallistatin,39802,0.0592089957622648,0.00233494182526012,0.0546325097847549,0.0637854817397746,5.49678554550608e-138
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP6,Charged multivesicular body protein 6,39958,0.143566578999291,0.00569451057951241,0.132405338263447,0.154727819735135,1.6337998384299e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.199909788898322,0.00795376607148105,0.184320407398219,0.215499170398425,2.84991449046162e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.266605222681371,0.0106177721195756,0.245794389327002,0.287416056035739,5.15286981028348e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,TTR,Transthyretin,39862,0.0619720636029288,0.00247660322250675,0.0571179212868155,0.066826205919042,1.5594572505898e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,CFH,Complement factor H,39418,0.0572387847733425,0.00233843952860507,0.0526554432972766,0.0618221262494085,7.89787827817598e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF9,Protein turtle homolog A,39958,0.209399453172611,0.0085670935795131,0.192607949756765,0.226190956588457,1.23466232000155e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRN,"Attractin, Isoform 2",39979,0.0405058534038879,0.00166314856353102,0.0372460822193671,0.0437656245884087,9.26710897641045e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL6,C-X-C motif chemokine 6,42296,0.182092689843121,0.00752370728020979,0.16734622357391,0.196839156112332,9.43382765637257e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,42181,0.0603987448409616,0.00249775389670882,0.0555031472034123,0.0652943424785108,1.62715465963942e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.196443113523105,0.00814564907394348,0.180477641338176,0.212408585708034,8.30502715334008e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAT,Tissue-type plasminogen activator,42272,0.12218067640118,0.00510310159907336,0.112178597266996,0.132182755535363,3.91050142276677e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,SYAP1,Synapse-associated protein 1,39736,0.140241302007437,0.00584679243430139,0.128781588836206,0.151701015178668,5.26236368865736e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0880306683443532,0.00367533496103779,0.0808270118207192,0.0952343248679873,1.02284733513277e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,FN1,Fibronectin,39979,0.064678984141296,0.00272369961058648,0.0593405329045465,0.0700174353780455,1.05333125023357e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,SORT1,Sortilin,42129,0.0900048739081215,0.00380056353225399,0.0825557693849037,0.0974539784313393,1.61473984007785e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0463638804864098,0.00195862467339517,0.0425249761265553,0.0502027848462643,1.9284702990552e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.141466846417728,0.00603505074485848,-0.15329554587765,-0.129638146957805,3.5960677923258e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,42189,0.080492257345681,0.00343579737281506,0.0737580944949635,0.0872264201963985,5.04444687151249e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,F13B,Coagulation factor XIII B chain,39925,0.0596380945898514,0.00256245857608912,0.0546156757807168,0.0646605133989861,4.454823026002e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A5,Zinc transporter ZIP5,42119,0.121878338457572,0.00529110013437496,0.111507782194197,0.132248894720947,3.41931912568837e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,GUSB,Beta-glucuronidase,42211,0.139952694373217,0.00609290056760804,0.128010609260705,0.151894779485729,1.39188672179828e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,GCG,Pro-glucagon,41843,0.283821765729432,0.0123965435472528,0.259524540376817,0.308118991082048,8.28023068852897e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,41843,0.254983900581193,0.0111387276312869,0.233151994423871,0.276815806738515,8.96077348064941e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF2,Alpha-2-antiplasmin,39786,0.030770510724816,0.00134255270228315,0.028139107428341,0.033401914021291,1.20481692441363e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,42140,0.089628723673321,0.00394891377579246,0.0818888526727678,0.0973685946738742,5.80781645534107e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0499194249074494,0.00220798357981104,0.0455917770910198,0.054247072723879,1.08135951540037e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN3,Contactin-3,42137,0.0638376467304839,0.00283092133817337,0.0582890409076641,0.0693862525533037,1.4393826457726e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,CFI,Complement factor I,39979,0.0439403918536488,0.00194526160076496,0.0401276791161495,0.0477531045911482,1.48737841056776e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,AFM,Afamin,39979,0.0453099616102881,0.00202650405593697,0.0413380136606517,0.0492819095599246,2.10694310035485e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR37,Prosaposin receptor GPR37,41900,0.144517286207746,0.00652032044784014,0.131737458129979,0.157297114285513,6.49745863133188e-107
NMR metabolomics,X23428.Concentration of VLDL Particles,SOST,Sclerostin,42129,0.0853910823495037,0.00387091975847373,0.0778040796228952,0.0929780850761122,5.64081907641702e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIP2,Cysteine-rich protein 2,42016,0.0799715266444614,0.00363888679833388,0.072839308519727,0.0871037447691958,3.40107169004321e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0437453261104839,0.00199284508103368,0.0398393497516579,0.04765130246931,5.77812218408623e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB2,Carboxypeptidase B2,39959,0.049549775195624,0.00225437990320654,0.0451311905853392,0.0539683598059089,6.84771486365645e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,KYNU,Kynureninase,42296,0.0988283637579287,0.00454793596135649,0.0899144092736699,0.107742318242187,5.75999051098219e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL13,C-X-C motif chemokine 13,42249,0.124126207705333,0.00574537378884012,0.112865275079206,0.135387140331459,8.19165159482093e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG2,Desmoglein-2,42137,-0.0584542493952462,0.00270670094456518,-0.0637593832465939,-0.0531491155438985,1.00855036597697e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO3,Beta-enolase,39638,0.136299046871619,0.0063009798352228,0.123949126394582,0.148648967348656,1.15491575121017e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT2,Linker for activation of T-cells family member 2,42070,0.27188760386504,0.012623299343197,0.247145937152374,0.296629270577707,3.42282696014614e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0578176632641365,0.00268637081984258,0.052552376457245,0.0630829500710279,4.71594665645349e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN2,Ficolin-2,42116,0.0869159776283515,0.00405673042167856,0.0789647860018615,0.0948671692548414,3.58229570012646e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.301269307353136,0.0140554656640403,0.273720594651617,0.328818020054655,6.08421200108559e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.152361093551802,0.00711187705526928,0.138421814523474,0.166300372580129,7.64341928462384e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAPIN,SNARE-associated protein Snapin,39934,0.12491123724935,0.00584513190720124,0.113454778711235,0.136367695787464,2.28135447779305e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA3,Glutathione S-transferase A3,41843,0.164262844063756,0.00771724614880478,0.149137041612098,0.179388646515413,7.0032987934502e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,39657,0.18555210717631,0.00870365569689706,0.168492942010391,0.202611272342228,7.29834607848084e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,NUMB,Protein numb homolog,39657,0.179179332883722,0.00841727383567661,0.162681476165796,0.195677189601648,1.40024851900321e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.155123374687829,0.00731826340990953,0.140779578404406,0.169467170971251,4.12372448930461e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,F10,Coagulation factor X,39990,0.0612514718162711,0.00290584411695441,0.0555560173470405,0.0669469262855018,8.67920805631943e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.125534911659258,0.00599912565338035,0.113776625378632,0.137293197939883,1.10024429666417e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,ELN,Elastin,39958,0.0728111679431982,0.00348049831261534,0.0659893912504722,0.0796329446359243,2.19911247748945e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.108302626535656,0.00521409650299641,0.0980829973897827,0.118522255681529,2.26229719862442e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,GRP,Gastrin-releasing peptide,39638,0.111255589383779,0.00536059283672598,0.100748827423796,0.121762351343762,6.86147534767477e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.141615638757518,0.00683596880947886,0.12821713989094,0.155014137624097,7.55344142842004e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0858748607732119,0.00414664376632208,0.0777474389912206,0.0940022825552032,8.1797414090568e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBC,Inhibin beta C chain,42137,0.0822719049488293,0.0039825021731158,0.0744662006895223,0.0900776092081363,2.24917044000632e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0495320184031626,0.00240492964927979,0.0448183562905742,0.054245680515751,8.23051148952385e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,EEF1D,Elongation factor 1-delta,39958,0.188059036958935,0.00914446991021777,0.170135875934908,0.205982197982962,2.66446355726314e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,NOMO1,Nodal modulator 1,42137,0.0477291679637951,0.002332158855332,0.0431581366073444,0.0523001993202458,1.05807444762266e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR2,Cadherin-related family member 2,42070,0.134944479096963,0.00659745008639954,0.12201347692762,0.147875481266306,1.35417186542735e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0609577854801232,0.00298463650139486,0.0551078979373892,0.0668076730228571,4.39332881145294e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,NCS1,Neuronal calcium sensor 1,42262,0.0571336423725313,0.00283420648316229,0.0515785976655332,0.0626886870795294,4.44334596769652e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.250068228505971,0.012423452498013,0.225718261609866,0.274418195402077,8.21459115643241e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR3,Anterior gradient protein 3,41827,0.119342506365132,0.00593332630272879,0.107713186811784,0.130971825918481,1.1732069851316e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5E,5'-nucleotidase,42181,0.108349247025413,0.00539046044310221,0.0977839445569329,0.118914549493894,1.42035263446955e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP29,Synaptosomal-associated protein 29,42181,0.183506039187164,0.00917323940192801,0.165526489959385,0.201485588414943,9.1989745025983e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA80,N-alpha-acetyltransferase 80,39649,0.247431552479887,0.0123601010748384,0.223205754373204,0.27165735058657,1.34224893159159e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0520773023275743,0.00260665536443666,0.0469682578132784,0.0571863468418701,1.5668998269502e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,YTHDF3,YTH domain-containing family protein 3,41913,0.170580923669967,0.00859214080974236,0.153740327682872,0.187421519657062,1.8362231751693e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,DTYMK,Thymidylate kinase,39958,0.133810329248735,0.00675366802131366,0.12057313992696,0.14704751857051,6.44367006675734e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.157001470303121,0.00798100702804908,0.141358696528144,0.172644244078097,9.69405289652591e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,LEFTY2,Left-right determination factor 2,42247,0.101485825618963,0.00516988649518248,0.0913528480884055,0.111618803149521,1.25056367729477e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR5,Cadherin-related family member 5,42145,0.0761622208287955,0.00388323096463359,0.0685510881381137,0.0837733535194774,1.76847575828818e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPIND1,Heparin cofactor 2,39959,0.0576202839293952,0.00293787368343993,0.0518620515098529,0.0633785163489374,2.94707582840104e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,GH1,Somatotropin,42129,-0.348966832143594,0.0178207649603147,-0.383895531465811,-0.314038132821377,3.21201917471122e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.081277068320601,0.00414867505587787,0.0731456652110803,0.0894084714301216,4.49991192059474e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,FYB1,FYN-binding protein 1,42115,0.181670021543725,0.00928579156759642,0.163469870071236,0.199870173016214,4.51782977249639e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,YES1,Tyrosine-protein kinase Yes,42070,0.223802463979187,0.0114523201575038,0.20135591647048,0.246249011487895,6.95796831372265e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,KITLG,Kit ligand,42145,-0.0747369478629138,0.00382998465220109,-0.082243717781228,-0.0672301779445997,1.17920491717091e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,PLTP,Phospholipid transfer protein,42267,-0.0740715204059699,0.00379857805506402,-0.0815167333938953,-0.0666263074180444,1.49934828589953e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0870829374037015,0.00447949833975293,-0.0958627541496172,-0.0783031206577858,7.79920426023951e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,SARG,Specifically androgen-regulated gene protein,39915,0.214582767936756,0.0110566082722496,0.192911815723147,0.236253720150366,1.45137864687689e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0750822254046765,0.0038788166808642,-0.0826847060991704,-0.0674797447101827,2.26753897106064e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL10,C-X-C motif chemokine 10,42185,0.128001590661083,0.00661315537480296,0.11503980612647,0.140963375195697,2.34170741447547e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,APOE,Apolipoprotein E,39979,0.135331190407925,0.00703493552066429,0.121542716787423,0.149119664028427,3.50320876549076e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH9,Myosin-9,39966,0.219589269261117,0.0114203411156409,0.197205400674461,0.241973137847773,4.16684518764216e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0580890321104362,0.00302121354490804,0.0521674535624164,0.0640106106584559,4.27306507010674e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,C9,Complement component C9,39990,-0.11127940777308,0.00579320022781211,-0.122634080219592,-0.0999247353265682,5.93566879209084e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,HEG1,Protein HEG homolog 1,39736,0.0533125525427464,0.00277729220292615,0.0478690598250112,0.0587560452604817,8.03850378196231e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0490785986526434,0.00257429752360813,0.0440329755063714,0.0541242217989153,9.39697147665877e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL22,C-C motif chemokine 22,41991,0.0988565345144129,0.00520066441421663,0.0886632322625483,0.109049836766277,1.61282003318891e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAP1,Proline-rich acidic protein 1,39966,0.0747949602799443,0.00393061560352465,0.067090953697036,0.0824989668628526,1.68463589605787e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS1,Protein MTSS 1,39930,0.213346441866712,0.0112188409561549,0.191357513592649,0.235335370140776,2.12233080315947e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,TJAP1,Tight junction-associated protein 1,42181,0.158313375200796,0.00834173848638477,0.141963567767482,0.17466318263411,2.72129615969131e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0716836000819855,0.00377733492587327,0.0642800236272739,0.0790871765366971,2.8344830458818e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.0986804024143096,0.00520930827509737,0.0884701581951187,0.1088906466335,5.30090438939957e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,IL16,Pro-interleukin-16,42296,0.0802842544798936,0.00425010187431302,0.07195405480624,0.0886144541535471,1.37240812139169e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,42119,0.0811356281722446,0.00429928785429638,0.0727090239778237,0.0895622323666655,1.97333263899501e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,STAB2,Stabilin-2,39966,0.0533316347893353,0.00282646592451659,0.0477917615772828,0.0588715080013879,3.21832340895816e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0561127887600893,0.00298241515109203,0.0502672550639489,0.0619583224562297,5.49548467185447e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,42070,0.127495030892858,0.00677631496705917,0.114213453557422,0.140776608228294,5.69037024915038e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0619570637811618,0.00329370223066507,0.0555014074090583,0.0684127201532654,6.12865284369882e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,MLN,Promotilin,42119,0.167994619356376,0.00896769580868526,0.150417935571353,0.185571303141399,2.51757789806568e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.215013915901716,0.0114844972964391,0.192504301200695,0.237523530602736,4.9250439086109e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,39736,0.143711195053264,0.00769032014074276,0.128638167577408,0.15878422252912,9.32352898359974e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,BTD,Biotinidase,39979,0.0385959491209297,0.00206928838331776,0.0345401438896269,0.0426517543522325,1.67891671271191e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRL,Appetite-regulating hormone,42145,0.154972529908781,0.00834605788121064,0.138614256461608,0.171330803355954,5.07646952019031e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,F9,Coagulation factor IX,42199,0.0341065195991419,0.00184325350252086,0.030493742734201,0.0377192964640828,1.63327735968092e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.186061532830612,0.010043417246364,0.166376435027738,0.205746630633485,1.65965341636224e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA1,Glutathione S-transferase A1,42119,0.156836427007366,0.00850603279127472,0.140164602736467,0.173508251278264,5.36899576268446e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL5,C-X-C motif chemokine 5,42101,0.207588392216525,0.0113056344936595,0.185429348608952,0.229747435824097,2.14402804533661e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS2,Protein MTSS 2,39919,0.185227461576065,0.0101131862873396,0.165405616452879,0.20504930669925,7.23617323050382e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL17,C-X-C motif chemokine 17,42296,0.0782274822908943,0.00428284728215494,0.0698331016178706,0.086621862963918,1.1684401363567e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM1,Isthmin-1,42119,0.0722076404109698,0.00396748419831157,0.0644313713822792,0.0799839094396605,3.85590625313152e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY1,Aminoacylase-1,42145,0.114923598444014,0.00631578930102614,0.102544651414003,0.127302545474026,4.09714564073221e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.132105495530277,0.00726931303701,0.117857641977737,0.146353349082817,6.3282120532958e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFC,Vascular endothelial growth factor C,42181,0.100816800990363,0.00556650796384362,0.0899064453812299,0.111727156599497,1.84426215523539e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP10,Stromelysin-2,42124,-0.104832025049456,0.0057917598229401,-0.116183874302419,-0.0934801757964936,2.26442299981921e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFC,Platelet-derived growth factor C,41843,0.0507949081540168,0.0028071303923135,0.0452929325850823,0.0562968837229513,2.58887889867399e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.163744842057317,0.0090510094060329,0.146004863621492,0.181484820493141,2.70063111428423e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,CKB,Creatine kinase B-type,39966,-0.104599032940106,0.00578294365158861,-0.115933602497219,-0.0932644633829921,4.08488559263844e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,41997,0.0418267374114054,0.0023191046341448,0.0372812923284816,0.0463721824943292,7.21629445178223e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.110843578929876,0.0061551413330249,0.098779501917147,0.122907655942605,1.19816577701977e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,TCTN3,Tectonic-3,39958,0.0551845901242001,0.00306159292513346,0.0491838679909386,0.0611853122574617,1.23414517374008e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,DAB2,Disabled homolog 2,42262,0.20063286673574,0.0111445892951853,0.178789471717176,0.222476261754303,1.2451230003712e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP20,Centrosomal protein 20,41843,0.135633752227344,0.00755713897540585,0.120821759835548,0.150445744619139,3.47536561757401e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,EHBP1,EH domain-binding protein 1,39958,0.135545903904381,0.00754627008592715,0.120755214535964,0.150336593272798,3.71665365621895e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0707935976520617,0.00394940095465653,-0.0785344235231885,-0.0630527717809349,4.95598724684309e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL17,C-C motif chemokine 17,42107,0.164733327179126,0.00919354859778597,0.146713971927465,0.182752682430786,5.6125079337227e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZN,Kazrin,39930,0.189454735161664,0.0105709163339124,0.168735739147196,0.210173731176132,7.48776276867464e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.190998661065052,0.0106896725921898,0.17004690278436,0.211950419345744,1.3647819731943e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.193961189868736,0.0108463614653332,0.172702321396683,0.215220058340789,1.48865915347545e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,42185,0.225100273121523,0.0126037434074232,0.200396936042973,0.249803610200072,1.55037253292425e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.130715376927461,0.00733142453502913,0.116345784838804,0.145084969016118,2.62159477348602e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPC,C-type natriuretic peptide,42119,0.0942366337603681,0.00528887432676343,0.0838704400799117,0.104602827440824,3.25392940757759e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.194876651163822,0.0109803158544439,0.173355232089112,0.216398070238532,1.558917754824e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,C1S,Complement C1s subcomponent,39979,0.0377803067007929,0.00213106172256783,0.0336034257245599,0.0419571876770259,2.16183374933665e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.14008964024082,0.00790839065380694,0.124589194559358,0.155590085922282,2.80698555908069e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,CD63,CD63 antigen,41992,0.0897556006588792,0.00507578278860121,0.0798070663932209,0.0997041349245376,3.45412364571169e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK1,Dickkopf-related protein 1,42249,0.104745554745206,0.00592621799798909,0.0931301674691477,0.116360942021265,3.84804887960378e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,AXIN1,Axin-1,42119,0.171441160335034,0.00970296581656095,0.152423347334574,0.190458973335493,4.34170615801085e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.196479975829253,0.011126802280645,-0.218288508299317,-0.174671443359189,5.20663889351702e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,CREG1,Protein CREG1,41960,0.0717101715107599,0.00406192849348934,0.0637487916635208,0.079671551357999,5.7211147448351e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.177009324751842,0.010056772974189,0.157298049722432,0.196720599781253,1.4057388890356e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,ADIPOQ,Adiponectin,39979,-0.122494775382232,0.00695894784625639,-0.136134313160894,-0.108855237603569,1.89680039545842e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.144126454933097,0.00820079299217961,0.128052900668425,0.160200009197769,2.17433108620503e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL3,C-X-C motif chemokine 3,42129,0.16823252747823,0.0095884322772733,0.149439200214774,0.187025854741686,3.66328848013082e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK10,Kallikrein-10,42138,0.0721143328936078,0.00411039001455389,0.0640579684650822,0.0801706973221334,3.72019347376635e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,DPY30,Protein dpy-30 homolog,42216,0.106004382365963,0.00604517928267168,0.0941558309719268,0.11785293376,4.30425898869628e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0647480642864258,0.00370279738922101,0.0574905814035526,0.072005547169299,1.01897308322531e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,TPD52L2,Tumor protein D54,39736,0.192140626958412,0.0109941428420048,0.170592106988083,0.213689146928742,1.71121261556285e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,41839,0.138732093143149,0.00794704067103962,0.123155893427911,0.154308292858387,1.73035159846888e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP5,Retinol-binding protein 5,42070,0.0987770014925695,0.0056632553259833,0.0876770210536422,0.109876981931497,2.18489635924508e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF1,Pigment epithelium-derived factor,39815,0.0462755161312225,0.00265285798329629,0.0410759144839618,0.0514751177784832,2.96079794387624e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,STC1,Stanniocalcin-1,42249,0.0800237110382279,0.0046082121092456,0.0709916153041065,0.0890558067723493,7.86567517862908e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,42145,0.0541639657438595,0.00312080507223006,0.0480471878022886,0.0602807436854304,9.39448367450323e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.148733413491201,0.00855908778918202,0.131957601424405,0.165509225557998,9.45328755260719e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,CPM,Carboxypeptidase M,42195,0.0591283105677659,0.00342049119381844,0.0524241478278817,0.06583247330765,3.03233203271893e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,CD6,T-cell differentiation antigen CD6,42284,0.0905804604961287,0.00524520733093384,0.0802998541274984,0.100861066864759,4.02519125056577e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,RTBDN,Retbindin,42070,0.0519938663700622,0.00301655112759443,0.0460814261599771,0.0579063065801473,7.21769849454025e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.169430546826279,0.00983468338176697,0.150154567398016,0.188706526254543,8.31080321965285e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS15,Enteropeptidase,42070,0.152198889136752,0.00884734474474501,0.134858093437051,0.169539684836452,1.26987468904697e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,MINK1,Misshapen-like kinase 1,39929,0.161834353865596,0.00940226294528341,0.143405918492841,0.180262789238352,1.46034590391472e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,DCXR,L-xylulose reductase,42181,0.0937800480846411,0.00545762202014205,0.0830831089251627,0.10447698724412,1.7409987167045e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R2,Interleukin-1 receptor type 2,42100,0.034595233830273,0.00201367963627336,0.0306484217431772,0.0385420459173688,1.85523436387529e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,TXLNA,Alpha-taxilin,42016,0.152070882146342,0.00886126916027556,0.134702794592202,0.169438969700482,2.57278740556415e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,42181,0.0386303863066453,0.00226332514635965,0.0341942690197804,0.0430665035935102,1.21154802306354e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.113573742394691,0.00665601079756802,0.100527961231458,0.126619523557924,1.76453252740593e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.0901262152850911,0.00529115088076259,0.0797555595587965,0.100496871011386,2.20339367891808e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0574079015854312,0.00337365586718274,-0.0640202670851094,-0.050795536085753,2.82677879222329e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.142263247478571,0.00838249441026617,0.125833558434449,0.158692936522693,8.44015128998991e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.069613415694626,0.00410477194618545,0.0615680626801025,0.0776587687091495,1.00401596633782e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",41839,0.0861549404480019,0.00508717374118421,0.0761840799152808,0.0961258009807229,1.1468179893265e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL5,C-C motif chemokine 5,42217,0.171908047007535,0.0101584056371818,0.151997571958659,0.191818522056412,1.36440262952067e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,NFX1,Transcriptional repressor NF-X1,39575,0.11544751435897,0.0068214654223681,0.102077442131129,0.128817586586812,1.89872683644585e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.112931511227314,0.00668571906402744,0.0998275018618202,0.126035520592808,2.39150299957845e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC5,Glypican-5,42016,0.0956935913574468,0.00567281251653971,0.084574878825029,0.106812303889865,3.41478003691499e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0566381080900814,0.00335801383045547,0.0500564009823887,0.0632198151977741,3.50616261413745e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,HJV,Hemojuvelin,39934,0.0717324800911862,0.00424913687909789,0.0634041718081544,0.0800607883742181,3.62037721158419e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0472211910090695,0.0028001779604068,0.0417328422066722,0.0527095398114669,3.67866883012604e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,ARF6,ADP-ribosylation factor 6,39930,0.185097356858923,0.0109716522584978,0.163592918432267,0.206601795285579,4.35529189833252e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.12400994450481,0.00737157020971424,0.10956166689377,0.138458222115849,7.46334130406667e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,F2,Prothrombin,39979,0.0253064040806862,0.00150388730514488,0.0223587849626022,0.0282540231987702,8.81298657822217e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNA4,Plexin-A4,42119,0.136103912324214,0.00809680359486504,0.120234177278279,0.151973647370149,8.99855912785296e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.16036548338743,0.00955578117476572,0.141636152284889,0.179094814489971,1.40879868735795e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP85,Centrosomal protein of 85 kDa,41843,0.109993067789509,0.006553774521055,0.0971476697282411,0.122838465850777,1.43431485030786e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL16,C-C motif chemokine 16,42310,0.0866509146509924,0.0051689429783019,0.0765197864135207,0.0967820428884642,1.8790387677572e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP5,Microfibrillar-associated protein 5,42310,0.0682855488740106,0.0040737973521234,0.0603009060638487,0.0762701916841724,1.92996262263116e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,NCK2,Cytoplasmic protein NCK2,42185,0.179692298733551,0.0107586789203771,0.158605288049612,0.200779309417491,5.25189397319899e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN1,Perilipin-1,41839,0.0569792085694401,0.00341235470169016,0.0502909933541274,0.0636674237847528,5.83340682569547e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.115559945558545,0.00691721929632074,0.102002195737756,0.129117695379334,6.85635778291849e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.142179212408186,0.0085134330990233,0.1254928835341,0.158865541282272,7.10835570110023e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBIN,Erbin,42070,0.172099568739091,0.0103197052013737,0.151872946544399,0.192326190933784,8.04881685161403e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0864977922531252,0.00518821524804059,0.0763288903669657,0.0966666941392848,1.12911147278159e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,39929,0.0810881018787264,0.00486983251352315,0.071543230152221,0.0906329736052318,1.59588262575475e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF2,Growth/differentiation factor 2,42145,0.059113747494498,0.00355938456768544,0.0521373537418346,0.0660901412471615,2.4680441487667e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0334743090455715,0.00201616965873537,0.0295226165144501,0.0374260015766928,2.69184251948969e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,42249,0.15958702260017,0.00961402983985401,0.140743524114056,0.178430521086283,2.80452046150773e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,SORD,Sorbitol dehydrogenase,42204,0.114813882391846,0.00691986214500317,0.10125095258764,0.128376812196052,3.18190844585525e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG16L1,Autophagy-related protein 16-1,39930,0.144551306656001,0.00870659550447704,0.127486379467226,0.161616233844776,3.52168487962722e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0878405890963822,0.00530665620538516,0.0774395429338272,0.0982416352589371,6.24013849739578e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP4,Dipeptidyl peptidase 4,41948,0.0465293209949784,0.00281330158249852,0.0410152498932813,0.0520433920966755,7.73093356378532e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,LEP,Leptin,42145,0.115608492413298,0.00700580112918988,0.101877122200085,0.12933986262651,1.3876606951204e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,39929,0.147333273674761,0.00892510875238096,0.129840060520095,0.164826486829428,1.63892377812421e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.187402350784206,0.0113799942868397,0.165097561982,0.209707139586412,2.41964086540771e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0468334704231265,0.0028532454606769,0.0412411093201998,0.0524258315260532,7.42274109809548e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,42016,0.0501316133659452,0.00305713526064977,0.0441396282550716,0.0561235984768187,7.51605622129426e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.182332579362149,0.0111310131603439,0.160515793567875,0.204149365156423,1.27638400013966e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0713562593715396,0.00435681014350275,0.0628169114902742,0.079895607252805,1.32618241244668e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R9B,Neurabin-2,42296,0.156039316132408,0.00955305374796108,0.137315330786405,0.174763301478412,2.06009321265832e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.169295310757117,0.0103916098444563,0.148927755461982,0.189662866052251,5.51503376273266e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.0803915557947139,0.00494112629187807,0.0707069482626329,0.0900761633267949,5.94439812382452e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF21,Fibroblast growth factor 21,42247,0.196405398437554,0.012095002034688,0.172699194449565,0.220111602425542,9.5576723552416e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0392685688394444,0.00241970123482931,0.0345259544191789,0.0440111832597098,1.13059148689363e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,C4BPB,C4b-binding protein beta chain,42181,0.0624490361954087,0.00384834838797673,0.0549062733549743,0.0699917990358431,1.14769251191742e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO1,Forkhead box protein O1,42119,0.141579367352065,0.00872655822570352,0.124475313229686,0.158683421474444,1.2212032619648e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,NPL,N-acetylneuraminate lyase,39958,0.0760789970370599,0.00468780780700269,0.0668908937353346,0.0852671003387852,1.42841671868289e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CMIP,C-Maf-inducing protein,39919,0.137321871995851,0.00846957850609667,0.120721498123902,0.1539222458678,1.83967687811327e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,SELP,P-selectin,42217,0.0910774825100566,0.00562385184098182,0.0800547329017323,0.102100232118381,1.92589155809112e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.146785600605364,0.00906923928137759,0.129009891613864,0.164561309596864,2.89200274415783e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,GLA,Alpha-galactosidase A,39713,0.0640459666677572,0.00396337576763958,0.0562777501631836,0.0718141831723308,4.46334000181091e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.206435877172931,0.0127977896659436,-0.23151954491818,-0.181352209427682,5.32405164312101e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,BCR,Breakpoint cluster region protein,42119,0.150015069170305,0.00930018199444738,0.131786712461188,0.168243425879421,5.4266837147437e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CES3,Carboxylesterase 3,42070,0.115477589494675,0.00716045983571557,0.101443088216672,0.129512090772678,5.73685128646483e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,SLA2,Src-like-adapter 2,39934,0.173810307436086,0.0107819322421957,0.152677720241383,0.19494289463079,8.03064812835042e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0452362037095963,0.00281181001333351,0.0397250560834626,0.0507473513357299,1.04690684959211e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.140531577791891,0.00875159246932323,0.123378456552017,0.157684699031764,2.16745628394685e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,F11R,Junctional adhesion molecule A,42137,0.090092906901696,0.00561736714129593,0.079082867304756,0.101102946498636,2.32934353643883e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0513295139475716,0.0032019932738726,0.0450536071307813,0.0576054207643619,2.61116561787147e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,42070,0.221011532213869,0.0138173343985608,0.19392955679269,0.248093507635048,4.62144594700502e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,UPB1,Beta-ureidopropionase,39958,0.146259775278951,0.00915199139949167,0.128321872135948,0.164197678421955,7.18943614390853e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,BECN1,Beclin-1,39638,0.0961193023689116,0.0060140697913014,0.0843317255779609,0.107906879159862,7.34753336082141e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,EZR,Ezrin,42249,0.0390911370897969,0.00244886044325052,0.0342913706210259,0.0438909035585679,7.55950098939273e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA5,Integrin alpha-5,42137,0.0399197648828909,0.00250723608572056,0.0350055821548786,0.0448339476109032,1.45740466380075e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.0926763190015221,0.00581462634372459,0.0812796513678219,0.104072986635222,1.46180111578191e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,42185,0.137405897137531,0.00863585388014034,0.120479623532456,0.154332170742606,1.71734408852726e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,42185,0.204538282160428,0.0128736495893629,0.179305928965277,0.229770635355579,2.46103585559188e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH2,Neutral ceramidase,42016,0.0848820722605408,0.00536371879697567,0.0743691834184685,0.0953949611026131,6.67332621043387e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN2,CCN family member 2,42146,0.0899774469455261,0.00569100008636015,0.0788230867762602,0.101131807114792,8.30645651396208e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK2,Docking protein 2,42145,0.19518572045185,0.0123841855509821,0.170912716771926,0.219458724131775,1.79742622062696e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFR,Epidermal growth factor receptor,42310,0.025392261380554,0.00161124136405369,0.0222342283070088,0.0285502944540992,1.81361535048457e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,FST,Follistatin,42166,0.0772277195002878,0.00491140473866319,0.067601366212508,0.0868540727880677,3.17289099690522e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE4,Ribonuclease 4,39645,0.0440755747497531,0.00280253358713497,0.0385826089189685,0.0495685405805376,3.905782422244e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,SEC31A,Protein transport protein Sec31A,39638,0.123148202622523,0.00783506245119527,0.10779148021818,0.138504925026866,4.52449425411135e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.110709691820909,0.00705556780021895,0.0968807789324801,0.124538604709338,5.40574630240656e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.16449997247576,0.0104851400133099,0.143949098049672,0.185050846901847,5.50189101562797e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,IKBKG,NF-kappa-B essential modulator,42119,0.144074095910957,0.00920918283180094,0.126024097560627,0.162124094261287,1.09005528169482e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.118227053201289,0.0075626775174918,0.103404205267005,0.133049901135573,1.6774004312295e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0964267948907478,0.00617982012719149,0.0843143474414525,0.108539242340043,2.05404757422053e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD7B,OTU domain-containing protein 7B,39934,0.0996318596598546,0.00639066557432967,0.0871061551341685,0.112157564185541,3.09868702138183e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,USO1,General vesicular transport factor p115,42070,0.139769091127527,0.00897791400766181,0.12217237967251,0.157365802582544,3.55301093720242e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBP2,Poly(rC)-binding protein 2,39934,0.114888166439214,0.00738194927686579,0.100419545856557,0.129356787021871,4.67271588516939e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,MME,Neprilysin,42070,0.122075660196018,0.00785177555796772,0.106686180102401,0.137465140289635,4.87254196549295e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A4,Protein S100-A4,42181,0.087789432532229,0.00564794630131431,0.0767194577816529,0.098859407282805,5.12951664391676e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,39930,0.151543569603268,0.0097540538381397,0.132425624080514,0.170661515126022,7.05503468382638e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,KHK,Ketohexokinase,39638,0.0990224565062345,0.00637722779390371,0.0865230900301833,0.111521822982286,8.36333516974519e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0712713829478812,0.00459079274136302,0.0622734291748097,0.0802693367209527,8.46010315130037e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.169583297257441,0.0109502537556342,0.148120799896398,0.191045794618484,1.50717027342055e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,39934,0.178901004498798,0.0115521992826761,0.156258693904753,0.201543315092843,1.51535703503366e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC3B,Tetranectin,39726,0.0329578755729975,0.00212912374002017,0.0287847930425579,0.037130958103437,1.71924006823545e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM20A,Pseudokinase FAM20A,39958,0.0439918362186564,0.00284608194899573,0.0384135155986248,0.0495701568386881,2.36160791520608e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLM2,Protein GOLM2,42249,0.0354002062724137,0.00229296957366454,0.0309059859080312,0.0398944266367962,2.54081366302248e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPK2,SRSF protein kinase 2,42119,0.132359676917079,0.00858065903614414,0.115541585206236,0.149177768627921,3.13890909759529e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.115922464572612,0.00751131240978959,0.101200292249424,0.1306446368958,3.51961720118987e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN1,Dynactin subunit 1,42262,0.0992759306567256,0.00644299754838558,0.0866476554618899,0.111904205851561,4.02225775401517e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.177676728664514,0.0115352664125565,0.155067606495903,0.200285850833125,5.38732436552657e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.113503994356902,0.00737974993086241,0.0990396844924118,0.127968304221392,7.80500557635582e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.106789998121837,0.00694671656189514,0.0931744336605224,0.120405562583151,8.77332025950609e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0869409041968087,0.00566532281691534,0.0758368714756547,0.0980449369179628,1.05299035712002e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.163872864269994,0.0106713133683361,0.142957090068056,0.184788638471933,1.10823508191748e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINH1,Serpin H1,39757,0.20009483505844,0.01303478283316,0.174546660705446,0.225643009411433,1.20517519710392e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,42119,0.0516610271038417,0.00337200715594335,0.0450518930781927,0.0582701611294907,1.53918125641644e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.098158851113465,0.00642649833436684,0.085562914378106,0.110754787848824,3.17007781468152e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,THPO,Thrombopoietin,41900,0.0601120751269678,0.00393601527026793,0.0523974851972426,0.0678266650566929,3.24133976975969e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0880362842816711,0.00575952389528214,0.0767476174469181,0.0993249511164241,3.27902703878978e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,F11,Coagulation factor XI,39822,0.0486365240588686,0.00318777651249599,0.0423884820943765,0.0548845660233608,4.90044418903725e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SCLY,Selenocysteine lyase,42224,0.074730490562126,0.00490713324403038,0.0651125094038264,0.0843484717204255,6.08031299297155e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.171663487346778,0.0112822115027807,0.149550352801328,0.193776621892228,7.5761876629805e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.131067650812191,0.00861801404729329,0.114176343279496,0.147958958344886,1.03555764984238e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH2,Cadherin-2,42145,0.0540512419296775,0.00355854265967256,0.0470764983167193,0.0610259855426357,1.11165606210907e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99L2,CD99 antigen-like protein 2,42137,0.0376377420793927,0.00248194166740489,0.0327731364112791,0.0425023477475062,1.60614108305115e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN2,Prorelaxin H2,39709,0.0791359213869924,0.00521526638580726,0.0689139992708102,0.0893578435031747,1.72567816148803e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,NUCB2,Nucleobindin-2,42231,0.0572492401352018,0.00378032719447748,0.0498397988340259,0.0646586814363776,2.17319940263054e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.149336413174833,0.00986786067953666,0.129995406242941,0.168677420106725,2.52648779493957e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP23,Synaptosomal-associated protein 23,42145,0.132607952618936,0.00876227826389979,0.115433887221693,0.14978201801618,2.54020473132789e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0752952169472606,0.00497691457421,0.065540464381809,0.0850499695127122,2.80011230377024e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6A,Ras-related protein Rab-6A,42119,0.0676341415685269,0.00447528585227734,0.0588625812980633,0.0764057018389905,3.49022470082996e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,RILPL2,RILP-like protein 2,39958,0.151134605367339,0.00999269285152118,0.131548927378357,0.17072028335632,3.51292897266345e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,RGCC,Regulator of cell cycle RGCC,39934,0.117156775113987,0.00774685162098639,0.101972945936853,0.13234060429112,3.59367073844861e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINC1,Antithrombin-III,39959,0.0221749279507281,0.00146689239241909,0.0192998188615866,0.0250500370398695,3.93156904614714e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3F,Semaphorin-3F,42145,0.0406154353018806,0.00268918353106045,0.0353446355810021,0.0458862350227591,4.0174640152037e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,FUOM,Fucose mutarotase,39736,0.098576380406342,0.00653240622387083,0.0857728642075552,0.111379896605129,5.96997172541917e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD1,Sushi domain-containing protein 1,41900,0.0740878567015935,0.00491478913847696,0.0644548699901786,0.0837208434130083,6.27765245968991e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.129520470936415,0.00859382642270034,0.112676571147922,0.146364370724908,6.6045779212792e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0960573075466458,0.00637368406443757,0.0835648867803482,0.108549728312943,6.64549794250868e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,39575,0.0927798740878438,0.00615097950197226,0.0807239542639781,0.104835793911709,6.69650840662077e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0589409725579032,0.00392026804832636,0.0512572471831836,0.0666246979326229,1.10036923358444e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,SPOCK1,Testican-1,42016,0.0395760923134139,0.00263616145158485,0.0344092158683076,0.0447429687585202,1.55726741069334e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP4,Secreted frizzled-related protein 4,39736,0.0609080092097831,0.00405486906518854,0.0529604658420136,0.0688555525775527,1.6698902266599e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,42137,-0.060268588114294,0.00401980843313239,-0.0681474126432335,-0.0523897635853546,2.07328582828893e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.0986183924133503,0.00658084015348618,0.0857199457125174,0.111516839114183,2.35469153365601e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.0843421709058057,0.00562855877285495,0.0733101957110101,0.0953741461006014,2.38023325660416e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,41900,0.0531170973831421,0.00355152114084786,0.0461561159470803,0.0600780788192039,3.6294225090154e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2B3,SH2B adapter protein 3,41843,0.14855477022337,0.00994172203468603,0.129068995035385,0.168040545411355,4.4540592633042e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.154368066911219,0.0103352412128522,0.134110994134029,0.174625139688409,4.77875589238621e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR5,Complement factor H-related protein 5,39864,0.0630321487790885,0.00421911675099675,0.0547626799471349,0.0713016176110421,5.47063037029194e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,OPHN1,Oligophrenin-1,39929,0.163964424059261,0.01098055834676,0.142442529699612,0.185486318418911,6.06254621205367e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.142887942333314,0.00957655972977375,0.124117885262957,0.161657999403671,6.08553085957535e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,39958,0.137775461704294,0.00924218235872257,0.119660784281198,0.155890139127391,8.73118927786267e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.164035295915755,0.0110265409135963,0.142423275725106,0.185647316106404,1.15327741224986e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL13,C-C motif chemokine 13,42275,0.102189153193856,0.00687608539278636,0.0887120258239945,0.115666280563717,1.42672832676459e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA2,Apolipoprotein A-II,39990,-0.0742554450332057,0.00499883601595164,-0.0840531636244709,-0.0644577264419405,1.88507726998692e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.0817592921475998,0.00551614831504331,0.0709476414501149,0.0925709428450847,2.63982332586769e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.153965804847008,0.0103922403141796,0.133597013831216,0.1743345958628,3.3565946982357e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC4,Syndecan-4,42145,0.0706305862838845,0.00477865868713004,0.0612644152571097,0.0799967573106594,4.72144787728567e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.117078888596262,0.00791704741372075,0.101561475665369,0.132596301527154,4.9935999995734e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,39657,0.145134483750967,0.00982887582871934,0.125869887126677,0.164399080375257,7.06668885132967e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.116817785936557,0.00792042141599369,0.101293759961209,0.132341811911905,8.84352872117293e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,39736,0.123971099530186,0.00842740449475978,0.107453386720457,0.140488812339915,1.57400479988996e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,AAMDC,Mth938 domain-containing protein,39638,0.0789333012438373,0.00536674631344026,0.0684144784694944,0.0894521240181803,1.65004360164913e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,FETUB,Fetuin-B,42199,0.0477282664115106,0.0032485075598887,0.0413611915941288,0.0540953412288925,1.69739930732565e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRN,Agrin,42185,0.0531368142410943,0.00361775840913631,0.0460460077591871,0.0602276207230014,1.81613557066036e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,42310,0.0985129930421132,0.00671024683156842,0.0853609092522391,0.111665076831987,1.98906436897929e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D23,TBC1 domain family member 23,42070,0.133350360096078,0.00909286577660778,0.115528343173927,0.151172377018229,2.53161957595787e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.103690418999204,0.00707151041618416,0.0898302585834832,0.117550579414925,3.06966338271689e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PAXX,Protein PAXX,39736,0.0687928528723929,0.00469238145209876,0.0595957852262793,0.0779899205185065,3.2422094909562e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.114597583188076,0.00782935137713564,0.0992520544888905,0.129943111887262,3.82378914390489e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0815691285342963,0.0055826583824912,0.0706271181046135,0.092511138963979,5.47362279305968e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.133871480333957,0.00915951043475407,0.115918839881839,0.151824120786075,6.09714139155335e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2AP,CD2-associated protein,42145,0.092847686029811,0.00636721161444983,0.0803679512654893,0.105327420794133,8.39687069097749e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,FAP,Prolyl endopeptidase FAP,42310,0.0405386235001807,0.00278080916016122,0.0350882375462647,0.0459890094540967,8.82836231814071e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.149684887883336,0.0102684525115578,0.129558720960682,0.169811054805989,9.03859845513938e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PLSCR3,Phospholipid scramblase 3,39911,0.0851904875185274,0.00584326469159574,0.0737376887229998,0.0966432863140551,1.02998340653331e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,39934,0.17503112026368,0.0120145552413952,0.151482591990546,0.198579648536815,1.20409347538086e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,DBNL,Drebrin-like protein,42185,0.136026401725069,0.00935583938168817,0.117688956536961,0.154363846913178,1.55525059221556e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA11,Annexin A11,42087,0.0971365459324807,0.00668171844368655,0.084040377782855,0.110232714082106,1.59947425981588e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0453974705380454,0.00312327815236984,-0.0515190957166902,-0.0392758453594005,1.96872829690763e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.181457401282561,0.0125079337302743,0.156941851171224,0.205972951393899,2.52642425660323e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3B1,AP-3 complex subunit beta-1,39930,0.113103625269394,0.00780623061238749,0.0978034132691145,0.128403837269673,3.75601657975637e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX2,Heme oxygenase 2,41839,0.0697784063780492,0.00481928666296405,0.0603326045186396,0.0792242082374587,3.76900992118815e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.122823528721798,0.00848079211566774,0.10620117617509,0.139445881268507,4.1158437338396e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB1,BPI fold-containing family B member 1,42098,-0.0945182215538156,0.00653544079787681,-0.107327685517654,-0.0817087575899771,4.70420736442584e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7,Interleukin-7,42119,0.0941632527526349,0.0065164804395947,0.0813909510910293,0.106935554414241,5.60955742233071e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.170221419279485,0.0117983580684462,0.14709663746533,0.193346201093639,7.75485792799737e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.112497348717924,0.00780075914627558,0.0972078607912241,0.127786836644624,9.82033763978007e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK13,Kallikrein-13,41839,0.06521480600307,0.00452818829877439,0.0563395569374722,0.0740900550686678,1.13255700982397e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON2,Spondin-2,42070,-0.0507263646643323,0.00352412584920272,-0.0576336513287697,-0.043819077999895,1.25078996080326e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,BACH1,Transcription regulator protein BACH1,42119,0.108822148737872,0.00756810804617877,0.0939886569673611,0.123655640508382,1.54382667878984e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.15314290082781,0.0106514557797737,0.132266047499453,0.174019754156166,1.58050672506642e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY4,Protein canopy homolog 4,42070,0.109098181345157,0.00758879211629252,0.0942241487972238,0.12397221389309,1.61156079114379e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,APOL1,Apolipoprotein L1,39990,0.0777220146555291,0.00540795676026218,0.0671224194054152,0.088321609905643,1.98000823337228e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD5,Programmed cell death protein 5,42249,0.082956229679757,0.00577963790415643,0.0716281393876104,0.0942843199719036,2.21326220591383e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0331301222484688,0.0023082578959446,0.0286059367724174,0.0376543077245203,2.23471249882781e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,41900,0.111533647247634,0.00777079834273848,0.0963028824958669,0.126764411999402,2.26700236311302e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.117897466164519,0.00820958914049156,0.101806671449155,0.133988260879882,2.31958363819317e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,AZI2,5-azacytidine-induced protein 2,39934,0.0808625184962029,0.00563213106373485,0.0698235416112826,0.0919014953811232,2.4405889260472e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.137689587468912,0.00961158429641875,0.118850882247932,0.156528292689893,3.35092016969276e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18R1,Interleukin-18 receptor 1,42296,0.0477743215909732,0.00333668534508585,0.0412344183146049,0.0543142248673414,3.64241616155933e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,STK11,Serine/threonine-protein kinase STK11,41900,0.10552953126028,0.00737458435042979,0.0910753459334377,0.119983716587122,4.17290130719615e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0478800084546002,0.0033475502522925,0.0413188099601069,0.0544412069490935,4.51975990568459e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.150066263477097,0.010498054863764,0.129490075944119,0.170642451010074,5.09250432996997e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.0768991145917526,0.00538700953380775,0.0663405759054894,0.0874576532780158,7.83264950657716e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0607092021752637,0.00426435190362703,0.0523510724441547,0.0690673319063727,1.15510887782244e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.093077184488534,0.0065380621833485,0.0802625826091709,0.105891786367897,1.15951759511125e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0738515894179759,0.00518401606529118,0.0636909179300052,0.0840122609059466,1.20737097929103e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,MITD1,MIT domain-containing protein 1,42016,0.138875512053987,0.00975909773108277,0.119747680501065,0.158003343606909,1.27465587591429e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,IST1,IST1 homolog,39850,0.142099200204328,0.00997902465560149,0.122540311879349,0.161658088529307,1.29125060747297e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.153277975149553,0.0107852165641526,0.132138950683813,0.174416999615292,1.8987489296546e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",41900,0.133244898956038,0.00938289016422077,0.114854434234165,0.151635363677911,1.94400813712508e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,42217,0.0660964169820235,0.00466564251429043,0.0569517576540142,0.0752410763100327,3.08840580024689e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,DNMBP,Dynamin-binding protein,42016,0.0864720605696974,0.00612571115528877,0.0744656667053314,0.0984784544340633,6.32217371613877e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP43,Centrosomal protein 43,41797,0.100402908475109,0.00711591835119313,0.0864557085067709,0.114350108443448,7.02044860333173e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,EREG,Proepiregulin,41997,0.11427308644577,0.00810688656424267,0.0983835887798545,0.130162584111686,8.42060286319606e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.100862771712466,0.00716439087455647,0.0868205655983354,0.114904977826597,1.07921804279503e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,SHBG,Sex hormone-binding globulin,39990,-0.0668327164510186,0.00474568191317634,-0.0761342530008442,-0.0575311799011929,1.14655648796729e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0770066952436312,0.00546794771774138,0.0662895177168581,0.0877238727704043,1.15998063663099e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.126422074556584,0.00899306099870758,0.108795674999117,0.14404847411405,1.63277371753844e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB3,Plexin-B3,42099,0.0681133882260227,0.00485420388925857,0.0585991486030759,0.0776276278489695,2.04149190408017e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP2,Methionine aminopeptidase 2,42247,0.0788767034432453,0.00563056289912803,0.0678408001609543,0.0899126067255362,2.79471793176918e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.0939533905151248,0.00670330819978131,0.0808149064435534,0.107091874586696,2.9126610257779e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT,Linker for activation of T-cells family member 1,42296,0.107133930047832,0.00765985863962775,0.0921206071141614,0.122147252981502,3.79610169458916e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,SYTL4,Synaptotagmin-like protein 4,39958,0.102876667742455,0.0073659014912635,0.0884395008195785,0.117313834665331,5.75283707073399e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR,GMP reductase 1,42296,0.0671311373910822,0.00481205745216907,0.0576995047848308,0.0765627699973335,6.23098640512157e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,BID,BH3-interacting domain death agonist,42119,0.0932609741119159,0.00668648623484716,0.0801554610916155,0.106366487132216,6.54694283539845e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSB,Arylsulfatase B,42070,0.0782339343858533,0.00561010629841633,0.0672381260409573,0.0892297427307493,6.79436276260786e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX15,Sorting nexin-15,39736,0.0764139272453882,0.00547547412776458,0.0656819979549697,0.0871458565358068,6.80048926802954e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,LYN,Tyrosine-protein kinase Lyn,42070,0.119442219960895,0.00857304632514125,0.102639049163618,0.136245390758171,8.11738250802194e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,APPL2,DCC-interacting protein 13-beta,39736,0.159058967442331,0.011460797077888,0.13659580516967,0.181522129714991,1.96425926530975e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,DAG1,Dystroglycan,42185,0.0664349523823324,0.00479410185540697,0.0570385127457348,0.0758313920189301,2.25593271850104e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCC,Tubulin-specific chaperone C,42016,0.112584897374138,0.00812445214939082,0.096660971161332,0.128508823586944,2.27844917700223e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,C19orf12,Protein C19orf12,41839,0.0933331747472368,0.00673687429983491,0.0801289011195604,0.106537448374913,2.41115273673146e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0358944106966693,0.00259442685941327,0.0308093340522193,0.0409794873411193,3.07597296101163e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.0927637361336901,0.00670642394533907,0.0796191452008256,0.105908327066555,3.26066355249751e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CRKL,Crk-like protein,42143,0.147306107820765,0.0106525053823955,0.12642719727127,0.16818501837026,3.38096160670678e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT2,Omega-amidase NIT2,39903,0.102081771283789,0.00738929633352613,0.0875987504700778,0.1165647920975,4.64080497037971e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0742867099764458,0.00538287639662679,0.0637362722390573,0.0848371477138344,5.01953963411092e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,42166,0.072733042640721,0.00527203361366631,0.062399856757935,0.083066228523507,5.25492875184207e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,HS1BP3,HCLS1-binding protein 3,39638,0.127799254217105,0.00925914257909286,0.109651334762083,0.145947173672127,5.59647263378035e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,39736,0.107707688149012,0.00781923772614577,0.0923819822057664,0.123033394092258,8.11481109597729e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,BRAP,BRCA1-associated protein,39813,0.153657955826922,0.0111574166809676,0.131789419132226,0.175526492521618,8.39343971854163e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,MSTN,Growth/differentiation factor 8,41900,0.0751219606139311,0.00546062035734017,0.0644191447135443,0.0858247765143178,9.06619121880467e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CTBS,Di-N-acetylchitobiase,39860,0.0383810445268877,0.00279080684031646,0.0329110631198674,0.0438510259339079,1.08559649837298e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",42107,0.151952982336073,0.0110629879492261,0.13026952595559,0.173636438716556,1.20749865541739e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS6,Growth arrest-specific protein 6,42236,-0.0350189907672846,0.00255046765898345,-0.0400179073788922,-0.0300200741556771,1.28176499327076e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.099663370990702,0.00725862930309881,0.0854364575566283,0.113890284424776,1.28670289985226e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC27,Cell division cycle protein 27 homolog,41843,0.0845012130564876,0.00615456225740944,0.0724382710319651,0.0965641550810101,1.31676532160358e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,42181,0.0343044945284189,0.00249906610414838,0.0294063249642881,0.0392026640925498,1.34771965936371e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GTPBP2,GTP-binding protein 2,39649,0.114247559644595,0.00831652441436895,0.0979471717924321,0.130547947496758,1.35571368859971e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,39990,0.101818589661813,0.00742783552399291,0.0872600320347867,0.116377147288839,1.98110842772724e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF19,Fibroblast growth factor 19,42185,0.107478872164841,0.0078483589843851,0.0920960885554465,0.122861655774236,2.0956674347361e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.131832783081943,0.00962644765508143,0.112964945677983,0.150700620485902,2.1127995999872e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.126289483871107,0.0092164925221733,0.108225158527648,0.144353809214567,2.17392472456286e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,AMN,Protein amnionless,41913,0.0653725641749961,0.00477581833350614,0.0560119602413241,0.0747331681086681,2.30961065804291e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0564338864019945,0.00412831125173744,0.0483423963485891,0.0645253764553999,2.95008329692776e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,39990,0.0370534731417124,0.0027091402815923,0.0317435581897915,0.0423633880936333,2.99418529145926e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MGLL,Monoglyceride lipase,42166,0.120390567494927,0.00881321887865281,0.103116658492767,0.137664476497086,3.33602368305111e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,KLB,Beta-klotho,41839,-0.103032391652778,0.00754353531046044,-0.117817720861281,-0.088247062444276,3.4752127189516e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0866567289529249,0.00634099113857414,0.0742283863213196,0.0990850715845302,3.48603445213301e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,AFP,Alpha-fetoprotein,41976,0.0899323001834631,0.00658873739101714,0.0770183748970695,0.102846225469857,3.8978557824387e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP2B,DNA topoisomerase 2-beta,39657,0.111468593338509,0.00816504706456573,0.0954651010919607,0.127472085585058,4.31071638984206e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.104691744991392,0.00768932678476365,0.0896206644932557,0.119762825489529,6.22794533893697e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.108025314231084,0.00793599128678258,-0.123579857153177,-0.0924707713089897,6.39771931641258e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GASK1A,Golgi-associated kinase 1A,39575,0.0590551209946833,0.00433494118376554,0.0505586362745028,0.0675516057148637,6.39908562801102e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,39657,0.121613271690321,0.00893156637562883,0.104107401594088,0.139119141786553,6.98481398187237e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBPL,FK506-binding protein-like,39930,0.081886575942,0.00601725809230152,0.070092750081089,0.093680401802911,7.58521448665431e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,TAX1BP1,Tax1-binding protein 1,39929,0.0855063422851203,0.00629389775613349,0.0731703026830987,0.0978423818871419,1.03394105607829e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM13A,Protein FAM13A,39930,0.0935745800126521,0.00688868524617591,0.0800727569301473,0.107076403095157,1.05898921105126e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,MAX,Protein max,41839,0.145063840873216,0.010714658427417,0.124063110355479,0.166064571390953,1.74184520122007e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0438294920720469,0.00323609800941603,0.0374867399735915,0.0501722441705023,1.84381859394741e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM5,Tripartite motif-containing protein 5,42119,0.118549313393977,0.00876560027859609,0.101368736847928,0.135729889940025,2.08700716216126e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,STAMBP,STAM-binding protein,41997,0.0861467200445569,0.00637021943271367,0.0736610899564381,0.0986323501326757,2.12786783416663e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM17,Splicing factor 45,39934,0.105437965737325,0.00779299768820269,0.0901636902684473,0.120712241206202,2.18359238618957e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0877211661731856,0.00649005335113846,0.0750006616049542,0.100441670741417,2.61977383365695e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.098626198936038,0.00731292572203524,0.0842928645208489,0.112959533351227,3.8976080398214e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0682602606206264,0.00507191520664481,0.0583193068156026,0.0782012144256503,5.73458337389853e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,39736,0.172540348953743,0.0128236323064576,0.147406029633086,0.1976746682744,6.01652308214021e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,MYDGF,Myeloid-derived growth factor,39958,0.135629416761341,0.0100826302062689,0.115867461557054,0.155391371965628,6.18013466376858e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN2,Matrilin-2,42144,0.0402421187309685,0.00299502563614661,0.0343718684841211,0.0461123689778158,6.76905373860842e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PENK,Proenkephalin-A,39736,0.0423156182033444,0.00314838504765949,0.0361447835099318,0.048486452896757,7.29223512434345e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ANG,Angiogenin,42152,0.0443578456039186,0.00331467715610808,0.0378610783779468,0.0508546128298904,1.38938055562767e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD1,COMM domain-containing protein 1,39638,0.0828802581075155,0.00619119855311608,0.070745508943408,0.095015007271623,1.49544672401572e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0659908314888918,0.00492997358775535,0.0563280832568913,0.0756535797208923,1.5096147015817e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TWF2,Twinfilin-2,39966,0.115515364473646,0.00863280873643918,0.0985950593502248,0.132435669597066,1.58202019114171e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,42310,0.0309761185932747,0.00231712014719067,0.026434563104781,0.0355176740817684,1.65928624508064e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,HEXIM1,Protein HEXIM1,42119,0.108752792317613,0.00815366321108562,0.092771612423885,0.124733972211341,2.5049849383439e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR4,Complement factor H-related protein 4,39945,0.0991071842435795,0.00742899531257122,0.0845463534309399,0.113668015056219,2.70228302729204e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0545383973464907,0.00409233054419928,0.0465174294798601,0.0625593652131213,2.92081354999466e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLGA3,Golgin subfamily A member 3,39934,0.105006554100823,0.00787469043718471,0.0895721608439406,0.120440947357705,2.92321509851081e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0506781026127297,0.00380289781860308,0.0432244228882677,0.0581317823371918,3.31095460020529e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.0976906576921553,0.007342702096498,0.0832989615830193,0.112082353801291,3.89834001699568e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC4,Apical endosomal glycoprotein,39919,0.0763139485208554,0.00573402042486688,0.0650752684881163,0.0875526285535944,4.10713747652277e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK1,Docking protein 1,39929,0.184727630783513,0.0139209592645446,0.157442550625005,0.21201271094202,6.87792944897631e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,41843,0.121292376116511,0.00916215751478259,0.103334547387537,0.139250204845485,9.41646316091319e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4D,Semaphorin-4D,42249,0.0401941304291989,0.00303988816898422,0.0342359496179899,0.046152311240408,1.14467274780802e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.111785095028986,0.00846223701160968,0.0951991104862312,0.128371079571741,1.35628420981319e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PMVK,Phosphomevalonate kinase,41832,0.14494136991965,0.0109718584199964,0.123436527416457,0.166446212422843,1.36272889569116e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0809357030782597,0.00614827984893314,0.0688850745743507,0.0929863315821686,2.46303667810248e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.11834914874887,0.00898715345649127,0.100734327974147,0.135963969523593,2.5778581890161e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PPY,Pancreatic prohormone,42089,0.136809996518089,0.0103987483939463,0.116428449665955,0.157191543370224,2.72929144062603e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.0965077247052563,0.0073306070572385,0.0821397348730688,0.110875714537444,2.7395921754659e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0745776010898247,0.00567140485237517,0.0634616475791694,0.08569355460048,2.95709997334857e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2L,Ataxin-2-like protein,39934,0.0640960694174779,0.00487836672165427,0.0545344706430356,0.0736576681919203,3.80944234738986e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,42119,0.087238376071549,0.00664448024693793,0.0742151947875506,0.100261557355547,3.87451324797583e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.050423077873385,0.00384139296783726,0.0428939476564239,0.057952208090346,4.03969909409217e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,COCH,Cochlin,39958,0.0610741103591711,0.00465425090086703,0.0519517785934718,0.0701964421248705,4.72212912242706e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDC,Nuclear migration protein nudC,42296,0.0841973225347778,0.00642244828330021,0.0716093238995094,0.0967853211700462,4.96691876574582e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,SPART,Spartin,39736,0.10363218113688,0.00790203100099312,0.0881442003749333,0.119120161898826,5.27956351089353e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,C1R,Complement C1r subcomponent,39979,0.0250240008384897,0.00191081328438197,0.021278806801101,0.0287691948758783,6.6306637069872e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.193978519451765,0.0148135241899948,0.164944012039375,0.223013026864155,6.76251355764534e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.114315070049319,0.00873802542038564,0.0971885402253633,0.131441599873275,7.92741977594236e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0626623162117651,0.00480310074301715,0.0532482387554515,0.0720763936680788,1.26691186034127e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,NEXN,Nexilin,39990,0.0923012705967013,0.00707538203411181,0.0784335218098421,0.10616901938356,1.27590747684472e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0687888478407686,0.00528207612094848,0.0584359786437096,0.0791417170378276,1.70946278888811e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0596567946044348,0.00458545286769609,0.0506693069837504,0.0686442822251191,1.82984891426808e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0370330527490157,0.00284753647713585,0.0314518812538294,0.0426142242442019,1.94482737462943e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SIAE,Sialate O-acetylesterase,42147,0.0610802383906411,0.00469800957753222,0.0518721396186779,0.0702883371626043,2.04166081723664e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.101588794169314,0.00781677034385972,0.0862679242953493,0.116909664043279,2.20531137108869e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0265138628870747,0.00203936173949989,0.0225167138776549,0.0305110118964945,2.27015060730263e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GLB2,Endophilin-B2,39929,0.0867329159404741,0.00667243713643293,0.0736549391530655,0.0998108927278826,2.33972826971766e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,39934,0.100704082324652,0.00774765443810111,0.0855186796259738,0.11588948502333,2.35957499953461e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0541978447460701,0.00416969038610272,0.0460252515893087,0.0623704379028314,2.38465807306731e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS4,Galectin-4,42123,-0.0740160554641993,0.00570213613040402,-0.0851922422797912,-0.0628398686486075,2.67603884946937e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXJ3,Forkhead box protein J3,39657,0.0596779778578614,0.00459829121454969,0.0506653270773441,0.0686906286383788,3.0888838156977e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,THOP1,Thimet oligopeptidase,42081,0.0410067852926934,0.00316730363297388,0.0347988701720646,0.0472147004133222,4.12654896189316e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PLG,Plasminogen,39742,0.028770767746154,0.00222141667066064,0.0244167910716591,0.0331247444206488,4.33480228591926e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.136279816082205,0.0105381895481426,0.115624964567845,0.156934667596565,4.99130874683374e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS8,Galectin-8,42249,0.0795196058552408,0.00615103950073439,0.0674635684338014,0.0915756432766802,5.23980736129564e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0873316484036717,0.00675487431562209,0.0740920947450524,0.100571202062291,5.75011038158231e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CNST,Consortin,42145,0.14222373017421,0.0110102453769811,0.120643649235327,0.163803811113092,6.01446627501341e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.112855711502654,0.00874824144901002,0.0957091582625946,0.130002264742714,8.36084686962706e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH9,Protocadherin-9,39930,0.0442991298803798,0.0034349578052911,0.0375666125820093,0.0510316471787504,8.67727006204444e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.107353496476877,0.00834097055675618,0.0910051941856353,0.12370179876812,1.09518603814069e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0946379925013042,0.00735411148907137,0.0802239339827243,0.109052051019884,1.12329095386848e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,DDHD2,Phospholipase DDHD2,39934,0.0865713085227544,0.00672976722215009,0.0733809647673403,0.0997616522781686,1.31581528027051e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,HGF,Hepatocyte growth factor,42296,0.0448765695863941,0.00349210950274807,0.0380320349610079,0.0517211042117804,1.40236534575386e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB27B,Ras-related protein Rab-27B,39958,0.107556188034925,0.00836681982754673,0.0911572211729337,0.123955154896917,1.47117242940815e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.058083385807224,0.00452310286159541,0.049218104198497,0.0669486674159511,1.60729366857188e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PXN,Paxillin,41839,0.0665069620440963,0.0051792500758417,0.0563556318954465,0.076658292192746,1.61680562457307e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,EHD3,EH domain-containing protein 3,39638,0.153905759161238,0.0119898999631821,0.130405555233401,0.177405963089075,1.9017013697027e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,KIFBP,KIF-binding protein,42070,0.106771649592385,0.00835017850637492,0.0904052997198897,0.123137999464879,3.19988151455563e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CD36,Platelet glycoprotein 4,39657,0.060491155448031,0.00472884918117627,0.0512226110529255,0.0697596998431364,3.33669280929265e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN3,Centrin-3,39930,0.102101559616541,0.00798278258572772,0.0864553057485144,0.117747813484567,3.36118769263809e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0620100697374231,0.00484916452542807,0.0525057072675841,0.0715144322072621,3.46672336532311e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOT,Angiomotin,39736,0.0497142834037918,0.00389439628276484,0.0420812666895727,0.0573473001180109,4.63911737557339e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1B,Meprin A subunit beta,42145,0.14789909578443,0.011594001947296,0.12517485196773,0.17062333960113,4.68427523969705e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRY2,Protein sprouty homolog 2,41913,0.119861359729167,0.00939690358231899,0.101443428707822,0.138279290750512,4.79101604797275e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0828610047698662,0.00649310625789888,0.0701345165043843,0.095587493035348,4.89318865642068e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP6,Bone morphogenetic protein 6,41886,0.0517055967395897,0.00405470576400383,0.0437583734421422,0.0596528200370372,5.00787217427808e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNLR1,Interferon lambda receptor 1,42119,0.0468915020947299,0.00367917289348388,0.0396803232235015,0.0541026809659583,5.41742893518447e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT2,Signal transducer and activator of transcription 2,39657,0.101767534885661,0.00798757643795191,0.0861118850672755,0.117423184704047,6.38011163410765e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,39657,0.0654726799253831,0.00514187824720563,0.0553945985608601,0.0755507612899061,7.01441862528252e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.025122805457027,0.00197823468548649,-0.0290001454405805,-0.0212454654734735,9.65070865767524e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,LPP,Lipoma-preferred partner,39575,0.0850859427265339,0.00670450086705646,0.0719451210271032,0.0982267644259645,1.20156117879853e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT2A1,Bile salt sulfotransferase,42119,0.0752112052526238,0.00594405985305896,0.0635608479406282,0.0868615625646194,1.72982649071624e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.096802222962099,0.00765094247299045,0.0818063757150377,0.11179807020916,1.75272743577699e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT1,Deaminated glutathione amidase,39638,0.0570878538766649,0.00450957687632924,0.0482490831990595,0.0659266245542702,1.78201655226078e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.142443607019424,0.0112676101459362,0.120359091133388,0.164528122905459,2.01409156196955e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CASC3,Protein CASC3,39649,0.0553490668044636,0.0043767252278544,0.046770685357869,0.0639274482510583,2.09710614323255e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0485652095475956,0.00384539191990257,0.0410282413845866,0.0561021777106046,2.35350447074973e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL8,C-C motif chemokine 8,42239,0.0771383874851687,0.00612623391289749,0.0651309690158896,0.0891458059544478,3.73689160127871e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0930030543928813,0.00739083468321285,0.0785170184137841,0.107489090371978,4.59355145158519e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,NID1,Nidogen-1,42189,0.0458504004413198,0.00364669918913711,0.0387028700306111,0.0529979308520286,4.71026865538457e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.110588774199746,0.00880796418750242,0.0933251643922409,0.12785238400725,5.89138804661207e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0787173651427581,0.00627656413764602,0.0664152994329719,0.0910194308525443,7.65569012110764e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0870968587943322,0.00695572139976208,0.0734636448507985,0.100730072737866,8.94128708603599e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,REN,Renin,42145,-0.102741247228946,0.00821109429511269,-0.118834992047367,-0.0866475024105254,1.00514961935649e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CTF1,Cardiotrophin-1,41900,0.107090144601313,0.00855907670773706,0.0903143542541487,0.123865934948478,1.0212741127261e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE2,Angiotensin-converting enzyme 2,41900,0.069056427446525,0.00552569301000916,0.0582260691469071,0.079886785746143,1.22382190653663e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CD207,C-type lectin domain family 4 member K,41832,0.049305959394873,0.00394653730253113,0.041570746281912,0.057041172507834,1.28697799964964e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0345828220645297,0.00276829041217649,0.0291569728566638,0.0400086712723957,1.29010617341811e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0621387270619791,0.00497218480177683,0.0523932448504965,0.0718842092734616,1.34492132447876e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0795481575886384,0.00636535612009915,0.0670720595932441,0.0920242555840327,1.35286542441292e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ICA1,Islet cell autoantigen 1,41913,0.100866511533147,0.00809386404222731,0.0850025380103814,0.116730485055912,1.89449740822708e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0369606082902734,0.00296631899228883,0.0311466230653873,0.0427745935151595,1.94705121395833e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,FIS1,Mitochondrial fission 1 protein,42125,0.0966463592222194,0.00775997087932872,0.0814368162987351,0.111855902145704,2.06750898713092e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,OGA,Protein O-GlcNAcase,39930,0.0902852270851227,0.00724886914128086,0.0760774435682122,0.104493010602033,2.2360645228304e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,OGFR,Opioid growth factor receptor,42070,0.040405862837644,0.0032479834268468,0.0340398153210243,0.0467719103542638,2.46895042117328e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,42137,0.0627994824159244,0.00505108606679695,0.0528993537250024,0.0726996111068464,2.70061335990004e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ST13,Hsc70-interacting protein,39736,0.0687331375829153,0.00552650098935705,0.0579011956437755,0.0795650795220551,2.82113307738072e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,39919,0.0698732869955076,0.00561889267507974,0.0588602573523513,0.0808863166386639,2.85227476456322e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0713770853779623,0.00574692936157211,0.060113103829281,0.0826410669266436,3.17174553239501e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0387595774751879,0.00312282753168878,0.0326388355130779,0.0448803194372979,3.90227247680345e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL4,C-C motif chemokine 4,42148,0.0780036341477834,0.00629341259138439,0.06566854546867,0.0903387228268969,4.33705007742929e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.120235025992197,0.00970786945070744,0.10120760186881,0.139262450115584,4.85534772829468e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,GRAP2,GRB2-related adapter protein 2,42145,0.161419074847875,0.0130589291714962,0.135823573671743,0.187014576024008,6.56681103023791e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0347214557078372,0.00281052836029331,0.0292128201216623,0.0402300912940121,7.13550445061478e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,LSP1,Lymphocyte-specific protein 1,42119,0.0504753216790647,0.00409373458406568,0.042451601894296,0.0584990414638334,9.61009661134975e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.123941708226311,0.0100468022470475,0.104249975822098,0.143633440630524,9.63197317058986e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL1,Growth-regulated alpha protein,42117,0.115982681338375,0.00940795498554999,0.0975430895666966,0.134422273110053,9.81882373119001e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,39934,0.0750488920454139,0.00608845057853097,0.0631155289114932,0.0869822551793347,1.08842195003618e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53,Cellular tumor antigen p53,41843,0.0554154774854296,0.00449883672897877,0.0465977574966312,0.064233197474228,1.12553191937983e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,HPSE,Heparanase,39866,0.119362434780511,0.00969044439982746,0.100369163756849,0.138355705804173,1.21730980141778e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,41992,0.0505307817335446,0.00410745796348903,0.0424801641251061,0.0585813993419831,1.35488635249139e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,YJU2,Splicing factor YJU2,39919,0.0412959386868465,0.00335521084853007,0.0347197254237275,0.0478721519499654,1.36467120129436e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.113759657994701,0.00926082333864052,0.0956084442509658,0.131910871738437,1.68681432273924e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.135161650761472,0.0110156260167163,0.113571023768708,0.156752277754236,2.22030632770871e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0924775121999442,0.00753822028739848,0.0777026004366432,0.107252423963245,2.24476151374902e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0474440706292084,0.0038698267108649,0.0398592102759132,0.0550289309825036,2.28069371587971e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,EGF,Pro-epidermal growth factor,42081,0.128677747383075,0.0105228144450722,0.108053031070734,0.149302463695417,3.32459423957123e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0606507198945325,0.00496230017706079,0.0509246115474934,0.0703768282415717,3.87704251961464e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,NSFL1C,NSFL1 cofactor p47,42249,0.0776592074501958,0.00635805430173433,0.0651974210187965,0.0901209938815951,3.92920332401822e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0758936447275159,0.00621075128317919,0.0637205722124846,0.0880667172425471,4.05062091417186e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0292105931307445,0.00239614021006488,0.0245141583190173,0.0339070279424716,5.2438036491442e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,DLG4,Disks large homolog 4,39929,0.0893188180378583,0.00732508805762303,0.0749616454449172,0.103675990630799,5.49240211975275e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,42016,0.0978310226376463,0.00803025013849093,0.0820917323662041,0.113570312909089,5.80068903526285e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,CD226,CD226 antigen,39657,0.0527680256082843,0.00432879393204621,0.0442835895014738,0.0612524617150949,5.80206013136473e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.104161237109956,0.00857262092866432,0.0873589000897743,0.120963574130138,8.54604820200438e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,42145,0.099027346850834,0.00815032082218422,0.0830527180393529,0.115001975662315,8.58637709416644e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0418099486769411,0.00344241037130711,0.0350628243491791,0.048557073004703,9.06499095750467e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0752473406420817,0.00619854573656282,0.0630981909984186,0.0873964902857449,9.76848279277152e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2,Microtubule-associated protein 2,39929,0.0577383158830817,0.00475630332948289,0.0484159613572952,0.0670606704088682,1.05792822545165e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN1,Pantetheinase,39990,0.0901727476187819,0.00743053768827155,0.0756088937497697,0.104736601487794,1.1060398369272e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.097572239209471,0.00804402875723788,0.0818059428452847,0.113338535573657,1.10830244154677e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,A1BG,Alpha-1B-glycoprotein,39979,0.0203947167142699,0.00168166348906646,0.0170986562756996,0.0236907771528401,1.21453632962096e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,42070,0.0454049803573556,0.003746572517884,0.0380616982223029,0.0527482624924082,1.25228474483782e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0574520693053827,0.00474001882375851,0.048161632410816,0.0667425061999494,1.34185646861108e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,RWDD1,RWD domain-containing protein 1,42249,0.076163618031022,0.00629927410326015,0.0638170407886321,0.0885101952734119,1.75052456089682e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.112214612430667,0.00928821704006081,0.0940097070321481,0.130419517829186,1.98190705661394e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.100746067529425,0.00834336641406794,0.0843930693578521,0.117099065700998,2.14428534193253e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0610995749666536,0.00506107894466837,0.0511798602351036,0.0710192896982036,2.38275826561559e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,F12,Coagulation factor XII,39979,0.0506317381615629,0.00419729771550961,0.0424050346391641,0.0588584416839617,2.64589432385239e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPING1,Plasma protease C1 inhibitor,39959,0.0227137118509823,0.00188350767705799,0.0190220368039486,0.026405386898016,2.76735391228478e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,42105,0.0778019221148204,0.00647011355793948,0.065120499541259,0.0904833446883818,3.88552953877167e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED8,Protein TMED8,39930,0.126165018517869,0.0104950759860776,0.105594669585157,0.146735367450581,4.36145108983701e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,MPI,Mannose-6-phosphate isomerase,42070,0.103473905434358,0.00861721373180517,0.08658416652002,0.120363644348696,4.76723584327697e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN2,Centrin-2,41839,0.0826114227707011,0.00688044567290955,0.0691257492517984,0.0960970962896039,4.8640348649988e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,WASHC3,WASH complex subunit 3,39929,0.0926415927309869,0.00771502834710848,0.0775201371706543,0.10776304829132,5.11957333468312e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,DLK1,Protein delta homolog 1,42310,0.0702930308086055,0.00585902190348062,0.0588093478777835,0.0817767137394275,5.36320351938905e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0715686930093378,0.00596589775205502,0.0598755334153099,0.0832618526033656,5.51003021818484e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF2,TNF receptor-associated factor 2,42119,0.0841701289489641,0.00701703635066191,0.0704167377016668,0.0979235201962615,5.54146424184323e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,QDPR,Dihydropteridine reductase,42081,0.0511282859275567,0.00426313099116208,0.042772549184879,0.0594840226702344,5.68028655812565e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0711553589727164,0.00593289384962421,0.059526887027453,0.0827838309179799,6.16052021803029e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL16,C-X-C motif chemokine 16,42295,0.0283047395453067,0.00236188378147251,0.0236754473336206,0.0329340317569928,6.29942105751174e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO3,Forkhead box protein O3,41843,0.116442489521404,0.00972156607621046,0.097388220012032,0.135496759030777,6.8723544692025e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP1,Syntaxin-binding protein 1,39934,0.094882266266099,0.00791811132783581,0.0793627680635408,0.110401764468657,6.89639252259822e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.105985034149408,0.00884568474826207,0.0886474920428147,0.123322576256002,7.06822214594267e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP7,Caspase-7,39929,0.102784523803365,0.00858637278633943,0.0859552331421399,0.119613814464591,7.98439288128407e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKA,Diacylglycerol kinase alpha,39657,0.0674076020788454,0.00563106788523186,0.0563707090237909,0.0784444951338998,8.07327723851614e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN9,Septin-9,42070,0.0348268284286997,0.00291136638650294,0.029120550311154,0.0405331065462455,8.20246093239471e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0450418923862958,0.00376833836569519,0.0376559491895333,0.0524278355830584,9.17288751147923e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,MESD,LRP chaperone MESD,42137,0.14737426173335,0.0123357297815876,0.123196231361438,0.171552292105262,9.83802034351503e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,OXT,Oxytocin-neurophysin 1,42249,0.17497908202873,0.0146566917524579,0.146251966193912,0.203706197863547,1.08429185409506e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,39736,0.145393356672729,0.0121814772528359,0.12151766125717,0.169269052088287,1.22043615216795e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0795108030158268,0.0066635950981756,0.0664501566234026,0.0925714494082509,1.28055070353212e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,TADA3,Transcriptional adapter 3,39919,0.0489641129238618,0.00410577628931839,0.0409167913967978,0.0570114344509259,1.36321525085347e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",42070,0.102312256816238,0.00859509291038611,0.0854658747118816,0.119158638920595,1.65031746652605e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.11949438262738,0.0100472498176771,0.0998017729847328,0.139186992270027,1.8626879942184e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,GET3,ATPase GET3,39958,0.0652272966806488,0.00548608662177759,0.0544745669019647,0.0759800264593329,2.08671439255128e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,RRAS,Ras-related protein R-Ras,39649,0.15870636879435,0.0133474137530774,0.132545437838318,0.184867299750382,2.09171335489511e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,LBR,Delta(14)-sterol reductase LBR,42249,0.0818048022491178,0.00688446454509837,0.068311251740725,0.0952983527575106,2.10753162202365e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.119519209539056,0.0100567955343867,0.0998078902916586,0.139230528786454,2.25119033584345e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,HNMT,Histamine N-methyltransferase,41961,0.0575975870498402,0.00485059644073883,0.0480904180259921,0.0671047560736883,2.34045468801587e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0805074317683789,0.00677900261572643,0.0672205866415551,0.0937942768952027,2.46953842942135e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,MTDH,Protein LYRIC,39657,0.115077018046894,0.0096936152684631,0.0960775321207064,0.134076503973082,2.6171073455922e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.046885553730161,0.00395217878809171,0.0391392833055012,0.0546318241548207,2.65297326357513e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.114920169087301,0.00968791039696344,0.0959318647092525,0.133908473465349,2.6890590950999e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0844246748183727,0.00711319665761427,0.0704828093694487,0.0983665402672967,2.7022504974753e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,TDRKH,Tudor and KH domain-containing protein,41839,0.10193772754818,0.00859738472798578,0.0850868534813283,0.118788601615033,2.88835612254023e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CD22,B-cell receptor CD22,42296,0.0511302527260436,0.00431907513018736,0.0426648654708764,0.0595956399812108,3.55288047839441e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBP,Protein AMBP,42239,0.0240785225380571,0.00203886828673793,0.0200823406960508,0.0280747043800635,4.97827234567374e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0880755388130281,0.00747267928346908,0.0734290874174287,0.102721990208627,7.12560945747329e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.091545656174843,0.00777740947927086,0.0763019335954721,0.106789378754214,7.89764565438266e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,42310,0.0856544432527449,0.00727846160966903,0.0713886584977936,0.0999202280076962,8.09701923248729e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0346392731585837,0.0029433566358164,0.0288702941523836,0.0404082521647839,8.73504726419901e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARC,SPARC,42181,0.0831371914587939,0.00707329841090418,0.0692735265734217,0.0970008563441661,9.63413416275842e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0421905007051762,0.00359085610912766,0.035152422731286,0.0492285786790664,1.08597583333856e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS1,Galectin-1,42145,0.041607367775365,0.00354332421363042,0.0346624523166493,0.0485522832340806,1.09948139473767e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.101606832823798,0.00865138235716003,0.0846501234037642,0.118563542243831,1.14866509355258e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,41843,0.072147263246737,0.00614983560443104,0.0600935854620522,0.0842009410314218,1.25893428874207e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,41913,0.04481319114426,0.00382198255789107,0.0373221053307935,0.0523042769577265,1.35513866034617e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0549354834029487,0.00468651470724264,0.0457499145767531,0.0641210522291443,1.39662921803984e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0796700967199919,0.00679837808506314,0.0663452756732681,0.0929949177667156,1.45851413264895e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.057835254190396,0.00493664039173317,0.048159439022599,0.067511069358193,1.51896747693326e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD2,Polycystin-2,39575,0.0696175979887247,0.00594591621047199,0.0579636022161996,0.0812715937612498,1.77436987984261e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,MVK,Mevalonate kinase,41913,0.0978535932674736,0.00837760634629122,0.0814334848287428,0.114273701706204,2.28391003774146e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CRADD,Death domain-containing protein CRADD,41997,0.0881821023129615,0.00756133925524193,0.0733618773726873,0.103002327253236,2.81463152562614e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB1,Heat shock protein beta-1,41949,0.0825863614459618,0.00709259990587316,0.0686848656304504,0.0964878572614731,3.48241401972479e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.111643182044639,0.00958672047846856,0.0928532099068403,0.130433154182437,3.63463868972451e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.115004144787202,0.00989376946701768,0.0956123566318471,0.134395932942556,4.41013688734298e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL18,C-C motif chemokine 18,42020,0.0826183336469585,0.00710879784017007,0.0686850898802252,0.0965515774136918,4.48848630544239e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.141584129563648,0.0121876671416411,0.117696301966031,0.165471957161264,4.73574856023348e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0552744107569973,0.00476024119182512,0.0459443380210201,0.0646044834929746,5.38273093342619e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,EGLN1,Egl nine homolog 1,42119,0.0655755081881196,0.00565528053285826,0.0544911583437174,0.0766598580325218,6.08767898125478e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB9,Serpin B9,42016,0.0385181878913633,0.00332434052355548,0.0320024804651946,0.0450338953175321,6.75161322448263e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0519125038424382,0.00448425215856571,0.0431233696116494,0.060701638073227,7.57611389270005e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0315282397127822,0.0027227793954926,0.0261915920976167,0.0368648873279477,7.8040698835465e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX6,Peroxiredoxin-6,42262,-0.0703583450660382,0.00607945714983478,-0.0822740810797144,-0.0584426090523621,7.85118491682692e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6AP2,Renin receptor,41843,0.0460801739929715,0.00398258695844419,0.0382743035544209,0.0538860444315222,8.1859746869028e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0439588416541003,0.00379758831078986,0.0365155685649522,0.0514021147432484,8.23400165804012e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC22D1,TSC22 domain family protein 1,39934,0.0775977272033341,0.00670607247634252,0.0644538251497028,0.0907416292569655,8.58167965937841e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0623943704813563,0.00539465832183606,0.0518208401705577,0.072967900792155,8.61804454456142e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,BLMH,Bleomycin hydrolase,42310,0.0362024989289476,0.00313153431146325,0.0300646916784796,0.0423403061794156,9.05928228510453e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,AP2B1,AP-2 complex subunit beta,39649,0.0570253286601816,0.00493778563077563,0.0473472688238613,0.0667033884965018,1.12309662943184e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP5,Fatty acid-binding protein 5,42218,0.0777474657067347,0.00673928784821851,0.0645384615242264,0.090956469889243,1.19953575785969e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,STK24,Serine/threonine-protein kinase 24,41839,0.07245487475218,0.00628715602884521,0.0601320489356434,0.0847777005687166,1.39286729536497e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,UBXN1,UBX domain-containing protein 1,39736,0.0806922721618384,0.00700624138028143,0.0669600390564867,0.09442450526719,1.6086251739324e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LG,CMRF35-like molecule 9,42137,-0.0434815239036669,0.00377891611402002,-0.0508881994871462,-0.0360748483201877,1.69875728999941e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.098069792389574,0.00852955910070611,0.08135185655219,0.114787728226958,1.89082738514128e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CES2,Cocaine esterase,42070,0.0648115831765643,0.00563719665538879,0.0537626777320022,0.0758604886211263,1.89133608607615e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0684724610238535,0.00595729603474831,0.0567961607957469,0.0801487612519602,1.96079839797466e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGT1,Protein SGT1 homolog,41843,0.0928304935451502,0.0080841419306575,0.0769855753610615,0.108675411729239,2.23533634969791e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0563357774426096,0.00491032687502906,0.0467115367675527,0.0659600181176666,2.65002457091388e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,FUS,RNA-binding protein FUS,41831,0.046014052214314,0.00401917613914547,0.0381364669815889,0.0538916374470391,3.31432525943794e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ESM1,Endothelial cell-specific molecule 1,42123,-0.0402098682786037,0.0035129444543396,-0.0470952394091093,-0.0333244971480981,3.38364101940665e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0621237366204391,0.00543365534640991,0.0514737721414757,0.0727737010994025,3.93261789745197e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0813097032742298,0.00711415675551415,0.067365956033422,0.0952534505150375,4.10065990362468e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.040523243656372,0.00355411288127684,-0.0474893049036746,-0.0335571824090694,5.60649172084998e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,COMT,Catechol O-methyltransferase,41740,0.0962928021200978,0.00844604181974017,0.0797385601534071,0.112847044086789,5.72053404959552e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCB,Tubulin-folding cofactor B,42016,0.115399839422043,0.0101302434598215,0.0955445622407932,0.135255116603293,6.31835156843043e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,C3,Complement C3,39445,0.0533714765331943,0.00468318278349288,0.0441924382775483,0.0625505147888404,6.44636918590912e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE2,Glia-derived nexin,39958,0.0750069247900918,0.0065869454972495,0.0620965116154827,0.0879173379647008,7.03143218794137e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CERT,Ceramide transfer protein,41839,0.0706325436206341,0.00620800836754449,0.0584648472202469,0.0828002400210213,7.43588147307203e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB6,Serpin B6,42216,0.0674048959314186,0.00592807680337358,0.0557858653968064,0.0790239264660308,7.99868977151279e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CACYBP,Calcyclin-binding protein,39713,0.120012775434004,0.010558164769551,0.0993187724856839,0.140706778382324,8.93138031260723e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PF4,Platelet factor 4,39914,0.112868562286383,0.0099347322813125,0.0933964870150104,0.132340637557755,9.47568148661028e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0800363465930619,0.00705368336292339,0.0662111272017321,0.0938615659843918,1.12612800599341e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,C2,Complement C2,42199,0.0259402081391836,0.00228941642443443,0.0214529519472922,0.0304274643310751,1.25837299878753e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0666766486287268,0.00588635853363007,0.0551393859028118,0.0782139113546417,1.31663900892161e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARA5,Scavenger receptor class A member 5,42249,0.0349459697554107,0.00308901040808616,0.0288915093555618,0.0410004301552596,1.53173053085588e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL24,C-C motif chemokine 24,42166,0.094299962859798,0.00833739149324243,0.0779586755330429,0.110641250186553,1.57868485103868e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.029750139245118,0.00263100029696059,0.0245933786630752,0.0349068998271607,1.63493334440117e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,BIN2,Bridging integrator 2,42137,0.102186871537561,0.00903881708238695,0.0844707900560826,0.119902953019039,1.67428092501536e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,39638,0.0657926283111274,0.00582520511282227,0.0543752262899957,0.077210030332259,2.02601812049189e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,RFC4,Replication factor C subunit 4,39919,0.0254206986511713,0.00225088268059145,0.021008968597212,0.0298324287051305,2.02608676490049e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.10859034534585,0.00961546238753312,0.0897440390662852,0.127436651625415,2.03415591985875e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0757298080822592,0.00671099967956576,0.0625762487103103,0.0888833674542081,2.26105804428505e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D5,TBC1 domain family member 5,42119,0.0890059105842736,0.00789266351995504,0.0735362900851617,0.104475531083385,2.30414751773708e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0425615192635368,0.00377281783164927,0.0351667963135042,0.0499562422135694,2.33358027103511e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT1,Angiopoietin-1,42085,0.0953761523509062,0.00845853470540064,0.078797424328321,0.111954880373491,2.34024726095503e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA1,Ephrin type-A receptor 1,42162,0.0368230234306295,0.00326591587144167,0.0304218283226038,0.0432242185386551,2.35697618258825e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FGL1,Fibrinogen-like protein 1,39990,-0.0742511201639175,0.00658597739494326,-0.0871596358580063,-0.0613426044698287,2.51819022069026e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PPBP,Platelet basic protein,39908,0.0983040793636815,0.00872541117024793,0.0812022734699956,0.115405885257367,2.75307502678052e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0338283243441266,0.0030062656209175,0.0279360437271283,0.0397206049611249,3.04263951319208e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP25,Synaptosomal-associated protein 25,39586,0.0550360332234989,0.0048940831278519,0.0454436302929092,0.0646284361540886,3.52028957698685e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.065578407819399,0.00583777902124252,0.0541363609377637,0.0770204547010344,3.75267303446146e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.102223379109751,0.00909781028188812,0.0843916709572503,0.120055087262252,3.8640391895451e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM106A,Transmembrane protein 106A,39919,0.0817869775694889,0.00727921749060737,0.0675197112878984,0.0960542438510794,3.88432092441617e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0405573506447537,0.00361157229024373,-0.0476360323336314,-0.0334786689558759,3.91636368180699e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.1291141637227,0.0115145128315459,0.10654571857287,0.15168260887253,4.71192358133826e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.145619095822247,0.0129846113662265,0.120169257544443,0.171068934100051,4.90743607358445e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.137850768806774,0.012307203105108,0.113728650720762,0.161972886892786,5.41984040472299e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.106236863285791,0.00949929022414905,0.087618254446459,0.124855472125123,6.57239879484155e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL2,Chordin-like protein 2,42145,0.0517360393700373,0.00462935919522782,0.0426624953473907,0.0608095833926838,7.17693859148391e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO9B,Unconventional myosin-IXb,41913,0.0746358492321436,0.00668158445550243,0.0615399436993588,0.0877317547649284,7.64874286380032e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.105744492076,0.00948010734996526,0.087163481670068,0.124325502481932,9.12418795652276e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0639784204713805,0.00574056916521679,0.0527269049075555,0.0752299360352054,1.01057691638076e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP3,Syntaxin-binding protein 3,41843,0.0489898335366588,0.00440097158866455,0.0403639292228763,0.0576157378504413,1.17984864863028e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0734592258776084,0.00660420253022528,0.0605149889183669,0.08640346283685,1.29660272621509e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSO,Cathepsin O,42296,0.0344829271402209,0.00310037710338447,0.0284061880175873,0.0405596662628544,1.2975782688465e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAM1,Vascular cell adhesion protein 1,42199,-0.0312324987751102,0.00281077399344439,-0.0367416158022612,-0.0257233817479592,1.46038703741068e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA4,Protein disulfide-isomerase A4,39966,0.0691999334901841,0.0062261582096324,0.0569966633993046,0.0814032035810636,1.49813900582116e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0888072114193938,0.0079988121293176,0.0731295396459313,0.104484883192856,1.62276527779868e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,BGLAP,Osteocalcin,39966,0.0950084283241583,0.00855417871280138,0.0782422380470676,0.111774618601249,1.6318866919874e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0498644370340373,0.0044902462546263,0.0410635543749698,0.0586653196931049,1.67790876178936e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0986939802123992,0.00891474647003654,0.0812210771311276,0.116166883293671,2.42810215160604e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0647094724610397,0.00585946815744638,0.0532249148724448,0.0761940300496346,3.29817547519908e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.0938552150787779,0.00850908612981619,0.0771774062643381,0.110533023893218,3.63767068801368e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB1,Beta-crystallin B1,39958,0.0741105029404477,0.00671919372770481,0.0609408832341462,0.0872801226467491,3.81852468978986e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0664390116419045,0.00602985072704241,0.0546205042169014,0.0782575190669076,4.122886530233e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP2,Caspase-2,42119,0.0761572125305255,0.00691730945344957,0.0625992860017644,0.0897151390592867,4.51759018941456e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,42070,0.066675714381283,0.00605617951824453,0.0548056025255237,0.0785458262370423,4.52825744544389e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOA,Elongin-A,42070,0.0599444891058806,0.00544867683807789,0.0492650825032479,0.0706238957085133,4.93781373103133e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM3,Dynamin-3,39934,0.0616383322270588,0.00560165559075539,0.0506590872691782,0.0726175771849393,5.0892513108935e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0268334151609833,0.00244032982840157,0.0220503686973162,0.0316164616246504,5.25829228866253e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0801717535889973,0.00729309303189163,0.0658772912464897,0.0944662159315049,5.46663074496382e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,42185,0.0981051262945968,0.00893367988813362,0.0805951137138549,0.115615138875339,6.14803222223846e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0300330258856606,0.00273629654255347,0.0246698846622558,0.0353961671090654,6.54978483677204e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,RP2,Protein XRP2,42070,0.0472650035450334,0.00431509728641981,0.0388074128636505,0.0557225942264162,8.38331271233434e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0843994427002096,0.0077083989057761,0.0692909808448884,0.0995079045555307,8.77828933854872e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA3,Annexin A3,42224,0.0769412657509006,0.00703281495618271,0.0631569484367825,0.0907255830650188,9.643876070103e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.124166841800537,0.0113492749805133,0.10192226283873,0.146411420762343,9.68642160487726e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,DBN1,Drebrin,39657,0.0568224941478068,0.00519341003785139,0.046643410473618,0.0670015778219955,1.01477182652089e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0679644501940204,0.00621559887070056,0.0557818764074473,0.0801470239805935,1.09282894993945e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,NUB1,NEDD8 ultimate buster 1,42119,0.09285734126701,0.00851773357935971,0.0761625834514649,0.109552099082555,1.47389110453908e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB2,BPI fold-containing family B member 2,39927,0.0678412606872758,0.00622758205493179,0.0556351998596094,0.0800473215149421,1.69104480615461e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA2,Integrin alpha-2,39736,0.0383532338812107,0.00352409669501262,0.031446004358986,0.0452604634034354,1.90628554922765e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CD69,Early activation antigen CD69,42082,0.0962736458840466,0.00887037863245963,0.0788877037644257,0.113659588003668,2.49269185580542e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0742303276782851,0.00684471659576267,0.0608146831505903,0.08764597220598,2.88509489330283e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,42119,0.0656668121133871,0.00605896202006933,0.0537912465540513,0.077542377672723,2.94428035020173e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR2,GMP reductase 2,39736,0.0733190020334271,0.00676621080653515,0.0600572288526183,0.086580775214236,3.17522698486539e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,GMFG,Glia maturation factor gamma,39958,0.0792325492589093,0.00731641385360444,0.0648923781058446,0.093572720411974,3.39041836698387e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.118645685430085,0.0109629925359435,0.0971582200596356,0.140133150800534,3.66232185846336e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L1,Bcl-2-like protein 1,39929,0.109614441219431,0.0101352218582736,0.0897494063772145,0.129479476061647,3.95659792696268e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0581869215091034,0.00538639484699061,0.0476295876090018,0.068744255409205,4.53388358074406e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0552218417147815,0.00511689630125817,0.0451927249643155,0.0652509584652475,4.83572719575928e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPB,Natriuretic peptides B,41900,-0.153505048862251,0.0142243280719048,-0.181384731883184,-0.125625365841318,4.87419393644551e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTD,Deoxycytidylate deaminase,39736,0.105255234765255,0.00975487666386794,0.0861356765040742,0.124374793026436,5.21827896794623e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0706181742135988,0.0065488730774508,0.0577823829817952,0.0834539654454024,5.5827587942293e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PSPN,Persephin,42119,0.094318212516568,0.00875275470849477,0.0771628132879182,0.111473611745218,5.76136911458165e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1,Allograft inflammatory factor 1,41843,0.0570095182738014,0.00529300824950843,0.0466352221047648,0.0673838144428379,6.11924219325006e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0632765602739048,0.00587522091296603,0.0517611272844913,0.0747919932633182,6.16210246896129e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,39958,0.0305566770417061,0.00284253267153862,0.0249853130054905,0.0361280410779218,7.99216286823868e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG6,Large proline-rich protein BAG6,41900,0.0401058469713138,0.00374422559881749,0.0327671647976315,0.047444529144996,1.15602266341518e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,41843,0.0490441395736566,0.00458284709228072,0.0400617592727864,0.0580265198745268,1.28405703167552e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP10,Caspase-10,41839,0.0771097237265398,0.00721503085980175,0.0629682632413284,0.0912511842117512,1.49637924335487e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.110801929469265,0.0103673435091708,0.0904819361912904,0.13112192274724,1.56842982693424e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,WDR46,WD repeat-containing protein 46,39919,0.0397476916491743,0.00372063476816605,0.0324552475035688,0.0470401357947797,1.63438503485911e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0306417061505859,0.00287052159333396,0.0250154838276513,0.0362679284735204,1.70230013924816e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ATOX1,Copper transport protein ATOX1,42181,0.0768059524069269,0.00719734143210824,0.0626991631999948,0.0909127416138591,1.76308045163547e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,TTF2,Transcription termination factor 2,39649,0.0539483977933787,0.00505770790008133,0.0440352903092193,0.0638615052775381,1.96176263324444e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CRLF1,Cytokine receptor-like factor 1,42185,0.0268501436442618,0.00251994204297418,0.0219110572400324,0.0317892300484912,2.09928078717917e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,42093,0.0966950027340236,0.0090756898773427,0.0789066505744319,0.114483354893615,2.12018819947916e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,42137,0.0574688347659799,0.00539570548108488,0.0468932520230535,0.0680444175089062,2.19761844141008e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0892240319890751,0.00838019975932981,0.0727988404607887,0.105649223517362,2.2901458657503e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.113430905780228,0.0106703190661832,0.0925170804105089,0.134344731149947,2.87194639600222e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,42296,0.071920306111265,0.00677099053875196,0.0586491646553111,0.0851914475672188,2.98432147890672e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN4,Cerebellin-4,42262,0.0340538442146481,0.00321589928485108,0.02775068161634,0.0403570068129562,4.22084645206301e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0462754146800575,0.00436866017683145,0.0377128407334679,0.0548379886266472,4.29232578167392e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFA,Vascular endothelial growth factor A,42253,0.0607389220246481,0.00573961924225637,0.0494892683098256,0.0719885757394705,4.53761152834583e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0587928453395338,0.00555560361715602,0.047903862249908,0.0696818284291596,4.55362549544236e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0515443584327027,0.00486944028305134,0.0420002554779221,0.0610884613874834,4.61460626629181e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0470524943769299,0.00445952335009353,0.0383118286107466,0.0557931601431132,6.3600709392785e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.081207406089659,0.00770118841348984,0.0661130767992189,0.0963017353800991,7.12674757178435e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0424851967668102,0.00403272156962599,0.0345810624903432,0.0503893310432771,7.47058569953782e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,YWHAQ,14-3-3 protein theta,39736,0.079511911535669,0.00755291748802206,0.0647081932591457,0.0943156298121922,8.54480604145467e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRD2,Protein ZNRD2,39930,0.0746739441856695,0.00709747828929968,0.0607628867386421,0.0885850016326969,9.06936206170389e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0936881954036925,0.00890771137187046,0.0762290811148264,0.111147309692559,9.45806850911111e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,42181,0.088915926611158,0.00847475038051571,0.0723054158653472,0.105526437356969,1.1801316337937e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSD,Cathepsin D,41225,0.044032251963242,0.00419675059735138,0.0358066207924333,0.0522578831340507,1.19882366123165e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0565269628423636,0.00539103980645578,0.0459605248217102,0.0670934008630169,1.26592572128615e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,IDUA,Alpha-L-iduronidase,42262,0.0500544885177538,0.00477572027653279,0.0406940767757495,0.059414900259758,1.32042727837575e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP1,Secreted frizzled-related protein 1,41968,0.0456679962110721,0.00436056343219916,0.0371212918839617,0.0542147005381824,1.44416172163743e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.106257344338156,0.0101771733271936,0.0863100846168566,0.126204604059456,2.10581280377162e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SDHB,Succinate dehydrogenase,39930,0.0696895006105406,0.00667623108788498,0.056604087678286,0.0827749135427952,2.15721840740909e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0598016204038747,0.00573639885689116,0.0485582786443681,0.0710449621633814,2.39112666027265e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CLUL1,Clusterin-like protein 1,42123,-0.0471718651250401,0.00452625723651121,-0.0560433293086021,-0.0383004009414782,2.45866064881117e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18,Interleukin-18,42069,0.0467842684391877,0.00448923609871085,0.0379853656857144,0.0555831711926609,2.47096315712258e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,39930,0.061406856456811,0.00589780558099386,0.049847157518063,0.072966555395559,2.8472163017129e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP3R1,Calcineurin subunit B type 1,42016,0.0425837202179012,0.00409219737222001,0.03456301336835,0.0506044270674524,2.90240083969308e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0487606628063762,0.00468595542954787,0.0395761901644624,0.05794513544829,2.92209946747044e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA12,Serpin A12,41751,0.113893451170993,0.0109738332621194,0.0923847379772391,0.135402164364747,3.87819438459641e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,MICALL2,MICAL-like protein 2,39649,0.0722423923633797,0.00696251520299847,0.0585958625655027,0.0858889221612567,4.16185337673377e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CA13,Carbonic anhydrase 13,41967,0.110581784665959,0.010668432104183,0.0896716577417599,0.131491911590157,4.4370880261065e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL26,C-C motif chemokine 26,42119,0.093892260341277,0.00909495412399164,0.0760661502582533,0.111718370424301,6.82230064759535e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRG1,Scrapie-responsive protein 1,39958,0.0286901329356816,0.00277804889038904,0.0232451571105191,0.0341351087608441,6.82327853678602e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,BLNK,B-cell linker protein,39657,0.0439671506655159,0.00426049805200228,0.0356165744835914,0.0523177268474404,7.43985250406288e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0725232249064965,0.00703381222919808,0.0587369529372682,0.0863094968757247,8.18440780820475e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,TST,Thiosulfate sulfurtransferase,41809,0.0786634834964934,0.0076412442249921,0.0636866448155089,0.093640322177478,9.24527989411308e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0257042480165246,0.00249644938625231,0.0208112072194701,0.0305972888135792,9.40008313967721e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,LACTB2,Endoribonuclease LACTB2,42145,0.0686095896850444,0.00667861490779989,0.0555195044657567,0.0816996749043322,1.14831809547297e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,LARP1,La-related protein 1,39919,0.0650294750295988,0.00632952384306297,0.0526236082971954,0.0774353417620022,1.18425317982622e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0642320930167191,0.00625652413905089,0.0519693057041794,0.0764948803292589,1.27895679825185e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO2,Amphoterin-induced protein 2,42070,0.0243512549295936,0.00237423773089657,0.0196977489770363,0.0290047608821508,1.36321007549951e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.0942039321567432,0.00920765933196633,0.0761569198660892,0.112250944447397,1.85015177907578e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TALDO1,Transaldolase,39948,0.0459420416090372,0.00449442344754928,0.0371329716518406,0.0547511115662337,2.01624250211447e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0372937405969183,0.00364901213014012,-0.044445804371993,-0.0301416768218437,2.05407350914888e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,NHLRC3,NHL repeat-containing protein 3,39481,0.0335924130487853,0.0032902212134019,0.0271435794705176,0.040041246627053,2.30852918210446e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0534350053268123,0.00523429997408799,0.0431757773775999,0.0636942332760248,2.31261691214568e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG2,Bone marrow proteoglycan,39966,-0.0532062644424925,0.00521248088209313,-0.063422726971395,-0.0429898019135899,2.33816107768754e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,VSNL1,Visinin-like protein 1,39929,0.0401897754527874,0.00394428770609902,0.0324589715488333,0.0479205793567415,2.81486048916192e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CIAPIN1,Anamorsin,42181,0.0631836697963585,0.00621081601762714,0.0510104704018093,0.0753568691909077,3.19102294927633e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP3,Caspase-3,42310,0.0908241366352569,0.00892905501248864,0.0733231888107791,0.108325084459735,3.23131552070003e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL3,Insulin-like 3,39929,0.0931300102545364,0.00916074001009547,0.0751749598347493,0.111085060674324,3.5630699214166e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0836152219622888,0.00823180981140852,0.0674808747319282,0.0997495691926495,3.91271536186049e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PON3,Serum paraoxonase/lactonase 3,42185,-0.0301687748506018,0.00297407788466742,-0.0359979675045499,-0.0243395821966536,4.29765639327956e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,39952,0.0489875761377059,0.00483259355616114,0.0395156927676301,0.0584594595077818,4.79558525829493e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,39930,0.10193209649244,0.0100648572853668,0.0822049762131213,0.121659216771759,5.27673164676268e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CEMIP2,Cell surface hyaluronidase,39657,0.0334234912119492,0.00330027518790689,0.0269549518436517,0.0398920305802467,5.30938228152527e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,MIA,Melanoma-derived growth regulatory protein,42181,0.0378931783016483,0.00374658589058941,0.0305498699560931,0.0452364866472035,5.81890887848948e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,APP,Amyloid-beta precursor protein,42112,0.0676975657586652,0.00670607394288563,0.0545536608306094,0.0808414706867211,7.06692041923071e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCG,Gamma-synuclein,42016,0.0682988424632126,0.00677270853187299,0.0550243337407416,0.0815733511856837,7.87263767952442e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0932464293359085,0.00924394833868294,0.07512829059209,0.111364568079727,7.97459314358008e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0881867789820581,0.00875258215270286,0.0710317179627604,0.105341840001356,8.60480412539329e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0635271800374119,0.00630549586063258,0.051168408150572,0.0758859519242517,8.63793808246124e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.122315097205291,0.0121628748789824,0.0984758624424856,0.146154331968097,1.04270112139541e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NRGN,Neurogranin,39990,0.0945161899214253,0.00940029242528978,0.0760916167678573,0.112940763074993,1.10062652142327e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0349256481749613,0.00347683107943696,0.0281110592592648,0.0417402370906577,1.16717028891233e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPACT,Protein IMPACT,39929,0.0554352664198635,0.0055172066421502,0.0446215414012491,0.0662489914384779,1.1811178498154e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,POMC,Pro-opiomelanocortin,39638,0.0750708782912566,0.00747466990050704,0.0604205252862628,0.0897212312962504,1.24111178579777e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0470592697684102,0.00468751938159945,0.0378717317804753,0.0562468077563451,1.29060286408295e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,DSC2,Desmocollin-2,41984,-0.0357982156173373,0.00356778566132342,-0.0427910755135312,-0.0288053557211434,1.3128576077679e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0380747046620188,0.00379360843840198,0.0306392321227509,0.0455101772012866,1.32124173205794e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0498989885213153,0.00497810260638384,0.040141907412803,0.0596560696298277,1.50307429374577e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0548409348916352,0.00547345844762761,0.0441129563342851,0.0655689134489853,1.51285622884424e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SMTN,Smoothelin,39897,0.0943062378856923,0.00943080423451232,0.0758218615860481,0.112790614185336,1.91098856828979e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,41843,0.0531659301026238,0.00532551566075949,0.0427279194075352,0.0636039407977124,2.18296001061338e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0278213136046491,0.00278721052014541,0.0223583809851641,0.0332842462241342,2.29945922483875e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB33A,Ras-related protein Rab-33A,39575,0.0674824742841336,0.00676683617867503,0.0542194753739305,0.0807454731943366,2.52635865544409e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0467877703030542,0.00469390886900596,0.0375877089198025,0.0559878316863059,2.53422659112514e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CFB,Complement factor B,39794,0.0333139238433826,0.00334184546225338,0.026763906737366,0.0398639409493992,2.61261340623442e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PGF,Placenta growth factor,42296,0.0264593225493497,0.00265574999143552,0.0212540525661361,0.0316645925325633,2.65521979167773e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,REEP4,Receptor expression-enhancing protein 4,39934,0.0632459297887038,0.00634670018585486,0.0508063974244283,0.0756854621529793,2.69947734369081e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPN,Asporin,39958,0.0281793787624805,0.00282914328795879,0.0226342579180813,0.0337244996068798,2.82982723024764e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.054291749728299,0.00545178037310585,0.0436062601970116,0.0649772392595865,2.88432813139461e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,THTPA,Thiamine-triphosphatase,39897,0.0888650775533932,0.00892412588789999,0.0713737908131092,0.106356364293677,2.90601016047006e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0241799305959378,0.00243135670765091,0.019414471448942,0.0289453897429336,3.18120303585118e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,39930,0.0889012482942234,0.00894611574156001,0.0713668614407658,0.106435635147681,3.55958583515416e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0664904048505381,0.00669782430614582,0.0533626692104923,0.0796181404905839,3.79690685974832e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ESYT2,Extended synaptotagmin-2,39929,0.0842343244513502,0.00848589734487496,0.0676019656553953,0.100866683247305,3.97204296652976e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SELE,E-selectin,42310,0.0507955559198443,0.005121182381904,0.0407580384513125,0.0608330733883762,4.12912755790794e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.0994005360079418,0.0100182419843572,0.0797647817186017,0.119036290297282,4.14874627762667e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,C5,Complement C5,39979,0.0151799829248923,0.00153180344332335,0.0121776481759785,0.0181823176738061,4.67545547802973e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK7,Kallikrein-7,39475,0.0399182282368336,0.0040353079486885,0.0320090246574041,0.0478274318162631,5.62395889118199e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD4B,FERM domain-containing protein 4B,39575,0.0707940308634299,0.00715940064728194,0.0567616055947573,0.0848264561321025,5.83796388769501e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL3,C-C motif chemokine 3,42119,0.0594166016084021,0.00601222391330762,0.0476326427383192,0.0712005604784851,5.92282518157857e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB6,Integrin beta-6,41913,0.0307662874023942,0.00311691292876066,0.0246571380620233,0.0368754367427651,6.68049311552724e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0667008176874329,0.00675956107921878,0.0534520779721641,0.0799495574027017,7.15966630402828e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP170,Centrosomal protein of 170 kDa,39638,0.0776085788137191,0.00786709028432524,0.0621890818564416,0.0930280757709966,7.341123612424e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS27,Serine protease 27,42107,0.040153820285456,0.00407273953983613,0.0321712507873771,0.0481363897835348,7.47267854739726e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME1,Proteasome activator complex subunit 1,42002,0.0362635580241511,0.00368128434842045,0.029048240701247,0.0434788753470552,8.12895241509834e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.0726823607840962,0.00738265704413469,0.0582123529775923,0.0871523685906002,8.88465037809927e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0669066643539784,0.0068077753018637,0.0535634247623255,0.0802499039456312,1.01622158466423e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0375009224584866,0.00381917763668998,0.0300153342905742,0.0449865106263989,1.11256632060055e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX1,Peroxiredoxin-1,41742,-0.0912124728719239,0.00929654996480441,-0.109433710802941,-0.0729912349409073,1.20244196871369e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,GPI,Glucose-6-phosphate isomerase,39990,0.0477541354070395,0.00486679607293274,0.0382152151040914,0.0572930557099877,1.22615036329905e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CLU,Clusterin,39979,0.0300697981638981,0.00306864243720875,0.024055258986969,0.0360843373408273,1.39585894979143e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,GSR,"Glutathione reductase, mitochondrial",39949,0.0228568955255998,0.00233415650574724,0.0182819487743352,0.0274318422768644,1.4914906981006e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,GP5,Platelet glycoprotein V,39736,0.0364991708178014,0.00372843587012759,0.0291914365123513,0.0438069051232514,1.541316844209e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CD244,Natural killer cell receptor 2B4,42296,0.0273023777990527,0.00279192788625816,0.0218301991419868,0.0327745564561187,1.64121563433921e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0241619374054943,0.00247092089282146,0.0193189324555642,0.0290049423554243,1.65438571469396e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,GRK5,G protein-coupled receptor kinase 5,41900,0.0509706273183578,0.00522092547513715,0.040737613387089,0.0612036412496266,1.93491061687843e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB2B,Ras-related protein Rab-2B,39919,0.0618742664499467,0.00633860620628159,0.0494505982856348,0.0742979346142587,2.01901761276472e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,UROD,Uroporphyrinogen decarboxylase,39736,0.0674116827199961,0.00691052582474077,0.0538670521035042,0.0809563133364881,2.16002446714728e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO2,Roundabout homolog 2,42249,0.0223695913736232,0.00229413927831244,0.0178730783881308,0.0268661043591156,2.16653091757996e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.07941479288,0.00814829414828804,-0.0953854494106446,-0.0634441363493554,2.27059121311189e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,GLB1,Beta-galactosidase,42016,0.0425952582716023,0.0043713935535149,0.0340273269067131,0.0511631896364915,2.31915520055562e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CLTA,Clathrin light chain A,41900,0.0462675549540716,0.00474894817342032,0.0369596165341677,0.0555754933739754,2.35450539525113e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0290284874267562,0.00298027959225918,0.0231871394259282,0.0348698354275842,2.48869423064368e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1A,Meprin A subunit alpha,39930,0.0753730832731115,0.00773944892547183,0.0602037633791867,0.0905424031670363,2.51917314014586e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0549388655736612,0.00564713726605588,0.0438704765321917,0.0660072546151307,2.79628968759481e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40LG,CD40 ligand,42296,0.0781083348625159,0.00803873320854195,0.0623524177737737,0.0938642519512582,3.02568394152188e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.058910800081867,0.0060692758262664,0.0470150194623849,0.0708065807013492,3.46677321413064e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ARFIP1,Arfaptin-1,39934,0.0683404992870796,0.00704495775205461,0.0545323820930525,0.0821486164811066,3.65400795419899e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0432558256925749,0.00446050989163856,0.0345132263049633,0.0519984250801865,3.76745434924104e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN3,Ataxin-3,39929,0.0601297621917878,0.00621485311187018,0.0479486500925223,0.0723108742910534,4.67883458964796e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0321460201976268,0.00332452310538914,0.0256299549110641,0.0386620854841895,4.79868785635969e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.071187684967808,0.00738764294605748,0.0567079047935353,0.0856674651420806,6.82885322115063e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0632353985158188,0.00656492056910681,0.0503681542003695,0.0761026428312682,6.85528702893385e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CCS,Copper chaperone for superoxide dismutase,42016,0.0452257791788779,0.00469884116702838,0.0360160504915023,0.0544355078662535,7.38661835379742e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0350380391841038,0.00364360046539291,0.0278965822719337,0.0421794960962739,8.29192444266685e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0564757497350942,0.00588053632851349,0.0449498985312078,0.0680016009389807,9.04906569498464e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA6,Corticosteroid-binding globulin,39979,0.0150861607046072,0.00157181575725344,0.0120054018203905,0.018166919588824,9.85900594747865e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0774645444322913,0.00807307639524433,0.0616413146976124,0.0932877741669702,1.01560413319935e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ADD1,Alpha-adducin,39736,0.0680538249907525,0.007108779620061,0.0541206169354329,0.081987033046072,1.25526843784483e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BTC,Probetacellulin,41843,0.0711679577084173,0.00743675782298623,0.0565919123753643,0.0857440030414703,1.2588100407965e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,MIF,Macrophage migration inhibitory factor,42105,0.06498909079089,0.0067926331821835,0.0516755297538104,0.0783026518279697,1.28135419851906e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0417170288012969,0.00436259295118138,0.0331663466169814,0.0502677109856124,1.3476532755394e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM3,Junctional adhesion molecule C,39736,0.0495433488853325,0.00518475126707769,0.0393812364018603,0.0597054613688048,1.48629328766053e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0830416461330058,0.00869531682789244,0.0659988251503367,0.100084467115675,1.5677534510673e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0622019978976017,0.00652141527844244,0.0494200239518545,0.0749839718433489,1.70519201597008e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL7,C-C motif chemokine 7,42119,0.0542360990992491,0.00569426582637534,0.0430753380795535,0.0653968601189448,1.93264135180245e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0287925730609004,0.00302205397231466,0.0228693472751636,0.0347157988466371,1.93763320790693e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS10,Regulator of G-protein signaling 10,39934,0.05767917741265,0.00605746888060932,0.0458065384066557,0.0695518164186442,2.04276770966289e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP2,Retinol-binding protein 2,42070,-0.0752196300891287,0.00790398040735172,-0.0907114316875381,-0.0597278284907193,2.08759893269106e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,GP6,Platelet glycoprotein VI,42115,0.0849520202420027,0.0089369361598662,0.067435625368665,0.10246841511534,2.31668317451585e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0388302011194394,0.00408755213208524,0.0308185989405523,0.0468418032983265,2.5276427130442e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,STX8,Syntaxin-8,42119,0.0460053200327921,0.0048485451298415,0.0365021715783028,0.0555084684872814,2.73058519999084e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0626660011543372,0.00660589557267195,0.0497184458319002,0.0756135564767742,2.79243388417432e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.030817937403965,0.00325463929106662,-0.0371970304144555,-0.0244388443934744,3.28613174373074e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0676759139626718,0.00714498628257127,0.0536717408488321,0.0816800870765114,3.29588790809058e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4R,Reticulon-4 receptor,42262,0.0323450426469297,0.00341859331866887,0.0256445997423388,0.0390454855515207,3.52398902288438e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PKN3,Serine/threonine-protein kinase N3,39757,0.0708929630270819,0.00749626129563012,0.0562002908876469,0.0855856351665169,3.79863278924957e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA4,Laminin subunit alpha-4,42185,0.0327875295954433,0.00346845328724024,0.0259893611524524,0.0395856980384342,3.82123190213324e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BMPER,BMP-binding endothelial regulator protein,39736,0.0222759396771032,0.00235596374920374,0.0176582507286639,0.0268936286255425,3.87199531677255e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0336459902433786,0.00356713254865909,0.0266544104480068,0.0406375700387504,4.65860093689322e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0434260198449404,0.00460470328756602,0.034400801401311,0.0524512382885697,4.72629655219171e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,39513,0.0510646304886545,0.00541590118798529,0.0404494641602034,0.0616797968171057,4.99376910037594e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0362225491397387,0.00384841727526974,0.02867965128021,0.0437654469992674,5.78774888882738e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,HAO1,Hydroxyacid oxidase 1,42262,0.117809825053485,0.0125322253856029,0.0932466632977029,0.142372986809266,6.27786753852946e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0234810412947771,0.00250418419942943,0.0185728402638954,0.0283892423256587,8.09522499120946e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FRZB,Secreted frizzled-related protein 3,41973,0.023467529736141,0.00250544410221608,0.0185568592957974,0.0283782001764845,8.6714610001048e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCA,Calcitonin,41997,0.0658754698385842,0.00704871480382423,0.0520599888230887,0.0796909508540797,1.05483124751806e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164,Sialomucin core protein 24,42137,0.02559822636561,0.00274022407121528,0.020227387186028,0.0309690655451919,1.09445987537829e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,GNAS,Neuroendocrine secretory protein 55,39934,0.0820765885463677,0.00880177752731684,0.0648251045928267,0.0993280724999088,1.31512859338638e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,F2R,Proteinase-activated receptor 1,42166,0.054114342961568,0.00580998385438614,0.0427267746069711,0.0655019113161648,1.4175107130832e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,FADD,FAS-associated death domain protein,42145,0.0720339450894541,0.00773814356845426,0.0568671836952838,0.0872007064836245,1.48687191196252e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM1,Dynamin-1,39930,0.109620868589399,0.0117795666739966,0.086532917908366,0.132708819270433,1.5706058888814e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0633886544727664,0.00681825781441869,0.0500248691565057,0.076752439789027,1.71745280163412e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.112370464319965,0.012107865515196,0.0886390479101813,0.13610188072975,1.93383196004966e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0437597149674406,0.00472274393634924,0.0345031368521961,0.0530162930826851,2.23235818831837e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,39919,0.045591358320285,0.00492116462349298,0.0359458756582388,0.0552368409823313,2.31641270755302e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SWAP70,Switch-associated protein 70,39930,0.0344133500939441,0.00373243898853157,0.0270977696764222,0.0417289305114659,3.4925272248341e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,BST2,Bone marrow stromal antigen 2,42249,0.0475641263340562,0.00517028365574841,0.0374303703687893,0.0576978822993231,4.10997136449212e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1A,Lithostathine-1-alpha,42105,-0.0465368416265992,0.00505942313887511,-0.0564533109787944,-0.036620372274404,4.17201762204795e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0691209369720568,0.00752636895214399,0.0543692538258546,0.083872620118259,4.77026946106554e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PQBP1,Polyglutamine-binding protein 1,41843,0.0526583469190096,0.00573393744376446,0.0414198295292312,0.0638968643087879,4.77944282405186e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAN,Neurocan core protein,42249,0.0348813003054542,0.00379953739046803,0.0274342070201368,0.0423283935907715,4.9037475287918e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0662514710019063,0.00722707077703749,0.0520864122789128,0.0804165297248998,5.69145066825457e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0498049450984661,0.00543284872990516,0.039156561587852,0.0604533286090802,5.7045965254383e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0226084900899025,0.00247504608760078,0.017757399758205,0.0274595804216,7.48911252498362e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0402276060001243,0.00440941650090019,0.0315851496583599,0.0488700623418887,8.34092180027024e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,VGF,Neurosecretory protein VGF,39934,0.0280168602323958,0.00307178131994755,0.0219961688452986,0.034037551619493,8.71845564437888e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0739493988743841,0.00811239400314783,-0.0898496911205539,-0.0580491066282144,8.90882737059596e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,FGA,Fibrinogen alpha chain,39735,0.0288998970921302,0.00317356534643276,0.022679709013122,0.0351200851711384,9.96294290720236e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0732367162008783,0.00806048001571504,0.0574381753700768,0.0890352570316798,1.20381492167032e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC79,Protein unc-79 homolog,39560,0.0516345121386814,0.00568927503125463,0.0404835330774223,0.0627854911999405,1.32167672294444e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ABHD14B,Protein ABHD14B,41976,0.0514616675830846,0.00567382987613323,0.0403409610258634,0.0625823741403057,1.3540033261597e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0483925489951186,0.0053444583090335,0.0379174107094129,0.0588676872808242,1.55476446780669e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF15,Growth/differentiation factor 15,42310,-0.042046322286668,0.00464689720373561,-0.0511542408059898,-0.0329384037673462,1.64561006071309e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0401741140215508,0.00443882665616995,0.0314740137754577,0.0488742142676439,1.65957447191691e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PARK7,Parkinson disease protein 7,42137,0.0464529168392896,0.00513656777380689,0.0363852440026281,0.0565205896759511,1.72002264461886e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PROK1,Prokineticin-1,42119,0.0454601184499538,0.00504058655364351,0.0355805688048125,0.0553396680950951,2.15416343450682e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,BAP18,Chromatin complexes subunit BAP18,39929,0.0625490074696258,0.00694102220762727,0.0489446039426763,0.0761534109965752,2.35774135199207e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAN,Aggrecan core protein,41994,0.0249977692542545,0.00277585309232436,0.0195570971932988,0.0304384413152103,2.43475426525329e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0242356870011548,0.00269176422273281,0.0189598291245985,0.0295115448777111,2.46856690431354e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRIB,Protein scribble homolog,39638,0.0803475346147027,0.00892493232648176,0.0628546672547984,0.0978404019746069,2.56555894187623e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,42249,0.0431346866383249,0.00479562841621883,0.033735254942536,0.0525341183341138,2.67989007667909e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN6,Dynactin subunit 6,41839,0.0658051973113396,0.00731782602846004,0.0514622582955579,0.0801481363271213,2.74243853432474e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,DXO,Decapping and exoribonuclease protein,39929,0.041359220761275,0.00461588632014507,0.0323120835737906,0.0504063579487593,3.74723499920046e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,TSHB,Thyrotropin subunit beta,42145,0.0618265020398042,0.00690750434290954,0.0482877935277015,0.0753652105519069,3.98901157435833e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP1,Guanylate-binding protein 1,39911,0.0588843639421899,0.00658312786511126,0.0459814333265719,0.071787294557808,4.30713251457549e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0301512411926476,0.00337272709784436,0.0235406960808726,0.0367617863044225,4.3959667448216e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0359839559803871,0.00403430163625268,0.0280767247733318,0.0438911871874423,5.27835001486253e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGA,Chromogranin-A,39966,-0.077110306179788,0.00865271910496064,-0.0940696356255108,-0.0601509767340651,5.79056259403885e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0445918521467196,0.00500474367095337,0.034782554551651,0.0544011497417882,5.90616822557862e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,STX4,Syntaxin-4,42070,0.0532786722691038,0.00598563772591986,0.0415468223263009,0.0650105222119067,6.22897283429725e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0279835132589766,0.00314482133367225,0.021819663444979,0.0341473630729742,6.53161249395618e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0300138008889433,0.0033755219915686,0.0233977777854689,0.0366298239924178,6.76910646347843e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0376216829150691,0.00424239461948768,0.0293065894608732,0.0459367763692649,8.59382946366647e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CST3,Cystatin-C,42184,0.0257606702523603,0.00290960223057682,0.0200578498804298,0.0314634906242909,9.50538078751363e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.051854113211227,0.00585688568526372,0.0403746172681101,0.0633336091543439,9.5313279085106e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0965404567251961,0.0109093405210851,0.0751581493038692,0.117922764146523,1.01079927433395e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,BDNF,Brain-derived neurotrophic factor,39966,0.0755565258771204,0.00854699295599971,0.058804419683361,0.0923086320708798,1.09658811197484e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,39966,0.024261386957046,0.00274888497427171,0.0188735724074735,0.0296492015066186,1.24431935925806e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,IDS,Iduronate 2-sulfatase,42296,0.00822001240474171,0.000933788092668729,0.00638978774311101,0.0100502370663724,1.49170097697093e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0392440780470292,0.00445765049651695,0.0305070830738559,0.0479810730202024,1.5148378388155e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0470343896257342,0.00534514303081351,0.0365579092853397,0.0575108699661286,1.57723182796346e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.073556057081478,0.00838466327781202,0.0571221170569664,0.0899899971059896,1.95108527998759e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0276302182813965,0.0031505074267183,0.0214552237250286,0.0338052128377644,2.0392376519204e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP7,Matrilysin,41881,0.0461617568154608,0.00526671456331387,0.0358389962713656,0.056484517359556,2.09583897336775e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.043674653302348,0.00499302709548584,0.0338883201951957,0.0534609864095002,2.49715370280812e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0459599070342612,0.00525994669228559,0.0356504115173814,0.0562694025511409,2.66193593321271e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ENAH,Protein enabled homolog,41913,0.0427198634804373,0.00489198810921719,0.0331315667863716,0.052308160174503,2.78232271030473e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ECE1,Endothelin-converting enzyme 1,41839,0.0312735706899851,0.0035815420324061,0.0242537483064692,0.0382933930735011,2.80234761220788e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.0862568797810778,0.00987735202080919,0.0668972698202918,0.105616489741864,2.84238499410705e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0322307258383391,0.00369104120142983,0.0249962850835367,0.0394651665931416,2.85840012602888e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.077453960740509,0.00887274309403896,0.0600633842761926,0.0948445372048254,2.92351991991556e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFA2,BPI fold-containing family A member 2,39281,-0.0985815492294139,0.0113084881649432,-0.120746186032703,-0.0764169124261252,3.26567363731574e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,39990,0.0234130343693539,0.0026915692852067,0.0181375585703487,0.028688510168359,3.81853376860566e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0498211255704932,0.0057283415477857,0.0385935761368333,0.0610486750041532,3.86708492284528e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH7,Protocadherin-7,39930,0.0308815835481541,0.00355409774760847,0.0239155519628415,0.0378476151334667,4.15760020731638e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,FMNL1,Formin-like protein 1,41839,0.0556303294013988,0.00640579260662799,0.043074975892408,0.0681856829103897,4.25024526627976e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,RASSF2,Ras association domain-containing protein 2,41843,0.0502684352866808,0.00578982510373321,0.0389203780833637,0.0616164924899979,4.33176449901036e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO1A,Coronin-1A,41883,0.0781993241303271,0.00900889009456469,0.0605418995449803,0.0958567487156739,4.40531468949507e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,LAP3,Cytosol aminopeptidase,41913,0.0422481590643209,0.0048739950351041,0.0326951287955169,0.0518011893331249,4.89807368781859e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,MARCO,Macrophage receptor MARCO,42145,0.0226924156291767,0.00262185280719195,0.0175535841270805,0.027831247131273,5.47482052701847e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPA1,Inositol monophosphatase 1,42016,0.0536114291407803,0.00620463385372819,0.0414503467874731,0.0657725114940876,6.2215520951542e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17D,Interleukin-17D,41913,0.0298919116586506,0.00346119307590315,0.0231079732298804,0.0366758500874208,6.46091581704953e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,41843,0.0339361296456302,0.00393383551342667,0.0262258120393139,0.0416464472519465,7.02581081802964e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGED1,Melanoma-associated antigen D1,41843,0.0421601251943084,0.00489479298153718,0.0325663309504955,0.0517539194381213,7.89754232336313e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,NBN,Nibrin,41913,0.047521099216286,0.0055180149367049,0.0367057899403444,0.0583364084922277,7.98049811459236e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,DBI,Acyl-CoA-binding protein,42085,0.0679695947503356,0.00790549502505676,0.0524748245012243,0.0834643649994468,9.01603306801934e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,VIT,Vitrin,39958,0.0335966534627822,0.00391246109035105,0.0259282297256941,0.0412650771998702,1.00812594081924e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0297303688827383,0.00346382375722825,0.0229412743185709,0.0365194634469056,1.02336445726603e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0351255567057665,0.00409326428238538,0.0271027587122911,0.0431483546992418,1.06428730503777e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0560630080382865,0.00653921848102486,0.0432461398154778,0.0688798762610952,1.13549881031138e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PEPD,Xaa-Pro dipeptidase,39990,0.0230010640615356,0.00268576477405182,0.0177369651043941,0.0282651630186772,1.22940654955765e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CD27,CD27 antigen,42181,-0.0370734968452666,0.00433283109753445,-0.0455658457964341,-0.0285811478940991,1.28804865382721e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,RILP,Rab-interacting lysosomal protein,42224,0.0508028994133069,0.00594497348398804,0.0391507513846904,0.0624550474419235,1.41437640137942e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0288384454763741,0.0033754737544919,0.0222225169175699,0.0354543740351782,1.43974096752265e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO2,Gamma-enolase,42249,0.056376072697091,0.00660396550257288,0.0434323003120481,0.0693198450821338,1.52569803988697e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0949897400954149,0.0111368851745652,0.0731614451532671,0.116818035037563,1.62688987696898e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF2,Fibroblast growth factor 2,42119,0.059704916999413,0.00700732159501467,0.0459705666731842,0.0734392673256417,1.75743570776832e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK6,Kallikrein-6,42158,0.0267006473452208,0.00313389585899411,0.0205582114615924,0.0328430832288493,1.76310709402272e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM1,Probable carboxypeptidase X1,42181,0.0594209012416365,0.0069774792909707,0.0457450418313339,0.0730967606519391,1.82213943455534e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,RBKS,Ribokinase,41830,0.0427448558017976,0.00502656334888392,0.0328927916379851,0.0525969199656101,2.03029094195291e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAN,Brevican core protein,42016,0.0297450131652502,0.00350391185148751,0.0228773459363347,0.0366126803941657,2.29960935686269e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PARD3,Partitioning defective 3 homolog,39757,0.0640574285314415,0.00756082428082268,0.049238212941029,0.078876644121854,2.708104375171e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0496039684515556,0.00586011573193927,0.0381181416169546,0.0610897952861565,2.83311003721714e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,OPLAH,5-oxoprolinase,39638,0.0598769813774686,0.00707758289260745,0.046004918907958,0.0737490438469792,3.00856902177813e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0215995803153038,0.00255866932459102,0.0165845884391054,0.0266145721915022,3.44201204088228e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",39934,0.054596646563533,0.00646707691942874,0.0419211758014527,0.0672721173256133,3.49131863025409e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0218713066862064,0.00259158154188799,0.016791806864106,0.0269508065083069,3.57695216668364e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0183491242201901,0.0021759060512297,0.0140843483597799,0.0226139000806003,3.71340888573422e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0541526814496354,0.00642724247359355,-0.0667500766978787,-0.041555286201392,3.94699654566053e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0757302535195466,0.00900463255070901,0.058081173720157,0.0933793333189363,4.5850967827859e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0228195451054451,0.00271610602829927,-0.0281431129209116,-0.0174959772899785,4.92817197860193e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0648591053767851,0.00772139133863338,0.0497251783530636,0.0799930324005065,4.99954253269328e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMB1,Laminin subunit beta-1,39638,0.0268747473538651,0.0031996781962247,0.0206033780892647,0.0331461166184655,5.0450818698821e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.07576547502793,0.00903591576773095,0.0580550801231774,0.0934758699326827,5.58282645331758e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BP1,SH3 domain-binding protein 1,39930,0.042201993704138,0.00503517722200897,0.0323330463490005,0.0520709410592756,5.84559725187092e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS9,Galectin-9,42129,0.0266667173008961,0.00318568590407444,0.0204227729289102,0.032910661672882,6.28085512067783e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1F,Protein phosphatase 1F,39958,0.045399545882711,0.00543127194498325,0.0347542528705438,0.0560448388948782,7.0661890189591e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,IL32,Interleukin-32,42119,-0.0376610964294766,0.00450833774895861,-0.0464974384174354,-0.0288247544415177,7.25823344269347e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL11,Eotaxin,42296,0.0316834714180006,0.00379429494505432,0.0242466533256942,0.0391202895103071,7.45793065185196e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CD72,B-cell differentiation antigen CD72,39736,0.0369844974968032,0.00443096693373246,0.0282998023066875,0.0456691926869188,7.84037842851844e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL1,Chordin-like protein 1,42166,0.0276295254067338,0.00331889655618774,0.0211244881566059,0.0341345626568618,9.24067829018943e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0332541928586089,0.00399688348224806,0.0254203012334027,0.0410880844838151,9.79837320496951e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0359531361024465,0.00432143449780858,0.0274831244867417,0.0444231477181514,9.85366064147881e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,C1RL,Complement C1r subcomponent-like protein,39958,0.0167393671845698,0.00201308523907693,0.0127937201159791,0.0206850142531606,1.01957234828695e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0171770968838499,0.00206783682332073,-0.0212300570575585,-0.0131241367101412,1.07563985271833e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN5,CCN family member 5,42137,0.0319964625179071,0.00385398103433555,0.0244426596906094,0.0395502653452047,1.11836023154863e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0705698104776343,0.00850511473497743,0.0538997855970785,0.0872398353581901,1.18514729270015e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB10,Ras-related protein Rab-10,39958,0.0451559544333851,0.00544258773143639,0.0344884824797698,0.0558234263870004,1.19037392019868e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF23,Fibroblast growth factor 23,42250,0.0425362628583936,0.00512875166813291,0.0324839095888531,0.0525886161279341,1.19993716660236e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOTL2,Angiomotin-like protein 2,39882,0.0412381245227207,0.00497460016724194,0.0314879081949265,0.0509883408505149,1.26347708896608e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,STX16,Syntaxin-16,41843,0.04788823547843,0.00579032618272437,0.0365391961602902,0.0592372747965697,1.46184213071748e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,HRG,Histidine-rich glycoprotein,39925,0.0262075331124578,0.00317636636933485,0.0199818550285614,0.0324332111963541,1.74748076560719e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL19,C-C motif chemokine 19,42249,0.0943905229246517,0.0114559593661163,0.0719368425670638,0.11684420328224,1.88693214597165e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF6,SLAM family member 6,41843,0.0322191229919383,0.00392265289258887,0.0245307233224641,0.0399075226614125,2.34424497168048e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,TREH,Trehalase,39966,0.0628733659452236,0.00766711244128844,0.0478458255602982,0.0779009063301489,2.65324140573311e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI1,Neuroserpin,39713,0.0242152294206629,0.00295369978958417,0.0184259778330779,0.0300044810082479,2.70655872664025e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PTX3,Pentraxin-related protein PTX3,42119,-0.0412597448788706,0.00504391846861796,-0.0511458250773618,-0.0313736646803794,3.08769476005715e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.074503123340874,0.00910624431044252,0.0566548844924067,0.0923513621893414,3.10687613586105e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ING1,Inhibitor of growth protein 1,41820,0.0395324247502393,0.00483327262542229,0.0300592104044116,0.0490056390960669,3.11597966536039e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAL,Integrin alpha-L,39657,0.0364483160954913,0.00445922805296157,0.0277082291116867,0.045188403079296,3.31734724909168e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.046220883175778,0.00566211044383173,0.0351231467058678,0.0573186196456881,3.54946698214979e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,DPT,Dermatopontin,42310,0.021011493508214,0.00257929117472438,0.0159560828057542,0.0260669042106737,4.07717394145067e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL,Podocalyxin,42070,0.012515391456648,0.00153659926300685,0.00950365690115456,0.0155271260121414,4.12921658590309e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRBP,Acrosin-binding protein,39919,0.0330795226194184,0.00406406615763936,0.0251139529504452,0.0410450922883915,4.38373528730131e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0388116012832985,0.00477195918362672,0.0294585612833902,0.0481646412832069,4.54870644915157e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0580447068641865,0.00714764108734598,0.0440353303329883,0.0720540833953846,5.11837526477803e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRN1,Secernin-1,42119,0.0455382625750867,0.00561509719745293,0.0345326720680789,0.0565438530820944,5.49678208264164e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0501263662153801,0.00618723261225744,0.0379993902953555,0.0622533421354047,5.88745189322087e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF1,Scavenger receptor class F member 1,42310,0.034859426276658,0.00431537415566149,0.0264012929315614,0.0433175596217545,7.13261896227288e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0393236710176476,0.00487013712620831,0.0297782022502793,0.0488691397850159,7.4633714933284e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSV,Cathepsin L2,42200,0.0328153197978557,0.00406567748880639,0.0248465919197952,0.0407840476759163,7.53544035140728e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN4,CCN family member 4,42262,0.0320220623294045,0.00396997683145674,0.0242409077397493,0.0398032169190597,7.86179206422829e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PER3,Period circadian protein homolog 3,39657,0.10100431697252,0.012537065603094,0.0764316683904556,0.125576965554584,8.66064507125702e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0460374438671082,0.00571475415213961,0.0348365257289146,0.0572383620053018,8.6893854038164e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,42181,0.0344212189513606,0.00427593481819965,0.0260403867076893,0.0428020511950319,8.96473873228693e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0249205476069871,0.00309607373174886,0.0188522430927593,0.0309888521212148,9.028407364336e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0727552421282936,0.00904191238525328,0.0550330938531972,0.0904773904033901,9.39455559542218e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",39638,0.07198796978441,0.00895042389398495,0.0544451389521995,0.0895308006166205,9.66506691463199e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0322876624468461,0.00401590027345439,0.0244164979108755,0.0401588269828167,9.87956134085113e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0301904164949437,0.00375740290041742,0.0228259068101255,0.0375549261797618,1.0134558554649e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0617809826982351,0.00769672554291201,0.0466954006341276,0.0768665647623426,1.09811222016683e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,41920,0.0234075346182998,0.0029171194839068,0.0176899804298424,0.0291250888067571,1.10700678390716e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,TMSB10,Thymosin beta-10,42137,0.0618815735204852,0.00771594937146719,0.0467583127524095,0.0770048342885608,1.14423437583622e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SDK2,Protein sidekick-2,39736,0.0322046196145944,0.00401550638160164,0.0243342271066551,0.0400750121225336,1.16267289915953e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA6,Integrin alpha-6,42119,0.0413915226347382,0.00516603820774915,0.0312660877475498,0.0515169575219265,1.21817369145936e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,KLF4,Krueppel-like factor 4,39586,0.0331461990077227,0.00413688311922685,0.0250379080940381,0.0412544899214074,1.23904753108293e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0586755082608874,0.00732846662775449,0.0443117136704886,0.0730393028512862,1.27740134356978e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,C7orf50,Uncharacterized protein C7orf50,39929,0.0185934553052648,0.00232332952573543,0.0140397294348234,0.0231471811757063,1.33325739791345e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG4A,Cysteine protease ATG4A,41843,0.0471918160841997,0.00590473046966585,0.0356185443636546,0.0587650878047447,1.43466044851406e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS4,Thrombospondin-4,42189,0.0368731089402839,0.00461595431282769,0.0278258384871417,0.0459203793934262,1.47898193542253e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGN,Secretagogin,41913,-0.0360166374588731,0.00451213850995287,-0.0448604289383807,-0.0271728459793654,1.55508486748716e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCA,Tubulin-specific chaperone A,39736,0.0684372879503213,0.0085770110333429,0.0516263463249692,0.0852482295756733,1.61778591139248e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0228998076849709,0.00287105810492196,0.0172725337993238,0.0285270815706179,1.66050632000319e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX9,Sorting nexin-9,42145,0.0550012353455078,0.00689784126751654,0.0414814664611754,0.0685210042298402,1.66285474655994e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0418497758846934,0.00526267184045336,0.0315349390774049,0.052164612691982,2.01080090984262e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS2,Trypsin-2,42217,0.0460589733410421,0.00580387598618941,0.0346833764081108,0.0574345702739733,2.252263265711e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0381239964573695,0.00480995994555736,0.0286964749640771,0.047551517950662,2.44192074498093e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0129720798815328,0.00163924668825818,0.00975915637254676,0.0161850033905188,2.69483455987998e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,FXN,"Frataxin, mitochondrial",42262,0.0583527156086545,0.00737764326200034,0.0438925348151339,0.0728128964021752,2.78408496032693e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0746094768140197,0.00943785243930379,0.0561112860329843,0.0931076675950552,2.91935637407566e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,EPCAM,Epithelial cell adhesion molecule,42125,-0.0750401355224925,0.00949803546911805,-0.0936562850419639,-0.0564239860030211,2.98918716813863e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3BP,Galectin-3-binding protein,39979,0.0251855354951746,0.00318838162680388,0.018936307506639,0.0314347634837103,3.0660144131671e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,C7,Complement component C7,39722,-0.0268489697663889,0.00340464448004329,-0.0335220729472738,-0.0201758665855041,3.4124447401565e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0461044733253508,0.00584796927855943,0.0346424535393743,0.0575664931113272,3.42196919729759e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0243349371412365,0.0030883385587465,-0.0303880807163796,-0.0182817935660933,3.53388760745243e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PPL,Periplakin,39657,0.025952263707819,0.00329387210070909,0.0194962743904292,0.0324082530252089,3.61076327318302e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD14,Monocyte differentiation antigen CD14,41932,0.0329700733832154,0.00418706335077827,0.02476342921569,0.0411767175507408,3.69122096323257e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH1,Protocadherin-1,42264,0.0164482735065535,0.00209214091216305,0.0123476773187139,0.0205488696943931,4.06457799323697e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ANPEP,Aminopeptidase N,42187,0.0217780036361743,0.00277030143726116,0.0163482128191424,0.0272077944532061,4.0887291583165e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKZ,Diacylglycerol kinase zeta,41913,0.0288152922871698,0.00366841493449584,0.0216251990155579,0.0360053855587816,4.30390210243021e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL2,C-C motif chemokine 2,41992,0.0413602844792821,0.00526741665240013,0.0310361478405778,0.0516844211179863,4.40122006863703e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CDCP1,CUB domain-containing protein 1,42016,0.0446373104302669,0.00568638446281133,0.0334919968831567,0.0557826239773771,4.47968214974629e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ACYP1,Acylphosphatase-1,39701,0.0520874030507148,0.00664077374206701,0.0390714865162635,0.0651033195851662,4.7802219865083e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0608429951237898,0.00775950176151184,0.0456343716712266,0.0760516185763531,4.86540648670089e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0501654191212331,0.00641791000642622,0.0375863155086377,0.0627445227338285,5.91124195212428e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA4,Annexin A4,42088,0.0574487673685476,0.00735662257494445,0.0430297871216565,0.0718677476154387,6.18224232424563e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5,T-cell surface glycoprotein CD5,42239,0.0281670821063122,0.00361040543549971,0.0210906874527328,0.0352434767598917,6.55331142910202e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CA9,Carbonic anhydrase 9,42262,-0.0368650332221334,0.00474023001623035,-0.0461558840539449,-0.0275741823903219,7.95296159539724e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DHPS,Deoxyhypusine synthase,39919,0.0318499555025993,0.00410305654086509,0.0238079646825037,0.0398919463226948,9.04402890763291e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0271164551565857,0.00349616167097002,0.0202639782814845,0.033968932031687,9.38803151686067e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC13,Mucin-13,41839,0.0414203239122212,0.00534188504580996,0.0309502292224337,0.0518904186020088,9.56194837996294e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,LGMN,Legumain,42185,0.0285797768118,0.00368609634519338,0.021355027975221,0.035804525648379,9.58078560246788e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD274,Programmed cell death 1 ligand 1,42016,0.0265367146313333,0.003427206690998,0.0198193895169772,0.0332540397456893,1.04068794234195e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TSNAX,Translin-associated protein X,39575,0.0310082198184351,0.00400813286641951,0.0231522794002528,0.0388641602366173,1.11298684097457e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB4,Ephrin type-B receptor 4,42310,-0.0199183746008286,0.00257726401199902,-0.0249698120643467,-0.0148669371373105,1.16368504133727e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RB,Interleukin-17 receptor B,41934,-0.0423512335116342,0.00548277936429565,-0.0530974810656537,-0.0316049859576147,1.20372266124125e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,STK4,Serine/threonine-protein kinase 4,42145,0.0684691330768567,0.00887236759678411,0.0510792925871598,0.0858589735665535,1.27288945067824e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PTN,Pleiotrophin,41900,0.0389946223606039,0.00506035795382751,0.029076320771102,0.0489129239501058,1.39105270689846e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0563850984217149,0.00732799704282095,0.0420222242177859,0.070747972625644,1.51982044046906e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0393246724170824,0.00511219595204659,0.029304768351071,0.0493445764830937,1.54311990561069e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZD2,PDZ domain-containing protein 2,39575,0.0461818487758567,0.00600711127694249,0.0344079106730494,0.057955786878664,1.62390395550947e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,42185,0.030753352642671,0.00400780847468284,0.0228980480322927,0.0386086572530494,1.78938803634845e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0181341493939544,0.00236360904233064,0.0135014756709864,0.0227668231169225,1.82839151657889e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS7_LGALS7B,Galectin-7,42076,0.0342118719763885,0.00446710615242002,0.0254563439176452,0.0429674000351317,2.00721702757932e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TEK,Angiopoietin-1 receptor,42181,0.0172058668490399,0.00224696725185803,0.0128018110353981,0.0216099226626816,2.02569279881845e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0512881043695426,0.00670044155707224,0.0381552389176811,0.0644209698214042,2.09916548323641e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0244099449542275,0.00319531479444259,-0.030672761951335,-0.01814712795712,2.33321123597469e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,LBP,Lipopolysaccharide-binding protein,42217,-0.0454861547766346,0.00595474626233207,-0.0571574574508054,-0.0338148521024637,2.34145133682376e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0283981118748004,0.00371769023332372,0.0211114390174859,0.0356847847321149,2.34361092306625e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM2,Paralemmin-2,39929,0.0301665149946899,0.00395163268184177,0.02242131493828,0.0379117150510998,2.45973864645775e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0244925916827649,0.00320899013404491,0.0182029710200369,0.0307822123454929,2.45982112545463e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ASS1,Argininosuccinate synthase,39575,0.0601498406898556,0.00788608343438462,0.0446931171584617,0.0756065642212494,2.59462734261685e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0251128086137933,0.00329842331136718,0.0186478989235137,0.031577718304073,2.87726396169535e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM1,Intercellular adhesion molecule 1,42126,0.0224984076485097,0.0029568274334458,0.016703025878956,0.0282937894180635,2.94522125213134e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0330967051289162,0.00435018592099832,0.0245703407237595,0.0416230695340729,2.96344340110954e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TPMT,Thiopurine S-methyltransferase,41843,0.0552126962433,0.00726108400682516,0.0409809715899227,0.0694444208966773,3.06616451899221e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0509407632699023,0.00670516365225792,0.0377986425114768,0.0640828840283279,3.26310410277152e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM3,Myomesin-3,39736,-0.0752034296241169,0.00990146064760957,-0.0946102924934317,-0.0557965667548022,3.31957815947725e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0232526247854867,0.00306999466151591,0.0172354352489155,0.0292698143220579,3.84855953330459e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,XRCC4,DNA repair protein XRCC4,41839,0.0283466076045992,0.00374367543577787,0.0210090037504746,0.0356842114587239,3.92231955689043e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CD84,SLAM family member 5,42119,0.0244512713976671,0.00323343409448026,0.0181137405724858,0.0307888022228485,4.22430088053106e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0865543355108345,0.0114464850682603,-0.108989446244625,-0.0641192247770442,4.23802877701658e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ERMAP,Erythroid membrane-associated protein,39657,0.0343699399218411,0.00455205206307258,0.0254479178782189,0.0432919619654634,4.67986212928367e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,APOB,Apolipoprotein B-100,39990,0.017534830218071,0.00232389440575332,0.0129799971827945,0.0220896632533475,4.85046998718634e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIT2,Slit homolog 2 protein,41839,0.0394382586513394,0.00523971912102256,0.0291684091741351,0.0497081081285436,5.53603066783824e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1B,Lithostathine-1-beta,42310,-0.0435515124036372,0.00579757781844036,-0.0549147649277803,-0.0321882598794941,6.1819451365883e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,NGRN,Neugrin,39929,0.0171501667942389,0.00228568855118261,0.012670217233921,0.0216301163545568,6.68972982134386e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TCOF1,Treacle protein,39958,0.024776343293487,0.00330596449222897,0.0182966528887183,0.0312560336982558,7.15296805198265e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TF,Serotransferrin,39979,0.0163378123152819,0.0021890769461747,0.0120472215007795,0.0206284031297843,9.05101498703199e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0256833273024914,0.0034439770707026,0.0189331322439143,0.0324335223610685,9.46441039038694e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH1,Acid ceramidase,39876,0.0358830202827073,0.00481680203543351,0.0264420882932576,0.045323952272157,1.00497833249698e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAV,Integrin alpha-V,42262,0.0125602268680509,0.00168766872738445,0.00925239616237741,0.0158680575737244,1.04813022640059e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PYY,Peptide YY,39575,0.0758495927673411,0.0102047134106611,0.0558483544824454,0.0958508310522368,1.14235561313839e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,41913,0.0495325428259687,0.00666743288142951,0.0364643743783669,0.0626007112735706,1.16058583612167e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD276,CD276 antigen,42123,-0.0270590113230586,0.0036460078056169,-0.0342051866220677,-0.0199128360240494,1.22668302988901e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PRELP,Prolargin,42123,0.017635842307478,0.00237638432571551,0.0129781290290756,0.0222935555858804,1.22901897152974e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.032581822114076,0.00439248335507225,-0.0411910894900176,-0.0239725547381344,1.26337286571795e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0350407245944874,0.00472931052383267,-0.0443101732211994,-0.0257712759677753,1.34454461303778e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,EPPK1,Epiplakin,39638,0.0559872606504375,0.00755497852434062,0.0411795027427299,0.0707950185581451,1.34873744891409e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSA,Arylsulfatase A,42137,0.033893002707812,0.00458244957651449,0.0249114015378436,0.0428746038777804,1.48303949361762e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SPAG1,Sperm-associated antigen 1,39934,0.0440421666820889,0.00595500728595355,0.03237035240162,0.0557139809625579,1.5045199029106e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA1,GDNF family receptor alpha-1,42247,0.0214037269774046,0.00289840162076819,0.0157228598006989,0.0270845941541102,1.61690419817269e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,DDT,D-dopachrome decarboxylase,39966,0.0305847139850905,0.00414534533324301,0.0224598371319342,0.0387095908382468,1.7176753435299e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0285437638735605,0.00387358570031335,0.0209515359009463,0.0361359918461747,1.82106557820317e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA2,Annexin A2,39492,0.0529030036470756,0.00719463430439901,0.0388015204104536,0.0670044868836977,2.07535920215813e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMA,Granzyme A,42296,0.0253013556562333,0.00344657217990462,0.0185460741836202,0.0320566371288463,2.2391684208937e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF3,Trefoil factor 3,42143,-0.0268850322211367,0.00366529339247133,-0.0340690072703805,-0.0197010571718928,2.34268717284046e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.020062105855059,0.00273835289981821,0.0146949341714154,0.0254292775387027,2.5302241431829e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP3,Stromelysin-1,42137,-0.0369213582323999,0.00504774931214888,-0.0468149468842117,-0.0270277695805881,2.73023268309522e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NID2,Nidogen-2,42137,0.0541479292438441,0.00740572103515752,0.0396327160149354,0.0686631424727529,2.78720467419228e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.026108941290158,0.0035732724142485,0.0191053273582309,0.033112555222085,2.88855202386448e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,39934,0.0270445281985196,0.00370203135965467,0.0197885467335965,0.0343005096634428,2.95168545870248e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.027130398299157,0.00372120064869177,0.0198368450277211,0.0344239515705928,3.29247502050826e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PVR,Poliovirus receptor,42249,0.0276572314192538,0.00379568496581764,0.0202176888862512,0.0350967739522563,3.3558515896781e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL11,C-X-C motif chemokine 11,42249,0.0577229598778624,0.00792428851875302,0.0421913543811064,0.0732545653746183,3.41046407986316e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0416413749869462,0.00571652006044008,0.0304369956684836,0.0528457543054087,3.41310797097163e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS53,Serine protease 53,39929,0.0283632455374479,0.00389310089733698,0.0207327677786675,0.0359937232962284,3.41723386604399e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0343906095884633,0.00472167193203067,0.0251361326016832,0.0436450865752434,3.47222369909637e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,39757,0.0262403918134926,0.00360284886542165,0.0191788080372661,0.033301975589719,3.47869582841723e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0435465536262236,0.00597981421476858,0.0318261177652772,0.05526698948717,3.50589004171886e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0511412390436433,0.00703103652393367,0.0373604074567333,0.0649220706305532,3.6924975385373e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0356762150415069,0.00491078091591768,0.0260510844463082,0.0453013456367055,3.94299368602167e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS1,Nephrin,39657,0.0246757959021354,0.00339825696064003,0.018015212259281,0.0313363795449899,4.09113887754241e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0363587787858332,0.00501040161940776,0.026538391611794,0.0461791659598724,4.18351103791201e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR2,Interferon gamma receptor 2,42016,0.0388518057872425,0.00536253024904194,0.0283412464991203,0.0493623650753647,4.55871296037348e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SF3B4,Splicing factor 3B subunit 4,42070,0.0532483447634815,0.00735589738170405,0.0388307858953416,0.0676659036316214,4.76967459148039e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN3,Calsyntenin-3,39929,0.0222896386600156,0.00308420795921609,0.0162445910599521,0.0283346862600792,5.25433422786301e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,42032,0.021118971993596,0.00292382032467118,0.0153882841572404,0.0268496598299515,5.3562299552439e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML2,Trem-like transcript 2 protein,42137,0.0252497258525578,0.0035014112785581,0.018386959746584,0.0321124919585317,5.83618922770372e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0536799019285127,0.0074667231070085,0.039045124638776,0.0683146792182494,6.86583193862577e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0230124798304947,0.00320412401587289,0.0167323967593839,0.0292925629016056,7.22083235911578e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,39638,0.0181069377918806,0.00252128478071593,0.0131652196216774,0.0230486559620838,7.33177568258954e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR2,Folate receptor beta,42249,-0.0211615993701385,0.0029494747162138,-0.0269425698139176,-0.0153806289263594,7.62020320229155e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0491763683816621,0.00685777160794953,0.035735136030081,0.0626176007332431,7.93028379131264e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA1,Carboxypeptidase A1,42310,0.0470084530594605,0.00657526450900104,0.0341209346218184,0.0598959714971025,9.164391828637e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ERI1,3'-5' exoribonuclease 1,39757,0.0249746301948065,0.0035036926761596,0.0181073925495336,0.0318418678400793,1.08057769652958e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSZ,Cathepsin Z,42168,0.0233322695798931,0.00327834993767569,0.0169067037020488,0.0297578354577375,1.15776590582713e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0441172111967767,0.00621074600033585,0.0319441490361184,0.056290273357435,1.27866140386628e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK1D,Casein kinase I isoform delta,39657,0.0466493295634398,0.00656801640437388,0.033776017410867,0.0595226417160126,1.30047696127134e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.038966290282911,0.00549692719487095,0.028192312980964,0.0497402675848581,1.43593478379081e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSL,Cathepsin L1,42145,0.0176010008836526,0.002485277102888,0.0127298577619921,0.022472144005313,1.48981291562886e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPK2,Death-associated protein kinase 2,39657,0.0399139348127706,0.00565316214202432,0.0288337370144029,0.0509941326111382,1.75903667460103e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0532440630512462,0.00756887126994303,0.0384090753621579,0.0680790507403345,2.11518261462654e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0487189190516486,0.00692695784579796,0.0351420816738846,0.0622957564294126,2.11709762690465e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.031946493686914,0.00454759415223632,0.0230332091485308,0.0408597782252971,2.26773792143264e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0378107072364662,0.00538421808934239,0.0272576397813551,0.0483637746915773,2.30734854458977e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,HGFAC,Hepatocyte growth factor activator,39897,0.0193513108567449,0.00275763775974913,0.0139463408476367,0.0247562808658532,2.39057825755677e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0211765698789133,0.00302577747053774,0.0152460460366594,0.0271070937211673,2.70425118271654e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1,Integrin beta-1,42167,0.0149787998300416,0.00214339156249288,0.0107777523675556,0.0191798472925277,2.910935086397e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GC,Vitamin D-binding protein,39979,0.0184331601557766,0.00263844205796456,0.0132618137221661,0.0236045065893871,2.97812209702732e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR15L,Protein GPR15L,39930,0.0443989747290232,0.00635887234334727,0.0319355849360626,0.0568623645219839,3.06826047415478e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CLC,Galectin-10,42119,-0.0475750109643153,0.00681877931538362,-0.0609398184224672,-0.0342102035061634,3.15458760131483e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.0387676906496787,0.0055590040078014,0.027872042794388,0.0496633385049694,3.22924969468898e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,BRDT,Bromodomain testis-specific protein,39575,0.0259608392035011,0.00373119176814921,0.0186477033379286,0.0332739750690735,3.65351616313717e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC1,MANSC domain-containing protein 1,42181,-0.0196268951923302,0.00282188729859656,-0.0251577942975794,-0.0140959960870809,3.68073592590179e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR3,Toll-like receptor 3,42296,0.0431863131630412,0.00621203719103064,0.0310107202686211,0.0553619060574612,3.76351095776433e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CD101,Immunoglobulin superfamily member 2,39930,0.0306290071842877,0.00440851263486059,0.021988322419961,0.0392696919486145,3.91655301528824e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0285966837499636,0.00411895499636215,0.0205235319570938,0.0366698355428334,4.02033558859512e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRB1,Chymotrypsinogen B,42137,0.0411854311874003,0.00593422854376854,0.029554343241614,0.0528165191331866,4.09024591399879e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0260184875307622,0.0037518463105183,-0.033372106299378,-0.0186648687621463,4.25104942890377e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DTNB,Dystrobrevin beta,39900,0.0321131639300089,0.00463172101351521,0.0230349907435191,0.0411913371164987,4.33514096285485e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,C8B,Complement component C8 beta chain,39979,0.0213887667789623,0.00308871634111303,0.0153348827503807,0.0274426508075438,4.60083065565189e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0225562477980575,0.00326029022727984,-0.028946416643526,-0.016166078952589,4.76772992843759e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD1,Polycystin-1,39958,0.0191644580572644,0.00277157728039041,0.0137321665876992,0.0245967495268296,4.94217843008234e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA10,N-alpha-acetyltransferase 10,39575,0.0357392577539338,0.00517163656042196,0.0256028500955067,0.0458756654123608,5.09260350153608e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0258284681952204,0.00374138877118823,0.0184953462036915,0.0331615901867493,5.29911974025208e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0285320305612938,0.0041367881262142,0.020423925833914,0.0366401352886737,5.5953873733851e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0474310530335234,0.00688405963436735,-0.0609238099168834,-0.0339382961501634,5.82737460923321e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GGH,Gamma-glutamyl hydrolase,41933,0.0237219585665007,0.00345381084563769,0.0169524893090508,0.0304914278239506,6.7831318050739e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TNF,Tumor necrosis factor,41880,0.0253918282967071,0.00369742681751801,0.0181448717343718,0.0326387848590424,6.82760042909132e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0346396556380946,0.00504786669800537,0.024745836910004,0.0445334743661851,7.08070689400223e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0241307781116118,0.00351728488847584,-0.0310246564930245,-0.0172368997301992,7.15926698882271e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,L1CAM,Neural cell adhesion molecule L1,42181,0.0206477404142652,0.00301463987871516,0.0147390462519835,0.0265564345765469,7.74828375645356e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0477082793060075,0.00698239018774947,0.0340227945380186,0.0613937640739965,8.76971851800812e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA9,Serpin A9,42025,0.0500172975789867,0.00734552936450302,0.0356200600245608,0.0644145351334127,1.02305278880329e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1A,Protein phosphatase 1A,41843,0.0216003131366089,0.00318430579316425,0.015359073782007,0.0278415524912108,1.22393972541211e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP9,Caspase-9,39657,0.0442095443204224,0.00651911565069199,0.0314320776450661,0.0569870109957787,1.2497895479172e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML1,Trem-like transcript 1 protein,39990,0.0366340250806241,0.0054042068010151,0.0260417797506345,0.0472262704106137,1.27166185664536e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0306214929041623,0.00452084296236097,0.0217606406979348,0.0394823451103898,1.32015693255553e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CR1,Complement receptor type 1,39970,0.0244902676651713,0.00361764936282983,0.0173996749140248,0.0315808604163177,1.35436157889948e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DMD,Dystrophin,39638,0.0354636160765176,0.00525024538030671,0.0251731351311164,0.0457540970219188,1.50371212190008e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PMM2,Phosphomannomutase 2,39575,0.0413479983646668,0.00612154475607856,0.0293497706427528,0.0533462260865807,1.50573468416059e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0426438183688006,0.00631490893785907,0.0302665968505968,0.0550210398870043,1.52220042658359e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH1,Neurexophilin-1,41839,0.0265521503214117,0.00394077262413424,0.0188282359781085,0.0342760646647148,1.67449488878006e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,C2orf69,UPF0565 protein C2orf69,39649,0.0403286775818296,0.0060081362668184,0.0285527304988656,0.0521046246647937,2.00904187150914e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,EDF1,Endothelial differentiation-related factor 1,39934,0.045418813301142,0.00676938307486771,0.0321508224744013,0.0586868041278827,2.04672218050277e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0159197807853982,0.00237332814647215,0.0112680576183128,0.0205715039524836,2.05344792563566e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0259726750966198,0.0038733314553399,-0.033564404749086,-0.0183809454441536,2.10239721536176e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0321868225871531,0.00481783601048886,0.022743864006595,0.0416297811677113,2.4720066084349e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN2,Dynactin subunit 2,42070,0.0643718717217493,0.00963998090046085,0.045477509156846,0.0832662342866525,2.52421242179695e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPH,Hephaestin,39958,0.0189652850635289,0.00284433519055235,0.0133903880900463,0.0245401820370115,2.71819917295568e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0177159253452789,0.00266819005890556,0.012486272829824,0.0229455778607338,3.28736997150338e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,42262,0.0247800641742735,0.00373319095470145,0.0174630099030587,0.0320971184454883,3.30481157698953e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM,Paralemmin-1,39859,0.020681231981889,0.00312128206570454,0.0145635191331082,0.0267989448306699,3.60940630397218e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0336104385821186,0.0050872437196863,0.0236394408915335,0.0435814362727038,4.07710262169875e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LF,CMRF35-like molecule 1,42262,0.0401297167222605,0.00610004128132302,0.0281736358108674,0.0520857976336536,4.92199740031624e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,AFAP1,Actin filament-associated protein 1,39736,0.0561294320244531,0.00853915441793322,0.0393926893653039,0.0728661746836022,5.14515170421462e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0214446382010823,0.00326431823576614,-0.027842701943184,-0.0150465744589807,5.2362176046436e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0681016300460882,0.0103767309744637,0.0477632373361393,0.0884400227560371,5.47053541811723e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DENR,Density-regulated protein,39657,0.0384985620045208,0.00587181797909724,0.0269897987654902,0.0500073252435514,5.75407179276217e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR2,Complement factor H-related protein 2,39904,0.0382266341085343,0.00583074124273357,0.0267983812727765,0.0496548869442921,5.76580321830582e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP10,Bone morphogenetic protein 10,39736,0.0188916042269499,0.00288836520858322,0.0132304084181268,0.024552800035773,6.39623932136997e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN1,Ficolin-1,39978,0.0371391552644608,0.00568620328624143,0.0259941968234276,0.048284113705494,6.79120195287179e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSS,Cathepsin S,39358,0.0160828507819961,0.00246742474862158,0.0112466982746977,0.0209190032892944,7.44047008469514e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,HPCAL1,Hippocalcin-like protein 1,42296,0.0487344257556125,0.00748203994283222,0.0340696274676614,0.0633992240435637,7.59723044387604e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0284906076226585,0.00437544371922891,0.0199147379329698,0.0370664773123472,7.70854395199863e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS22,Brain-specific serine protease 4,39657,0.0230221910161193,0.00353647118735732,0.016090707488899,0.0299536745433397,7.84404599571465e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.03934465687601,0.00605848331219879,0.0274700295841004,0.0512192841679197,8.70000935293195e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP8,Caspase-8,42224,0.0402740500686246,0.00620545433777265,0.0281113595665902,0.052436740570659,8.87447293296829e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSH,Pro-cathepsin H,41865,0.0491619398813854,0.00758937524170269,0.0342867644076481,0.0640371153551226,9.63969419155636e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SMS,Spermine synthase,39586,0.0423795332961961,0.00655751706040728,0.0295267998577978,0.0552322667345944,1.07177664468993e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LACRT,Extracellular glycoprotein lacritin,39895,0.0299449081103168,0.00463666483464913,0.0208570450344045,0.0390327711862291,1.1024301500884e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN5,Contactin-5,42170,0.0242165354221459,0.00376125614931242,0.0168444733694936,0.0315885974747983,1.24789219694032e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH3,Neurexophilin-3,39657,0.019719298855218,0.00306365116873555,0.0137145425644963,0.0257240551459397,1.27291235180151e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0377171772313603,0.00586384743727669,0.026224036254298,0.0492103182084226,1.30130761107133e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0371503045823471,0.00577848347253825,-0.0484761321885221,-0.0258244769761721,1.32695190379595e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.068190939774622,0.0106111056889471,0.0473931726242858,0.0889887069249583,1.35927104111313e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0750224562472133,0.0116955262345238,0.0520992248275467,0.09794568766688,1.46790161492332e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0338410025331303,0.00527796216232452,0.0234961966949743,0.0441858083712864,1.48575793269979e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL12,Stromal cell-derived factor 1,41913,0.0256524312143738,0.00401450713027052,0.0177839972390436,0.0335208651897041,1.71485251944593e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0171217731355587,0.00267924560349178,-0.0223730945184025,-0.0118704517527148,1.71925159727737e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LY75,Lymphocyte antigen 75,42119,0.0250447220302418,0.00392832038434147,0.0173452140769325,0.0327442299835511,1.8838162454933e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOB,Elongin-B,39575,0.0255093050505793,0.00400223064337122,0.0176649329895717,0.0333536771115868,1.91833271014149e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,INSR,Insulin receptor,39657,0.0111435673250972,0.00174979350635611,0.00771397205263926,0.0145731625975552,1.98454742237199e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PVALB,Parvalbumin alpha,42208,0.0721732636242669,0.0113517201176409,0.0499238921936907,0.094422635054843,2.11040965788623e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SPP1,Osteopontin,42286,-0.0284227365478334,0.00447245738073837,-0.0371887530140806,-0.0196567200815862,2.14946460737798e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SCT,Secretin,39649,0.0311787998655125,0.00490643247382042,0.0215621922168245,0.0407954075142005,2.17085761353232e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0366723652798004,0.00577132931594849,-0.0479841707390594,-0.0253605598205414,2.17722957688246e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0393746810732615,0.00620712898293163,0.0272087082667155,0.0515406538798075,2.33502384715201e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0241116602565338,0.00381201455146594,0.0166401117356606,0.0315832087774071,2.62483578113473e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,42070,0.0235985062901332,0.00373392930384276,0.0162800048546014,0.030917007725665,2.69769203697435e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0307230204077896,0.00486119584780635,0.0211950765460892,0.0402509642694901,2.7128679497043e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,42070,-0.026095447960571,0.00413016450491292,-0.0341905703902003,-0.0180003255309417,2.72851106980446e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYM,Ketimine reductase mu-crystallin,39586,0.0487459151005694,0.00772089919264891,0.0336129526829776,0.0638788775181613,2.83316271658955e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0403300678855626,0.00642982876517658,0.0277276035058165,0.0529325322653087,3.66729011883836e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,XCL1,Lymphotactin,42262,0.0346439051660043,0.00554126953668344,0.0237830168741047,0.0455047934579038,4.17339556149516e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,MDM1,Nuclear protein MDM1,39649,0.02004240123913,0.00320576930322291,0.0137590934048131,0.0263257090734469,4.20239459237649e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,41820,0.0422935333359898,0.0067763656428502,0.0290118566760034,0.0555752099959762,4.47121793102444e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF22,Kinesin-like protein KIF22,39575,0.0790872309577725,0.012678380178427,0.0542376058080557,0.103936856107489,4.5963717640714e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0301290011175307,0.00483124125826603,-0.0395982339837321,-0.0206597682513293,4.61412780385844e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO1,Roundabout homolog 1,42144,0.0151725489364349,0.00243354156328972,0.0104028074723871,0.0199422904004828,4.65902625983276e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0537725675704699,0.00863317851808481,0.0368515376750237,0.0706935974659161,4.84880985332361e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NADK,NAD kinase,42145,0.034485977705383,0.00555372788003961,0.0236006710605054,0.0453712843502606,5.4699686690341e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC16,Mucin-16,42070,0.120443313575229,0.0194024297262185,0.082414551311841,0.158472075838618,5.53641565295323e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0191848466132075,0.00309004841992574,0.0131283517101531,0.025241341516262,5.53792828365833e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH17,Cadherin-17,42145,-0.0428630497257137,0.00693191394570857,-0.0564496010593025,-0.0292764983921249,6.45229988249556e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.039371151882131,0.00637452219836565,0.0268770883733343,0.0518652153909277,6.74852836478724e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0260403014968893,0.00421795037361873,0.0177731187645966,0.034307484229182,6.86654130251566e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SAA4,Serum amyloid A-4 protein,39979,0.02078195718514,0.00336774058470268,0.0141811856391227,0.0273827287311572,7.02157882924267e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB1,Carboxypeptidase B,42310,0.0388720230053438,0.00630842248489002,0.0265075149349594,0.0512365310757283,7.3877841210252e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,FEN1,Flap endonuclease 1,41843,0.0402108807464932,0.00653283212204254,0.0274065297872899,0.0530152317056966,7.71479065931837e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0422593884623563,0.00687189889714872,0.0287904666239448,0.0557283103007678,7.98489615534181e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA3,Protein disulfide-isomerase A3,39736,0.0154418870429633,0.00251147904121491,0.010519388122182,0.0203643859637445,8.0887252507163e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LTB,Lymphotoxin-beta,39919,0.0215436304945405,0.00350572974886393,0.0146724001867671,0.0284148608023138,8.25159067505141e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,EBI3_IL27,Interleukin-27,42247,-0.0191006248480176,0.00311204261841508,-0.0252002283801112,-0.0130010213159241,8.60706516346223e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSC,Dipeptidyl peptidase 1,42123,0.0276623195138796,0.00450909152230112,0.0188245001301694,0.0365001388975898,8.76515258304496e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0352648420574391,0.0057556294819274,0.0239838082728614,0.0465458758420168,9.20800231085235e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0249819103370031,0.00407924379884337,0.0169865924912701,0.0329772281827361,9.3747324628546e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QA,Complement C1q subcomponent subunit A,42230,-0.0139178176807241,0.00227430528234492,-0.0183754560341201,-0.00946017932732806,9.63867261713041e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTG,Protogenin,42262,0.0152717724068545,0.00249631142588177,0.0103790020121262,0.0201645428015828,9.75061832417783e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMB,RGM domain family member B,42249,0.0173894595294472,0.00284775936081864,0.0118078511822427,0.0229710678766518,1.04690768912088e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,AGXT,Serine--pyruvate aminotransferase,42145,0.0476134108103522,0.00779803339427074,0.0323292653575816,0.0628975562631229,1.05067674363423e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0252890673359875,0.00414476628342923,0.0171653254204662,0.0334128092515088,1.08049303599895e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0250573318655238,0.00410811537719267,0.0170054257262261,0.0331092380048214,1.09896719066816e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD86,T-lymphocyte activation antigen CD86,39930,0.018881938925899,0.00309902400017614,0.0128078518855537,0.0249560259662442,1.1450848825076e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0308146490517905,0.00506265470178039,0.0208918458363009,0.04073745226728,1.19202814851125e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GFAP,Glial fibrillary acidic protein,41820,0.0281590164888906,0.00462771723808584,0.0190886907022424,0.0372293422755389,1.19814281436024e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM2,Myomesin-2,39575,-0.0345835538167653,0.00568737525828981,-0.0457308093230133,-0.0234362983105173,1.23596167064386e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1B,Interleukin-1 beta,41825,0.0348521390576194,0.00573880128238125,0.0236040885441521,0.0461001895710866,1.28928076453843e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0347348265353831,0.00571959475932958,0.0235244208070972,0.0459452322636691,1.29650344063195e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,39934,0.0179656021356865,0.00296942536117155,0.0121455284277902,0.0237856758435827,1.4923856308741e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A13,Protein S100-A13,39657,0.0219420780857203,0.00363681013225332,0.0148139302265038,0.0290702259449368,1.65757237376728e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,COL1A1,Collagen alpha-1(I) chain,42310,-0.0143833705720715,0.00238783425792641,-0.0190635257176072,-0.00970321542653571,1.74939751466686e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG2,Secretogranin-2,42193,0.0201878361374648,0.00335216721213554,0.0136175884016791,0.0267580838732505,1.76365332053472e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0333082430010878,0.00553156420855335,0.0224663771523232,0.0441501088498523,1.78291649355714e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAD,Chondroadherin,39736,0.0288152606126698,0.00479255299700311,0.0194218567385437,0.0382086644867959,1.88403882935329e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0402208151373468,0.00669943773393195,-0.0533517130958535,-0.0270899171788402,1.97921380345698e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0367308656992226,0.00612052016280592,0.024734646180123,0.0487270852183222,2.00729737724525e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,39736,0.0183384032029237,0.00305685076863176,0.0123469756964054,0.0243298307094419,2.04561040329693e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL3,Myosin light chain 3,39638,-0.0480689199616661,0.00802011592373515,-0.063788347172187,-0.0323494927511452,2.11731967122442e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0278117531945188,0.00464146125975126,-0.0369090172636313,-0.0187144891254064,2.12444234459367e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0343352867998604,0.00575086773558502,0.0230635860381138,0.045606987561607,2.42547963054998e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGR1,Prostaglandin reductase 1,39958,0.0508237603462401,0.0085285891298691,0.0341077256516967,0.0675397950407835,2.60961809763334e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R1,Interleukin-1 receptor type 1,42113,-0.0144342904802856,0.00242592110881812,-0.0191890958535692,-0.00967948510700214,2.74735400032438e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0240028073257698,0.00403530862091798,0.0160936024287706,0.031912012222769,2.79246092377272e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LXN,Latexin,41960,-0.0413857696613218,0.00696763208045941,-0.0550423285390223,-0.0277292107836214,2.92610024451063e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0141858876770966,0.00238896852309371,0.00950350937183298,0.0188682659823603,2.95451720679759e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IMMT,MICOS complex subunit MIC60,39919,0.0269903834196929,0.00454514357976847,0.0180819020033467,0.0358988648360391,2.96467526976991e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0396454920396297,0.00667649749591226,0.0265595569476417,0.0527314271316178,2.97138955619353e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA2,Adenosine deaminase 2,42096,-0.0264637808356523,0.00445942951119997,-0.0352042626776042,-0.0177232989937003,3.02259083614974e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF7,SLAM family member 7,42119,-0.0359694732295232,0.00606186835433999,-0.0478507352040296,-0.0240882112550169,3.03378614563304e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0209275224740172,0.00352934357723634,0.014010009062634,0.0278450358854004,3.12579843931564e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX,Glutaredoxin-1,42057,0.033441612726446,0.0056435233842848,0.0223803068932478,0.0445029185596442,3.18645776545542e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,EFHD1,EF-hand domain-containing protein D1,39934,0.0217043184723158,0.00367115244772179,0.0145088596747811,0.0288997772698505,3.47452373123614e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0259992046318531,0.00440950960677446,0.0173565658025751,0.034641843461131,3.82940060727534e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CA7,Carbonic anhydrase 7,39757,-0.0201723238724612,0.00342427791876923,-0.0268839085932489,-0.0134607391516735,3.95017217215447e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0552916933330843,0.00939783901174013,0.0368719288700736,0.0737114577960949,4.13476753760033e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0205449576587843,0.00349491860499608,0.013694917192992,0.0273949981245766,4.25585179376285e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0306353857187623,0.00521249617476625,0.0204188932162205,0.0408518782213042,4.27053426868425e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0188437120077366,0.00321218049133869,0.0125478382447128,0.0251395857707605,4.58337402533564e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,STX6,Syntaxin-6,41843,0.0390517749799433,0.00666433888124914,0.025989670772695,0.0521138791871916,4.74408888346457e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.01531081384109,0.00261806039473314,0.010179415467413,0.0204422122147669,5.08660667712526e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0338000655092809,0.00578048471520389,0.0224703154674813,0.0451298155510805,5.11482419858414e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LEPR,Leptin receptor,42145,-0.0186719495471419,0.00319415871936067,-0.0249325006370888,-0.012411398457195,5.16195606230566e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0234050902104538,0.00400408508134398,0.0155570834510196,0.031253096969888,5.19946108204613e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,41802,0.0172813516542536,0.00296027536635185,0.011479211936204,0.0230834913723032,5.41534496052199e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,TPM3,Tropomyosin alpha-3 chain,39575,-0.0275781636507171,0.00472473744020188,-0.0368386490335128,-0.0183176782679214,5.4662772102828e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0354056112699062,0.00606786255755407,0.0235126006571003,0.0472986218827122,5.52795368543472e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17C,Interleukin-17C,41913,-0.0420203367254331,0.00720853867485782,-0.0561490725281544,-0.0278916009227117,5.69688233084424e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,39638,0.0238410995065239,0.00410546081962246,0.0157943963000639,0.0318878027129839,6.52912566439167e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RCOR1,REST corepressor 1,41900,0.0263602711820521,0.00454088835718056,0.0174601300019782,0.035260412362126,6.57988021676802e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GLO1,Lactoylglutathione lyase,41900,0.0333072846591383,0.00574596669465995,0.0220451899376048,0.0445693793806718,6.91927372998538e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS2,Growth arrest-specific protein 2,39757,0.0308331394665319,0.005321596256878,0.020402810803051,0.0412634681300128,7.0603191325279e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGF,Hepatoma-derived growth factor,42243,0.0537288496127323,0.00928450570195616,0.0355312184368982,0.0719264807885664,7.32559917066394e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD1,Bromodomain-containing protein 1,39757,-0.0179526621442484,0.00310508054721194,-0.0240386200167838,-0.011866704271713,7.59302286497571e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CILP,Cartilage intermediate layer protein 1,39966,0.032511310624689,0.00563416599707851,0.0214683452704151,0.0435542759789629,8.11561048802517e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0510752426813592,0.00886554014549054,0.0336987839961977,0.0684517013665207,8.57447864524241e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0298774934974668,0.00518789256283233,0.0197092240743155,0.0400457629206182,8.68441013206018e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0211475798361971,0.00367402178667392,0.0139464971343162,0.028348662538078,8.84510502797735e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0425051659826111,0.00739276590413163,0.0280153448105131,0.0569949871547091,9.14236610820083e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0219128324685941,0.00381728033443407,0.0144309630131033,0.0293947019240849,9.69210650167888e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF4,Neurotrophin-4,41843,0.0220504220053019,0.00384781857024081,0.0145086976076299,0.0295921464029739,1.02238252956565e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0286223829661576,0.0049942825037155,0.0188335892588752,0.03841117667344,1.02436881209386e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A12,Protein S100-A12,41910,0.0427408409126577,0.00746248362187601,0.0281143730137807,0.0573673088115346,1.04169371424525e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CDA,Cytidine deaminase,39946,0.0278270725471089,0.00485848149107124,0.0183044488246093,0.0373496962696086,1.04496030967182e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,OCLN,Occludin,39934,0.0258274768003329,0.00451437230623623,0.0169793070801099,0.0346756465205559,1.0847434400775e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0487544869847938,0.00852439447219415,0.0320466738192933,0.0654623001502943,1.09601224523219e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCA2A,Guanylin,42083,-0.020461982401948,0.00357943395843551,-0.0274776729604816,-0.0134462918434144,1.11017196011289e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0399795527461339,0.00699749149162335,0.0262644694225522,0.0536946360697157,1.13076285865807e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF2,Scavenger receptor class F member 2,42249,-0.0164770015358944,0.00288955008594723,-0.022140519704351,-0.0108134833674379,1.20670484653025e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL1,Fc receptor-like protein 1,42145,0.0265342381352076,0.00465586042856816,0.017408751695214,0.0356597245752012,1.2294746553922e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300A,CMRF35-like molecule 8,39736,0.0177647896083351,0.00312498883947258,0.0116398114829688,0.0238897677337013,1.34295509467275e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,39945,0.0287392371067975,0.00505685463455615,0.0188278020230674,0.0386506721905276,1.35436972332254e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0694901755371164,0.0122463221223104,0.0454873841773879,0.0934929668968449,1.42613707738708e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0173685803668688,0.00306769003206543,0.0113559079040205,0.023381252829717,1.52856427182787e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ADM,Pro-adrenomedullin,42262,0.0150422020901228,0.00265891211052052,0.00983073435350254,0.020253669826743,1.5687993497216e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0203344372105998,0.00359559227536209,0.0132870763508901,0.0273817980703095,1.5866269922423e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12A_IL12B,Interleukin-12,42070,0.0442454844004562,0.0078251475599753,0.0289081951829046,0.0595827736180077,1.59690968412333e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,XG,Glycoprotein Xg,42261,0.0198750434737686,0.00352307654612542,0.0129698134433628,0.0267802735041745,1.7203264937074e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD83,CD83 antigen,42119,0.0197746786778353,0.00350544989631922,0.0129039968810496,0.026645360474621,1.72331731978527e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA,Adenosine deaminase,42296,0.0203611474525788,0.00361026241936597,0.0132850331106215,0.0274372617945361,1.73617715067203e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN2,Alpha-actinin-2,39575,-0.0371874887291619,0.00659379139276537,-0.050111319858982,-0.0242636575993417,1.7448514761058e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,COMP,Cartilage oligomeric matrix protein,42042,0.0190854258068355,0.00338774232083774,0.0124454508579935,0.0257254007556775,1.79953666563478e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GNLY,Granulysin,42137,0.0308692738367862,0.00548523228287643,0.0201182185623484,0.041620329111224,1.86246029513796e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.036394111790122,0.00648214043925829,-0.0490991070510682,-0.0236891165291757,2.00998414236423e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,AGT,Angiotensinogen,39990,0.0124679109563635,0.00222156431658761,0.00811364489585176,0.0168221770168752,2.04412999013902e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0283559257593108,0.00505352114359803,0.0184510243178587,0.0382608272007629,2.04954229390007e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QL2,Complement C1q-like protein 2,39657,0.0246818854103079,0.00439851119685261,0.0160608034644768,0.033302967356139,2.05504331340075e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0220281004709547,0.00392794607273246,0.0143293261683991,0.0297268747735103,2.08629357822314e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,COL2A1,Collagen alpha-1(II) chain,39638,0.0450941341691708,0.00804550682941626,0.0293249407835149,0.0608633275548266,2.13394872076756e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP6,Gastrotropin,41881,0.0323902743485338,0.00578158114634356,0.0210583753017004,0.0437221733953672,2.15703587225158e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA1,BolA-like protein 1,39586,0.0311229026150901,0.00556614783926502,0.0202132528501306,0.0420325523800495,2.30544001595772e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,41814,0.0305646905766661,0.00546774403449633,0.0198479122690533,0.0412814688842789,2.31566175018356e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0350385777817507,0.00627448299657405,0.0227405911084656,0.0473365644550358,2.39240889208487e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD46,Membrane cofactor protein,42107,0.0162636248988098,0.00291378483517386,0.010552606621869,0.0219746431757505,2.42884494732955e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRD1,Natural killer cells antigen CD94,42296,0.0267725493946644,0.0047966718376626,0.0173710725928457,0.0361740261964831,2.43002467333577e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0184353976316651,0.00330995869217799,0.0119478785949962,0.024922916668334,2.6001441154887e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0210468451799058,0.00378164195063235,0.0136348269566664,0.0284588634031452,2.66431949666898e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LCP1,Plastin-2,39966,0.0271690899547741,0.00488459328518935,0.017595287115803,0.0367428927937452,2.72415892534062e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.031745354536426,0.00572742131057077,0.0205196087677073,0.0429711003051447,3.04730672082964e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0325250772248771,0.00587739216536011,0.0210053885807713,0.0440447658689829,3.20282846035135e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0440309930797387,0.00798144019901877,0.0283873702896619,0.0596746158698155,3.51960862774083e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RPL14,60S ribosomal protein L14,39638,0.0218830948378829,0.00398889077612298,0.0140648689166818,0.0297013207590839,4.20183299064234e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0249573150158202,0.00456154472454502,-0.0338979426759285,-0.016016687355712,4.54768325822703e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN8,Tetraspanin-8,39930,0.0531721144732199,0.00973549509646857,0.0340905440841415,0.0722536848622983,4.81621900773363e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,AREG,Amphiregulin,42070,-0.0217357928898525,0.00398106582368217,-0.0295386819042695,-0.0139329038754354,4.85135597970526e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.034938776053745,0.00640081598670089,0.0223931767198112,0.0474843753876787,4.9059425648845e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,42093,0.0227186993819044,0.00417169802257317,0.014542171257661,0.0308952275061478,5.24430618035824e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0232768555149453,0.00429269851439922,-0.0316905446031678,-0.0148631664267228,5.98032068210302e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0315613833761717,0.0058247126445664,0.0201449465928216,0.0429778201595219,6.11375178828812e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TPR,Nucleoprotein TPR,39575,0.0270141302611009,0.00498742591078324,0.0172387754759658,0.0367894850462361,6.20781100717002e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0172557316119599,0.00318792044720349,-0.0235040556884788,-0.0110074075354411,6.33375666833789e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NFIC,Nuclear factor 1 C-type,39934,0.0252184646087687,0.0046661023380349,0.0160729040262203,0.0343640251913172,6.6265311703843e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0211237420426062,0.00391054990599894,0.0134590642268483,0.0287884198583641,6.73382544026335e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NME3,Nucleoside diphosphate kinase 3,42144,0.0130789383325405,0.00242868530285835,0.00831871513893811,0.0178391615261428,7.3575214131431e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CA4,Carbonic anhydrase 4,42310,-0.0132752525782169,0.00246778996437362,-0.0181121209083892,-0.00843838424804457,7.59578090708183e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP8,GTPase IMAP family member 8,39560,0.0275721213094474,0.00512547218979511,0.017526195817449,0.0376180468014458,7.62594493534693e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0262713299687625,0.0048883943310965,0.0166900770798134,0.0358525828577117,7.84874003175121e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ICOSLG,ICOS ligand,42070,0.0104242042502279,0.00194404973090795,0.00661386677764835,0.0142345417228075,8.36142889637769e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GSN,Gelsolin,39943,0.0103637857530409,0.00193330841725456,0.00657450125522196,0.0141530702508598,8.45499162012189e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0278900479197236,0.0052186447339152,-0.0381185915981974,-0.0176615042412498,9.22315985777689e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TPP1,Tripeptidyl-peptidase 1,42057,0.0256932971673058,0.0048137531542452,0.0162583409849852,0.0351282533496264,9.57784381724589e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0224949748599611,0.00421841367453691,-0.0307630656620535,-0.0142268840578688,9.83761602317231e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBP1,Z-DNA-binding protein 1,39657,0.0225274340553832,0.00422459264125539,0.0142472324785226,0.0308076356322437,9.88054850911279e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0526706337200778,0.00989009559959235,0.0332860463448768,0.0720552210952788,1.02249922622389e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0168890643995602,0.00317941701332447,0.0106574070534443,0.0231207217456762,1.10533499826421e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN2,Transcobalamin-2,42286,-0.0163374599663692,0.00307717354348549,-0.0223687201116008,-0.0103061998211376,1.11802459147639e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL20,C-C motif chemokine 20,42296,0.0466206762897407,0.00879893691811356,0.0293747599302381,0.0638665926492433,1.18603254795198e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG3,Proteasome assembly chaperone 3,42119,0.0265860359849376,0.00501989247280125,0.0167470467382472,0.0364250252316281,1.20132112545055e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CSDE1,Cold shock domain-containing protein E1,39575,0.0651656373076038,0.0123104459376419,0.0410371632698256,0.089294111345382,1.22296949576069e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN1,Tetraspanin-1,41900,0.0392273417747359,0.0074113485627539,0.0247010985917382,0.0537535849577335,1.22321963618434e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GIP,Gastric inhibitory polypeptide,39638,0.0273695299394415,0.00517045000702119,0.01723544792568,0.0375036119532031,1.22331354458532e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX5,Sorting nexin-5,39638,0.0160849160521883,0.00304213209789331,0.0101223371403174,0.0220474949640592,1.26448798108655e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA,Lymphotoxin-alpha,42119,0.0214794406216878,0.00406698763142319,0.0135081448640983,0.0294507363792772,1.30178866109494e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP1,Interstitial collagenase,41693,0.048407440815112,0.00916548139140055,0.0304430972879669,0.0663717843422571,1.30185916824496e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0379739509581101,0.00719299100297429,0.0238756885922805,0.0520722133239397,1.32114514648873e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MDK,Midkine,42129,0.0274081734908568,0.0051999121301367,0.0172163457157889,0.0376000012659248,1.37849514387663e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0361510974186444,0.00686976415176235,0.0226863596811902,0.0496158351560986,1.44396290861424e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0306400994137382,0.00582217591591457,0.0192286346185456,0.0420515642089307,1.44624485214265e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0148524281634535,0.00282772631008134,0.00931008459569412,0.020394771731213,1.52901016649167e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,BGN,Biglycan,41820,-0.0629258041172287,0.011991730540489,-0.0864295959765871,-0.0394220122578703,1.56617822595709e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,APRT,Adenine phosphoribosyltransferase,42002,0.0250743268085039,0.00478375468036926,0.0156981676349801,0.0344504859820276,1.61644374291525e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC2,Mucin-2,39966,0.0495498698753098,0.00946154244914999,0.0310052466749758,0.0680944930756438,1.66144864619048e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE,Angiotensin-converting enzyme,39990,-0.0144206540350012,0.00275708997981701,-0.0198245503954425,-0.00901675767455986,1.7215394831433e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT2,Angiopoietin-2,42262,-0.0198185970274768,0.00379507297455649,-0.0272569400576075,-0.0123802539973461,1.79414032856091e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,STAM,Signal transducing adapter molecule 1,39919,0.0192368229620979,0.00368722443093276,0.0120098630774697,0.0264637828467261,1.8490323782766e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ENSA,Alpha-endosulfine,39919,0.0281450655128555,0.00540381683327863,0.0175535845196294,0.0387365465060816,1.93854271801685e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTL1,Cytokine-like protein 1,39966,0.0135445801720965,0.00260359087195624,0.00844154206306231,0.0186476182811308,2.00296815361704e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0285838821094769,0.00549767130806552,0.0178084463456685,0.0393593178732854,2.03561140457226e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,41900,0.0272976953792185,0.00527449202032116,0.0169596910193891,0.037635699739048,2.30714477891513e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0288023347956056,0.00557065355210917,0.0178838538334717,0.0397208157577396,2.37717355272588e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.0116549825722045,0.00225715711242049,0.00723095463186036,0.0160790105125487,2.45726058339089e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SELENOP,Selenoprotein P,39979,0.0118941857818954,0.00231239216959607,0.00736189712948708,0.0164264744343037,2.73902633153149e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,39575,0.0229326908265022,0.00446338567329168,0.0141844549068505,0.0316809267461539,2.82510237388399e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP9,Fatty acid-binding protein 9,42119,0.0293633319288798,0.00572642848889971,0.0181395320906364,0.0405871317671232,2.9737754415479e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0340092910926313,0.00664898086591576,0.0209772885954364,0.0470412935898262,3.18937841183295e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CABP2,Calcium-binding protein 2,39649,0.0340126802226683,0.00667210421545683,0.0209353559603729,0.0470900044849637,3.49413289564852e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0202922978205228,0.00398423065647819,-0.02810138990722,-0.0124832057338255,3.57032134076523e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0371190665699501,0.00728872260592287,0.0228331702623413,0.051404962877559,3.58879941103226e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP1,"Fatty acid-binding protein, liver",42123,-0.0491894115863831,0.00966218643732373,-0.0681272970035376,-0.0302515261692286,3.61118912060361e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0331654610960243,0.00652253112573551,0.0203813000895827,0.0459496221024659,3.74142080282491e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0245848697442211,0.00485217811455911,-0.034095138848757,-0.0150746006396853,4.09901178900411e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GRN,Progranulin,42077,0.0129415754715237,0.00255623587881039,0.00793135314905532,0.017951797793992,4.18710551557236e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0321341081147812,0.00636437139319094,0.0196599401841269,0.0446082760454354,4.51062280888665e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGES2,Prostaglandin E synthase 2,39579,0.0286993537602061,0.00570030743972603,0.0175267511783431,0.0398719563420692,4.86185501652859e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0226597258431413,0.00450808339863313,0.0138238823818203,0.0314955693044622,5.07482970762414e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SELL,L-selectin,39979,0.0119393778198426,0.00238184680451561,0.00727095808299205,0.0166077975566932,5.44918092711801e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0499314400207259,0.00996449774226583,0.0304010244458848,0.0694618555955669,5.48510539579909e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0260206589441606,0.00520523372636941,-0.0362229170478447,-0.0158184008404766,5.8364621568278e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0228165102040272,0.00456541259372283,0.0138683015203305,0.031764718887724,5.88892909782313e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH5,Cadherin-5,42310,-0.0154309123330071,0.00309055727993077,-0.0214884046016714,-0.00937342006434279,6.02032982911111e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB2,Calretinin,41839,0.0148787726643052,0.00298767195940763,0.00902293562386629,0.0207346097047442,6.43669744343335e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,THBD,Thrombomodulin,42145,0.0149389766653456,0.00300466799544972,0.00904982739426411,0.020828125936427,6.7103398549313e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CST5,Cystatin-D,41846,0.0283969382709351,0.00571691327840883,0.0171917882452538,0.0396020882966164,6.87804930368681e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB8,Serpin B8,42296,0.0295151786473501,0.00594473130705974,0.017863505285513,0.0411668520091872,6.95527840285147e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0186357840464416,0.00375892392515464,0.0112682931531385,0.0260032749397447,7.23672060528272e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAC1,Cartilage acidic protein 1,42310,0.0155815740177212,0.00315023525384741,0.00940711292018024,0.0217560351152621,7.65877634543264e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ECM1,Extracellular matrix protein 1,39720,0.0184321460503103,0.00373095390075638,0.0111194764048278,0.0257448156957928,7.91255053376563e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0316339914161345,0.00640607729534032,0.0190780799172674,0.0441899029150015,8.00091941958749e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0492038907345309,0.0099721861362886,0.0296584059074053,0.0687493755616566,8.16977967329951e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTXR,Neuronal pentraxin receptor,42145,0.0171159754627567,0.00347084940809874,0.0103131106228832,0.0239188403026302,8.26310880671404e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0234732890734361,0.00477446566218791,0.0141153363755478,0.0328312417713244,8.91983875532372e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFLAM,Pikachurin,39930,0.0155101215465278,0.0031551926853111,0.0093259438833181,0.0216942992097376,8.96849421967271e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,39757,0.0358820491353475,0.00731174769387732,0.0215510236553479,0.050213074615347,9.35718047012192e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,41839,0.0426682125417489,0.00872515860734328,0.0255669016713561,0.0597695234121417,1.0189030383772e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CA12,Carbonic anhydrase 12,42070,-0.016274870245619,0.00332850286000652,-0.0227987358512318,-0.00975100464000627,1.02234219102758e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK3,NT-3 growth factor receptor,42249,0.0105343053095544,0.00215590607388388,0.00630872940474196,0.0147598812143668,1.03939222282204e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0203536048493637,0.00416584761790008,-0.0285186661804478,-0.0121885435182795,1.04401337885461e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FGR,Tyrosine-protein kinase Fgr,41839,0.0291001810763777,0.0059613378483903,0.0174159588935327,0.0407844032592227,1.0651785572278e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0174383639336355,0.003581600781946,0.0104184264010213,0.0244583014662496,1.13488222142243e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.0109213736620465,0.00224398584983117,0.0065231613963774,0.0153195859277156,1.14854950610455e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CD55,Complement decay-accelerating factor,41714,0.0130183971345217,0.00267933127376638,0.0077669078379396,0.0182698864311038,1.19450992141165e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0117032112503693,0.00241126250227917,-0.0164292857548365,-0.00697713674590215,1.22924062191031e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LUZP2,Leucine zipper protein 2,39919,0.022147912915852,0.00458276187214732,0.0131656996464432,0.0311301261852607,1.36342932149404e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CD302,CD302 antigen,42070,0.0152996604639847,0.0031664578498426,0.00909340307829318,0.0215059178496762,1.36801365002226e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0198077883573866,0.00410204416843918,0.0117677817872458,0.0278477949275273,1.39182109970142e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MTPN,Myotrophin,41900,0.0159390941758773,0.00330692455489898,0.00945752204827533,0.0224206663034793,1.45206975337905e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0376768372887628,0.00781801573077165,0.0223535264564504,0.0530001481210753,1.46031209652119e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0116022612386572,0.00240792337467047,0.00688273142430307,0.0163217910530113,1.46293821391321e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,COPB2,Coatomer subunit beta',39575,0.0211541236044434,0.00439373177697234,0.0125424093215776,0.0297658378873092,1.49453309870512e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MILR1,Allergin-1,41913,-0.0249639538964278,0.00520335648340609,-0.0351625326039038,-0.0147653751889519,1.62268158484432e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0223636956270023,0.00466172790484656,0.0132267089335031,0.0315006823205016,1.62875848014251e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NEO1,Neogenin,39934,0.011054600251723,0.0023050380169411,0.0065367257385184,0.0155724747649275,1.64054424458138e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0218741121998754,0.00456712056145468,0.0129225558994242,0.0308256685003265,1.69388965328804e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0274510741460073,0.00575487172228668,0.0161715255703254,0.0387306227216892,1.86469597286708e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CD93,Complement component C1q receptor,41654,-0.015278832750717,0.00320469174200387,-0.0215600285650446,-0.00899763693638942,1.88404275828346e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL8,Interleukin-8,42035,0.0328574819760651,0.00689674955950088,0.0193398528394434,0.0463751111126868,1.91589403380974e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSF,Cathepsin F,42181,0.0195102564447126,0.00409714590770219,0.0114798504656163,0.0275406624238089,1.93746032225826e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0255224034173732,0.00536162010926536,0.0150136280032131,0.0360311788315333,1.95854304124427e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17A,Interleukin-17A,41877,-0.0207333800176656,0.00436912671753776,-0.0292968683840397,-0.0121698916512916,2.10234180957661e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MCAM,Cell surface glycoprotein MUC18,42217,-0.0154504297088577,0.00325685115647245,-0.0218338579755437,-0.00906700144217166,2.11689259748265e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0196717865157295,0.00414833802437981,-0.0278025290435139,-0.011541043987945,2.13698362721043e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSE,Cathepsin E,39736,0.0256911662803898,0.00542554974386235,0.0150570887824196,0.03632524377836,2.21518119012199e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0334494137780125,0.00707747764129422,0.0195775576010758,0.0473212699549492,2.31607732479874e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFA,Protransforming growth factor alpha,42119,0.0217007818511074,0.00459766647375103,0.0126893555625554,0.0307122081396594,2.38261538802831e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0156492719761117,0.00332104988800804,0.00914001419561596,0.0221585297566075,2.48110382720564e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0234103426064637,0.00496921103421613,-0.0331499962335273,-0.0136706889794,2.4885177246968e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A11,Protein S100-A11,42027,0.0221608011130229,0.00470512173177722,0.0129387625187395,0.0313828397073062,2.50281547417926e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0172439995787192,0.00366833932735279,-0.0244339446603307,-0.0100540544971078,2.61744306673602e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL3,Fc receptor-like protein 3,41913,0.0255575362585098,0.00544785142185233,0.0148797474716792,0.0362353250453403,2.74167349011612e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SIL1,Nucleotide exchange factor SIL1,39638,0.0157031087506441,0.00335039461981156,0.00913633529581346,0.0222698822054748,2.80633861481921e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM4,Intercellular adhesion molecule 4,42119,-0.0249679060300754,0.0053369626310309,-0.0354283527868959,-0.0145074592732548,2.92067949550028e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0912364687531125,0.0195271743832847,0.0529632069618744,0.12950973054435,3.00750921300781e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0177382617635089,0.0038053443429925,-0.0251967366757742,-0.0102797868512436,3.17055048140171e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DGCR6,Protein DGCR6,39586,0.0199318525545579,0.00427652700436959,0.0115498596259935,0.0283138454831223,3.1875487209774e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA7,Thyroxine-binding globulin,39979,0.00874478032012231,0.00187759708593625,0.00506469003168727,0.0124248706085574,3.23804331690631e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0174613265238285,0.00375031526082509,0.0101107086126113,0.0248119444350457,3.25586443322405e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM25,Transmembrane protein 25,39934,-0.0222543904881894,0.00478211777579955,-0.0316273413287565,-0.0128814396476223,3.29776900365178e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL34,Interleukin-34,41814,0.01720826830855,0.00371219290899661,0.00993237020691668,0.0244841664101834,3.59297465716192e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0423126147026169,0.00913241351866993,0.0244130842060239,0.06021214519921,3.63345367817983e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPS,Colipase,42115,0.0346863788452949,0.00750178519249405,0.0199828798680066,0.0493898778225833,3.80355961899922e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG3,Desmoglein-3,42196,0.0165096444182017,0.00357328281891543,0.00950601009312742,0.0235132787432759,3.86701576483491e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0141521954396431,0.00306844198239532,0.00813804915414824,0.0201663417251379,4.02207874003818e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BSG,Basigin,42284,0.00978332896854506,0.00212446854798516,0.00561937061449415,0.013947287322596,4.16039428547715e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF1C,Kinesin-like protein KIF1C,39575,0.0163265511127548,0.0035607429114035,0.00934749500640394,0.0233056072191057,4.58669893694121e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.048612915570624,0.0106186860427684,0.0278002909267978,0.0694255402144501,4.74318007143375e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO1,R-spondin-1,42016,0.0158519430267059,0.00346614928919281,0.00905829041988798,0.0226455956335238,4.84263152508575e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,AHCY,Adenosylhomocysteinase,42145,0.031229600693844,0.00683762701941746,0.0178278517357858,0.0446313496519022,4.9836619487427e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN4B,Sodium channel subunit beta-4,39638,0.0202136678527221,0.00444523882149924,0.0115009997625836,0.0289263359428606,5.49268730639106e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CCND2,G1/S-specific cyclin-D2,39757,0.0172296988085709,0.0037913490223203,0.00979865472482308,0.0246607428923186,5.56505340469357e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA4,Carboxypeptidase A4,39518,0.0204279632011772,0.00449950956606109,0.0116089244516974,0.0292470019506569,5.68447520552952e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0205941850243894,0.00453751731924183,0.0117006510786754,0.0294877189701034,5.72139978891866e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0168900407004822,0.00372761591259632,0.0095839135117934,0.024196167889171,5.91921531208287e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM1,Neural cell adhesion molecule 1,42217,0.0150711487302488,0.00332915561318314,0.00854600372840981,0.0215962937320877,6.03288875091215e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3,Granulocyte colony-stimulating factor,41913,0.0220885270443128,0.00488330081608152,0.012517257444793,0.0316597966438326,6.14155439089875e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0155243588856664,0.00343487236905873,0.00879200904231135,0.0222567087290215,6.24743647126082e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,STC2,Stanniocalcin-2,42113,0.0109788455545015,0.00244042826416627,0.00619560615673557,0.0157620849522674,6.89283928501253e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN1,Nectin-1,39657,0.0151693091580143,0.00337260987105085,0.00855899381075459,0.0217796245052739,6.9361497864905e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TXN,Thioredoxin,39854,0.0196706888834032,0.00438649795669277,0.0110731528882854,0.028268224878521,7.38528133385531e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0191774050514422,0.00427996221533736,0.010788679109381,0.0275661309935034,7.50048130180407e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MENT,Protein MENT,39736,-0.0108631968021346,0.00243111224376421,-0.0156281767999125,-0.00609821680435677,7.95821861113844e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP13,Collagenase 3,41839,-0.0146331282277452,0.00327879972217251,-0.0210595756832033,-0.00820668077228704,8.15053052368457e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,AK1,Adenylate kinase isoenzyme 1,42145,0.0278916571957327,0.00625366255069734,0.0156344785963659,0.0401488357950995,8.25994932355207e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD6,MICOS complex subunit MIC25,39919,0.0131620874468547,0.0029607621688678,0.00735899359587385,0.0189651812978356,8.85195954987422e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,42185,0.0130812430696499,0.00294403855917328,0.00731092749367025,0.0188515586456295,8.92907647460468e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0131275876529954,0.00296050915282541,0.00732498971345764,0.0189301855925332,9.31250827695685e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0174854146608897,0.00394421117263115,0.00975476076253266,0.0252160685592468,9.35986533424287e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0172368147890322,0.00388981059703393,0.00961278601884573,0.0248608435592187,9.45798068032837e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0124738601567654,0.00282262248455425,0.00694152008703902,0.0180062002264917,9.98338043488545e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,39736,0.0236463216995415,0.00536273835092243,0.0131353545317335,0.0341572888673494,1.04641680757239e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00785084516980381,0.00178455569605459,0.00435311600553681,0.0113485743340708,1.09416070230081e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00825477281688964,0.00187724899351802,0.00457536478959433,0.011934180844185,1.10615664514872e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,39638,0.0231303171115826,0.00526781425296766,0.012805401175766,0.0334552330473992,1.13946037275931e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB1,Lamin-B1,39908,0.0273830257024087,0.00623746110199524,0.0151576019424981,0.0396084494623194,1.14331658018105e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0127101275959214,0.00289772687857371,-0.0183896722779259,-0.00703058291391693,1.16197253469238e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.014050935298334,0.00320539445433787,0.00776836216783174,0.0203335084288362,1.17668649522545e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0189333984656933,0.00433591883674433,0.0104349975456745,0.0274317993857122,1.27125000359339e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDHB15,Protocadherin beta-15,39919,-0.0177216259467294,0.00406308362775936,-0.0256852698571377,-0.00975798203632106,1.30245310815722e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CBS,Cystathionine beta-synthase,39638,0.0230192890530805,0.00528381748406687,0.0126630067843094,0.0333755713218515,1.33313539712724e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0182332629841899,0.00418729351529854,0.0100261676942048,0.026440358274175,1.34397111391087e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0118126572710699,0.00272119311885406,0.00647911875811596,0.0171461957840239,1.42880754679032e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE3,Eosinophil cationic protein,42081,0.0479596099351489,0.0110710676257935,0.0262603173885937,0.0696589024817041,1.48845325425043e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.012148385377651,0.00280782544169546,0.00664504751192795,0.0176517232433741,1.5249859722708e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB2,Lysosome membrane protein 2,41777,0.0144724468865897,0.00335040339852191,0.00790565622548681,0.0210392375476927,1.57447061590152e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC1,Syndecan-1,42145,0.0177410348816102,0.00411602008644352,0.00967363551218091,0.0258084342510395,1.64229020971378e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0138438710873647,0.00321964170173566,0.00753337335196282,0.0201543688227666,1.72140526244457e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,39919,0.0253858201998563,0.00591219127439347,0.0137979253020451,0.0369737150976675,1.77097037376191e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,39929,0.10573800543268,0.024630114252401,0.0574629814979742,0.154013029367386,1.77711436360002e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.032085228392376,0.00748263570383902,0.0174192624128515,0.0467511943719005,1.81571547016674e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO4,Roundabout homolog 4,39638,-0.00798808139120244,0.001863414911077,-0.0116403746169134,-0.00433578816549152,1.82807161002125e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI2,Serpin I2,39930,0.0252926141489619,0.00590093995906988,0.0137267718291849,0.0368584564687389,1.83257404205239e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SEL1L,Protein sel-1 homolog 1,39638,0.0137475836882988,0.00321087999956701,0.00745425888914745,0.0200409084874501,1.87154164127805e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX1,Neuronal pentraxin-1,42137,0.0181768324427736,0.0042476331417259,0.0098514714849908,0.0265021934005563,1.88783587602746e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,41843,0.0231348895476429,0.00542190104768532,0.0125079634941797,0.0337618156011062,1.99555810756589e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0127462740174417,0.00299222990306616,0.00688150340743204,0.0186110446274514,2.06001833976618e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0204175495559443,0.00480330807668168,0.0110030657256482,0.0298320333862404,2.14828329514672e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MB,Myoglobin,42310,-0.0242357732033265,0.00570868353471055,-0.0354247929313592,-0.0130467534752939,2.19618558341163e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0211197867805149,0.00497569584058496,0.0113674229329683,0.0308721506280614,2.20455123051335e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0448676732548434,0.0105806537706364,0.0241295918643961,0.0656057546452908,2.24798721546899e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY2,Protein canopy homolog 2,41900,0.026247761900362,0.00619854247708311,0.0140986186452791,0.0383969051554449,2.30594819436457e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYGD,Gamma-crystallin D,39929,0.0423784737456354,0.0100087157268615,0.0227613909209868,0.0619955565702841,2.31221096920115e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0175082434660016,0.00413995710453732,-0.0256225593908947,-0.00939392754110845,2.36543332734087e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0134318475890698,0.00318155685962961,0.00719599614419575,0.0196676990339438,2.43958931034819e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G15,Phospholipase A2 group XV,42181,0.0117882931471024,0.00279414085686801,0.00631177706764107,0.0172648092265637,2.47054254967602e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RPA2,Replication protein A 32 kDa subunit,39657,0.0133467962138142,0.00316444543045038,0.00714448317013149,0.019549109257497,2.48733313185305e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS1,"Nitric oxide synthase, brain",41839,-0.0251430903057558,0.00597159971332036,-0.0368474257438637,-0.0134387548676479,2.56552510921115e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2,Brorin,41973,0.0174894412990122,0.00416617157325253,0.00932374501543722,0.0256551375825871,2.71066377340502e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0165075176373544,0.00393870071523027,0.00878766423550304,0.0242273710392057,2.79771325009898e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LPA,Apolipoprotein(a),39775,-0.0781861318964682,0.0186719939870523,-0.114783240111091,-0.0415890236818458,2.84397546118498e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0124088838111459,0.00296415063311264,-0.0182186190520467,-0.00659914857024514,2.85305488019739e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG4,Desmoglein-4,42018,0.0203927998050814,0.00487514865670597,0.0108375084379377,0.0299480911722251,2.89502804621356e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CPQ,Carboxypeptidase Q,39960,0.0159728023618341,0.00382055170816305,0.0084845210138345,0.0234610837098336,2.92717367746771e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNXB,Tenascin-X,42137,0.0110979765911918,0.00265917563949473,0.00588599233778212,0.0163099608446014,3.01876059189862e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SNU13,NHP2-like protein 1,39575,0.0268539577857671,0.00644314324327562,0.0142253970289469,0.0394825185425873,3.09865248841705e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0147327745796663,0.00353623140202143,0.00780176103170429,0.0216637881276283,3.11567843785454e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0129406282262547,0.00310743721311601,0.00685005128854727,0.019031205163962,3.14084832815565e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0145727813696581,0.00351378466657479,0.00768576342317154,0.0214597993161447,3.38470343136744e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CD209,CD209 antigen,42171,0.0164337653726592,0.00396922884370931,0.00865407683898893,0.0242134539063294,3.48961393684633e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NINJ1,Ninjurin-1,41843,0.0228077782044336,0.00552371312657858,0.0119813004763396,0.0336342559325276,3.6647271844177e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL5,Insulin-like peptide INSL5,39930,0.0430874649759314,0.0104583756742138,0.0225890486544723,0.0635858812973905,3.8173116269627e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LAYN,Layilin,41997,-0.0150029701613771,0.00364189087297126,-0.0221410762724008,-0.00786486405035348,3.81885409546119e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK4,Dickkopf-related protein 4,41992,0.0193229185088234,0.00469120981210073,0.0101281472771059,0.0285176897405408,3.82867901690447e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBB,Inhibin beta B chain,39736,0.021990185679003,0.00534099725567873,0.0115218310578727,0.0324585403001333,3.86197896431758e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0117026783069558,0.00284597573867969,0.00612456585914362,0.017280790754768,3.94519965162662e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TK1,"Thymidine kinase, cytosolic",39757,0.0198100947160993,0.00481872659860425,0.0103653905828349,0.0292547988493636,3.96659954101386e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF1,Trefoil factor 1,42084,-0.0336419285037874,0.00818880650769202,-0.0496919892588638,-0.0175918677487111,4.00967589420228e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0263882786939382,0.00643982540975696,0.0137662208908146,0.0390103364970618,4.20281583965398e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPG,Macrophage-capping protein,42015,0.0244953979989791,0.00598681462444695,0.0127612413350631,0.0362295546628952,4.30990316116559e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD3,Bromodomain-containing protein 3,39575,0.0197944702123305,0.00485095516385634,0.0102865980911721,0.029302342333489,4.52510235290861e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL4,Myosin light chain 4,39638,-0.0214674117566649,0.00526653413181869,-0.0317898186550295,-0.0111450048583002,4.60997564671609e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,39657,0.0435304298028193,0.0106955820488914,0.0225670889869921,0.0644937706186465,4.73513119497092e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0156166716097118,0.00383802896928158,0.00809413482991993,0.0231392083895037,4.75589101333399e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12B,Interleukin-12 subunit beta,42296,0.0226759894216158,0.0055754444853647,0.011748118230301,0.0336038606129306,4.78646167609281e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0126963032356655,0.00312554826727366,0.00657022863180915,0.0188223778395219,4.89600163035607e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,39757,0.0184761108654403,0.00455625978731428,0.00954584168230426,0.0274063800485762,5.04524703650041e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX2,Sorting nexin-2,39919,0.0352527087448845,0.00871369674208745,0.0181738631303931,0.0523315543593759,5.2521012530296e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB2A2,Mammaglobin-A,39575,-0.0128552556353274,0.0031803394394718,-0.0190887209366921,-0.00662179033396267,5.33358727540915e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIC5,Chloride intracellular channel protein 5,39649,-0.0129742078560023,0.00321365129108701,-0.0192729643865329,-0.0066754513254718,5.44541059785054e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.01468064032984,0.0036393343135234,0.00754754507533416,0.0218137355843459,5.51643607055706e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00892016716332438,0.00221156225260879,0.00458550514821116,0.0132548291784376,5.5273847590206e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0220967538897298,0.00550460436746249,0.0113077293295033,0.0328857784499563,5.9968430338594e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP112,Centrosomal protein of 112 kDa,39575,0.0181223679744538,0.00453485139720794,0.00923405923592626,0.0270106767129814,6.4776394800437e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP152,Centrosomal protein of 152 kDa,39560,0.0171779149913241,0.00430073272881253,0.00874847884285151,0.0256073511397966,6.53417527868014e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0145945312876035,0.0036561315244486,-0.0217605490755228,-0.00742851349968424,6.59987703400421e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0313757980453687,0.00786457368678711,-0.0467903624714715,-0.015961233619266,6.66253676974677e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC3,Membrane primary amine oxidase,42217,-0.012036798231493,0.00301762856961423,-0.0179513502279369,-0.00612224623504913,6.67480768079678e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,VIM,Vimentin,41900,0.0465889951546782,0.0116910346376386,0.0236745672649066,0.0695034230444499,6.78347081623621e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL14,C-C motif chemokine 14,42152,0.0163834266680654,0.0041132654414045,0.0083214264029126,0.0244454269332183,6.83860590231166e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0290654333930696,0.00730646752998928,0.0147447570342907,0.0433861097518486,6.99179964390432e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMB,Granzyme B,42119,0.0274032962112801,0.00689395787383103,0.0138911387785713,0.040915453643989,7.07531567493925e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAP,Cartilage-associated protein,39649,0.0199685664565862,0.00503210847048665,0.0101056338544324,0.0298314990587401,7.28660654423157e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0210096055723776,0.00530350903191986,0.0106147278698146,0.0314044832749405,7.49515792759424e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM5,Intercellular adhesion molecule 5,42145,0.0185339550728385,0.00468137701846289,0.00935845611665123,0.0277094540290258,7.56229234058348e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2,Ataxin-2,39586,0.0427749564522172,0.0108293363147372,0.0215494572753324,0.0640004556291021,7.86674726979432e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAP,Prosaposin,39886,0.0115062076176941,0.00291342313016707,0.00579589828256668,0.0172165169528216,7.88310001935252e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PRUNE2,Protein prune homolog 2,39757,0.0116316581855951,0.0029495149315146,0.00585060891982649,0.0174127074513637,8.07639131800198e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL15,C-C motif chemokine 15,42310,0.0174312983914343,0.00443030450762583,0.00874790155648771,0.026114695226381,8.37603050738114e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GRSF1,G-rich sequence factor 1,39486,0.033353206285673,0.00851057905634449,0.0166724713352378,0.0500339412361082,8.94506019217535e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0137855746466397,0.00353811359692747,0.00685087199666186,0.0207202772966176,9.81406723917683e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CFC1,Cryptic protein,41843,0.0189568979864688,0.00486535285401753,0.00942080639259442,0.0284929895803432,9.81519912684958e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0180487264951416,0.00463803374489174,0.00895818035515383,0.0271392726351294,0.000100127255804507
NMR metabolomics,X23428.Concentration of VLDL Particles,CST1,Cystatin-SN,38503,0.0424532563593287,0.0109125289935307,0.0210646995320086,0.0638418131866489,0.000100766358703418
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL5,Fc receptor-like protein 5,42137,-0.0233890912719369,0.00601565085346957,-0.0351797669447373,-0.0115984155991366,0.000101539475525158
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB37,Ras-related protein Rab-37,41913,0.031716158941506,0.00826414106771986,0.0155184424487751,0.0479138754342369,0.000124712985569938
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.026436011610961,0.0069017213692296,0.012908637727271,0.039963385494651,0.000128540137903198
NMR metabolomics,X23428.Concentration of VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0153624129831983,0.00402337937744877,-0.0232482365629979,-0.00747658940339872,0.000135121461792661
NMR metabolomics,X23428.Concentration of VLDL Particles,NFASC,Neurofascin,42296,0.0113063766451135,0.00296515018177693,0.00549468228883069,0.0171180710013963,0.000137843327530463
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0152590405543186,0.00400192102866236,0.00741527533814041,0.0231028057704969,0.000137941754285719
NMR metabolomics,X23428.Concentration of VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0128706481284543,0.00337639471473207,0.00625291448757945,0.0194883817693292,0.000138612062869987
NMR metabolomics,X23428.Concentration of VLDL Particles,HYAL1,Hyaluronidase-1,42077,-0.00894778608887319,0.00234786170908809,-0.0135495950386858,-0.00434597713906054,0.000139000855546191
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN2,Prefoldin subunit 2,41839,0.0213479406223271,0.00560798207769028,0.0103562957500542,0.0323395854946001,0.000141464635063568
NMR metabolomics,X23428.Concentration of VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0146209118863433,0.00384167296291238,0.00709123287903505,0.0221505908936516,0.000142073951197971
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1,Methionine aminopeptidase 1,41839,0.0112238167263813,0.00295100109185971,0.00543985458633628,0.0170077788664263,0.000143368938901722
NMR metabolomics,X23428.Concentration of VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0318331228569196,0.00837759998696696,0.0154130268824643,0.0482532188313748,0.000145595659901951
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF20B,Kinesin-like protein KIF20B,39586,0.0290023365816796,0.00763771879802377,0.014032407737553,0.0439722654258062,0.000147097107820549
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L,Seizure 6-like protein,42181,0.0106103942626544,0.00279826916858412,0.00512578669222956,0.0160950018330793,0.000150224714249967
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF16,Fibroblast growth factor 16,39657,0.0179932199270312,0.00475357114549039,0.00867622048187007,0.0273102193721924,0.000154396329789274
NMR metabolomics,X23428.Concentration of VLDL Particles,TMOD4,Tropomodulin-4,39560,-0.015494684405465,0.0040958662186888,-0.0235225821940951,-0.00746678661683495,0.000155770276742306
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0146059866528369,0.00386114815434419,0.00703813627032231,0.0221738370353515,0.000155887232847673
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.021569992215391,0.00570769509217833,0.0103829098347215,0.0327570745960605,0.000158223660972667
NMR metabolomics,X23428.Concentration of VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0104616735397173,0.00276943303484572,0.0050335847914197,0.0158897622880149,0.000159188578360824
NMR metabolomics,X23428.Concentration of VLDL Particles,YAP1,Transcriptional coactivator YAP1,39929,0.0106393544294092,0.00281760837290523,0.005116842018515,0.0161618668403035,0.000160166561962502
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.021377481366516,0.00566283503329327,0.0102783247012612,0.0324766380317709,0.000160805407249574
NMR metabolomics,X23428.Concentration of VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0202151920296779,0.00536062049896076,0.00970837585171478,0.0307220082076409,0.000163383698392625
NMR metabolomics,X23428.Concentration of VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0130323476339851,0.00345630316798696,-0.0198067018432396,-0.0062579934247307,0.00016370309958986
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.019540329528117,0.00518332745596643,0.00938100771442276,0.0296996513418112,0.000164056956316962
NMR metabolomics,X23428.Concentration of VLDL Particles,RCC1,Regulator of chromosome condensation,39919,0.0199300390065237,0.0053174299185475,0.00950787636617056,0.0303522016468768,0.000179094978471467
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFB,Vascular endothelial growth factor B,39657,0.0113113370673208,0.00301921058782282,0.00539368431518808,0.0172289898194535,0.000180262798270305
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0203980059400939,0.00545222714023872,0.00971164074522606,0.0310843711349618,0.000183875056508113
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAM,Integrin alpha-M,42137,-0.0119789553819014,0.00321280406424554,-0.0182760513478226,-0.00568185941598012,0.000193404471635452
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.00787693240523987,0.00211415577513048,0.00373318708598413,0.0120206777244956,0.000195488254359599
NMR metabolomics,X23428.Concentration of VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0263900050976824,0.00708416369193671,0.0125050442614864,0.0402749659338783,0.0001959519304102
NMR metabolomics,X23428.Concentration of VLDL Particles,FOSB,Protein fosB,41839,0.014557755500622,0.00390945368563233,0.00689522627678263,0.0222202847244614,0.000197114100053291
NMR metabolomics,X23428.Concentration of VLDL Particles,CR2,Complement receptor type 2,42217,0.0176677812775659,0.00474733152762355,0.00836301148342375,0.0269725510717081,0.000198742540509322
NMR metabolomics,X23428.Concentration of VLDL Particles,CAT,Catalase,39827,0.0198773437714651,0.00534206276179149,0.00940690075835381,0.0303477867845765,0.00019947339372966
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPJ,Centromere protein J,39757,0.0266953104516506,0.00717729885377948,0.0126278046982429,0.0407628162050584,0.000200668375229892
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT1A1,Sulfotransferase 1A1,42249,-0.0485768526209423,0.0130665561696139,-0.0741873027133856,-0.022966402528499,0.000201890559283265
NMR metabolomics,X23428.Concentration of VLDL Particles,CLASP1,CLIP-associating protein 1,39560,0.0284631261113938,0.00768579032954565,0.0133989770654843,0.0435272751573033,0.000213820715899213
NMR metabolomics,X23428.Concentration of VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",39929,0.0224147860040788,0.00605745028526128,0.0105421834449667,0.0342873885631909,0.00021630782882574
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0137310661489859,0.0037107084851969,0.00645807751799995,0.0210040547799718,0.00021631348119815
NMR metabolomics,X23428.Concentration of VLDL Particles,SYT1,Synaptotagmin-1,39929,0.0150659981421429,0.00408999305856654,0.00704961174735253,0.0230823845369334,0.000231011484944182
NMR metabolomics,X23428.Concentration of VLDL Particles,ERC2,ERC protein 2,39649,0.0276795367934351,0.00752170195519781,0.0129370009612474,0.0424220726256228,0.000234383044391705
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,39657,-0.047127886456674,0.0128154209974036,-0.072246111611585,-0.022009661301763,0.000236707177501551
NMR metabolomics,X23428.Concentration of VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0111377264116604,0.00302929696272767,0.00520030436471418,0.0170751484586066,0.000237427175392557
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,42145,0.0118305649166595,0.00322124192379981,0.00551693074601185,0.0181441990873071,0.000240951507893831
NMR metabolomics,X23428.Concentration of VLDL Particles,RALY,RNA-binding protein Raly,39919,0.0180116723956029,0.00490794461356837,0.00839210095300894,0.027631243838197,0.000243758994449213
NMR metabolomics,X23428.Concentration of VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0159834132971712,0.00436046334879815,-0.0245299214608156,-0.00743690513352686,0.000247990434024598
NMR metabolomics,X23428.Concentration of VLDL Particles,NCF2,Neutrophil cytosol factor 2,42097,0.0308843272070995,0.00844928225470127,0.014323733987885,0.047444920426314,0.000257896007312311
NMR metabolomics,X23428.Concentration of VLDL Particles,LIFR,Leukemia inhibitory factor receptor,42119,-0.00891725055875378,0.00244036210224535,-0.0137003602791547,-0.0041341408383529,0.000259093978836509
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN3,Neuronal-specific septin-3,39934,-0.0291220906545931,0.00799427878307339,-0.0447908770694169,-0.0134533042397693,0.000270821941235566
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300C,CMRF35-like molecule 6,42249,0.0130183879794317,0.00358204451933384,0.00599758072153732,0.020039195237326,0.000279710534322003
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0115209806858133,0.00317169722577912,-0.0177375072483404,-0.00530445412328625,0.000281789626138832
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0151194803728548,0.00416424537585346,0.00695755943618204,0.0232814013095276,0.000283807380697684
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3,Galectin-3,42196,0.010873506835794,0.003015157990045,0.00496379717530581,0.0167832164962822,0.000311729250280125
NMR metabolomics,X23428.Concentration of VLDL Particles,PMS1,PMS1 protein homolog 1,39649,0.0181483772946476,0.00504294729139244,0.00826420060351846,0.0280325539857768,0.000321131574082968
NMR metabolomics,X23428.Concentration of VLDL Particles,DCC,Netrin receptor DCC,39649,0.00820333459017982,0.0022808041087571,0.0037329585370159,0.0126737106433437,0.00032370462850049
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0122194364949444,0.00340934102540727,0.0055371280851461,0.0189017449047426,0.000339413844921545
NMR metabolomics,X23428.Concentration of VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0144100948776878,0.00402172572039433,0.00652751246571487,0.0222926772896606,0.000341048650978682
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF5,Fibroblast growth factor 5,41913,-0.0124277271669488,0.00346960433292331,-0.0192281516594785,-0.00562730267441908,0.000342339010541301
NMR metabolomics,X23428.Concentration of VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0196063310893649,0.00547771572856848,0.00887000826137066,0.0303426539173591,0.000345968848656693
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0110446016702714,0.00310155962497207,-0.0171236585352166,-0.00496554480532612,0.000370983502263071
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.031374426332987,0.00883355352833986,0.0140606614174408,0.0486881912485331,0.000384294762816414
NMR metabolomics,X23428.Concentration of VLDL Particles,LYZL2,Lysozyme-like protein 2,39560,0.0131801061993238,0.0037202625259281,0.00588839164850469,0.0204718207501428,0.000397565133200459
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM2,Intercellular adhesion molecule 2,42310,-0.0117190019995377,0.00333233646424211,-0.0182503814694522,-0.00518762252962315,0.000438273447875601
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0160838856389542,0.0045745638017579,0.00711774058750871,0.0250500306903997,0.000439642828125153
NMR metabolomics,X23428.Concentration of VLDL Particles,NRTN,Neurturin,41913,0.0177158168513647,0.00504315537790963,0.0078312323106618,0.0276004013920675,0.000444807940900664
NMR metabolomics,X23428.Concentration of VLDL Particles,NGF,Beta-nerve growth factor,42016,0.00435054001996119,0.00123913037415355,0.00192184448662023,0.00677923555330215,0.000447953686580282
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0179797403194785,0.00512670428348232,0.00793139992385319,0.0280280807151039,0.00045481462134796
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM26,Tripartite motif-containing protein 26,39560,0.0205941483165885,0.0058733592158084,0.00908236425360402,0.0321059323795729,0.000456086992496914
NMR metabolomics,X23428.Concentration of VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0205967307458606,0.00588213870025164,0.00906773889336735,0.0321257225983538,0.00046401332391184
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB2,Plexin-B2,42255,0.00871457780518664,0.00248944063799047,0.00383527415472533,0.013593881455648,0.000465663664455524
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0133797283175058,0.00382403371753886,0.00588462223112961,0.0208748344038819,0.000469103768456526
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL1,Delta-like protein 1,42181,-0.0109158759940681,0.00312096938335599,-0.0170329759854458,-0.00479877600269032,0.000470980792242924
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK14,Kallikrein-14,42262,0.0164360062313654,0.00471083298795897,0.00720277357496585,0.025669238887765,0.000486392869318465
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA4,Ephrin-A4,41992,0.0114747791434076,0.00328943470907746,0.00502748711361583,0.0179220711731995,0.000487527845031254
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0154935228300538,0.00444277258997546,0.0067856885537019,0.0242013571064057,0.000489366731953695
NMR metabolomics,X23428.Concentration of VLDL Particles,SATB1,DNA-binding protein SATB1,39934,0.010395850357433,0.00298822177744739,0.00453893567363613,0.0162527650412299,0.000505288449677167
NMR metabolomics,X23428.Concentration of VLDL Particles,S100P,Protein S100-P,41900,0.0189193323843469,0.00544833691805554,0.00824059202495805,0.0295980727437358,0.000517280200407869
NMR metabolomics,X23428.Concentration of VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00925166670680296,0.00266761496364807,-0.0144801920355532,-0.00402314137805274,0.00052608329124902
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD6,Programmed cell death protein 6,42145,-0.0248833366938722,0.00717742390769003,-0.0389510875529446,-0.0108155858347997,0.000528151379105475
NMR metabolomics,X23428.Concentration of VLDL Particles,VWF,von Willebrand factor,42310,-0.0261154935100231,0.00753687067291449,-0.0408877600289355,-0.0113432269911107,0.000531791244159343
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0234570465416317,0.00678426595745174,0.0101598852650262,0.0367542078182371,0.000547070118686218
NMR metabolomics,X23428.Concentration of VLDL Particles,SPESP1,Sperm equatorial segment protein 1,39958,0.0118314417770339,0.00342285809078724,0.00512263991909087,0.0185402436349769,0.000549043724524282
NMR metabolomics,X23428.Concentration of VLDL Particles,MERTK,Tyrosine-protein kinase Mer,42296,0.00866472465143801,0.00251091600959092,0.0037433292726398,0.0135861200302362,0.000560566891861686
NMR metabolomics,X23428.Concentration of VLDL Particles,CA2,Carbonic anhydrase 2,42103,0.0232686782642383,0.00674820854521551,0.0100421895156159,0.0364951670128607,0.00056621057280152
NMR metabolomics,X23428.Concentration of VLDL Particles,CA1,Carbonic anhydrase 1,41890,0.0197741815878665,0.00573517457656941,0.00853323941779041,0.0310151237579425,0.00056675964634979
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,39657,0.0227123247421852,0.00659304137291881,0.00978996365126432,0.0356346858331061,0.000573405241956759
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0126909710125652,0.00369549635835023,0.00544779815019872,0.0199341438749316,0.000596563510610106
NMR metabolomics,X23428.Concentration of VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0235553473016434,0.00687941282009098,0.0100716981742651,0.0370389964290217,0.000619246580735385
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH12,Protocadherin-12,39934,0.00886426246351909,0.00260301491852887,0.00376235322320251,0.0139661717038357,0.000663005409414006
NMR metabolomics,X23428.Concentration of VLDL Particles,COLEC12,Collectin-12,42123,0.00946277954369453,0.00278329563878192,0.00400752009168197,0.0149180389957071,0.000676183596886265
NMR metabolomics,X23428.Concentration of VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0102547503829798,0.0030207405152444,0.00433409897310082,0.0161754017928589,0.000689251091240765
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX9,Transcription factor SOX-9,39649,0.00955666142298394,0.00281955785119555,0.00403032803464067,0.0150829948113272,0.000702859577355817
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0121449722343377,0.00358766161994956,0.00511315545923654,0.0191767890094388,0.000713666094080969
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0108202425497865,0.00319975094195434,-0.017091754396017,-0.00454873070355596,0.000723194234006934
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0184520415858404,0.00548118849688389,0.00770891213194799,0.0291951710397328,0.000763631287590018
NMR metabolomics,X23428.Concentration of VLDL Particles,CPE,Carboxypeptidase E,42134,0.0133133908880182,0.00397829743388493,0.00551592791760373,0.0211108538584327,0.000820600867971312
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK15,Kallikrein-15,39900,0.0179108559091259,0.00536437159494143,0.00739668758304073,0.0284250242352112,0.000843966410908998
NMR metabolomics,X23428.Concentration of VLDL Particles,STX7,Syntaxin-7,39657,0.0166979456270691,0.00501827876601422,0.00686211924568126,0.026533772008457,0.000879386054353416
NMR metabolomics,X23428.Concentration of VLDL Particles,CIT,Citron Rho-interacting kinase,39649,0.0155042720694737,0.0046745630598732,0.00634212847212221,0.0246664156668252,0.00091370839756766
NMR metabolomics,X23428.Concentration of VLDL Particles,CA3,Carbonic anhydrase 3,42287,-0.019845692698188,0.00598639867828908,-0.0315790341076346,-0.00811235128874141,0.000918384628054165
NMR metabolomics,X23428.Concentration of VLDL Particles,NRCAM,Neuronal cell adhesion molecule,42145,0.00967720746693207,0.00292185304727665,0.00395037549426983,0.0154040394395943,0.000928705805197314
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.00826244847857912,0.00249484842802985,-0.0131523513975176,-0.00337254555964062,0.000929361902848315
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.00937441189256776,0.00283569973341489,0.00381644041507457,0.0149323833700609,0.000949325188581054
NMR metabolomics,X23428.Concentration of VLDL Particles,COL5A1,Collagen alpha-1(V) chain,39736,-0.0138714896596014,0.00419745532358701,-0.0220985020938319,-0.00564447722537083,0.000953655165887331
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,39951,0.00502876932628459,0.00152209465917578,0.00204546379430005,0.00801207485826912,0.000956627463568351
NMR metabolomics,X23428.Concentration of VLDL Particles,MET,Hepatocyte growth factor receptor,42158,0.00644824467622823,0.00195396086711416,0.00261848137668447,0.010278007975772,0.000969035816795119
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_E,,42119,0.00984101227403086,0.0029828301390905,0.00399466520141348,0.0156873593466482,0.000972046082477008
NMR metabolomics,X23428.Concentration of VLDL Particles,POF1B,Protein POF1B,39657,-0.015291848971343,0.0046462631038181,-0.0243985246548265,-0.00618517328785951,0.00100068322249959
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0110752444385538,0.00337631659977661,-0.0176928249741159,-0.00445766390299164,0.00104024876875266
NMR metabolomics,X23428.Concentration of VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0119014859619616,0.0036316716979347,0.00478340943400962,0.0190195624899136,0.00105135403251871
NMR metabolomics,X23428.Concentration of VLDL Particles,CA6,Carbonic anhydrase 6,42103,-0.0208231047406313,0.00637223518406878,-0.0333126857014061,-0.00833352377985649,0.00108662840831235
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP4,Guanylate-binding protein 4,41839,0.0162471377341873,0.00498468471891531,0.00647715568511329,0.0260171197832613,0.00111925464423083
NMR metabolomics,X23428.Concentration of VLDL Particles,TTN,Titin,39575,-0.0230522104982061,0.00707490845664971,-0.0369190310732395,-0.00918538992317266,0.00112420686834052
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTP1,Glutathione S-transferase P,41759,-0.023140093772849,0.00710568928747585,-0.0370672447763017,-0.00921294276939636,0.00113057072984939
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0190504921954693,0.00585317419734907,0.00757827076866511,0.0305227136222735,0.00113839032055414
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0176662772494074,0.00543288865323269,0.00701781548907132,0.0283147390097435,0.00114987723882248
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC1,Hamartin,39657,0.024595890268876,0.00756529251196825,0.00976791694541819,0.0394238635923337,0.00115283914371893
NMR metabolomics,X23428.Concentration of VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0172503330404739,0.00530853418094633,0.0068456060458191,0.0276550600351287,0.00115937373682425
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD2,Sushi domain-containing protein 2,42137,-0.00934354204502596,0.00288506805119327,-0.0149982754253648,-0.00368880866468715,0.00120413211235503
NMR metabolomics,X23428.Concentration of VLDL Particles,ALCAM,CD166 antigen,42310,0.00646478309722445,0.00200352050933207,0.00253788289893359,0.0103916832955153,0.00125515579660271
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,39966,0.0113939413423228,0.00354129281522081,0.00445300742449002,0.0183348752601556,0.00129696946108653
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK8,Kallikrein-8,41668,0.0119769020527253,0.00372924900351963,0.00466757400582678,0.0192862300996237,0.00132311939545899
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.0127990791041595,0.00399246709686282,0.00497384359430834,0.0206243146140106,0.00135067927683184
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0202907267913343,0.00633782065124224,-0.0327128552677691,-0.00786859831489954,0.00137083723193492
NMR metabolomics,X23428.Concentration of VLDL Particles,APLP1,Amyloid-like protein 1,42145,-0.0165487427036846,0.00516953150575032,-0.0266810244549553,-0.00641646095241402,0.00137168837406155
NMR metabolomics,X23428.Concentration of VLDL Particles,FMR1,Synaptic functional regulator FMR1,41843,0.0117576462007039,0.00367436106232532,0.0045558985185463,0.0189593938828616,0.00137791760324126
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA1,Alpha-1-antitrypsin,39795,-0.00267770005487122,0.000836818403049405,-0.00431786412484805,-0.00103753598489438,0.00137878737001826
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNG,Interferon gamma,41913,0.0371599063987907,0.0116227831872476,0.0143792513517855,0.059940561445796,0.00139111951907369
NMR metabolomics,X23428.Concentration of VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0285107050151446,0.0089186447202059,0.011030161363541,0.0459912486667482,0.00139377777928901
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0139871851134629,0.0043759772250809,-0.0225641004746215,-0.00541026975230438,0.00139492574083341
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0135660185906527,0.00425773650022985,0.00522085505020214,0.0219111821311032,0.00144543748771424
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN1,Calsyntenin-1,41839,0.0163459046378904,0.00515136567505831,0.0062492279147761,0.0264425813610047,0.00151154604652379
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0189802518644485,0.00598789622897553,0.00724397525565648,0.0307165284732406,0.00152899936910598
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0146851086203946,0.00464979059226701,0.00557151905955125,0.0237986981812379,0.00159077851790211
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK4,Kallikrein-4,42262,-0.0201073326994614,0.00636666237116861,-0.0325859909469519,-0.00762867445197093,0.00159080248134044
NMR metabolomics,X23428.Concentration of VLDL Particles,PPME1,Protein phosphatase methylesterase 1,42070,0.0186769077325117,0.00591498128613987,0.00708354441167755,0.0302702710533458,0.00159446582288939
NMR metabolomics,X23428.Concentration of VLDL Particles,EXTL1,Exostosin-like 1,39575,0.0153281616450084,0.00486270272510478,0.00579726430380305,0.0248590589862138,0.0016248709752005
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR4,Proline-rich protein 4,39652,-0.022866154496517,0.00726282374085116,-0.0371012890285853,-0.00863101996444875,0.00164613000712084
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA11,Integrin alpha-11,42119,-0.0108254745655683,0.0034419602886216,-0.0175717167312666,-0.00407923239986996,0.00166362517360425
NMR metabolomics,X23428.Concentration of VLDL Particles,STX3,Syntaxin-3,39929,0.0122247747003049,0.00389434481546503,0.00459185886199347,0.0198576905386164,0.00169897266517827
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA6C,Semaphorin-6C,39657,0.00826623273179851,0.00263847115991774,0.00309482925835974,0.0134376362052373,0.00173503233251868
NMR metabolomics,X23428.Concentration of VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,42310,0.0114270147197069,0.00364785851954976,0.0042772120213894,0.0185768174180244,0.00173673439156515
NMR metabolomics,X23428.Concentration of VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0170850806496081,0.0054559686045049,0.00639138218477847,0.0277787791144377,0.00174318989562283
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0203716802444144,0.00651858957911159,0.0075952446693557,0.0331481158194731,0.0017815311245981
NMR metabolomics,X23428.Concentration of VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.021763765156757,0.00696435227658481,-0.0354138956188632,-0.00811363469465077,0.00178164153728353
NMR metabolomics,X23428.Concentration of VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.00951890610243544,0.00304754985178909,0.00354570839292882,0.0154921038119421,0.00179112570462523
NMR metabolomics,X23428.Concentration of VLDL Particles,PIGR,Polymeric immunoglobulin receptor,41987,0.0117794560336404,0.00377880861133559,0.00437299115542264,0.0191859209118582,0.00182939037296877
NMR metabolomics,X23428.Concentration of VLDL Particles,CX3CL1,Fractalkine,42016,-0.0105769973088751,0.00339989857097079,-0.0172407985079778,-0.00391319610977236,0.00186862251605876
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5L,CD5 antigen-like,39925,0.015248110355874,0.00491260014765502,0.00561941406647012,0.0248768066452778,0.00191472915590146
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0111267313529941,0.00358513421219277,-0.018153594408892,-0.00409986829709631,0.00191589525997362
NMR metabolomics,X23428.Concentration of VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00956989466275144,0.00309174774963419,0.00351006907346842,0.0156297202520344,0.00197018757738954
NMR metabolomics,X23428.Concentration of VLDL Particles,QSOX1,Sulfhydryl oxidase 1,39767,0.0125728246894623,0.00408219218910935,0.00457172799880797,0.0205739213801166,0.00207559287274358
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A16,Protein S100-A16,41814,-0.018961785493478,0.00618805308300503,-0.0310903695361679,-0.0068332014507882,0.00218650918499875
NMR metabolomics,X23428.Concentration of VLDL Particles,BAX,Apoptosis regulator BAX,41814,0.0284940115113589,0.0093270513914765,0.010212990784065,0.0467750322386528,0.00225519448790326
NMR metabolomics,X23428.Concentration of VLDL Particles,ABO,Histo-blood group ABO system transferase,39990,0.0452195758433319,0.0148042983209198,0.016203151134329,0.0742360005523347,0.00225964637245589
NMR metabolomics,X23428.Concentration of VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0120962448077723,0.00396152487267827,0.00433165605732288,0.0198608335582217,0.00226779042826996
NMR metabolomics,X23428.Concentration of VLDL Particles,GM2A,Ganglioside GM2 activator,39733,0.0119683181388291,0.00393260556606811,0.00426041122933562,0.0196762250483226,0.00234501141990419
NMR metabolomics,X23428.Concentration of VLDL Particles,CD70,CD70 antigen,42119,0.0136574438019422,0.00449342076369528,0.00485033910509945,0.0224645484987849,0.00237478279280887
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0116478700383609,0.00383314290461435,0.00413490994531678,0.019160830131405,0.00238041769378176
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2,Apoptosis regulator Bcl-2,39930,0.0165124669726351,0.00545146971731446,0.00582758632669879,0.0271973476185715,0.00245922523832507
NMR metabolomics,X23428.Concentration of VLDL Particles,ITM2A,Integral membrane protein 2A,42119,-0.0190950363488398,0.0063089304912859,-0.0314605401117602,-0.00672953258591948,0.00247730985574787
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB1A1,Uteroglobin,42165,0.0164769439070411,0.00545045101051497,0.00579405992643178,0.0271598278876505,0.00250714623496606
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L2,Seizure 6-like protein 2,42070,0.00743622967274138,0.00246152956156875,0.00261163173206663,0.0122608276134161,0.00252431334574658
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00905409523070748,0.00299864920652741,0.00317674278591377,0.0149314476755012,0.0025376351814542
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36G,Interleukin-36 gamma,39624,0.02073052594351,0.00687113024987432,0.00726311065375636,0.0341979412332637,0.00255832260336431
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL4,Delta-like protein 4,39638,0.0271706605831018,0.00901129867116443,0.00950851518761954,0.0448328059785841,0.00257413255113244
NMR metabolomics,X23428.Concentration of VLDL Particles,SAFB2,Scaffold attachment factor B2,39934,0.00835030551707649,0.00278205291771318,0.00289748179835865,0.0138031292357943,0.00269246453542785
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD7,FERM domain-containing protein 7,39649,0.0103940557354649,0.00346815084217618,0.00359648008479959,0.0171916313861302,0.00273254493143101
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00916981941891139,0.00307391697969924,0.00314494213870088,0.0151946966991219,0.00285962672181471
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL2,Fc receptor-like protein 2,42229,0.0151771408354484,0.00509446807062397,0.00519198341702537,0.0251622982538713,0.00289566683812374
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00836698446640535,0.00280945305743524,0.00286045647383229,0.0138735124589784,0.00290502214625764
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0212426036316026,0.00713422672596344,0.00725951924871428,0.035225688014491,0.00291058678776286
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.00859343874784936,0.00289444295614579,-0.0142665469418951,-0.00292033055380361,0.00299352483399697
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK3,Prostate-specific antigen,39966,0.0346896071565441,0.0116884783961638,0.0117801895000631,0.0575990248130252,0.00300519265550596
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3C,Protein FAM3C,42129,0.00910406495467302,0.0030917893133985,0.00304415790041197,0.0151639720089341,0.00323928614702772
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,39638,0.017064861625581,0.00579824032623948,0.00570031058615166,0.0284294126650104,0.00325608852531177
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171B,Protein FAM171B,39919,0.00796682009790198,0.00270890671650436,0.00265736293355343,0.0132762772622505,0.00327845988663107
NMR metabolomics,X23428.Concentration of VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0112376937887089,0.00382724516531174,-0.0187390943127199,-0.00373629326469789,0.00332910745779507
NMR metabolomics,X23428.Concentration of VLDL Particles,APOH,Beta-2-glycoprotein 1,42137,-0.010929339511561,0.00372363894560302,-0.0182276718449429,-0.00363100717817908,0.00333975429996172
NMR metabolomics,X23428.Concentration of VLDL Particles,CD80,T-lymphocyte activation antigen CD80,39958,0.0102525173180648,0.00349584957819891,0.00340065214479497,0.0171043824913347,0.00336625303414888
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR3,Small proline-rich protein 3,39929,0.0188642079736592,0.0064349157486648,0.00625177310627619,0.0314766428410422,0.00337961067223604
NMR metabolomics,X23428.Concentration of VLDL Particles,MST1,Hepatocyte growth factor-like protein,39854,0.0201711201274696,0.00688336605191652,0.00667972266571322,0.033662517589226,0.00339189743983099
NMR metabolomics,X23428.Concentration of VLDL Particles,POSTN,Periostin,39966,-0.0113187314674408,0.0038633756602674,-0.0188909477615649,-0.0037465151733167,0.00339907425707599
NMR metabolomics,X23428.Concentration of VLDL Particles,PZP,Pregnancy zone protein,39979,0.00994595008189195,0.00339647662385122,0.00328885589914355,0.0166030442646403,0.00341481297710547
NMR metabolomics,X23428.Concentration of VLDL Particles,PREB,Prolactin regulatory element-binding protein,41913,0.00844592443466467,0.00288632646797275,0.00278872455743809,0.0141031243118913,0.00343726984540586
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP12,Macrophage metalloelastase,42146,0.0162355694060597,0.00556205444731262,0.00533394268932698,0.0271371961227924,0.00351747919168833
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM2,Junctional adhesion molecule B,42249,0.00810877636213071,0.00277798561666944,0.00266392455345861,0.0135536281708028,0.00351796299299729
NMR metabolomics,X23428.Concentration of VLDL Particles,CGA,Glycoprotein hormones alpha chain,42137,-0.0182700713822534,0.00629497497788814,-0.0306082223389142,-0.00593192042559266,0.00371000040622519
NMR metabolomics,X23428.Concentration of VLDL Particles,ARTN,Artemin,41913,0.0133156225586434,0.00460115867183985,0.00429735156183733,0.0223338935554495,0.00381020043285153
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.00807411944952968,0.00279774542565494,0.002590538415246,0.0135577004838134,0.00390858142654012
NMR metabolomics,X23428.Concentration of VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0165367209657542,0.00573266907260097,-0.0277727523480521,-0.00530068958345634,0.00392611548163998
NMR metabolomics,X23428.Concentration of VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.0103543135000143,0.00359127877563115,0.00331540709977722,0.0173932199002513,0.00394312572724408
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR158,Probable G-protein coupled receptor 158,39934,0.0101983758246256,0.00354020518634866,0.00325957365938225,0.017137177989869,0.00397499214296847
NMR metabolomics,X23428.Concentration of VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0112615837656833,0.00392277738216704,0.00357294009663588,0.0189502274347307,0.0041016847897364
NMR metabolomics,X23428.Concentration of VLDL Particles,CSTB,Cystatin-B,41959,0.0126590352827464,0.00441769756219471,0.00400034806084476,0.021317722504648,0.00416964437539187
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB6,Ephrin type-B receptor 6,41997,0.00954946394959154,0.00333606353271372,0.00301077942547265,0.0160881484737104,0.00420972018638759
NMR metabolomics,X23428.Concentration of VLDL Particles,TERF1,Telomeric repeat-binding factor 1,39657,-0.00850849803961857,0.00297310542515785,-0.014335784672928,-0.00268121140630918,0.00422004217407782
NMR metabolomics,X23428.Concentration of VLDL Particles,CD160,CD160 antigen,42296,-0.0141001601952418,0.0049303419876919,-0.0237636304911179,-0.00443668989936567,0.00424449019638388
NMR metabolomics,X23428.Concentration of VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0194208701213756,0.00679546362520593,0.00610176141597202,0.0327399788267793,0.00427097230984999
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0134270016270956,0.00470852613918328,0.00419829039429633,0.0226557128598948,0.0043573630487383
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300E,CMRF35-like molecule 2,42232,0.0121098597717098,0.00425170711792726,0.00377651382057235,0.0204432057228472,0.00440282699313142
NMR metabolomics,X23428.Concentration of VLDL Particles,MELTF,Melanotransferrin,39958,0.00873132533153852,0.0030700872407214,0.00271395433972457,0.0147486963233525,0.0044630758138801
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA10,Annexin A10,41839,-0.0235614902704239,0.00831101255735353,-0.0398510748828369,-0.00727190565801101,0.00458990891879726
NMR metabolomics,X23428.Concentration of VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.00900627309918847,0.00318370902030871,-0.0152463427789935,-0.0027662034193834,0.0046791857556778
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,42129,0.0219008116624245,0.0077647025804063,0.00668199460482815,0.0371196287200209,0.00480096358526653
NMR metabolomics,X23428.Concentration of VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0145320823990484,0.00515375447763484,0.00443072362288414,0.0246334411752127,0.00481529475362702
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00817110776418135,0.00291957043632134,-0.0138934658193712,-0.00244874970899151,0.00513753153119819
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPS,Calcyphosin,39929,0.0270803269867144,0.00970129862062687,0.00806578169028572,0.046094872283143,0.00525663865806181
NMR metabolomics,X23428.Concentration of VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0116574627177389,0.00417645440648874,0.00347161208102096,0.0198433133544568,0.00525805298788744
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN4,Nectin-4,42181,-0.00952633533252699,0.00341876861780185,-0.0162271218234186,-0.00282554884163535,0.00533576007961436
NMR metabolomics,X23428.Concentration of VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0115472357967551,0.00415062415214502,0.00341201245855087,0.0196824591349593,0.00540908633128175
NMR metabolomics,X23428.Concentration of VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0146511751284808,0.00527772820746063,0.00430682784185798,0.0249955224151037,0.0055102989116062
NMR metabolomics,X23428.Concentration of VLDL Particles,F3,Tissue factor,42174,-0.00737922199362089,0.00265890132833985,-0.012590668597167,-0.00216777539007479,0.00552279847603699
NMR metabolomics,X23428.Concentration of VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0331453680449768,0.011956315607117,0.00971098945502748,0.056579746634926,0.00557548904652336
NMR metabolomics,X23428.Concentration of VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0097588502859643,0.0035239618273939,0.00285188510427225,0.0166658154676563,0.00562555326750788
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC16A1,Monocarboxylate transporter 1,41839,0.0155077358362004,0.00560374685420348,0.00452439200196161,0.0264910796704392,0.00565861060787687
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL25,C-C motif chemokine 25,42296,0.0138211890449483,0.00499833971456079,0.00402444320440921,0.0236179348854875,0.00569717234365325
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA7A,Semaphorin-7A,42272,0.00798427850923646,0.00290694292910221,0.00228667036819613,0.0136818866502768,0.0060290958060453
NMR metabolomics,X23428.Concentration of VLDL Particles,TNR,Tenascin-R,42016,0.011673923362558,0.00426066988062858,0.00332301039652598,0.02002483632859,0.0061534115060387
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,42262,0.0165897303554314,0.0060587046860008,0.00471466917086984,0.0284647915399929,0.006186317124089
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP164,Centrosomal protein of 164 kDa,41913,0.0173187917513563,0.00633539789961661,0.00490141186810774,0.0297361716346049,0.00627184023328439
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK2,Protein AHNAK2,39638,0.00867949726196057,0.00318337201852761,0.00244008810564644,0.0149189064182747,0.00641089646694464
NMR metabolomics,X23428.Concentration of VLDL Particles,VASN,Vasorin,41975,0.00759908438173803,0.00278764954566061,0.00213529127224323,0.0130628774912328,0.00641938262596898
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRC,Chymotrypsin-C,42122,0.0181142350781863,0.0066472586575877,0.00508560810931441,0.0311428620470582,0.0064370836309561
NMR metabolomics,X23428.Concentration of VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,42247,0.00784206827926259,0.0028866015560817,0.00218432922934246,0.0134998073291827,0.00660168369983455
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN3,CCN family member 3,42299,0.00938625981970088,0.00345732598965441,0.00260990087997823,0.0161626187594235,0.00663808286358504
NMR metabolomics,X23428.Concentration of VLDL Particles,HMBS,Porphobilinogen deaminase,42262,0.0110940349598207,0.00408947531759142,0.00307866333734156,0.0191094065822999,0.00667956882274914
NMR metabolomics,X23428.Concentration of VLDL Particles,HRAS,GTPase Hras,39750,0.0274637577977382,0.0101254179554408,0.00761793860507416,0.0473095769904022,0.00669088852807519
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00708739639013162,0.00261887272262969,-0.0122203869264858,-0.00195440585377743,0.00681437488582492
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB6,Heat shock protein beta-6,42262,0.0111705593906532,0.00413747443689182,0.00306110949434528,0.0192800092869612,0.00694562042344943
NMR metabolomics,X23428.Concentration of VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00593129172920834,0.00220932725151841,0.00160101031623224,0.0102615731421844,0.00727121315468716
NMR metabolomics,X23428.Concentration of VLDL Particles,PROCR,Endothelial protein C receptor,39575,-0.00949766894299158,0.00353902022529853,-0.0164341485845767,-0.00256118930140647,0.00729216169049166
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN3,Perilipin-3,42145,-0.0116929417985835,0.00435756048311769,-0.0202337603454942,-0.00315212325167283,0.00729731162089392
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK3,Dickkopf-related protein 3,42310,-0.00805262169617738,0.00300133653735797,-0.013935241309399,-0.00217000208295575,0.00730499234341634
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0134519317942163,0.0050276919444152,0.00359765558316252,0.0233062080052701,0.00747120625449037
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB5,Integrin beta-5,42181,0.0104543502060705,0.00390775825639976,0.00279514402352697,0.018113556388614,0.00747562061762817
NMR metabolomics,X23428.Concentration of VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.00744523866232307,0.0027875213018222,0.00198169691075157,0.0129087804138946,0.00757344406394464
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0144432574300807,0.00541460111124367,0.00383063925204305,0.0250558756081183,0.00765168614250387
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP9,Matrix metalloproteinase-9,42125,-0.0162291141648813,0.00608827687842329,-0.0281621368465909,-0.00429609148317162,0.0076934740923268
NMR metabolomics,X23428.Concentration of VLDL Particles,BRK1,Protein BRICK1,41839,0.0123040523536921,0.00461752401711746,0.00325370528014191,0.0213543994272423,0.00771635514962838
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0090023594117941,0.00339841539006657,-0.0156632535763246,-0.00234146524726362,0.00808488353131414
NMR metabolomics,X23428.Concentration of VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0136464641004177,0.00516537056712801,0.00352233778884675,0.0237705904119885,0.0082533027839112
NMR metabolomics,X23428.Concentration of VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,42212,0.0224836127588941,0.00851679807626144,0.00579068852942169,0.0391765369883666,0.00830216832603235
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RA,Interleukin-17 receptor A,42137,0.01188740637957,0.00451519728953686,0.00303761969207776,0.0207371930670623,0.00847917016709336
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAU,Urokinase-type plasminogen activator,42137,0.00762756187226221,0.00290610295519218,0.00193160008008555,0.0133235236644389,0.00868303480412188
NMR metabolomics,X23428.Concentration of VLDL Particles,MBL2,Mannose-binding protein C,39826,0.0296128640445605,0.011288544252425,0.00748731730980761,0.0517384107793134,0.0087208768312464
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF9,Fibroblast growth factor 9,39539,0.0110463177443273,0.00421568330122506,0.0027835784739262,0.0193090570147284,0.00879761167993476
NMR metabolomics,X23428.Concentration of VLDL Particles,HSP90B1,Endoplasmin,41774,0.0169136707663281,0.00645974387561977,0.00425257277011337,0.0295747687625429,0.00884652405045767
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR2,Anterior gradient protein 2 homolog,41740,-0.0266220508439436,0.010195865721194,-0.0466059476574838,-0.00663815403040335,0.00903637129758822
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN15,Lipocalin-15,39934,-0.0161280150067439,0.00619251830133936,-0.0282653508773691,-0.00399067913611877,0.00921458210336122
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.018868727431776,0.0072454406203182,0.0046676638159523,0.0330697910475996,0.00922054519058875
NMR metabolomics,X23428.Concentration of VLDL Particles,CLNS1A,Methylosome subunit pICln,39649,-0.00889836476885869,0.00342784253342614,-0.0156169361343739,-0.00217979340334345,0.00944660840525775
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1B,Protein phosphatase 1B,39657,0.0163672701009153,0.00630789671730907,0.00400379253498952,0.0287307476668411,0.00947910422224023
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0150569915903847,0.00581260078696142,0.00366429404794033,0.0264496891328291,0.00959899243818973
NMR metabolomics,X23428.Concentration of VLDL Particles,LEG1,Protein LEG1 homolog,39398,-0.0187185150854853,0.00722690272570782,-0.0328832444278726,-0.00455378574309799,0.00960725247001439
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3B,Protein FAM3B,42070,0.00926932230843238,0.00357953670158323,0.00225343037332926,0.0162852142435355,0.00962100873925264
NMR metabolomics,X23428.Concentration of VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00863267971010125,0.00333492678987972,0.00209622320193701,0.0151691362182655,0.00965034419082161
NMR metabolomics,X23428.Concentration of VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.00708495351573145,0.00274668977996954,0.00170144154699114,0.0124684654844718,0.00990615342314929
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPF,Centromere protein F,39757,0.014209122923277,0.00550916003148264,0.00341116926157106,0.025007076584983,0.00991616011101063
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC1,Glypican-1,42262,0.00774911628674095,0.00300612814614803,0.00185710512029081,0.0136411274531911,0.00995430566776836
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0124580289675775,0.00483944350319441,-0.0219433382338386,-0.00297271970131649,0.0100581316043733
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM3,Intercellular adhesion molecule 3,42310,-0.00706929863439818,0.002756625325674,-0.0124722842727192,-0.00166631299607714,0.0103437335204914
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,39929,0.0101244152308999,0.00395002649219205,0.00238236330620353,0.0178664671555964,0.0103862380779855
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR1,Interferon gamma receptor 1,42185,0.00563443511299016,0.00220020602506849,0.00132203130385592,0.00994683892212439,0.010451836873241
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.00820683229898402,0.00320732359937765,0.00192047804420382,0.0144931865537642,0.0105169225535511
NMR metabolomics,X23428.Concentration of VLDL Particles,SHPK,Sedoheptulokinase,39757,-0.0104433368013739,0.00408399991297553,-0.018447976630806,-0.00243869697194188,0.0105669519359423
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA1,Annexin A1,39699,0.0116298010223596,0.00454830257359158,0.00271512797812013,0.0205444740665991,0.0105724959867726
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC4A1,Band 3 anion transport protein,39966,-0.0123808262281036,0.00486187369067866,-0.0219100986618338,-0.0028515537943734,0.0108935776208969
NMR metabolomics,X23428.Concentration of VLDL Particles,GSAP,Gamma-secretase-activating protein,41843,0.0218124158476312,0.00856902932426205,0.00501711837207764,0.0386077133231849,0.0109235486359661
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.00799513136828178,0.00315536176355997,-0.0141796404248593,-0.00181062231170425,0.011293719698041
NMR metabolomics,X23428.Concentration of VLDL Particles,PGM2,Phosphoglucomutase-2,39649,0.0156714078797926,0.00619442031763466,0.00353034405722865,0.0278124717023565,0.0114225261662682
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,42262,0.01365902688181,0.00540153883352589,0.00307201076809929,0.0242460429955208,0.0114588054245749
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00767577655574218,0.00303563963892358,0.00172592286345196,0.0136256302480324,0.0114652105228433
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH6,Cadherin-6,42145,-0.00998934102278337,0.00395974317487334,-0.0177504376455351,-0.00222824440003161,0.011656315961618
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP4,Bone morphogenetic protein 4,41992,-0.0121536140737458,0.00481793999243639,-0.0215967764589212,-0.00271045168857052,0.0116614047572961
NMR metabolomics,X23428.Concentration of VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0100809232226879,0.0040001959155701,0.0022405392281705,0.0179213072172053,0.0117455268927858
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00931374422593996,0.00369845736405575,0.00206476779239069,0.0165627206594892,0.0118070412720243
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,42070,0.00662839173732811,0.00264090462098657,0.00145221868019444,0.0118045647944618,0.0120883576495746
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD9,Enhancer of filamentation 1,39657,0.00868506608726777,0.00346235531250753,0.001898849674753,0.0154712824997825,0.0121411962059581
NMR metabolomics,X23428.Concentration of VLDL Particles,LIF,Leukemia inhibitory factor,41839,0.0127618855828149,0.00508968817033324,0.00278609676896179,0.0227376743966681,0.0121741649963973
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.00864367494971922,0.00344886195696869,-0.0154034443853779,-0.00188390551406058,0.0122140231925438
NMR metabolomics,X23428.Concentration of VLDL Particles,LTO1,Protein LTO1 homolog,41913,0.0105261888944581,0.00420458608108614,0.00228520017552924,0.0187671776133869,0.0123089801652707
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,39889,-0.00696675981335862,0.00278684325868228,-0.0124289726003759,-0.00150454702634136,0.0124377898956288
NMR metabolomics,X23428.Concentration of VLDL Particles,CD59,CD59 glycoprotein,41638,0.00598890483257377,0.00240460413435756,0.00127588072923295,0.0107019289359146,0.0127651412379031
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF3,Neurotrophin-3,42119,0.0086980845759771,0.00349962079970671,0.00183882780855194,0.0155573413434022,0.0129512685051528
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0146992060348633,0.0059400839523664,0.00305664148822519,0.0263417705815015,0.0133517139585062
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.010244696476809,0.00414334529685594,0.00212373969497137,0.0183656532586466,0.0134292418118463
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC12A2,Solute carrier family 12 member 2,39575,-0.00667093552395223,0.00269896145559421,-0.0119608999769169,-0.00138097107098758,0.0134635092203723
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO1,Amphoterin-induced protein 1,39649,0.0127209749049679,0.00517677274308074,0.00257450032852964,0.0228674494814061,0.0140131393847869
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN2,Neuroligin-2,39586,-0.011719041199071,0.00477823391184424,-0.0210843796662857,-0.00235370273185627,0.0141986900222324
NMR metabolomics,X23428.Concentration of VLDL Particles,EDN1,Endothelin-1,39638,0.00735983010603626,0.00300311544059347,0.00147372384247305,0.0132459363695995,0.014272023124557
NMR metabolomics,X23428.Concentration of VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0107547073049246,0.00439742239069514,0.00213575941916212,0.0193736551906871,0.0144703208053239
NMR metabolomics,X23428.Concentration of VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00709549109258215,0.00290334824331573,0.00140492853568332,0.012786053649481,0.0145445735005597
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4,Interleukin-4,41913,0.0234798927288867,0.00960803332654831,0.00464814740885205,0.0423116380489214,0.0145472903244881
NMR metabolomics,X23428.Concentration of VLDL Particles,STX5,Syntaxin-5,39657,0.00993939475502217,0.00406749701122967,0.00196710061301201,0.0179116888970323,0.0145564787805902
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00867237528083738,0.00355304507008088,0.00170840694347885,0.0156363436181959,0.0146690363217138
NMR metabolomics,X23428.Concentration of VLDL Particles,NEB,Nebulin,39575,-0.0099124156361307,0.00406721260138353,-0.0178841523348424,-0.00194067893741898,0.0148192279739755
NMR metabolomics,X23428.Concentration of VLDL Particles,CRH,Corticoliberin,41830,0.0212451347797793,0.00872019051739284,0.00415356136568936,0.0383367081938693,0.0148508400828497
NMR metabolomics,X23428.Concentration of VLDL Particles,APOF,Apolipoprotein F,39990,0.00643461470559206,0.00264572890431631,0.00124898605313209,0.011620243358052,0.0150278453410838
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00679398048882858,0.00279442156195558,-0.0122710467502615,-0.00131691422739564,0.0150618276496704
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.00978082860586037,0.00403359658484188,-0.0176866779121505,-0.00187497929957029,0.0153281231138095
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0217674008382227,0.00899237988738342,-0.0393924654174942,-0.00414233625895119,0.0155088319463303
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1A,Interleukin-1 alpha,41913,0.0142553659187743,0.00589084933207104,0.00270930122791509,0.0258014306096336,0.0155373561210198
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00704437691685095,0.00291283330955536,-0.0127535302035795,-0.00133522363012245,0.0156048348340604
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0188267848576259,0.0077848578695058,0.00356846343339457,0.0340851062818573,0.0156057558633474
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0135474333625703,0.0056120718419693,-0.0245470941728301,-0.00254777255231042,0.0157955412081939
NMR metabolomics,X23428.Concentration of VLDL Particles,NDRG1,Protein NDRG1,41839,0.0161746526755553,0.00671201063779751,0.00301911182547223,0.0293301935256385,0.0159744980766466
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.010914392549624,0.00453189387532371,0.00203188055398956,0.0197969045452585,0.0160410105539234
NMR metabolomics,X23428.Concentration of VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0303001338146321,0.0125897820940917,0.00562416091021238,0.0549761067190518,0.0161099210006953
NMR metabolomics,X23428.Concentration of VLDL Particles,HMCN2,Hemicentin-2,39721,-0.0142811794091224,0.0059350728799266,-0.0259139222537785,-0.00264843656446624,0.0161341064350407
NMR metabolomics,X23428.Concentration of VLDL Particles,CD109,CD109 antigen,42137,-0.00834273187268509,0.00347226187259406,-0.0151483651429694,-0.00153709860240073,0.0162888277489518
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0073966119522206,0.00308621686745807,0.00134762689200278,0.0134455970124384,0.0165586692183403
NMR metabolomics,X23428.Concentration of VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.00870421592015424,0.0036321571413883,0.00158518792303317,0.0158232439172753,0.0165693089997863
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0102483498546915,0.00427940957441202,-0.0186359926205391,-0.00186070708884393,0.0166456473890435
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.00888981548053618,0.00371451647633859,0.00160936318691255,0.0161702677741598,0.0167158319168244
NMR metabolomics,X23428.Concentration of VLDL Particles,AKAP12,A-kinase anchor protein 12,39736,0.00519935597649706,0.00217479625699691,0.000936755312783111,0.009461956640211,0.0168313100910059
NMR metabolomics,X23428.Concentration of VLDL Particles,YY1,Transcriptional repressor protein YY1,39657,0.0068102509073616,0.00285237944160996,0.00121958720180609,0.0124009146129171,0.0169769411535681
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00598716786008857,0.00251090173572358,0.00106580045807035,0.0109085352621068,0.017120537467503
NMR metabolomics,X23428.Concentration of VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0196659255627074,0.00826221798493499,0.00347197831223478,0.0358598728131799,0.0173189986850979
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0147468985299015,0.0062070971073817,0.00258098819943336,0.0269128088603696,0.0175244432842181
NMR metabolomics,X23428.Concentration of VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0167118128708084,0.00705391635044161,0.00288613682394289,0.030537488917674,0.0178459285489076
NMR metabolomics,X23428.Concentration of VLDL Particles,GUK1,Guanylate kinase,39575,-0.00974088517816644,0.0041129392173194,-0.0178022460441125,-0.00167952431222042,0.0178847824974178
NMR metabolomics,X23428.Concentration of VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.00864360928462788,0.00365016184907473,-0.0157979265088144,-0.0014892920604414,0.0178980788599727
NMR metabolomics,X23428.Concentration of VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.00795292085477033,0.00336183115976628,0.00136373178162843,0.0145421099279122,0.0180124585621948
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2,T-cell surface antigen CD2,39575,-0.00939465827613485,0.00397658349747898,-0.0171887619311936,-0.00160055462107606,0.0181697386872749
NMR metabolomics,X23428.Concentration of VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0144082846936186,0.00609956827603054,0.00245313087259874,0.0263634385146384,0.0181820288996503
NMR metabolomics,X23428.Concentration of VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0104560905575957,0.00442661529854673,0.00177992457244414,0.0191322565427473,0.0181886921570359
NMR metabolomics,X23428.Concentration of VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0129858564049141,0.005501764144128,-0.023769314127405,-0.00220239868242321,0.0182772329072124
NMR metabolomics,X23428.Concentration of VLDL Particles,RETN,Resistin,42105,-0.0103115032677168,0.00437230100377269,-0.0188812132351113,-0.00174179330032233,0.0183695591185935
NMR metabolomics,X23428.Concentration of VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.0079396234990631,0.003370934101239,0.00133259266063466,0.0145466543374916,0.0185212752276086
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G1B,Phospholipase A2,42299,-0.0106679317016893,0.00453664265600571,-0.0195597513074605,-0.00177611209591815,0.0187117914486173
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,42119,0.0115833134536154,0.00492971080539887,0.00192108027503358,0.0212455466321971,0.0188031375397981
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF2,Trefoil factor 2,42166,-0.0139581657664174,0.00594207831961804,-0.0256046392728687,-0.00231169225996602,0.0188362678275219
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00613216690972352,0.00261787040382039,-0.0112631929012115,-0.00100114091823555,0.0191765202252897
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL1,Follistatin-related protein 1,39638,-0.00555920405284339,0.00237613030540405,-0.0102164194514353,-0.00090198865425146,0.019321925605514
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.00996299576090724,0.00426976303960639,-0.0183317313185358,-0.00159426020327872,0.0196424586863977
NMR metabolomics,X23428.Concentration of VLDL Particles,LIPF,Gastric triacylglycerol lipase,39638,0.0149240837657958,0.00642485525605265,0.00233136746393261,0.027516800067659,0.0202043867150246
NMR metabolomics,X23428.Concentration of VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0217817200855768,0.00939527851706904,0.0033669741921215,0.0401964659790321,0.0204475541586068
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH3,Cadherin-3,42249,0.00867938703795912,0.00374574327006181,0.00133773022863798,0.0160210438472803,0.0205111853159517
NMR metabolomics,X23428.Concentration of VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.0081306534484762,0.00351202471573852,0.0012470850056287,0.0150142218913237,0.0206262216208656
NMR metabolomics,X23428.Concentration of VLDL Particles,CRNN,Cornulin,41749,0.0158485215030834,0.00685230556514637,0.00241800259539648,0.0292790404107703,0.0207449080179764
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSPN,Claspin,41820,0.00834963984710375,0.00361468031874934,0.00126486642235505,0.0154344132718525,0.0209076424648617
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.0127424151841955,0.00552084999334285,-0.0235632811711475,-0.00192154919724355,0.0210145588898945
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,39757,0.0161332775117105,0.00699294328665271,0.00242710866987124,0.0298394463535498,0.0210685977243695
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.0102796532203593,0.00446639732581102,-0.0190337919789489,-0.00152551446176968,0.0213789755681865
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO6,Unconventional myosin-VI,39934,0.00877778403345668,0.00382116206151831,0.00128830639288079,0.0162672616740326,0.0216283297334846
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.00716224180749038,0.0031179238050922,-0.0132733724654711,-0.00105111114950967,0.0216301339665846
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00884731733462862,0.00386449589512718,-0.0164217292890779,-0.00127290538017935,0.0220759398399661
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,39930,0.0117407652916402,0.00513572077659051,0.00167475256952275,0.0218067780137576,0.0222668491871159
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSB,Cathepsin B,42153,0.0117998974102448,0.00516435449381382,0.00167776260236968,0.0219220322181199,0.0223356178887925
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1,DNA topoisomerase 1,39930,0.0279753003891667,0.012322718232685,0.00382277265310412,0.0521278281252294,0.0232128412398048
NMR metabolomics,X23428.Concentration of VLDL Particles,CLMP,CXADR-like membrane protein,42262,0.00510697862472092,0.0022514983090261,0.00069404193902977,0.00951991531041207,0.0233290359411032
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.00872176585306409,0.00384760558744198,0.00118045890167781,0.0162630728044504,0.023417959008717
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0157855111970185,0.00697941081654153,0.00210586599659707,0.0294651563974399,0.023730518862872
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKCQ,Protein kinase C theta type,41913,0.00984416247259506,0.00435401247063461,0.00131029803015122,0.0183780269150389,0.0237790236664831
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC5D,Netrin receptor UNC5D,39657,0.00603647277277863,0.00267028553587573,0.000802713122462194,0.0112702324230951,0.0238028098807636
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA2,GDNF family receptor alpha-2,42070,0.00480089248304029,0.00212439831003147,0.000637071795378608,0.00896471317070198,0.0238443914902712
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI4,Protein-arginine deiminase type-4,41814,0.0167845504056486,0.00742840193863256,0.0022248826059288,0.0313442182053685,0.0238678806456353
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.00617123435446699,0.00273408304147224,0.000812431593181403,0.0115300371157526,0.0240146782070262
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.00661679107536722,0.00293477501154559,0.000864632052737869,0.0123689500979966,0.0241764018907512
NMR metabolomics,X23428.Concentration of VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0154622933722924,0.00685804268531727,-0.0289040570355142,-0.00202052970907054,0.0241766999007412
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH7B,Myosin-7B,39560,-0.00988311902559969,0.00438872896326811,-0.0184850277936052,-0.0012812102575942,0.0243462849213219
NMR metabolomics,X23428.Concentration of VLDL Particles,LY96,Lymphocyte antigen 96,42016,-0.00835977962517621,0.00371934587292587,-0.0156496975361109,-0.00106986171424151,0.0246148334143357
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0120394930054924,0.00536572407431109,0.00152267381984264,0.0225563121911421,0.0248662290585149
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.00622935797835372,0.00277830097566058,0.000783888066058992,0.0116748278906484,0.0249711082894197
NMR metabolomics,X23428.Concentration of VLDL Particles,CST7,Cystatin-F,42148,0.0215193985374374,0.00960290362089586,0.00269770744048148,0.0403410896343932,0.0250469880816621
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC4,MANSC domain-containing protein 4,39575,0.0155615131222559,0.00694511218970092,0.00194909323044212,0.0291739330140697,0.0250691678361284
NMR metabolomics,X23428.Concentration of VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.00829605852236564,0.00371318099413035,0.00101822377387016,0.0155738932708611,0.0254881506853477
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR101,Probable G-protein coupled receptor 101,39586,-0.0131782905623361,0.00593923973451873,-0.0248192004419929,-0.00153738068267942,0.0265171901074312
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR4,Toll-like receptor 4,39657,0.00643474146331066,0.00290303530556645,0.000744792264400419,0.0121246906622209,0.0266736929974656
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP290,Centrosomal protein of 290 kDa,39757,0.0120101307879671,0.00541925774667691,0.00138838560448035,0.0226318759714538,0.0266982628454719
NMR metabolomics,X23428.Concentration of VLDL Particles,RALB,Ras-related protein Ral-B,39657,0.006719216423032,0.00303255337775784,0.000775411802626632,0.0126630210434374,0.0267326186710207
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0145434339794635,0.00656590013529791,0.00167426971427961,0.0274125982446474,0.0267801812912191
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA2,Ephrin type-A receptor 2,41614,-0.00725815867279463,0.00328764487730028,-0.0137019426323032,-0.000814374713286083,0.0272820391583029
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMH,Granzyme H,41900,0.0176831361182716,0.00801472989247191,0.00197426552902667,0.0333920067075166,0.0273779556562262
NMR metabolomics,X23428.Concentration of VLDL Particles,DDI2,Protein DDI1 homolog 2,39736,0.0168639377831987,0.00766444894772909,0.00184161784564966,0.0318862577207477,0.027807458291561
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00691768353726816,0.00314636132435515,0.000750815341532075,0.0130845517330043,0.0279214038768766
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.00575520063916181,0.00262217825746439,0.000615731254531603,0.010894670023792,0.0281969605770511
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0103519046519102,0.00471786717126586,0.00110488499622911,0.0195989243075913,0.0282425219729293
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD1,Leiomodin-1,39934,-0.00777064451696525,0.00354275015511274,-0.0147144348209862,-0.00082685421294428,0.0282992934391989
NMR metabolomics,X23428.Concentration of VLDL Particles,EP300,Histone acetyltransferase p300,39657,0.00690305261300932,0.00314872069646458,0.00073156004793874,0.0130745451780799,0.0283760486262136
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR5,Proline-rich protein 5,39657,0.0105601938008991,0.00482527113465735,0.00110266237697066,0.0200177252248275,0.0286527218877386
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00566455820826316,0.00258986168787395,-0.0107406871164961,-0.000588429300030227,0.0287479403056212
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,42166,-0.00985628167000229,0.0045355819860887,-0.0187460223627361,-0.000966540977268429,0.0297898965219466
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.0114376478720944,0.00526843517926341,0.0011115149207381,0.0217637808234507,0.0299539759174644
NMR metabolomics,X23428.Concentration of VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0125349933525287,0.00578222666775247,0.00120182908373381,0.0238681576213235,0.030192603585752
NMR metabolomics,X23428.Concentration of VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00983157665363434,0.00456215524530273,0.000889752372841002,0.0187734009344277,0.0311775423054266
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX18,Sorting nexin-18,39930,0.00959759766315746,0.00446852793796132,0.000839282904753278,0.0183559124215616,0.0317491292433611
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0122679312707075,0.00571702840460689,0.001062555597678,0.023473306943737,0.0319054901859694
NMR metabolomics,X23428.Concentration of VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00854136292844142,0.00399671552088199,-0.0163749253493701,-0.000707800507512733,0.0326122918650893
NMR metabolomics,X23428.Concentration of VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0220472278290101,0.0103417306243715,-0.0423170198527782,-0.00177743580524204,0.0330396586228588
NMR metabolomics,X23428.Concentration of VLDL Particles,GH2,Growth hormone variant,41843,0.0351095791191057,0.0164889783624816,0.0027911815286418,0.0674279767095696,0.0332498600198761
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0134673956562771,0.0063305446912527,-0.0258752632511324,-0.00105952806142182,0.0334111092821764
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0061253258481993,0.00288961612477319,-0.0117889734527547,-0.000461678243643852,0.0340432385644675
NMR metabolomics,X23428.Concentration of VLDL Particles,CA14,Carbonic anhydrase 14,42262,0.00790521666507633,0.00373388047401976,0.0005868109359976,0.0152236223941551,0.0342644218996978
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.00933641859779259,0.00441412667286987,0.000684730318967638,0.0179881068766175,0.0344380351991671
NMR metabolomics,X23428.Concentration of VLDL Particles,IL19,Interleukin-19,41756,-0.0157353221774189,0.00746724899934313,-0.0303711302161314,-0.00109951413870633,0.0351152343849453
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL14,C-X-C motif chemokine 14,41913,0.0122349651455532,0.0058195637870851,0.000828620122866448,0.02364131016824,0.035538271389707
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC13A1,Solute carrier family 13 member 1,39919,0.0128563013522982,0.00612793970268644,0.00084553953503276,0.0248670631695636,0.0359289322454142
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP7,Dipeptidyl peptidase 2,42054,0.0134205018782502,0.00639723334608604,0.000881924519921591,0.0259590792365789,0.0359360929889393
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_DRA,,42060,-0.0077541418016199,0.00369785685880266,-0.0150019412448731,-0.000506342358366694,0.0360185080230241
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.00705974244848979,0.00336827746458602,-0.0136615662790784,-0.000457918617901196,0.0361086512952579
NMR metabolomics,X23428.Concentration of VLDL Particles,GBA,Lysosomal acid glucosylceramidase,39649,0.0118385499993108,0.00565931408860247,0.000746294385649948,0.0229308056129716,0.03647290583022
NMR metabolomics,X23428.Concentration of VLDL Particles,DBH,Dopamine beta-hydroxylase,39978,0.0243108029709922,0.0116449110255914,0.00148677736083296,0.0471348285811514,0.0368492464093344
NMR metabolomics,X23428.Concentration of VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00413321388853707,0.00198223170248744,-0.00801838802541246,-0.000248039751661688,0.0370795931066311
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP2,Dipeptidase 2,42070,0.00638224999192187,0.00306127736247269,0.000382146361475389,0.0123823536223683,0.0371033099857312
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.0111281011709038,0.00534070501443229,-0.0215958829991911,-0.000660319342616482,0.0372160750991112
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.00782689121929947,0.00376967270428077,0.000438332718909164,0.0152154497196898,0.0378906008270787
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA5,Protein disulfide-isomerase A5,39560,0.0130947097851065,0.00630714581616631,0.000732703985420481,0.0254567155847924,0.037901442235457
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG4,Proteasome assembly chaperone 4,39657,-0.011877360450093,0.00572174054478301,-0.0230919719178677,-0.000662748982318308,0.0379327359326823
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.00729482476792128,0.00352229113292708,0.000391134147384212,0.0141985153884584,0.0383733064834413
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSG1,Tryptase gamma,39657,0.00552570132251773,0.00267950432148993,0.000273872852397467,0.010777529792638,0.0392110304282672
NMR metabolomics,X23428.Concentration of VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0146947071166756,0.00713510762645079,0.000709896168832044,0.0286795180645192,0.0394659186438375
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR1,Cadherin-related family member 1,41839,0.00865310604065926,0.00420522504710962,0.000410864948324405,0.0168953471329941,0.0396381463166008
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.00664949203124588,0.00323387919181981,0.000311088815279062,0.0129878952472127,0.0397870107758984
NMR metabolomics,X23428.Concentration of VLDL Particles,APOD,Apolipoprotein D,39468,0.00892070225924408,0.00434725849665221,0.000400075605805747,0.0174413289126824,0.0401907092300323
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP7,GTPase IMAP family member 7,39736,-0.00675449533756274,0.00329305322903803,-0.0132088796664773,-0.000300111008648209,0.0402771881979678
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,42119,0.00927905311912599,0.00453346209221141,0.000393467418391615,0.0181646388198604,0.0406978238779015
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB5,Serpin B5,41900,0.0101302595250811,0.00495896744993602,0.000410683323206549,0.0198498357269557,0.0410902987229381
NMR metabolomics,X23428.Concentration of VLDL Particles,TNC,Tenascin,42217,-0.0100303195009818,0.00491549121791639,-0.0196646822880979,-0.00039595671386564,0.0413145423722945
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,39586,0.0092707999982045,0.00454777692199012,0.000357157231103874,0.0181844427653051,0.041520405084432
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0185486211212595,0.00910066148040409,-0.0363859176228515,-0.000711324619667445,0.0415569455685665
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0129586300990988,0.00637086453522073,0.000471735610066209,0.0254455245881315,0.0419708008098998
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN3,Matrilin-3,41992,0.00682514765351022,0.00335911049635416,0.000241291080656073,0.0134090042263644,0.0421903825630444
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2B,Sodium channel subunit beta-2,39649,-0.00584364674694372,0.00287909636376764,-0.0114866756199283,-0.00020061787395914,0.0424129066147091
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOPH1,Enolase-phosphatase E1,39919,0.0110287106818737,0.00544013211353954,0.000366051739336159,0.0216913696244112,0.0426564273681258
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB44,Ras-related protein Rab-44,39919,0.00926130462436417,0.0045794831858032,0.000285517580189893,0.0182370916685384,0.0431639759918098
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0122684113763043,0.00607410678319582,-0.0241736606713681,-0.000363162081240454,0.0434253181207844
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.00650784800596833,0.00322637692144138,-0.0128315467719934,-0.000184149239943214,0.0437073644841817
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGBL1,Integrin beta-like protein 1,39966,0.00809310996708445,0.00402093236653333,0.000212082528679122,0.0159741374054898,0.0441650415607018
NMR metabolomics,X23428.Concentration of VLDL Particles,CA8,Carbonic anhydrase-related protein,39657,0.00548300372748082,0.002724380242719,0.000143218451751586,0.0108227890032101,0.044184170598303
NMR metabolomics,X23428.Concentration of VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00777987467235224,0.00387961673121546,0.000175825879169944,0.0153839234655345,0.0449494613379962
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0151465982620479,0.00759494676439017,0.000260502603843143,0.0300326939202526,0.0461432515568763
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.015426135729382,0.00773919667425677,0.000257310247838689,0.0305949612109252,0.0462547271692164
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.0077065296136778,0.0038757159952433,0.000110126263000938,0.0153029329643547,0.0467859771580043
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4C,Semaphorin-4C,42070,0.00563323091186922,0.00283383684966361,7.89106865285516e-05,0.0111875511372099,0.0468489484238455
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.00445729660214627,0.00225125075335232,-0.00886974807871682,-4.48451255757269e-05,0.0477330873255966
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0151240594898261,0.00764106081711524,0.000147580288280201,0.0301005386913719,0.0478047596439782
NMR metabolomics,X23428.Concentration of VLDL Particles,UNG,Uracil-DNA glycosylase,39919,0.00707424023443993,0.00359413228227415,2.97409611825982e-05,0.0141187395076973,0.0490607881191658
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON1,Spondin-1,42144,0.00652332927456088,0.00331799811277963,2.00529735127995e-05,0.013026605575609,0.0493139574634802
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00628129624877162,0.00320235276814047,-0.0125579076743269,-4.6848232162942e-06,0.0498501186718841
NMR metabolomics,X23428.Concentration of VLDL Particles,HCG22,Protein PBMUCL2,39575,-0.0116361717203151,0.00593556312043223,-0.0232698754363622,-2.46800426787798e-06,0.0499724703076945
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.00675814626852393,0.0034493534342155,-2.58646253845345e-06,0.0135188789995863,0.0501039794811603
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0134419062271796,0.0068813626843932,-4.55646342310493e-05,0.0269293770885903,0.0507993257269319
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.0117199862721838,0.00601333343230907,-6.61472551419916e-05,0.0235061197995096,0.0513208789310465
NMR metabolomics,X23428.Concentration of VLDL Particles,CST6,Cystatin-M,41864,0.00985733795275573,0.00506485999802985,-6.97876433827828e-05,0.0197844635488942,0.0516492613440407
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0141210948588971,0.0072659323233356,-0.0283623222126349,0.000120132494840684,0.051984571301803
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,42016,-0.00722089002155812,0.003718887793283,-0.0145099100963928,6.81300532765555e-05,0.052196759888686
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.00847547616036082,0.00436644993517173,-0.0170337180332974,8.27657125757782e-05,0.0522737254444887
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B4,Protein ATP1B4,39560,-0.00831574281009467,0.00428573165716288,-0.0167157768581339,8.42912379445827e-05,0.052364953672993
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00821960247292256,0.00423800168242324,-8.68808246269892e-05,0.0165260857704721,0.0524617512615763
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0333447066792619,0.0172092711519049,-0.000385464778471796,0.0670748781369956,0.0526929653846259
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB39B,Ras-related protein Rab-39B,39575,0.0182596959671817,0.00943556877073737,-0.000234018823463508,0.036753410757827,0.0529916338073346
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK11,Kallikrein-11,42062,0.00634410355777252,0.00327900814475395,-8.27524059452247e-05,0.0127709595214903,0.053040312155
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,39575,0.00841324166775472,0.0043491892134315,-0.000111169190571025,0.0169376525260805,0.0530848334237753
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D2,DCN1-like protein 2,39560,-0.0157918812940266,0.0081668498186685,-0.0317989069386169,0.000215144350563658,0.0531811074129781
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0100769276788862,0.00521962110149001,-0.0203073850378066,0.000153529680034218,0.0535553126692126
NMR metabolomics,X23428.Concentration of VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0109623831628007,0.00568529058061465,-0.000180786375204018,0.0221055527008054,0.0538550869717124
NMR metabolomics,X23428.Concentration of VLDL Particles,CFD,Complement factor D,39979,0.00399484397979687,0.00207239119850118,-6.7042769265435e-05,0.00805673072885918,0.0539235895472816
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB1,Calbindin,42070,0.00886714867961457,0.00460492954306167,-0.000158513224786289,0.0178928105840154,0.0541781774261318
NMR metabolomics,X23428.Concentration of VLDL Particles,UROS,Uroporphyrinogen-III synthase,39649,0.0129789942235896,0.00674721282262962,-0.000245542908764442,0.0262035313559437,0.0544293695451457
NMR metabolomics,X23428.Concentration of VLDL Particles,PKLR,Pyruvate kinase PKLR,42143,-0.0121614284507725,0.00633864568945708,-0.0245851740021083,0.000262317100563408,0.0550539186529654
NMR metabolomics,X23428.Concentration of VLDL Particles,COL3A1,Collagen alpha-1(III) chain,39966,-0.004609640983864,0.00240783507090889,-0.00932899772284543,0.000109715755117428,0.0555898226349505
NMR metabolomics,X23428.Concentration of VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.00561584860927737,0.00293729311535442,-0.011372943115372,0.000141245896817292,0.0559086442711986
NMR metabolomics,X23428.Concentration of VLDL Particles,LPO,Lactoperoxidase,41647,-0.0119413614615112,0.00626162678967026,-0.0242141499692649,0.000331427046242479,0.0565334452649376
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.00864185590626023,0.00455366061408359,-0.0175670307098641,0.000283318897343602,0.0577460376483391
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH15,Cadherin-15,42230,0.0133477948133587,0.00703696290789167,-0.000444652486108997,0.0271402421128264,0.0578738918017563
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAN,Versican core protein,42249,0.00580075744134216,0.00305982904387156,-0.0001965074846461,0.0117980223673304,0.0580104720087757
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00923143945979927,0.00487071686654929,-0.00031516559863734,0.0187780445182359,0.0580751519584042
NMR metabolomics,X23428.Concentration of VLDL Particles,CD248,Endosialin,39966,0.00782466581787312,0.00413429917781558,-0.000278560570645413,0.0159278922063916,0.0584335332358948
NMR metabolomics,X23428.Concentration of VLDL Particles,ACHE,Acetylcholinesterase,39736,0.00662195729150583,0.0035048451099254,-0.00024753912394796,0.0134914537069596,0.0588679133385591
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D1,DCN1-like protein 1,39586,-0.0145238949346107,0.0077066286818656,-0.0296288871510672,0.000581097281845893,0.0595105441633757
NMR metabolomics,X23428.Concentration of VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.00826794528451418,0.00440738088439543,-0.000370521248900867,0.0169064118179292,0.060686155056445
NMR metabolomics,X23428.Concentration of VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.00710243918616109,0.00379830265434461,-0.0145471123886765,0.000342234016354345,0.0615245621215981
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00562638424956811,0.00301030161258038,-0.000273806911089441,0.0115265754102257,0.0616431980060189
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN2,Nectin-2,42129,0.00587652927125281,0.00314655200890538,-0.00029071266620173,0.0120437712087074,0.0618381773962293
NMR metabolomics,X23428.Concentration of VLDL Particles,JCHAIN,Immunoglobulin J chain,41913,-0.0116455426559212,0.00623955020692381,-0.0238750610614918,0.000583975749649518,0.0620063578187329
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP2,Neuropilin-2,42137,-0.00533141173646079,0.0028621499484497,-0.0109412256354222,0.000278402162500611,0.062521948593273
NMR metabolomics,X23428.Concentration of VLDL Particles,HEBP1,Heme-binding protein 1,41900,-0.00986554226330339,0.0052976209206892,-0.0202488792678542,0.000517794741247444,0.0625886263417918
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP2,Guanylate-binding protein 2,41913,0.011470495063309,0.00617431403921195,-0.000631160453546428,0.0235721505801644,0.0632228323462593
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFL4,Insulin growth factor-like family member 4,39657,0.0135569822255245,0.00731035882174173,-0.000771321065089283,0.0278852855161383,0.063695795007498
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB1,Scavenger receptor class B member 1,41839,0.010474885870947,0.00564883189250919,-0.000596824638371025,0.021546596380265,0.0637119719029516
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0103097287134588,0.00556302482429212,-0.000593799942153707,0.0212132573690714,0.063871150170698
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAM,Basal cell adhesion molecule,42137,-0.00462790082857659,0.00249838533087166,-0.00952473607708504,0.000268934419931853,0.0639963710382084
NMR metabolomics,X23428.Concentration of VLDL Particles,AZU1,Azurocidin,41751,0.0141780822702924,0.00766071831357786,-0.000836925624320245,0.029193090164905,0.0642277889015927
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBN,Ameloblastin,41913,-0.00514074741286566,0.00278512226807673,-0.0105995870582961,0.000318092232564735,0.0649450696024629
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0104926444827336,0.00570545058422347,-0.000690038662344374,0.0216753276278116,0.0659291720595435
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN4,Contactin-4,42137,-0.00439571060686114,0.00239196154633432,-0.0090839552376764,0.000292534023954127,0.0661283491224796
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00568178187687098,0.00309798483150114,-0.0117538321466132,0.000390268392871258,0.0666773044198961
NMR metabolomics,X23428.Concentration of VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0132525997381635,0.00723117134547036,-0.0274256955752854,0.000920496098958376,0.0668735875394854
NMR metabolomics,X23428.Concentration of VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00507530425102686,0.00277327684213906,-0.0105109268616194,0.000360318359565684,0.0672605925490182
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN2,Contactin-2,42262,0.00817972718342468,0.00447766555834733,-0.000596497310936087,0.0169559516777854,0.0677540808871217
NMR metabolomics,X23428.Concentration of VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0215129935521626,0.0117910726138071,-0.00159750877089939,0.0446234958752246,0.0680965919960798
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF174,Zinc finger protein 174,39657,0.00685840062847925,0.00376086320861179,-0.00051289126039985,0.0142296925173584,0.0682359094284588
NMR metabolomics,X23428.Concentration of VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00724011377207462,0.0039725925238196,-0.000546167574611803,0.015026395118761,0.0683992547971877
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.019444548477803,0.0106969800036506,-0.00152153232935218,0.0404106292849582,0.0691230293630539
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.00899038429708136,0.00495706278054141,-0.000725458752779814,0.0187062273469425,0.0697534622056711
NMR metabolomics,X23428.Concentration of VLDL Particles,CCNE1,G1/S-specific cyclin-E1,39657,0.016973541437441,0.00936854934065415,-0.00138881527024113,0.0353358981451231,0.0700507615263233
NMR metabolomics,X23428.Concentration of VLDL Particles,DHODH,Dihydroorotate dehydrogenase,39575,0.00859212099888025,0.00474785265410889,-0.000713670203173165,0.0178979122009337,0.0703718874083756
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.00976878708064604,0.00540310067750675,-0.0203588644085593,0.000821290247267193,0.0706340089841391
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0109368111104523,0.00605549316606334,-0.0228055777159364,0.000931955495031868,0.0709250539624922
NMR metabolomics,X23428.Concentration of VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0154664511183024,0.00859701436169025,-0.0323165992672153,0.00138369703061048,0.0720339161252815
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6B,Ras-related protein Rab-6B,41839,0.00866253144842601,0.00481558276715784,-0.00077601077520336,0.0181010736720554,0.0720645087170488
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.0113622340246582,0.00634108301198932,-0.00106628867884082,0.0237907567281573,0.0731810342024839
NMR metabolomics,X23428.Concentration of VLDL Particles,SCP2,Non-specific lipid-transfer protein,41843,0.0135026788629096,0.00755049823018191,-0.00129629766824691,0.0283016553940662,0.0737478484055184
NMR metabolomics,X23428.Concentration of VLDL Particles,MTR,Methionine synthase,39575,0.0119259307348549,0.00667628703125089,-0.00115959184639688,0.0250114533161066,0.074076372970868
NMR metabolomics,X23428.Concentration of VLDL Particles,OBP2B,Odorant-binding protein 2b,41979,0.0103633124742043,0.00583080442757615,-0.00106506420384495,0.0217916891522536,0.0755352952234358
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA10,Ephrin type-A receptor 10,41839,0.0118471815177566,0.0066854786573125,-0.00125635665057594,0.0249507196860891,0.0764048074316738
NMR metabolomics,X23428.Concentration of VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00883414832863231,0.00498613056040476,-0.0186069642270256,0.00093866756976102,0.0764600126760233
NMR metabolomics,X23428.Concentration of VLDL Particles,HBQ1,Hemoglobin subunit theta-1,42262,-0.0110279317093086,0.00625454447292309,-0.0232868388762379,0.00123097545762061,0.0778913017893935
NMR metabolomics,X23428.Concentration of VLDL Particles,PGR,Progesterone receptor,39657,0.0180414615063243,0.010249291164806,-0.00204714917669547,0.038130072189344,0.0783906461879516
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5,Interleukin-5,41913,0.024664166649252,0.014064064814023,-0.00290140038623304,0.052229733684737,0.0795047378432466
NMR metabolomics,X23428.Concentration of VLDL Particles,GKN1,Gastrokine-1,41538,0.00505711982054124,0.00288519826419762,-0.000597868777286088,0.0107121084183686,0.079663341507105
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN1,Contactin-1,42310,0.00472335330602089,0.00271930494912466,-0.00060648439426344,0.0100531910063052,0.0824147835702144
NMR metabolomics,X23428.Concentration of VLDL Particles,HSBP1,Heat shock factor-binding protein 1,39638,0.0170012580373632,0.00983902180341419,-0.00228322469732867,0.036285740772055,0.0840266102084118
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP1,Caspase-1,41839,0.0120906473312531,0.0070052209151482,-0.00163958566243734,0.0258208803249436,0.0843800926121275
NMR metabolomics,X23428.Concentration of VLDL Particles,PI16,Peptidase inhibitor 16,39990,0.00425634582544624,0.00246614456870187,-0.000577297529209419,0.0090899891801019,0.0843905611555688
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",39575,0.00972467473439275,0.00564192237465392,-0.00133349311992892,0.0207828425887144,0.0848000026426573
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.00717942255677665,0.00416886242844062,-0.000991547802966967,0.0153503929165203,0.0850687973263462
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00525144491169071,0.00305753086624737,-0.0112442054095356,0.000741315586154149,0.0859023377767545
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0108020943346131,0.00632237492499742,-0.00158976051838186,0.023193949187608,0.0875625650107724
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1,Programmed cell death protein 1,42232,0.00724551727295543,0.00426397905403673,-0.00111188167295656,0.0156029162188674,0.089297075430199
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0216396799039883,0.0128461734453879,-0.00353882004897191,0.0468181798569485,0.0921041230837751
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF1,Formylglycine-generating enzyme,39657,0.0113768340128169,0.00675714782718202,-0.00186717572845986,0.0246208437540937,0.0922729193409208
NMR metabolomics,X23428.Concentration of VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.00701149288370019,0.0041684588388328,-0.00115868644041209,0.0151816722078125,0.0925852685522969
NMR metabolomics,X23428.Concentration of VLDL Particles,NME1,Nucleoside diphosphate kinase A,39657,-0.00374839942390121,0.00224384382107102,-0.00814633331320041,0.000649534465397998,0.0948436438640153
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00889686238751048,0.00533487010008692,-0.00155948300865988,0.0193532077836808,0.0954026866408109
NMR metabolomics,X23428.Concentration of VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,39638,0.00659833575960992,0.0039568106925237,-0.00115701319773653,0.0143536847169564,0.0954256211801106
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00540590399026505,0.00324308749633025,-0.000950547502542236,0.0117623554830723,0.0955627071906389
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPACAM2,HEPACAM family member 2,39929,0.00742647233926122,0.00446287269134536,-0.00132075813577567,0.0161737028142981,0.0961287937708533
NMR metabolomics,X23428.Concentration of VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00386833167040501,0.00232657963900125,-0.000691764422037435,0.00842842776284745,0.0964015843550817
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX1,Heme oxygenase 1,42007,-0.0082775050588124,0.00501019021713953,-0.0180974778844059,0.00154246776678108,0.0985306765230586
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC8,Histone deacetylase 8,39657,0.0101346049818081,0.00615764296992705,-0.00193437523924894,0.0222035852028651,0.099821451708056
NMR metabolomics,X23428.Concentration of VLDL Particles,EDNRB,Endothelin receptor type B,39657,0.00736559167868617,0.00448193489523037,-0.00141900071596535,0.0161501840733377,0.100329560914441
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC2,Plexin domain-containing protein 2,39929,0.00459320848714619,0.00279962600664014,-0.000894058485868486,0.0100804754601609,0.100897695861684
NMR metabolomics,X23428.Concentration of VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0248101981569208,0.0151236428042562,-0.00483214173942138,0.054452538053263,0.100926898411542
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA2,Protein disulfide-isomerase A2,39560,0.00666172208427829,0.00408997035051878,-0.00135461980273852,0.0146780639712951,0.103385224628119
NMR metabolomics,X23428.Concentration of VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00694667061525978,0.00428985102663254,-0.0153547786274596,0.00146143739694001,0.105405237086881
NMR metabolomics,X23428.Concentration of VLDL Particles,CD33,Myeloid cell surface antigen CD33,42181,0.0130383157635102,0.0080817871159431,-0.00280198698373829,0.0288786185107586,0.106703423530459
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0128373826308667,0.00796829596478825,-0.0284552427218517,0.00278047746011824,0.107191031503047
NMR metabolomics,X23428.Concentration of VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.012679779941624,0.00788020904498894,-0.00276542978655434,0.0281249896698023,0.107630382880957
NMR metabolomics,X23428.Concentration of VLDL Particles,SAG,S-arrestin,39586,-0.00857649788885081,0.00534482370730603,-0.0190523523551706,0.00189935657746901,0.10860262223306
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMA,Repulsive guidance molecule A,42249,-0.00523267088831848,0.00327126719442135,-0.0116443545893843,0.00117901281274737,0.109713758822017
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0123037496832335,0.00769298974764267,-0.00277451022214615,0.0273820095886131,0.109767684100267
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99,CD99 antigen,42137,-0.00322831229013708,0.0020284931324136,-0.00720415882966774,0.000747534249393582,0.11152427309127
NMR metabolomics,X23428.Concentration of VLDL Particles,MUCL3,Mucin-like protein 3,39560,-0.00691892745020186,0.00436093389130136,-0.0154663578771525,0.0016285029767488,0.112638885113733
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00337224702549644,0.00212780195481895,-0.00754273885694157,0.000798244805948691,0.11302921986962
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00430342941612189,0.00272111223617516,-0.00102995056678142,0.0096368093990252,0.113793469221483
NMR metabolomics,X23428.Concentration of VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00871026666001723,0.00554382835389309,-0.00215563691361323,0.0195761702336477,0.116173295203492
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0131199962134084,0.00835145433581907,-0.0294888467116138,0.00324885428479695,0.116215368901877
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.00774849717460057,0.00495216125279709,-0.0174547332300829,0.00195773888088173,0.1176841436775
NMR metabolomics,X23428.Concentration of VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,39990,0.00431516732987359,0.0027692425594629,-0.0011125480866737,0.00974288274642088,0.119202197974868
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL28,C-C motif chemokine 28,42075,0.00931047809355942,0.00598944926095719,-0.00242884245791667,0.0210497986450355,0.120093487896068
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN4,Alpha-actinin-4,41913,0.00498318494814209,0.00321176230500153,-0.0013118691696609,0.0112782390659451,0.120795558218583
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.0074517752343593,0.00480989642845774,-0.00197562176541787,0.0168791722341365,0.121347433729557
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0052703418046229,0.00340903585805301,-0.001411368477161,0.0119520520864068,0.122129687444975
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH23,Cadherin-23,39929,-0.00419766250236271,0.00273362891424958,-0.00955557517429188,0.00116025016956647,0.124673243068555
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL6,Fc receptor-like protein 6,42119,-0.0107003866743672,0.00697855912068076,-0.0243783625509014,0.00297758920216713,0.125219638642907
NMR metabolomics,X23428.Concentration of VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.00524053114357767,0.00342195362059221,-0.00146649795278306,0.0119475602399384,0.125687560314751
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0229857350840083,0.0150155332377341,-0.052416180229967,0.00644471006195046,0.125848401786476
NMR metabolomics,X23428.Concentration of VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,39575,0.0061212470935486,0.00400242172718025,-0.00172349949172469,0.0139659936788219,0.126197641925938
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN10,Ataxin-10,41839,0.0113994630271236,0.00745812611443731,-0.00321846415717354,0.0260173902114207,0.12642173966792
NMR metabolomics,X23428.Concentration of VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00725640719204268,0.00474909695203841,-0.0020518228339526,0.016564637218038,0.126546843877108
NMR metabolomics,X23428.Concentration of VLDL Particles,MKI67,Proliferation marker protein Ki-67,39657,0.00635603033815229,0.00416262207933978,-0.00180270893735368,0.0145147696136583,0.126807152954597
NMR metabolomics,X23428.Concentration of VLDL Particles,EPO,Erythropoietin,42119,0.0112671920044442,0.00741461304265163,-0.00326544955915299,0.0257998335680414,0.128636754096559
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCB,Calcitonin gene-related peptide 2,39929,0.00630335872908721,0.0041496141975896,-0.00182988509818841,0.0144366025563628,0.128784652986483
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00719304463545457,0.00473743016298375,-0.00209231848399358,0.0164784077549027,0.128956719265517
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.0076032854480855,0.00503200115338422,-0.00225943681254756,0.0174660077087186,0.130819787154834
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG1,Arginase-1,42015,0.00776794431060748,0.005145581523853,-0.0023173954761444,0.0178532840973594,0.131160417364458
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D17,TBC1 domain family member 17,41839,0.00660919771396809,0.00437855483200714,-0.00197276975676591,0.0151911651847021,0.131208380679845
NMR metabolomics,X23428.Concentration of VLDL Particles,CPLX2,Complexin-2,39560,-0.0047271662372946,0.00313721924519632,-0.0108761159578794,0.00142178348329019,0.131890400516145
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.00853047998530798,0.00571856313323437,-0.0197388637264473,0.00267790375583138,0.135801993979435
NMR metabolomics,X23428.Concentration of VLDL Particles,RPS10,40S ribosomal protein S10,39575,-0.00635048182006542,0.00426732595658712,-0.0147144406949762,0.00201347705484533,0.136736320474949
NMR metabolomics,X23428.Concentration of VLDL Particles,COPE,Coatomer subunit epsilon,41839,0.00700680595524595,0.00471705996385298,-0.00223863157390589,0.0162522434843978,0.137456930722653
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC1,Sialoadhesin,42185,-0.00627962930330656,0.00422987693883664,-0.0145701881034264,0.00201092949681326,0.137675899701317
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPEP,Aspartyl aminopeptidase,39929,0.00862272047914234,0.00581564845850927,-0.00277595049953582,0.0200213914578205,0.138188417230544
NMR metabolomics,X23428.Concentration of VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.00602297750078822,0.00408092894008871,-0.0140215982233621,0.00197564322178566,0.140003575144433
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC51B,Organic solute transporter subunit beta,39575,-0.0109329974641571,0.00741511343696847,-0.0254666198006153,0.00360062487230114,0.140397011286522
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,41900,-0.00511455480284483,0.00347114775235943,-0.0119180043974693,0.00168889479177965,0.14065401202948
NMR metabolomics,X23428.Concentration of VLDL Particles,DUOX2,Dual oxidase 2,41900,0.0105312829140272,0.00715877988071761,-0.00349992565217932,0.0245624914802337,0.141287664123018
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00985638688663662,0.00671495680512727,-0.0230177022246861,0.00330492845141282,0.142179735040412
NMR metabolomics,X23428.Concentration of VLDL Particles,MRC1,Macrophage mannose receptor 1,39990,0.00424181106870582,0.00290287287288084,-0.00144781976214063,0.00993144189955227,0.143975557635734
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX2,Neuronal pentraxin-2,39966,0.00510336458515555,0.00349518926856059,-0.00174720638122321,0.0119539355515343,0.144287186200311
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00721846559636281,0.00495813004535514,-0.00249946929253325,0.0169364004852589,0.145453075597168
NMR metabolomics,X23428.Concentration of VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00873066484793592,0.00601709071575872,-0.020524162650823,0.00306283295495118,0.146814419804796
NMR metabolomics,X23428.Concentration of VLDL Particles,FH,"Fumarate hydratase, mitochondrial",39586,0.0121792951457182,0.00841200492291308,-0.00430823450319145,0.0286668247946278,0.147688412462596
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00908401667720125,0.00627420315793634,-0.0213814548667565,0.00321342151235398,0.14769104413761
NMR metabolomics,X23428.Concentration of VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00718267284414578,0.00499120864532207,-0.00260009610068547,0.016965441788977,0.150160672335018
NMR metabolomics,X23428.Concentration of VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00643216766603431,0.0044727129220278,-0.0151986849932088,0.00233434966114018,0.150435889133445
NMR metabolomics,X23428.Concentration of VLDL Particles,PCNA,Proliferating cell nuclear antigen,39560,0.00947268921107687,0.00659832286542779,-0.00346002360516161,0.0224054020273153,0.15113882534346
NMR metabolomics,X23428.Concentration of VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00863589840383619,0.00601592179941431,-0.00315530832301585,0.0204271051306882,0.151171186338155
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3D,Protein FAM3D,39930,-0.0128228792873345,0.00894107103872001,-0.0303473785232257,0.00470161994855675,0.151555711463141
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX101,Testis-expressed protein 101,39649,0.00901348648557839,0.00628699660979092,-0.00330902686961182,0.0213359998407686,0.151694388327372
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTN3,Myeloblastin,41800,-0.00700562214240546,0.00490092712100787,-0.0166114392995809,0.00260019501476995,0.152899078053355
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00503526827220572,0.00352879308638339,-0.0119517027215172,0.00188116617710572,0.153634410113457
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSAB1,Tryptase alpha/beta-1,42281,0.0075327612533827,0.005302332790934,-0.00285981101684794,0.0179253335236133,0.155441205522611
NMR metabolomics,X23428.Concentration of VLDL Particles,CD177,CD177 antigen,42123,-0.0185975067363131,0.0131080677640397,-0.044289319553831,0.00709430608120476,0.155985269269121
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB118,Beta-defensin 118,39586,0.00822722755506223,0.00582554424442364,-0.00319083916400811,0.0196452942741326,0.157899499361028
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR1,Toll-like receptor 1,39657,0.0038551968799372,0.00273726365856277,-0.00150983989084583,0.00922023365072024,0.159037019938779
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00694549152900205,0.0049331461933898,-0.00272347501004196,0.0166144580680461,0.159181242085033
NMR metabolomics,X23428.Concentration of VLDL Particles,CD7,T-cell antigen CD7,39636,0.00644520744318566,0.00457948055289976,-0.00253057444049787,0.0154209893268692,0.159333964675241
NMR metabolomics,X23428.Concentration of VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00647444050916162,0.00461187755331678,-0.00256483949533928,0.0155137205136625,0.160387724810479
NMR metabolomics,X23428.Concentration of VLDL Particles,GJA8,Gap junction alpha-8 protein,39560,-0.00892721360340644,0.00638644291111846,-0.0214446417091986,0.00359021450238574,0.162189961954161
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00837440355842846,0.00601372576573244,-0.020161306059264,0.00341249894240712,0.163784610347677
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00424791652203539,0.0030552133416738,-0.00174030162764526,0.010236134671716,0.164440607596387
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00447204563479276,0.00322274835424864,-0.0107886324091201,0.00184454113953458,0.165271898198053
NMR metabolomics,X23428.Concentration of VLDL Particles,ENG,Endoglin,42310,0.00244084016012332,0.00175949666490858,-0.00100777330309751,0.00588945362334415,0.165391833634935
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00399126343682326,0.00288158644657675,-0.00165664599846717,0.00963917287211368,0.166047031404083
NMR metabolomics,X23428.Concentration of VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.00561780903274225,0.00406203699218695,-0.0135794015374287,0.00234378347194416,0.166691213574901
NMR metabolomics,X23428.Concentration of VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00700830066251079,0.00508773557360828,-0.016980262386783,0.00296366106176144,0.168389149616713
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNIP4,Kv channel-interacting protein 4,41839,0.00706716926142377,0.00517852015784679,-0.00308273024795594,0.0172170687708035,0.172367954507254
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.00325032492742968,0.002383110841403,-0.00792122217657956,0.00142057232172019,0.172621637872251
NMR metabolomics,X23428.Concentration of VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.0096125037391189,0.00704790662379224,-0.0042013932435139,0.0234264007217517,0.172632634052882
NMR metabolomics,X23428.Concentration of VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.00479463491176909,0.00353400504138623,-0.0117212847928861,0.00213201496934791,0.174894642661017
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00807055948263688,0.00600568889386251,-0.00370059074933364,0.0198417097146074,0.179034641890804
NMR metabolomics,X23428.Concentration of VLDL Particles,KLHL41,Kelch-like protein 41,39934,-0.00718720276437793,0.00535687838613709,-0.0176866844012066,0.00331227887245077,0.179727491461389
NMR metabolomics,X23428.Concentration of VLDL Particles,SBSN,Suprabasin,39954,-0.00485594524686879,0.00362785252146827,-0.0119665361889466,0.00225464569520903,0.1807544967318
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASET2,Ribonuclease T2,42258,-0.00364097885680474,0.00272899897549804,-0.00898981684878089,0.00170785913517141,0.18216675618971
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6,Seizure protein 6 homolog,39649,0.00426350503996108,0.00319629971045388,-0.00200124239252852,0.0105282524724507,0.182268139478263
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPN3,Calpain-3,39919,-0.00528668387919222,0.00398136947274016,-0.0130901680457629,0.00251680028737849,0.184252580568881
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.00536886888369275,0.00404330848609451,-0.013293753516438,0.00255601574905249,0.184252923524402
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,39586,0.0102717821117595,0.00775996975278445,-0.00493775860369803,0.025481322827217,0.185634088591397
NMR metabolomics,X23428.Concentration of VLDL Particles,FSHB,Follitropin subunit beta,39638,-0.00552786888253887,0.00419329847547194,-0.0137467338944639,0.00269099612938613,0.187443083905537
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL2,Podocalyxin-like protein 2,42181,0.00380957821027899,0.00290605021623687,-0.00188628021354527,0.00950543663410325,0.189909416349443
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM25,RNA-binding protein 25,39560,-0.00625382300106772,0.00479182605209437,-0.0156458020631727,0.00313815606103726,0.191885428756265
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS8,Prostasin,42080,0.00552993393479865,0.00424715375708495,-0.00279448742908784,0.0138543552986851,0.192927385673169
NMR metabolomics,X23428.Concentration of VLDL Particles,RYR1,Ryanodine receptor 1,39575,-0.00448699365323739,0.00345056143841364,-0.0112500940725281,0.00227610676605334,0.193502775619963
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPE4,NXPE family member 4,39575,-0.00424909147845105,0.0032700361712732,-0.0106583623741465,0.00216017941724442,0.193833306336048
NMR metabolomics,X23428.Concentration of VLDL Particles,OSM,Oncostatin-M,42051,0.00908117314526053,0.00702333986737152,-0.00468457299478765,0.0228469192853087,0.196033527255815
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN2,Calsyntenin-2,42296,-0.00526862311723053,0.00407551867821661,-0.0132566397265351,0.00271939349207403,0.196119656044067
NMR metabolomics,X23428.Concentration of VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0075829993632107,0.00587344510443631,-0.0190949517679059,0.00392895304148447,0.196708307618439
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.00786037613064878,0.00608932609438272,-0.00407470301434136,0.0197954552756389,0.196784658534058
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3G,Semaphorin-3G,39736,0.00601144546590535,0.00465863026787828,-0.00311946985913608,0.0151423607909468,0.196942405404259
NMR metabolomics,X23428.Concentration of VLDL Particles,DLGAP5,Disks large-associated protein 5,39934,0.00650033271731467,0.00504679923175103,-0.00339139377691735,0.0163920592115467,0.197768443789553
NMR metabolomics,X23428.Concentration of VLDL Particles,DRAXIN,Draxin,42016,0.00556730431260674,0.00432828822503557,-0.00291614060846298,0.0140507492336765,0.198374510059106
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00601675690379984,0.00469453145980139,-0.00318452475741089,0.0152180385650106,0.19999087328279
NMR metabolomics,X23428.Concentration of VLDL Particles,PMCH,Pro-MCH,39575,-0.0107712240380828,0.0084340088341008,-0.0273018813529203,0.0057594332767548,0.201587627704417
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN4,Prefoldin subunit 4,39560,-0.00686120606521187,0.00540146184824735,-0.0174480712877767,0.00372565915735295,0.204022613324632
NMR metabolomics,X23428.Concentration of VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0100399201241378,0.00790413340649083,-0.00545218135258421,0.0255320216008599,0.204036095965178
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.00897717376197879,0.00708589464778875,-0.0228655272716447,0.00491117974768716,0.205215188984037
NMR metabolomics,X23428.Concentration of VLDL Particles,CD82,CD82 antigen,39757,-0.0053636985970486,0.00423494676958833,-0.0136641942654417,0.00293679707134453,0.205348867808364
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR2,Toll-like receptor 2,39757,-0.00298405474415669,0.00236553186252471,-0.00762049719470512,0.00165238770639173,0.207164829761272
NMR metabolomics,X23428.Concentration of VLDL Particles,EPN1,Epsin-1,39757,0.0055642446683638,0.00442114078626826,-0.00310119127272199,0.0142296806094496,0.208217785383819
NMR metabolomics,X23428.Concentration of VLDL Particles,ERVV_1,,39575,0.00560416170713697,0.00445401516619371,-0.0031257080186027,0.0143340314328766,0.20833647505905
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00464244255435239,0.00369510688954173,-0.0118848520578542,0.00259996694914941,0.209006345172297
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS5,Transmembrane protease serine 5,41946,0.00493099304605055,0.00392519366717665,-0.00276238654161569,0.0126243726337168,0.209050241600222
NMR metabolomics,X23428.Concentration of VLDL Particles,GAL,Galanin peptides,42185,0.00846535266552063,0.00677433469740612,-0.00481234334139536,0.0217430486724366,0.211459460978111
NMR metabolomics,X23428.Concentration of VLDL Particles,MPO,Myeloperoxidase,42137,0.00570930203802057,0.0045780418366009,-0.0032636599617172,0.0146822640377583,0.212380321492306
NMR metabolomics,X23428.Concentration of VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.00789940022917501,0.00633570700956325,-0.020317385967919,0.00451858550956896,0.212495064187214
NMR metabolomics,X23428.Concentration of VLDL Particles,REG4,Regenerating islet-derived protein 4,42144,-0.00645681172594488,0.00518761998210846,-0.0166245468908775,0.00371092343898771,0.21327909705307
NMR metabolomics,X23428.Concentration of VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00601431199239546,0.00484926967576982,-0.0155188805569043,0.00349025657211339,0.214908874390507
NMR metabolomics,X23428.Concentration of VLDL Particles,LY6D,Lymphocyte antigen 6D,42041,0.0050132348093169,0.00404320161782477,-0.00291144036161965,0.0129379099802535,0.215027705824574
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL3,Follistatin-related protein 3,42084,-0.00411012160543761,0.00332910912803533,-0.0106351754963869,0.00241493228551164,0.217000534448133
NMR metabolomics,X23428.Concentration of VLDL Particles,CD48,CD48 antigen,42166,-0.00385372496321356,0.0031269856015268,-0.00998261674220608,0.00227516681577896,0.217817726852688
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE6,Ribonuclease K6,39937,-0.00405824033372766,0.00329683004741397,-0.0105200272266591,0.00240354655920373,0.218366263851251
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,39657,0.0052749645559372,0.00428762671007504,-0.00312878379580989,0.0136787129076843,0.218619913976311
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK1,Cyclin-dependent kinase 1,39560,0.0045787732307547,0.00373396101612971,-0.00273979036085953,0.0118973368223689,0.220130599533368
NMR metabolomics,X23428.Concentration of VLDL Particles,THY1,Thy-1 membrane glycoprotein,42249,0.00364250948911756,0.00297295685165218,-0.00218448594012071,0.00946950491835583,0.220515599685585
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.00996027685593667,0.00819572761141458,-0.00610334926243591,0.0260239029743093,0.22427249860977
NMR metabolomics,X23428.Concentration of VLDL Particles,RAP1A,Ras-related protein Rap-1A,39657,-0.00858106213614283,0.00707334107623569,-0.0224448106455648,0.00528268637327912,0.225096316708531
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00339825061245658,0.00280868833799831,-0.00210677853002012,0.00890327975493328,0.226336230608937
NMR metabolomics,X23428.Concentration of VLDL Particles,TNPO1,Transportin-1,39757,0.00438646999624751,0.00362616449123683,-0.00272081240657668,0.0114937523990717,0.226430372125922
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP1,Dipeptidase 1,41997,-0.00565424315848159,0.00467616978495849,-0.0148195359370002,0.00351104962003705,0.226622251954984
NMR metabolomics,X23428.Concentration of VLDL Particles,EVPL,Envoplakin,39757,0.00412296062249917,0.00341267123152001,-0.00256587499128004,0.0108117962362784,0.227021727266077
NMR metabolomics,X23428.Concentration of VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0102675599996468,0.00856305838498224,-0.027051154434212,0.00651603443491839,0.230533263730983
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.005745788177932,0.00479242654569175,-0.0151389442074878,0.00364736785162382,0.230580743996394
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.0061961819665426,0.00519026616795188,-0.00397673972264309,0.0163691036557283,0.23257883229239
NMR metabolomics,X23428.Concentration of VLDL Particles,STX1B,Syntaxin-1B,39649,0.00489279609686046,0.00409871067579185,-0.00314067682769156,0.0129262690214125,0.232605201507439
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX2,Transcription factor SOX-2,39915,0.00298221453810502,0.00250769368299281,-0.00193286508056088,0.00789729415677093,0.234375699480108
NMR metabolomics,X23428.Concentration of VLDL Particles,OTOA,Otoancorin,39586,-0.00636843837517156,0.00537159446050979,-0.0168967635177707,0.00415988676742763,0.235815066854639
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20,Interleukin-20,41913,0.00563085700460892,0.00475016139158498,-0.00367945932289764,0.0149411733321155,0.235879184481783
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00356182081174116,0.00300700005791374,-0.00945554092525209,0.00233189930176977,0.236236973846501
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00674882153044768,0.00570593925315256,-0.0179324624666267,0.00443481940573133,0.236925370149759
NMR metabolomics,X23428.Concentration of VLDL Particles,MAG,Myelin-associated glycoprotein,39649,0.00586865231060536,0.00496577186743151,-0.00386426054956041,0.0156015651707711,0.237302260845305
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN6,Prefoldin subunit 6,39649,0.00782048173034824,0.00661954299469942,-0.00515382253926261,0.0207947859999591,0.237460070236644
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0062634249422687,0.00530610951083714,-0.00413654969897209,0.0166633995835095,0.237855375076227
NMR metabolomics,X23428.Concentration of VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00361083601212369,0.00306520750536768,-0.00961864272264435,0.00239697069839697,0.238818533835735
NMR metabolomics,X23428.Concentration of VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00726838304517513,0.00619326003024427,-0.00487040661410363,0.0194071727044539,0.240582465671357
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00526700671834703,0.00449770933208023,-0.0140825170092243,0.00354850357253023,0.241606530330895
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00359352163251169,0.00307576520725981,-0.00243497817371754,0.00962202143874093,0.242693023678832
NMR metabolomics,X23428.Concentration of VLDL Particles,FOS,Proto-oncogene c-Fos,39539,-0.00431143378957144,0.00369433851471117,-0.0115523372784053,0.00292946969926246,0.243220423984189
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00370555668948445,0.00319303058876546,-0.00255278326449585,0.00996389664346475,0.245864875886511
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.0043423034175685,0.00374699714165641,-0.0116864178152151,0.00300181098007806,0.246531956952357
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.00448925569382048,0.00390048680537036,-0.0121342098323464,0.00315569844470542,0.24977421046327
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A3,Protein S100-A3,39919,0.00497499774162447,0.00435655070162466,-0.00356384163355986,0.0135138371168088,0.25349565208535
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00421715703301898,0.00369679911478481,-0.00302856923195925,0.0114628832979972,0.253994932530835
NMR metabolomics,X23428.Concentration of VLDL Particles,TEF,Thyrotroph embryonic factor,39575,0.00495119475881724,0.00437725707065739,-0.00362822909967123,0.0135306186173057,0.258030097283495
NMR metabolomics,X23428.Concentration of VLDL Particles,MSMB,Beta-microseminoprotein,42103,-0.00802319686534545,0.00710721063656689,-0.0219533297130166,0.00590693598232566,0.258967984242538
NMR metabolomics,X23428.Concentration of VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00599601704648414,0.00533411940022137,-0.00445885697794974,0.016450891070918,0.261000518377621
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD3,Extracellular superoxide dismutase,39990,-0.00696313278545873,0.00620452352930255,-0.0191239989028917,0.00519773333197427,0.261772536427668
NMR metabolomics,X23428.Concentration of VLDL Particles,B2M,Beta-2-microglobulin,39979,0.00349420333681064,0.00311590538901261,-0.00261297122565408,0.00960137789927536,0.262137609082927
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A14,Zinc transporter ZIP14,41839,-0.00384208363822082,0.00343014750801344,-0.0105651727539272,0.00288100547748552,0.262694523847872
NMR metabolomics,X23428.Concentration of VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00578188784687292,0.0051784988071397,-0.00436796981512089,0.0159317455088667,0.264220673942242
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI2B,Protein EVI2B,39560,-0.00456414593313706,0.00408943093911821,-0.0125794305738087,0.00345113870753462,0.264410911200608
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00516163399494998,0.00463215634651461,-0.0142406604341186,0.00391739244421865,0.265172830692861
NMR metabolomics,X23428.Concentration of VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.00217337920758744,0.00195846025019585,-0.0060119612979713,0.00166520288279642,0.267131202978451
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00381095891490568,0.00343429312142874,-0.010542173432906,0.00292025560309464,0.267157807925681
NMR metabolomics,X23428.Concentration of VLDL Particles,RELB,Transcription factor RelB,39657,0.00532277747179981,0.0047976801387109,-0.00408067560007356,0.0147262305436732,0.267261018600993
NMR metabolomics,X23428.Concentration of VLDL Particles,CASQ2,Calsequestrin-2,39575,0.00539365040037491,0.00486339470164241,-0.00413860321484422,0.014925904015594,0.26744156132004
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.00571317886313519,0.00515622778507015,-0.00439302759560231,0.0158193853218727,0.267878763620469
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.0054806843616794,0.00495142186120312,-0.00422410248627871,0.0151854712096375,0.268365344878948
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.00436962280569302,0.00395093421800505,-0.00337420826159688,0.0121134538729829,0.268758044502488
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0045169101975103,0.00409632122882205,-0.0125456998060015,0.00351187941098092,0.270191776906557
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00692394971238998,0.00629048763118667,-0.0192533054695159,0.00540540604473589,0.271050696298
NMR metabolomics,X23428.Concentration of VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00446319828667461,0.00407784296112175,-0.00352937391712402,0.0124557704904732,0.273759695882706
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.00781922310425126,0.00714836126668259,-0.00619156497844661,0.0218300111869491,0.274044745621806
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.00935512303322658,0.00857687426901058,-0.0261657966004873,0.00745555053403416,0.275412088743192
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00858285500281819,0.00787367516529447,-0.00684954832115897,0.0240152583267954,0.275706199134807
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00413410429357803,0.00379727080475374,-0.0115767550708954,0.00330854648373931,0.276307909009725
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2BP,LRP2-binding protein,39649,-0.00860398046410298,0.00793158673791194,-0.0241498904704104,0.00694192954220444,0.27804535422257
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMA1,Proteasome subunit alpha type-1,41843,0.00508769531132231,0.00471006895100379,-0.00414403983264512,0.0143194304552897,0.28008425308607
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.00299100949464903,0.00276959120714597,-0.00243738927135707,0.00841940826065513,0.280185311504578
NMR metabolomics,X23428.Concentration of VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.0054003800607043,0.00500312908536883,-0.0152065130680272,0.00440575294661861,0.280432979136155
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2B,Alpha-amylase 2B,41300,-0.00550771552140956,0.00511086644776824,-0.0155250137590353,0.0045095827162162,0.281211296077722
NMR metabolomics,X23428.Concentration of VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00674664098619507,0.00626985006316082,-0.00554226513760014,0.0190355471099903,0.281930053504832
NMR metabolomics,X23428.Concentration of VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,39649,0.0039982573740323,0.0037463361083034,-0.00334456139824235,0.011341076146307,0.285884668201176
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD8,Frizzled-8,39586,0.00469603983079321,0.00440242841168702,-0.00393271985611335,0.0133247995176998,0.286133902791523
NMR metabolomics,X23428.Concentration of VLDL Particles,WIF1,Wnt inhibitory factor 1,42262,0.0036429856706807,0.00342391523505109,-0.00306788819001944,0.0103538595313808,0.287355461290475
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPEP,Glutamyl aminopeptidase,39575,0.00460929844614131,0.00433723263667711,-0.00389167752174583,0.0131102744140285,0.287928714616239
NMR metabolomics,X23428.Concentration of VLDL Particles,ESR1,Estrogen receptor,39657,0.0062101307688799,0.00584576425504254,-0.00524756717100348,0.0176678287087633,0.288109098978187
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA11,Serpin A11,42310,-0.00451392506955788,0.00425331413509345,-0.012850420774341,0.00382257063522528,0.288584801316534
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARCL1,SPARC-like protein 1,42169,0.00295360870338469,0.00278370747920667,-0.00250245795586039,0.00840967536262977,0.288693265793907
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRLB,Fc receptor-like B,41843,0.00664375674509612,0.00627129423310867,-0.00564797995179688,0.0189354934419891,0.289440772520318
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GL3,Endophilin-A3,39690,0.00922453274536985,0.00871024068008163,-0.00784753898759015,0.0262966044783299,0.289602565938204
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPP,"Alkaline phosphatase, placental type",42070,0.0111278666438665,0.0106062827188533,-0.00966044748508592,0.031916180772819,0.294115539639087
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPT,Microtubule-associated protein tau,41839,0.00562796279674136,0.00537263416252602,-0.00490240016180965,0.0161583257552924,0.29487712945159
NMR metabolomics,X23428.Concentration of VLDL Particles,H2AP,Huntingtin-interacting protein M,39560,-0.0054004401395595,0.00515599834233006,-0.0155061968905264,0.00470531661140742,0.294933984123792
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,39649,0.00447599474082328,0.00428891880410863,-0.00393028611522964,0.0128822755968762,0.296684791575846
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A14,Protein S100-A14,39934,0.00551524144785746,0.0052895310311906,-0.00485223937327612,0.015882722268991,0.297122859145124
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGB,Secretogranin-1,42210,0.00446398262190514,0.00430038047313695,-0.00396476310544329,0.0128927283492536,0.299268177491718
NMR metabolomics,X23428.Concentration of VLDL Particles,AMPD3,AMP deaminase 3,39929,0.00730620886775984,0.00703869332082177,-0.00648963004105083,0.0211020477765705,0.29928921896395
NMR metabolomics,X23428.Concentration of VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00627993037761543,0.00605200227020187,-0.00558199407198023,0.0181418548272111,0.299449793050843
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0086793362526084,0.00836831383653086,-0.0250812313722089,0.00772255886699208,0.299680662801811
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10,Interleukin-10,41913,-0.0081207442600623,0.00783026365449926,-0.0234680610228808,0.00722657250275625,0.299709411245094
NMR metabolomics,X23428.Concentration of VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00521698689172741,0.00508013573478194,-0.00474007914844519,0.0151740529319,0.304471896097476
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00523729084772741,0.00511000468534448,-0.0152529000310026,0.00477831833554777,0.305428596538569
NMR metabolomics,X23428.Concentration of VLDL Particles,HK2,Hexokinase-2,41900,0.00284633237446089,0.00278038756293384,-0.00260322724888944,0.00829589199781122,0.305987181584262
NMR metabolomics,X23428.Concentration of VLDL Particles,CA11,Carbonic anhydrase-related protein 11,41843,-0.00316030634160888,0.00310485408484256,-0.0092458203479003,0.00292520766468254,0.308763154729568
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.00718302810810714,0.00705861888115475,-0.0210179211151705,0.00665186489895617,0.308877860963443
NMR metabolomics,X23428.Concentration of VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.00748648241739195,0.00738626586145358,-0.021963563505841,0.00699059867105707,0.310810596725259
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00430546407436863,0.0042534707043257,-0.00403133850610973,0.012642266654847,0.311452690079927
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00408246266097301,0.00403609725650182,-0.0119932132837166,0.00382828796177056,0.31180537221591
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME2,Proteasome activator complex subunit 2,41955,-0.00360798399860965,0.00358914173604151,-0.010642701801251,0.0034267338040317,0.314794795549191
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF3,Fibroblast growth factor 3,39657,0.00304377028675894,0.00302960650877257,-0.0028942584704353,0.00898179904395319,0.315075297063351
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.00304038802879705,0.00303050596664747,-0.00898017972342609,0.00289940366583199,0.31575644013376
NMR metabolomics,X23428.Concentration of VLDL Particles,SHH,Sonic hedgehog protein,39657,-0.00436742389391749,0.00436335502447754,-0.0129195997418935,0.00418475195405849,0.316881342180936
NMR metabolomics,X23428.Concentration of VLDL Particles,CDAN1,Codanin-1,39929,0.00220803813367471,0.00223323440310952,-0.00216910129641995,0.00658517756376936,0.322822450641886
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,39958,-0.00388495747510367,0.00393513377531976,-0.0115978196747304,0.00382790472452306,0.323541542380502
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.00522685105945488,0.0053050332209472,-0.0156247161725114,0.00517101405360164,0.324512685872895
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP3,"Fatty acid-binding protein, heart",39958,0.00539289314699047,0.00555178565827158,-0.00548860674322182,0.0162743930372028,0.331379806020465
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA3,GDNF family receptor alpha-3,41989,0.00274329116400694,0.00283078034407072,-0.00280503831037167,0.00829162063838555,0.332515987096963
NMR metabolomics,X23428.Concentration of VLDL Particles,BEX3,Protein BEX3,39560,-0.00462666148923122,0.00478720615263664,-0.014009585548399,0.00475626256993659,0.333833473331182
NMR metabolomics,X23428.Concentration of VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.00718553915793002,0.00744223441373851,-0.0217723186088575,0.00740124029299746,0.334307546143195
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.00746037886479261,0.00774199072715146,-0.0226346806900095,0.00771392296042425,0.335254980529582
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF7,Fibroblast growth factor 7,39560,-0.00761966354034202,0.00795429011444935,-0.0232100721646627,0.00797074508397869,0.338118527487702
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO6,Coronin-6,39586,-0.00382116005857578,0.00399153859385509,-0.0116445757025318,0.00400225558538021,0.338429315737372
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00401460561006879,0.00419697126171068,-0.00421145806288414,0.0122406692830217,0.338816034007675
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC44A4,Choline transporter-like protein 4,39649,-0.00670129292645214,0.00702393676142975,-0.0204682089788545,0.00706562312595018,0.340071562480195
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00482156237838114,0.00505798921273926,-0.00509209647858781,0.0147352212353501,0.340480991000765
NMR metabolomics,X23428.Concentration of VLDL Particles,NMI,N-myc-interactor,39875,0.00704831027519264,0.00743862768539922,-0.00753139998818982,0.0216280205385751,0.343389947319163
NMR metabolomics,X23428.Concentration of VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.00286418487515466,0.00302916078878681,-0.00307297027086748,0.0088013400211768,0.344401827463526
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.00382918998530323,0.00405048688300348,-0.00410976430538359,0.01176814427599,0.344492560692865
NMR metabolomics,X23428.Concentration of VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00669742340505903,0.0071021849060444,-0.0206177058209061,0.007222859010788,0.345697120344762
NMR metabolomics,X23428.Concentration of VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00436514474436227,0.00463751871904487,-0.0134546814336902,0.00472439194496569,0.346588471736083
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.00480087321569532,0.00511401139061717,-0.00522258910991432,0.014824335541305,0.347866699777686
NMR metabolomics,X23428.Concentration of VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00323636871174577,0.00347003013147045,-0.00356489034593632,0.0100376277694279,0.351013861461748
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00274287958931056,0.00295467123002018,-0.00304827602152899,0.0085340352001501,0.353261539222455
NMR metabolomics,X23428.Concentration of VLDL Particles,OGN,Mimecan,42137,0.00408473143443664,0.00440179686656639,-0.00454279042403348,0.0127122532929068,0.353440148449486
NMR metabolomics,X23428.Concentration of VLDL Particles,CD58,Lymphocyte function-associated antigen 3,42100,0.00164110847621495,0.00177204613138914,-0.00183210194130777,0.00511431889373766,0.354405714699957
NMR metabolomics,X23428.Concentration of VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.00808265452048175,0.00874461739419106,-0.00905679557213272,0.0252221046130962,0.355350050400833
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN1,Neuroligin-1,39649,0.00632931012169015,0.00685698914317427,-0.00711038859893142,0.0197690088423117,0.356003866854069
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00370944267432276,0.00402737867456602,-0.0116031048764722,0.00418421952782663,0.357040926354411
NMR metabolomics,X23428.Concentration of VLDL Particles,OLFM4,Olfactomedin-4,39347,0.011649608771247,0.0126787496752695,-0.0132007405922812,0.0364999581347752,0.358205399573396
NMR metabolomics,X23428.Concentration of VLDL Particles,CLINT1,Clathrin interactor 1,39560,0.00469401809446738,0.00511465952346925,-0.00533071457153236,0.0147187507604671,0.358765934071231
NMR metabolomics,X23428.Concentration of VLDL Particles,ALMS1,Alstrom syndrome protein 1,39757,-0.00415102841674662,0.0045383781591291,-0.0130462496086397,0.00474419277514642,0.360395070890536
NMR metabolomics,X23428.Concentration of VLDL Particles,PSCA,Prostate stem cell antigen,39930,0.0241822163723085,0.0265476692327334,-0.0278512153238489,0.076215648068466,0.362368546624839
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.00412585521105971,0.00456832639895812,-0.0130797749530176,0.0048280645308982,0.366469131331003
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2A,Pancreatic alpha-amylase,41665,-0.00450029820005557,0.00498494632393788,-0.0142707929949738,0.00527019659486267,0.366660551136604
NMR metabolomics,X23428.Concentration of VLDL Particles,CHI3L1,Chitinase-3-like protein 1,41907,-0.00767405433085714,0.00851544977851861,-0.0243643358967536,0.00901622723503933,0.367502608817705
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,39649,-0.00470640977848083,0.00522713552555961,-0.0149515954085777,0.005538775851616,0.36793753204451
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00391542290842098,0.00435066086594846,-0.01244271820568,0.004611872388838,0.36816087371915
NMR metabolomics,X23428.Concentration of VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.00391131954095622,0.00434755808077636,-0.0124325333792779,0.00460989429736544,0.36831785760894
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS2,"Nitric oxide synthase, inducible",39575,-0.00370146698095125,0.00412031608025468,-0.0117772864982504,0.00437435253634792,0.369021145108367
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3A,Uroplakin-3a,39586,0.00443107165146885,0.00495229376844752,-0.00527542413468828,0.014137567437626,0.370939611608924
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP7,Retinoid-binding protein 7,39930,0.00568280370322733,0.00638103840878872,-0.00682403157799856,0.0181896389844532,0.373175249791568
NMR metabolomics,X23428.Concentration of VLDL Particles,NRXN3,Neurexin-3,39649,0.00326152447816874,0.00367099048704564,-0.00393361687644072,0.0104566658327782,0.37431325027503
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00677641447113286,0.0076395348284724,-0.00819707379267305,0.0217499027349388,0.375087952698642
NMR metabolomics,X23428.Concentration of VLDL Particles,OSTN,Osteocrin,39649,0.00366043096180186,0.0041302174984085,-0.00443479533507881,0.0117556572586825,0.375498761384671
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00400085635994455,0.004514471261789,-0.00484750731316189,0.012849220033051,0.375510027001854
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200,OX-2 membrane glycoprotein,42119,0.00244950839250592,0.00276522593857491,-0.0029703344471009,0.00786935123211273,0.375727177710498
NMR metabolomics,X23428.Concentration of VLDL Particles,TUBB3,Tubulin beta-3 chain,39586,-0.00259066851139967,0.00292619535682171,-0.00832601141077022,0.00314467438797088,0.375994370398813
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCL2,Phosducin-like protein 2,39560,-0.00470316421956956,0.00534425658626892,-0.0151779071286566,0.00577157868951753,0.378856464725797
NMR metabolomics,X23428.Concentration of VLDL Particles,PALLD,Palladin,39657,0.0034212566434461,0.00389984359276703,-0.00422243679837727,0.0110649500852695,0.380353374522981
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM132A,Transmembrane protein 132A,39638,0.00562074670812859,0.00641559241225414,-0.00695381441988952,0.0181953078361467,0.380990823756742
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNL1,Thioredoxin-like protein 1,39570,0.0090974830665952,0.0103978914965136,-0.0112823842665715,0.0294773503997619,0.38162822633844
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.00755403338607734,0.00864430491527452,-0.00938880424786073,0.0244968710200154,0.382205392371314
NMR metabolomics,X23428.Concentration of VLDL Particles,GPA33,Cell surface A33 antigen,42070,0.011856730590194,0.013611282705293,-0.0148213835121803,0.0385348446925683,0.383717396000183
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB2,Lamin-B2,39929,0.00254205069661076,0.00293019386242262,-0.00320112927373758,0.0082852306669591,0.385666390507879
NMR metabolomics,X23428.Concentration of VLDL Particles,EXOSC10,Exosome component 10,39575,-0.00515506794519265,0.00595811936754669,-0.0168329819055842,0.00652284601519887,0.386938443911095
NMR metabolomics,X23428.Concentration of VLDL Particles,PI3,Elafin,41966,0.00493647102616845,0.0057216729832867,-0.00627800802107347,0.0161509500734104,0.388281028599586
NMR metabolomics,X23428.Concentration of VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,39586,0.00524882290275344,0.00608369179908701,-0.00667521302345711,0.017172858828964,0.388283119857994
NMR metabolomics,X23428.Concentration of VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00570491388215033,0.00664506191988242,-0.00731940748081922,0.0187292352451199,0.390624510476514
NMR metabolomics,X23428.Concentration of VLDL Particles,IL24,Interleukin-24,41913,-0.00421488570747859,0.00490972819204267,-0.0138379529638822,0.00540818154892505,0.390644920736276
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0121194333292446,0.0141553454533552,-0.0398639104178208,0.0156250437593315,0.391919802183882
NMR metabolomics,X23428.Concentration of VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.00731074550304362,0.00857021412057159,-0.00948687417327669,0.0241083651793639,0.393655113746703
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN7,Tetraspanin-7,39586,-0.00850423819448737,0.00997348189649823,-0.0280522627116239,0.0110437863226492,0.393852612089467
NMR metabolomics,X23428.Concentration of VLDL Particles,DENND2B,DENN domain-containing protein 2B,39575,-0.00423664137495304,0.00500805493064041,-0.0140524290390082,0.00557914628910215,0.397590469813655
NMR metabolomics,X23428.Concentration of VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00230440334651356,0.00272955410945605,-0.0030455227080203,0.00765432940104742,0.398552794905832
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD1,Glutamate decarboxylase 1,39560,0.0022707500973728,0.00269532578541327,-0.0030120884420372,0.00755358863678281,0.399539368194798
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD4,Sushi domain-containing protein 4,39919,0.00331094571467898,0.00393258882397013,-0.00439692838030247,0.0110188198096604,0.399847599508922
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL4,Early placenta insulin-like peptide,39919,-0.00413355513101377,0.00491253773290336,-0.0137621290875044,0.00549501882547681,0.400125030918936
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00463575947978234,0.00551885103581744,-0.0154527075099845,0.00618118855041984,0.400934368577127
NMR metabolomics,X23428.Concentration of VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00240377358020009,0.00286264171711664,-0.00320700418534853,0.0080145513457487,0.401092157583933
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.00358101837519187,0.0042779899988074,-0.0119658787728544,0.00480384202247063,0.402563389133583
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.0036256295070974,0.00435515886813901,-0.0121617408886499,0.00491048187445506,0.405150107023479
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN1,Cerebellin-1,39586,0.00787717716402114,0.0094719784571277,-0.0106879006119491,0.0264422549399914,0.405636153425841
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR1,Folate receptor alpha,42110,-0.00249533872508058,0.0030013312685053,-0.00837794801135096,0.00338727056118981,0.405756389119348
NMR metabolomics,X23428.Concentration of VLDL Particles,CHP1,Calcineurin B homologous protein 1,39586,0.00626896442274856,0.00754536228875188,-0.00851994566320512,0.0210578745087023,0.406083903862814
NMR metabolomics,X23428.Concentration of VLDL Particles,IKZF2,Zinc finger protein Helios,41843,0.00750530879660671,0.00904349269901155,-0.0102199368934559,0.0252305544866693,0.40660314408298
NMR metabolomics,X23428.Concentration of VLDL Particles,CTNNA1,Catenin alpha-1,39586,-0.00285657807798847,0.00345725224895538,-0.00963279248594101,0.00391963632996407,0.408676393939971
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH4,Cadherin-4,39586,0.00391794339525142,0.00475583972464206,-0.00540350246504701,0.0132393892555498,0.410061217551894
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00350510157507896,0.00426628717682134,-0.0118670244416488,0.00485682129149085,0.411332988253228
NMR metabolomics,X23428.Concentration of VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00585768376502773,0.00713203799923812,-0.00812111071347898,0.0198364782435344,0.411481873795355
NMR metabolomics,X23428.Concentration of VLDL Particles,CDSN,Corneodesmosin,42246,0.00365708550635295,0.00445740889625252,-0.00507943593030199,0.0123936069430079,0.411973393337082
NMR metabolomics,X23428.Concentration of VLDL Particles,NUP50,Nuclear pore complex protein Nup50,39575,-0.00265970406948796,0.00324196352067647,-0.00901395257001384,0.00369454443103793,0.412006425834111
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2,Interleukin-2,41913,-0.00266143130775002,0.00325609478994208,-0.00904337709603648,0.00372051448053645,0.413732148921508
NMR metabolomics,X23428.Concentration of VLDL Particles,NCLN,Nicalin,41913,0.00424917430424892,0.005214101049146,-0.00597046375207724,0.0144688123605751,0.415121804702669
NMR metabolomics,X23428.Concentration of VLDL Particles,PTTG1,Securin,39757,0.00345528920888094,0.00425335739184465,-0.00488129127913457,0.0117918696968965,0.416598135566379
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,42185,0.00221591912549205,0.00274663922272051,-0.00316749375104016,0.00759933200202426,0.41981040241298
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53BP1,TP53-binding protein 1,39657,-0.00707751583347475,0.0087954155675114,-0.0243165303457971,0.0101614986788476,0.421020297863677
NMR metabolomics,X23428.Concentration of VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.0037671451633092,0.00469209319552199,-0.0129636478265323,0.0054293574999139,0.422066604810854
NMR metabolomics,X23428.Concentration of VLDL Particles,OMP,Olfactory marker protein,39586,-0.00392978794063214,0.00490185774018547,-0.0135374291113957,0.00567785323013138,0.422747562893328
NMR metabolomics,X23428.Concentration of VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00212097089765763,0.00265917272617589,-0.00733294944096238,0.00309100764564711,0.425116097665413
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00467235902234514,0.00585964128310663,-0.0161572559372341,0.00681253789254385,0.425247794399845
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP6,Guanylate-binding protein 6,39575,-0.00364393126401865,0.00457015815394483,-0.0126014412457505,0.00531357871771321,0.425275753485776
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP29,Dual specificity phosphatase 29,39649,-0.00547848929714468,0.00687465817071038,-0.018952819311737,0.00799584071744767,0.425519965362459
NMR metabolomics,X23428.Concentration of VLDL Particles,JUN,Transcription factor AP-1,41913,0.00389436209353907,0.00491562913727158,-0.00574027101551323,0.0135289952025914,0.428234383454791
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00270965758663617,0.00344775627009112,-0.00946725987601476,0.00404794470274242,0.431931740449282
NMR metabolomics,X23428.Concentration of VLDL Particles,TNN,Tenascin-N,39966,0.00346882053571765,0.0044144429632947,-0.00518348767233996,0.0121211287437753,0.432007517085104
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.00275901250728555,0.00351437734009612,-0.00412916707930285,0.00964719209387394,0.432429573370018
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,41843,-0.00378239017177403,0.00482142731859129,-0.013232387716213,0.0056676073726649,0.432763193671511
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLNL,Mesothelin-like protein,39649,0.00303665273405945,0.00387086986164653,-0.00455025219476775,0.0106235576628866,0.43277036943031
NMR metabolomics,X23428.Concentration of VLDL Particles,HBZ,Hemoglobin subunit zeta,39958,-0.00859343979254149,0.0109641026380944,-0.0300830809632065,0.0128962013781236,0.433185799904638
NMR metabolomics,X23428.Concentration of VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00500198009766554,0.00640388714521853,-0.00754963870696278,0.0175535989022938,0.434769234707519
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00428677671045037,0.00549868181767972,-0.00649063965220187,0.0150641930731026,0.435639824512678
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.00320539892454805,0.00413803411904001,-0.00490514794877038,0.0113159457978665,0.438578610369544
NMR metabolomics,X23428.Concentration of VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,39930,-0.00345141036931077,0.0044593515859288,-0.0121917394777312,0.00528891873910967,0.438963882650256
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00424021613486054,0.00548478347040372,-0.0149903917368518,0.00650995946713075,0.439487382831368
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA4,Apolipoprotein A-IV,39979,-0.0027224487288626,0.0035221553304446,-0.00962587317653402,0.00418097571880882,0.43956823450629
NMR metabolomics,X23428.Concentration of VLDL Particles,CHIT1,Chitotriosidase-1,42207,-0.0122788689328401,0.0159344252929378,-0.0435103425069981,0.018952604641318,0.440964852384301
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM19,Probable RNA-binding protein 19,39575,-0.00377573386341027,0.00491510518120954,-0.013409340018581,0.00585787229176042,0.442390936703105
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.00663899845915759,0.0086566586745997,-0.0103280525430578,0.023606049461373,0.443140153290508
NMR metabolomics,X23428.Concentration of VLDL Particles,KEL,Kell blood group glycoprotein,41839,0.00280479903128748,0.00368015543353681,-0.00440830561844468,0.0100179036810196,0.445989158304575
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00379373870705298,0.00499442050548157,-0.00599532548369089,0.0135828028977969,0.447512784369733
NMR metabolomics,X23428.Concentration of VLDL Particles,IL25,Interleukin-25,39510,0.00267019523600954,0.00351594205900458,-0.00422105119963943,0.00956144167165851,0.447597604145377
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1,Huntingtin-interacting protein 1,39575,0.00255129465973196,0.00336737330443664,-0.00404875701696385,0.00915134633642777,0.448676045474661
NMR metabolomics,X23428.Concentration of VLDL Particles,BSND,Barttin,39560,0.00258702303307509,0.00343419319717422,-0.00414399563338638,0.00931804169953657,0.451277915682581
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX33,Testis-expressed protein 33,39757,-0.00292531910089317,0.00394180648647231,-0.0106512598143789,0.00480062161259255,0.458026310290997
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.00289096628560585,0.00390322074864404,-0.0105412789529482,0.00475934638173647,0.458911269204283
NMR metabolomics,X23428.Concentration of VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.00654480590128148,0.00884115544230494,-0.0107838587656362,0.0238734705681992,0.459154554568859
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLON5,IgLON family member 5,39560,-0.00697644478070596,0.00948265802473926,-0.0255624545091949,0.011609564947783,0.46192561384104
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00358713435915305,0.00492146268979585,-0.00605893251284681,0.0132332012311529,0.466092791187617
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM2,Isthmin-2,39966,0.00320455691682638,0.00443248439287895,-0.00548311249321637,0.0118922263268691,0.469712682457234
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN8,Septin-8,39906,0.00240643516656959,0.00333172198720546,-0.00412373992835311,0.00893661026149229,0.470137468008454
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00284313341635072,0.00396247695347152,-0.00492332141245346,0.0106095882451549,0.473072158893719
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM1,Myomesin-1,39586,0.00359026716226395,0.005006329296149,-0.0062221382581881,0.013402672582716,0.473299491542042
NMR metabolomics,X23428.Concentration of VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00854794408235801,0.0120131226247566,-0.014997776262165,0.032093664426881,0.476758242066148
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,42081,0.00192664044231024,0.00271985971590364,-0.0034042846008609,0.00725756548548137,0.478733833262085
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.00631512977244072,0.0089370038437397,-0.0112013977612891,0.0238316573061705,0.479813087141879
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF6,Fibroblast growth factor 6,39657,0.00281489838435293,0.00399647120106855,-0.00501818516974143,0.0106479819384473,0.481232178666972
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00339017605621508,0.00484248555840232,-0.0128814477506836,0.00610109563825346,0.483885895822472
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0084035661699936,0.0120418996111619,-0.0320056894078709,0.0151985570678837,0.48527875046751
NMR metabolomics,X23428.Concentration of VLDL Particles,APOBR,Apolipoprotein B receptor,39638,-0.00304381144839667,0.00439032809507903,-0.0116488545147516,0.00556123161795824,0.488136322262073
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,39657,0.00144001939506252,0.00208727382404071,-0.00265103730005728,0.00553107609018231,0.490268787960617
NMR metabolomics,X23428.Concentration of VLDL Particles,STEAP4,Metalloreductase STEAP4,39586,0.00512684375270007,0.00744271724913976,-0.00946088205561387,0.019714569561014,0.490938304015214
NMR metabolomics,X23428.Concentration of VLDL Particles,PRC1,Protein regulator of cytokinesis 1,39919,0.00306819435295684,0.00450117311344811,-0.00575410494940145,0.0118904936553151,0.495478494463887
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00502656874788344,0.00739751128061482,-0.0195256908578885,0.00947255336212161,0.496838862895306
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18BP,Interleukin-18-binding protein,42217,-0.00216796036116535,0.00319496633038923,-0.00843009436872824,0.00409417364639754,0.497431398450232
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36A,Interleukin-36 alpha,39657,-0.00398502250079758,0.00587566330267033,-0.0155013225740314,0.00753127757243627,0.497643154956689
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM3,Paralemmin-3,39575,0.0052480541267408,0.00775155508957735,-0.0099449938488308,0.0204411021023124,0.498399652381221
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00444712985922451,0.0065762146935149,-0.0173365106585137,0.00844225094006471,0.498899496994567
NMR metabolomics,X23428.Concentration of VLDL Particles,RRP15,RRP15-like protein,39586,0.00629821230829516,0.00932294379327532,-0.0119747575265245,0.0245711821431148,0.499333964313437
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00165873374388245,0.00246685052922015,-0.00649376078115394,0.00317629329338905,0.501336740486079
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00262256597383459,0.00390579325611358,-0.0102779207558172,0.00503278880814803,0.501944594655952
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00278759940522789,0.00417212505799538,-0.00538976570844305,0.0109649645188988,0.504052705188345
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR3,Folate receptor gamma,42132,-0.0130303004932827,0.0195298864434521,-0.0513088779224488,0.0252482769358834,0.504657067500757
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00519917158121127,0.00779410628744621,-0.0204756199046058,0.0100772767421833,0.50474473254541
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT1,Diamine acetyltransferase 1,39575,-0.00329558571642919,0.00494394882500937,-0.0129857254134476,0.00639455398058918,0.505048216813101
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.00470712302167169,0.00707126915874456,-0.00915256452946765,0.018566810572811,0.505636602681185
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.00439549464851839,0.0066105477732247,-0.00856117898700203,0.0173521682840388,0.506114648102221
NMR metabolomics,X23428.Concentration of VLDL Particles,UMOD,Uromodulin,42274,-0.0036242483710495,0.0054787778234574,-0.014362652905026,0.00711415616292699,0.50829854994182
NMR metabolomics,X23428.Concentration of VLDL Particles,TPT1,Translationally-controlled tumor protein,41913,0.0043135258351796,0.00652321380503189,-0.00847197322268289,0.0170990248930421,0.508458460049766
NMR metabolomics,X23428.Concentration of VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.00640573061901934,0.00974073669483889,-0.0126861133028649,0.0254975745409036,0.510794345544192
NMR metabolomics,X23428.Concentration of VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0100261083378882,0.015254699703145,-0.0399253197560524,0.019873103080276,0.511033183479719
NMR metabolomics,X23428.Concentration of VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0031275903203605,0.00475948457430318,-0.0124561800859947,0.00620099944527373,0.511112430987712
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00203907092945481,0.00311670850836202,-0.00814781960584437,0.00406967774693476,0.512971840963315
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP1,Retinol-binding protein 1,39649,0.00467930398423152,0.00717018223666264,-0.00937425319962725,0.0187328611680903,0.514023890366389
NMR metabolomics,X23428.Concentration of VLDL Particles,UBQLN3,Ubiquilin-3,39575,-0.00374647067885485,0.00574759430239012,-0.0150117555115395,0.00751881415382978,0.514522667878353
NMR metabolomics,X23428.Concentration of VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,39560,0.00222667122194336,0.00342092352366439,-0.00447833888443884,0.00893168132832557,0.51512617757614
NMR metabolomics,X23428.Concentration of VLDL Particles,IL11,Interleukin-11,41913,0.00401537203138791,0.00620288571662779,-0.00814228397320256,0.0161730280359784,0.517423498679668
NMR metabolomics,X23428.Concentration of VLDL Particles,DAND5,DAN domain family member 5,39657,0.00361114768948345,0.00559365715504113,-0.00735242033439717,0.0145747157133641,0.518565426047096
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00395132461977574,0.00614010450683457,-0.00808328021362001,0.0159859294531715,0.519893180040693
NMR metabolomics,X23428.Concentration of VLDL Particles,S100G,Protein S100-G,39934,0.00321393036919287,0.00499628173639311,-0.00657878183413763,0.0130066425725234,0.520065540615236
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.0036102890382621,0.00562668441355853,-0.00741801241231261,0.0146385904888368,0.52112227462343
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.00413512150218362,0.00648250542373733,-0.0168408321327088,0.00857058912834155,0.523556399101768
NMR metabolomics,X23428.Concentration of VLDL Particles,CADPS,Calcium-dependent secretion activator 1,39649,0.00265623039410018,0.00416429551834218,-0.0055057888218505,0.0108182496100509,0.523579153360022
NMR metabolomics,X23428.Concentration of VLDL Particles,SHC1,SHC-transforming protein 1,39560,-0.00762977776722392,0.0119736355744012,-0.0310981034930502,0.0158385479586024,0.523998250267151
NMR metabolomics,X23428.Concentration of VLDL Particles,BTNL10,Butyrophilin-like protein 10,39560,-0.00259488030850515,0.00408169339398287,-0.0105949993607116,0.00540523874370128,0.524961641608475
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC1,Plexin domain-containing protein 1,41843,-0.00207806156939707,0.00327700766590675,-0.00850099659457431,0.00434487345578016,0.526004410207876
NMR metabolomics,X23428.Concentration of VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00271679122470749,0.00431103022866272,-0.00573282802347143,0.0111664104728864,0.528579684427687
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,39560,0.00280900005053114,0.00446562290938053,-0.0059436208518547,0.011561620952917,0.529344098646553
NMR metabolomics,X23428.Concentration of VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00222262633299266,0.00353357087722489,-0.00470317258636812,0.00914842525235344,0.529360236321239
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00245327938016035,0.00390620905613681,-0.00520289036986779,0.0101094491301885,0.529986436884509
NMR metabolomics,X23428.Concentration of VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.003232537907657,0.00515486994924323,-0.0133360830081737,0.00687100719285973,0.530616848502289
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.00330440606566696,0.00534473024321388,-0.0137800773423662,0.00717126521103226,0.536419716025657
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.00206548222601946,0.00334996772027174,-0.00863141895775207,0.00450045450571316,0.537530202101748
NMR metabolomics,X23428.Concentration of VLDL Particles,SSB,Lupus La protein,41839,0.00363044392152241,0.00598672149642602,-0.0081035302114726,0.0153644180545174,0.544248919947652
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.00212744316303785,0.00353347484562833,-0.00479816753439368,0.00905305386046938,0.547129515077415
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.0018156682472505,0.00302175096334117,-0.00410696364089819,0.00773830013539918,0.54793917226249
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK1,Kallikrein-1,42016,0.00771056411883897,0.0130076970130662,-0.0177845220267709,0.0332056502644488,0.5533455128077
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00299898003976754,0.00507801612101704,-0.00695393155742585,0.0129518916369609,0.554813332574132
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL2,Interferon lambda-2,39586,-0.0035278487899008,0.00598419050584791,-0.0152568621813627,0.0082011646015611,0.555519153753603
NMR metabolomics,X23428.Concentration of VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00181157829579623,0.00307328114212657,-0.0078352093343643,0.00421205274277184,0.5555640268127
NMR metabolomics,X23428.Concentration of VLDL Particles,CRX,Cone-rod homeobox protein,41900,0.00640500220584001,0.0109538070797508,-0.0150644596704716,0.0278744640821516,0.558740266209234
NMR metabolomics,X23428.Concentration of VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,41839,0.00226327875897572,0.00389196213876341,-0.00536496703300056,0.00989152455095201,0.560895626758918
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,39586,0.00644354183421543,0.0111076034139808,-0.0153273608571869,0.0282144445256178,0.561857800246867
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.00164663054731483,0.00284257029456491,-0.0039248072300324,0.00721806832466205,0.562413039567973
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.0023700758751342,0.00411099380580179,-0.0104276237345057,0.00568747198423731,0.564274444591142
NMR metabolomics,X23428.Concentration of VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.0015436551651919,0.0026869052798857,-0.00372267918338408,0.00680998951376788,0.565634205321412
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.00383127234055891,0.00669710955804539,-0.00929506239321005,0.0169576070743279,0.567278281143273
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.00336423669615317,0.00589265133540994,-0.0149138333135567,0.00818535992125032,0.56806283814935
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00196940098407018,0.00347734533396164,-0.008784997838635,0.00484619587049464,0.571166196102359
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00239312507057213,0.0042311967613486,-0.0106862707228154,0.00590002058167114,0.571683603074098
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.001373510874584,0.00243689355009678,-0.00340280048360568,0.00614982223277369,0.573014111521876
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.0020868570532992,0.00373249945040865,-0.00940255597610016,0.00522884186950176,0.576101769464215
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6,Interleukin-6,42070,-0.00423426117342278,0.00760085263083139,-0.0191319323298523,0.0106634099830067,0.577483987845949
NMR metabolomics,X23428.Concentration of VLDL Particles,TJP3,Tight junction protein ZO-3,39586,-0.00236807306749837,0.00425235368490312,-0.0107026862899085,0.00596654015491174,0.577617173404465
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB7,Integrin beta-7,42262,0.0026056558266148,0.00469372347633479,-0.00659404218700138,0.011805353840231,0.578810590811015
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.00346012830770955,0.00626109301686642,-0.0157318706207677,0.00881161400534864,0.580519386943171
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR2,TGF-beta receptor type-2,42181,0.00192131342522762,0.00348481067799246,-0.00490891550363761,0.00875154235409284,0.581410105109599
NMR metabolomics,X23428.Concentration of VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00280714455585424,0.00511856779984719,-0.00722524833184625,0.0128395374435547,0.583412061581688
NMR metabolomics,X23428.Concentration of VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00280346324068136,0.0051476857773627,-0.00728600088294953,0.0128929273643122,0.586035159981272
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX2,Peroxiredoxin-2,39819,0.00335488955376016,0.00616481623831433,-0.00872815027333593,0.0154379293808562,0.586315051099813
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC2,MAM domain-containing protein 2,39958,0.00196614844272532,0.00363201038626875,-0.00515259191436143,0.00908488879981208,0.588284642505425
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA1,Apolipoprotein A-I,39979,-0.00151723710541092,0.00280847773043421,-0.00702185345706197,0.00398737924624013,0.589045762531416
NMR metabolomics,X23428.Concentration of VLDL Particles,DCN,Decorin,41900,-0.00125726514510998,0.00234320549709929,-0.00584994791942458,0.00333541762920463,0.591582086985618
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF8,SLAM family member 8,41843,-0.0029403544686989,0.00548007561324066,-0.0136813026706506,0.0078005937332528,0.591584993730699
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3,Interleukin-3,39560,0.00335907598415356,0.0062680401874478,-0.00892628278324412,0.0156444347515512,0.592034873413858
NMR metabolomics,X23428.Concentration of VLDL Particles,NEFL,Neurofilament light polypeptide,41797,0.00257540681758582,0.00480942091601007,-0.00685105817779392,0.0120018718129656,0.592318655255563
NMR metabolomics,X23428.Concentration of VLDL Particles,LHB,Lutropin subunit beta,41843,0.0047772356433624,0.00900155656226988,-0.0128658152186866,0.0224202865054114,0.595627148585789
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG2,"Arginase-2, mitochondrial",39919,-0.00227094608416674,0.00430398055953802,-0.0107067479808613,0.00616485581252777,0.597760569893932
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOC,Myocilin,42137,0.00239245457608998,0.00455218364849754,-0.00652982537496521,0.0113147345271452,0.599201198802591
NMR metabolomics,X23428.Concentration of VLDL Particles,ZPR1,Zinc finger protein ZPR1,39586,0.00515404442033886,0.00985172367359604,-0.0141553339799094,0.0244634228205871,0.600872288941938
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15,Interleukin-15,42119,0.00174717414615636,0.00334933124356798,-0.00481751509123689,0.0083118633835496,0.601923524232285
NMR metabolomics,X23428.Concentration of VLDL Particles,SKIV2L,Helicase SKI2W,39575,-0.00210260933522978,0.00404491794744625,-0.0100306485122244,0.00582542984176486,0.603202953477808
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF20,Fibroblast growth factor 20,39657,-0.00225894538410757,0.00441447146283703,-0.0109113094512682,0.00639341868305301,0.608861638033346
NMR metabolomics,X23428.Concentration of VLDL Particles,TBR1,T-box brain protein 1,39649,0.00250337935340131,0.00489725296858756,-0.0070952364650303,0.0121019951718329,0.609235010011389
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0029754938425337,0.0058738501773539,-0.0144882401901473,0.00853725250507994,0.612467489097969
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO3,R-spondin-3,42262,0.00144096615260881,0.0028589829156463,-0.00416264036205794,0.00704457266727555,0.614259976660341
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00232311782453094,0.00461942301061912,-0.00673095127628252,0.0113771869253444,0.615043076836331
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR1B,Cornifin-B,39757,-0.00442745668422308,0.00883062988741862,-0.0217354912635636,0.0128805778951174,0.616117152941063
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRV1,Acrosomal protein SP-10,39657,0.00542024007045516,0.0108720507400101,-0.0158889793799646,0.026729459520875,0.618107703457726
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS8,Regulator of G-protein signaling 8,41913,-0.00323546081664946,0.00650622390052488,-0.0159876596616782,0.0095167380283793,0.618994863039864
NMR metabolomics,X23428.Concentration of VLDL Particles,TPBGL,Trophoblast glycoprotein-like,39649,-0.00205024722333636,0.00414888973274752,-0.0101820710995215,0.00608157665284878,0.621197585536623
NMR metabolomics,X23428.Concentration of VLDL Particles,BOC,Brother of CDO,41900,-0.00116946640064407,0.0023682481513776,-0.00581123277734418,0.00347229997605603,0.621447993542804
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.0030865297973869,0.00629035482012414,-0.0154156252448302,0.00924256565005641,0.623665012920228
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLN,Mesothelin,42048,0.0028861241657879,0.00591562186614972,-0.00870849469186554,0.0144807430234413,0.625641529772559
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,39649,-0.00518891108516586,0.0107737097679517,-0.0263053822303512,0.0159275600600195,0.630080377450082
NMR metabolomics,X23428.Concentration of VLDL Particles,FBLN2,Fibulin-2,39966,0.00157836251328224,0.00328105293344518,-0.00485250123627031,0.0080092262628348,0.630487623788899
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN15,Tetraspanin-15,39575,-0.00246169422094657,0.00514021798665302,-0.0125365214747865,0.00761313303289335,0.632013246046329
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC123,Cell division cycle protein 123 homolog,39560,0.00306965955481418,0.00642453318423002,-0.00952242548627666,0.015661744595905,0.632800140079596
NMR metabolomics,X23428.Concentration of VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00200744476700771,0.00422774287674573,-0.00627893127141392,0.0102938208054293,0.634920011936908
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,41839,0.00192461435481516,0.0040538629975406,-0.00602095712036442,0.00987018582999474,0.634965463094084
NMR metabolomics,X23428.Concentration of VLDL Particles,FBN2,Fibrillin-2,39649,0.00290046530679673,0.00613279080676652,-0.00911980467446565,0.0149207352880591,0.636262626975255
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",39575,0.0030236283549982,0.00643803483997516,-0.00959491993135311,0.0156421766413495,0.638613839083966
NMR metabolomics,X23428.Concentration of VLDL Particles,MN1,Transcriptional activator MN1,39649,-0.00280641632536971,0.00601273942777725,-0.0145913856038131,0.00897855295307369,0.640691501797473
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK12,Kallikrein-12,41843,0.00627901324172217,0.0135726174744773,-0.0203233170082533,0.0328813434916977,0.643641785936997
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00146013545540832,0.00316550302720633,-0.00474425047791608,0.00766452138873273,0.64461587758244
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH22,Cadherin-22,39757,0.0012869137625016,0.00281738643003617,-0.0042351636403693,0.00680899116537249,0.647841139540895
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH17,Protocadherin-17,42145,-0.00173195351197727,0.00381192281330144,-0.00920332222604809,0.00573941520209355,0.649583009599752
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3B,Sodium channel subunit beta-3,39586,0.00216373261243066,0.0047627491920113,-0.00717125580391149,0.0114987210287728,0.6496195260207
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP15,Matrix metalloproteinase-15,39958,0.00225342090953503,0.00496621599112969,-0.00748036243307916,0.0119872042521492,0.65001738575574
NMR metabolomics,X23428.Concentration of VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00248878715831197,0.00550303908964568,-0.0132747437740175,0.00829716945739356,0.651092882442575
NMR metabolomics,X23428.Concentration of VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.0025631800406552,0.00574744343176736,-0.00870180908560882,0.0138281691669192,0.655628644457044
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF830,Zinc finger protein 830,39919,-0.00352295342029544,0.00792126803979605,-0.0190486387782957,0.0120027319377048,0.656511721764603
NMR metabolomics,X23428.Concentration of VLDL Particles,DKKL1,Dickkopf-like protein 1,42070,-0.00378882606986183,0.00852458479792978,-0.0204970122738042,0.0129193601340805,0.656718106271018
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTA2,"Actin, aortic smooth muscle",41900,0.00197036971115833,0.00444265263771856,-0.00673722945877005,0.0106779688810867,0.657402663265777
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSD1,Tryptase delta,39934,-0.00161537605937096,0.00373473771711469,-0.00893546198491575,0.00570470986617383,0.665366436759625
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA4,Ephrin type-A receptor 4,39736,0.00129123316368245,0.00298983014915173,-0.00456883392865495,0.00715130025601985,0.665840561849378
NMR metabolomics,X23428.Concentration of VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,39757,0.00347867491220869,0.00807301166441208,-0.012344427950039,0.0193017777744564,0.666548130100793
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00177348300840014,0.00411808985200478,-0.00629797310152924,0.00984493911832952,0.666726451798054
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA1,Laminin subunit alpha-1,39575,-0.00226215728823314,0.0052828479804205,-0.0126165393298573,0.00809222475339104,0.668508161339144
NMR metabolomics,X23428.Concentration of VLDL Particles,CGN,Cingulin,39649,-0.00163594897298201,0.00382077847844984,-0.00912467479074371,0.00585277684477969,0.668534510666355
NMR metabolomics,X23428.Concentration of VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00220511487589056,0.00516337966348698,-0.00791510926454392,0.012325339016325,0.669338085721442
NMR metabolomics,X23428.Concentration of VLDL Particles,NRN1,Neuritin,39934,0.001503545441886,0.00355190109416377,-0.005458180702675,0.008465271586447,0.672079146031221
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00158890200039536,0.00376911376114785,-0.00579856097145443,0.00897636497224515,0.673354098153203
NMR metabolomics,X23428.Concentration of VLDL Particles,DNLZ,DNL-type zinc finger protein,39586,0.00359211734930628,0.00863517145608183,-0.0133328187046141,0.0205170534032267,0.677427787198735
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA1,Ephrin-A1,42113,0.00124690013017997,0.00299767100779932,-0.00462853504510669,0.00712233530546664,0.677448589035169
NMR metabolomics,X23428.Concentration of VLDL Particles,WNT9A,Protein Wnt-9a,41913,-0.00123350007564571,0.00296738448718678,-0.00704957367053179,0.00458257351924037,0.677646514572769
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAX,Integrin alpha-X,39757,0.00215611833164443,0.00527838955552161,-0.00818952519717792,0.0125017618604668,0.682928904703628
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.00200162676927645,0.00495359705808028,-0.0117106770031138,0.0077074234645609,0.68616365748396
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,41913,0.00149511905838238,0.00370521104945853,-0.00576709459855634,0.0087573327153211,0.686573734694123
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00226774426331494,0.00563308711635864,-0.0133085950113779,0.00877310648474799,0.687268204645417
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF12,Fibroblast growth factor 12,39657,0.00185799197566215,0.00463716088257033,-0.00723084335417569,0.0109468273055,0.688667551572196
NMR metabolomics,X23428.Concentration of VLDL Particles,IL21R,Interleukin-21 receptor,39657,-0.00220111251204489,0.00553786700766015,-0.0130553318470588,0.00865310682296899,0.691031704359656
NMR metabolomics,X23428.Concentration of VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,39575,0.00157717819750677,0.00397274952552392,-0.00620941087252012,0.00936376726753366,0.691375804693382
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC9,Histone deacetylase 9,39586,0.00270629881283204,0.00682086322651638,-0.0106625931111401,0.0160751907368041,0.691546413676886
NMR metabolomics,X23428.Concentration of VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00163853465506508,0.00412971710207208,-0.00645571086499619,0.00973278017512635,0.691547095376467
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNW1,Interferon omega-1,39575,0.00142774471453203,0.0036065067959826,-0.00564100860559387,0.00849649803465793,0.692201086878566
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD2,Glutamate decarboxylase 2,39657,-0.00182243836498868,0.00463397931666804,-0.010905037825658,0.00726016109568068,0.69412234578082
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.0013061119828621,0.00333153118832242,-0.00522368914624983,0.00783591311197404,0.695030732334623
NMR metabolomics,X23428.Concentration of VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00147463073995331,0.00376697422856322,-0.00885790022793721,0.0059086387480306,0.695462413012059
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.0068268889301509,0.0175853591710906,-0.0276404150451867,0.0412941929054885,0.697864702103029
NMR metabolomics,X23428.Concentration of VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00225175801484735,0.00584216739756307,-0.013702406114071,0.00919889008437627,0.699924871918151
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH4,Myosin-4,39575,-0.00178938776748989,0.00468350053593143,-0.0109690488179155,0.0073902732829357,0.702422745161413
NMR metabolomics,X23428.Concentration of VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.00411164708356816,0.0108294378617354,-0.0253373452925695,0.0171140511254331,0.704195379262456
NMR metabolomics,X23428.Concentration of VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.00258508215386037,0.00697415423839838,-0.0110842601534005,0.0162544244611212,0.710893438951464
NMR metabolomics,X23428.Concentration of VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.0023963274574687,0.00647206138265795,-0.0102889128525409,0.0150815677674783,0.711197873911032
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00182311076264053,0.00494413800756013,-0.00786739973217732,0.0115136212574584,0.712327239218716
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNB2,Ephrin-B2,39649,-0.00214011676779384,0.00590549252423918,-0.0137148821153026,0.00943464857971496,0.717064337327593
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB116,Beta-defensin 116,39586,0.00275901530819742,0.00767575500734765,-0.012285464506204,0.0178034951225988,0.719268778385801
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS2,Podocin,39657,-0.00373740229848217,0.0104222027404956,-0.0241649196698536,0.0166901150728893,0.719901164771554
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00603207858153002,0.016968305686177,-0.0392899577264369,0.0272258005633768,0.722228464678968
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00234143574045922,0.00667587361027509,-0.0154261480165984,0.01074327653568,0.725796798004032
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRAL,GDNF family receptor alpha-like,39574,-0.00226322382788335,0.00647021752267752,-0.0149448501723313,0.0104184025165646,0.726502269704396
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00284718791772822,0.0081830936912552,-0.0188860515525884,0.013191675717132,0.727895268328973
NMR metabolomics,X23428.Concentration of VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00233741153508004,0.00676044310526462,-0.0155878800213987,0.0109130569512386,0.729538420462397
NMR metabolomics,X23428.Concentration of VLDL Particles,SCIN,Adseverin,39586,-0.00260801462148092,0.00754369187972435,-0.0173936507057407,0.0121776214627788,0.729558828954333
NMR metabolomics,X23428.Concentration of VLDL Particles,TNNI3,"Troponin I, cardiac muscle",41900,0.00293604383817172,0.00855268075610087,-0.013827210443786,0.0196992981201294,0.731386251354521
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH1,Cadherin-1,41697,-0.00138813006023605,0.0040872414078871,-0.00939912321969477,0.00662286309922268,0.734144266196809
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00266684379309999,0.00789708686908788,-0.0181451340565122,0.0128114464703123,0.735595975308057
NMR metabolomics,X23428.Concentration of VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00102473509409814,0.00307151708013834,-0.004995438382973,0.00704490857116927,0.738667713734944
NMR metabolomics,X23428.Concentration of VLDL Particles,PRND,Prion-like protein doppel,39929,-0.00165346864670428,0.00499401530378191,-0.0114417386421168,0.00813480134870826,0.74058261030382
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.00114450319383631,0.00346118306475314,-0.00563941561307983,0.00792842200075246,0.740901386085705
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.00254089847433411,0.00771535248602483,-0.0125811923982746,0.0176629893469428,0.741912223382065
NMR metabolomics,X23428.Concentration of VLDL Particles,C9orf40,Uncharacterized protein C9orf40,39930,0.00259801224358816,0.00794498361609339,-0.0129741556439549,0.0181701801311312,0.743673678379766
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP4,Caspase-4,39757,0.00547876688424816,0.0169635277921697,-0.0277697475884045,0.0387272813569008,0.746721500475254
NMR metabolomics,X23428.Concentration of VLDL Particles,ESPL1,Separin,39560,0.00174663519039738,0.00546237624464128,-0.00895962224909952,0.0124528926298943,0.749158343032559
NMR metabolomics,X23428.Concentration of VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.00190469083381711,0.0059628857437602,-0.0135919468915871,0.00978256522395288,0.749409730435206
NMR metabolomics,X23428.Concentration of VLDL Particles,MORN4,MORN repeat-containing protein 4,39560,-0.00255685540456226,0.0080105754475814,-0.0182575832818218,0.0131438724726973,0.749592325140751
NMR metabolomics,X23428.Concentration of VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.000913268544239171,0.0028679566214091,-0.006534463522201,0.00470792643372266,0.750158012563673
NMR metabolomics,X23428.Concentration of VLDL Particles,BTLA,B- and T-lymphocyte attenuator,39560,0.00279187960805808,0.00876980801267518,-0.0143969440967853,0.0199807033129014,0.75022455579674
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_A,,39934,-0.00105154341971318,0.00335211011451311,-0.00762167924415888,0.00551859240473252,0.753757737992183
NMR metabolomics,X23428.Concentration of VLDL Particles,GLI2,Zinc finger protein GLI2,39657,-0.00106051661877447,0.00339497207516882,-0.00771466188610535,0.00559362864855641,0.754758703787809
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,42119,-0.00195255324041846,0.00629343004400397,-0.0142876761266663,0.0103825696458293,0.756373631115268
NMR metabolomics,X23428.Concentration of VLDL Particles,RTKN2,Rhotekin-2,39575,-0.00161193443596184,0.0052049166917554,-0.0118135711518024,0.00858970227987875,0.756799112193379
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP350,Centrosome-associated protein 350,39560,0.00115240340418595,0.00374132849147957,-0.006180600439114,0.0084854072474859,0.758073088870181
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.00918077178897338,0.0304586436604574,-0.0505181697855231,0.0688797133634699,0.763100696756267
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN1,Prorelaxin H1,39934,0.00136041277602509,0.00452639601975281,-0.00751132342269041,0.0102321489747406,0.763762426049077
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00128500082466479,0.00436666432295796,-0.00727366124833282,0.0098436628976624,0.768553179296594
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,42118,0.00141415828597889,0.00494041760944013,-0.00826906022852377,0.0110973768004815,0.774696657206368
NMR metabolomics,X23428.Concentration of VLDL Particles,PYDC1,Pyrin domain-containing protein 1,39638,-0.00119635260771705,0.00421648697397631,-0.00946066707671061,0.00706796186127651,0.776621031991381
NMR metabolomics,X23428.Concentration of VLDL Particles,TP73,Tumor protein p73,39649,0.000982189392695681,0.00349825630930569,-0.00587439297354347,0.00783877175893483,0.778895586953269
NMR metabolomics,X23428.Concentration of VLDL Particles,KDM3A,Lysine-specific demethylase 3A,39657,0.00250653500944277,0.00906903925364112,-0.0152687819276938,0.0202818519465794,0.782258507962042
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.000602761658847404,0.00219736158325332,-0.00490959036202391,0.0037040670443291,0.783850211256503
NMR metabolomics,X23428.Concentration of VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.000892760660058715,0.00327989539841992,-0.00553583432084432,0.00732135564096175,0.785478688856946
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.00148052880406476,0.0054513763753563,-0.0121652264997631,0.0092041688916336,0.785942993300562
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00207312322899599,0.00763771528160811,-0.0170430451809479,0.0128967987229559,0.786063606734196
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00163049438601671,0.00608423110692852,-0.0102945985835632,0.0135555873555966,0.788714385554864
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,42100,-0.00128763295040021,0.00485925960062482,-0.0108117817676249,0.00823651586682443,0.791024738592024
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL21,C-C motif chemokine 21,42185,0.00100752412229403,0.00389404155362836,-0.00662479732281756,0.00863984556740562,0.795843775142818
NMR metabolomics,X23428.Concentration of VLDL Particles,NOP56,Nucleolar protein 56,39575,0.00293272174709731,0.0114495383851582,-0.0195083734878128,0.0253738169820074,0.797845042895478
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L15,Bcl-2-like protein 15,39657,-0.00148131501953984,0.00579158306467443,-0.0128328178263017,0.00987018778722205,0.798132955293396
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,42070,-0.00122371008086859,0.00481326190071735,-0.0106577034062746,0.00821028324453742,0.79931621749784
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL1,Interferon lambda-1,41839,-0.00115086068012469,0.00462275243910868,-0.0102114554607777,0.00790973410052833,0.80339889231111
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.000932216948948265,0.00374522442069238,-0.00640842291560881,0.00827285681350534,0.803436443441068
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.00099548891184288,0.0040194734265113,-0.00887365682780502,0.00688267900411926,0.804396215512169
NMR metabolomics,X23428.Concentration of VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.00149418060555643,0.00604942899679557,-0.0133510614392757,0.0103627002281629,0.804916471657117
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00107793947425163,0.00436481727405748,-0.00963298133140429,0.00747710238290103,0.804942185967638
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF75D,Zinc finger protein 75D,39757,0.00150562912389449,0.00625155136759244,-0.0107474115565867,0.0137586698043757,0.809682870803902
NMR metabolomics,X23428.Concentration of VLDL Particles,ULBP2,UL16-binding protein 2,42016,0.000958574117114947,0.00400640900449465,-0.00689398753169456,0.00881113576592445,0.810907499706223
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,39919,0.000858513463252967,0.00363088427859464,-0.00625801972279253,0.00797504664929846,0.813089729776992
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG3,Proteoglycan 3,39966,-0.00119829013544746,0.00508107172967999,-0.0111571907256202,0.00876061045472532,0.813565631563378
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,39929,0.00112905352664109,0.00481377389319986,-0.00830594330403063,0.0105640503573128,0.814565023640103
NMR metabolomics,X23428.Concentration of VLDL Particles,RASA1,Ras GTPase-activating protein 1,41839,0.000776924947606717,0.00331473449953985,-0.00571995467149139,0.00727380456670483,0.814689515899345
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22,Interleukin-22,39919,-0.00166150893039883,0.00718560158025942,-0.0157452880277073,0.0124222701669096,0.81714222028818
NMR metabolomics,X23428.Concentration of VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.000853066072688171,0.00372489929506723,-0.00815386869101994,0.0064477365456436,0.818859801233537
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13,Interleukin-13,41913,-0.00110877688319235,0.00494810766545706,-0.0108070679074882,0.00858951414110348,0.822697719776061
NMR metabolomics,X23428.Concentration of VLDL Particles,PGA4,Pepsin A-4,39990,-0.0017137627280321,0.00765854067395157,-0.0167245024489772,0.013296976992913,0.822939161943948
NMR metabolomics,X23428.Concentration of VLDL Particles,TXK,Tyrosine-protein kinase TXK,39757,-0.001674136796006,0.00748416941678743,-0.0163431088529094,0.0129948352608974,0.82300231760827
NMR metabolomics,X23428.Concentration of VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.000600999333599026,0.00269663425738269,-0.00468440381087104,0.00588640247806909,0.823640550305764
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00109155049354786,0.00493398578061579,-0.0107621626235548,0.00857906163645909,0.824916712097871
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC1A4,Neutral amino acid transporter A,39649,0.00113416247485384,0.0051862865901143,-0.00903095924177018,0.0112992841914779,0.82689956479467
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAVL4,ELAV-like protein 4,39586,0.00182671099410272,0.0083805981592114,-0.0145992613979516,0.0182526833861571,0.827457276784206
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,39743,-0.0011930192675603,0.00547780438778738,-0.0119295158676236,0.00954347733250296,0.827595550757246
NMR metabolomics,X23428.Concentration of VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00155260977064822,0.00724852081129529,-0.015759710560787,0.0126544910194906,0.830397587325071
NMR metabolomics,X23428.Concentration of VLDL Particles,GAST,Gastrin,39929,-0.00285982948540768,0.013372525690715,-0.0290699798392091,0.0233503208683938,0.830661182292478
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00144187229833778,0.00674307557505303,-0.0146583004254417,0.0117745558287662,0.830683549701105
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00116401381998007,0.00549615905308749,-0.00960845792407141,0.0119364855640316,0.832277252280028
NMR metabolomics,X23428.Concentration of VLDL Particles,PRL,Prolactin,42249,0.00155762291035675,0.00748516254807622,-0.0131132956838726,0.0162285415045861,0.835158103592174
NMR metabolomics,X23428.Concentration of VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000933110786818101,0.00450295172718333,-0.00975889617209744,0.00789267459846123,0.835840314947822
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171A2,Protein FAM171A2,39934,0.00328556322620589,0.0159521046562703,-0.0279805619000838,0.0345516883524956,0.836822538406492
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0024860444744591,0.012091170936766,-0.0261847395105204,0.0212126505616022,0.837100025784077
NMR metabolomics,X23428.Concentration of VLDL Particles,REST,RE1-silencing transcription factor,39560,-0.000719779986761075,0.00350353138363856,-0.00758670149869264,0.00614714152517049,0.837228953594633
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31,Interleukin-31,39657,0.00115458024292168,0.00568664258532934,-0.00999123922432383,0.0123003997101672,0.839112406126552
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.000970426857700071,0.00490440853222053,-0.00864221386545217,0.0105830675808523,0.843151730836723
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD10,Frizzled-10,39649,0.00120113716319236,0.00608922413485519,-0.0107337421411238,0.0131360164675085,0.843630688082403
NMR metabolomics,X23428.Concentration of VLDL Particles,PITHD1,PITH domain-containing protein 1,39539,0.00154461086624718,0.00790355254632408,-0.013946352124548,0.0170355738570424,0.845058022074678
NMR metabolomics,X23428.Concentration of VLDL Particles,TCP11,T-complex protein 11 homolog,39757,0.00115397796882776,0.00591147045241029,-0.0104325041178964,0.0127404600555519,0.845232129038967
NMR metabolomics,X23428.Concentration of VLDL Particles,DCLRE1C,Protein artemis,39560,0.000598168021381998,0.0031158778245894,-0.00550895251481323,0.00670528855757722,0.847766004441685
NMR metabolomics,X23428.Concentration of VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0019505044928858,0.0102335337240469,-0.0220082305920177,0.0181072216062461,0.848842947012121
NMR metabolomics,X23428.Concentration of VLDL Particles,TYMP,Thymidine phosphorylase,42070,0.00128867773740644,0.00676679340517348,-0.0119742373367336,0.0145515928115465,0.848966113831025
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00088849684489009,0.00476475106362924,-0.00845041523982322,0.0102274089296034,0.852077392375466
NMR metabolomics,X23428.Concentration of VLDL Particles,TET2,Methylcytosine dioxygenase TET2,39750,-0.00186829820031385,0.0102679102206234,-0.0219934022327356,0.0182568058321079,0.855621303189379
NMR metabolomics,X23428.Concentration of VLDL Particles,BLVRB,Flavin reductase,42137,0.00117775348788286,0.00648493952184363,-0.0115327279749307,0.0138882349506964,0.855888660897055
NMR metabolomics,X23428.Concentration of VLDL Particles,MLLT1,Protein ENL,39560,0.00120782642596953,0.00679072215747462,-0.0121019890026807,0.0145176418546198,0.858832906658288
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI2,Protein-arginine deiminase type-2,41913,-0.00102202118959905,0.00580569593717418,-0.0124011852264604,0.0103571428472623,0.860267025111894
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.000749465904140256,0.00434049072401591,-0.00925682772321143,0.00775789591493092,0.862914608025454
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.000941619676389996,0.00548223583796624,-0.0116868019188038,0.00980356256602384,0.863630596308766
NMR metabolomics,X23428.Concentration of VLDL Particles,EPGN,Epigen,39919,-0.000811014626485545,0.00472636966704399,-0.0100746991738918,0.00845266992092067,0.863760133283694
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN1,Transcobalamin-1,39806,0.000600533595759381,0.00364339933537071,-0.0065405291015672,0.00774159629308597,0.86908247374807
NMR metabolomics,X23428.Concentration of VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00121140613132529,0.0073881199861221,-0.0156921213041246,0.013269309041474,0.86976027766501
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00104957536494209,0.00642485942189538,-0.0115431491019729,0.013642299831857,0.870236737215953
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.000901613182780795,0.00554151164608523,-0.00995974964354625,0.0117629760091078,0.870756307597605
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.000575604503838804,0.00361089962718898,-0.0076529677731292,0.00650175876545159,0.873350203794368
NMR metabolomics,X23428.Concentration of VLDL Particles,TG,Thyroglobulin,39919,-0.00168744936498152,0.010691041820148,-0.0226418913324716,0.0192669926025085,0.874587512560887
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE1,Ribonuclease pancreatic,39990,-0.000395942383468298,0.00252544216244559,-0.00534580902186165,0.00455392425492505,0.87541990299119
NMR metabolomics,X23428.Concentration of VLDL Particles,CLGN,Calmegin,39649,0.000730392236640438,0.00466307788647099,-0.00840924042084271,0.00987002489412359,0.875536894555406
NMR metabolomics,X23428.Concentration of VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.000580125329720329,0.00372677761341509,-0.00672435879257324,0.0078846094520139,0.87630060201282
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.000507529442122546,0.00331478010652384,-0.00700449845090928,0.00598943956666419,0.878313518863329
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL9,C-X-C motif chemokine 9,42185,-0.000985039605125381,0.00661051384648901,-0.0139416467442438,0.0119715675339931,0.881547126000011
NMR metabolomics,X23428.Concentration of VLDL Particles,PAEP,Glycodelin,42016,-0.00156248445295287,0.0106588044142099,-0.0224537411048044,0.0193287721988986,0.883457086000136
NMR metabolomics,X23428.Concentration of VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.000471836719236507,0.00323539596865477,-0.00586953937932683,0.00681321281779985,0.884053194310943
NMR metabolomics,X23428.Concentration of VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00101023381849042,0.00698512710665484,-0.0147010829475339,0.0126806153105531,0.885008507886534
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.00390834827001749,0.0272512039430703,-0.0573207079984352,0.0495040114584003,0.885961668713711
NMR metabolomics,X23428.Concentration of VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,41843,0.000702263414190861,0.00489916053909992,-0.00890009124244498,0.0103046180708267,0.886020987432525
NMR metabolomics,X23428.Concentration of VLDL Particles,GAGE2A,G antigen 2A,39560,-0.000957334439034415,0.00668918792495233,-0.014068142771941,0.0121534738938722,0.886200654343571
NMR metabolomics,X23428.Concentration of VLDL Particles,PCARE,Photoreceptor cilium actin regulator,39586,0.00118809297682857,0.00851044173445054,-0.0154923728226945,0.0178685587763516,0.888975321301942
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.000909770162873745,0.0065703764448754,-0.011968167669082,0.0137877079948295,0.889875113482329
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.000763418774679272,0.00566253092125108,-0.0118619793803314,0.0103351418309728,0.892757173615349
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD2,Bromodomain-containing protein 2,39586,0.000479542673709843,0.0035814295309683,-0.00654005920698803,0.00749914455440771,0.893486474359673
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.000493485878044927,0.00370074595413311,-0.00774694794814582,0.00675997619205596,0.89392079044319
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA2,Carboxypeptidase A2,42205,0.000863066515914781,0.00676735773478957,-0.0124009546442728,0.0141270876761023,0.898519846732325
NMR metabolomics,X23428.Concentration of VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,39575,0.00130080193279428,0.0101998632533209,-0.0186909300437147,0.0212925339093033,0.898522229381638
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR1,TGF-beta receptor type-1,39657,-0.000284905814999601,0.00224858813382538,-0.00469213855729735,0.00412232692729815,0.899176735854538
NMR metabolomics,X23428.Concentration of VLDL Particles,SHISA5,Protein shisa-5,39966,-0.00033564829910823,0.00265062498915614,-0.00553087327785426,0.0048595766796378,0.899235593919705
NMR metabolomics,X23428.Concentration of VLDL Particles,HMMR,Hyaluronan mediated motility receptor,39541,0.000620625810520696,0.00494855412756106,-0.00907854027949899,0.0103197919005404,0.900196854793393
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.000416844323659871,0.00335261120195352,-0.00615427363216903,0.00698796227948877,0.90105292500322
NMR metabolomics,X23428.Concentration of VLDL Particles,RUVBL1,RuvB-like 1,41843,0.00120990086687124,0.0100690540662381,-0.0185254451029555,0.020945246836698,0.904357964320415
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00043028308958611,0.00365498323212907,-0.00759405022455908,0.00673348404538686,0.906287670808906
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,39657,0.000677071768948506,0.00584047435520947,-0.0107702579672621,0.0121244015051591,0.907712081860586
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.000495051433199078,0.00428275204457524,-0.00888924544056655,0.00789914257416839,0.90797803289234
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",39575,0.000473044361119206,0.00412673726857278,-0.00761536068528344,0.00856144940752185,0.908741175218353
NMR metabolomics,X23428.Concentration of VLDL Particles,KHDC3L,KH domain-containing protein 3,39560,0.000770679820217457,0.00686803457263783,-0.0126906679421527,0.0142320275825876,0.910656916521571
NMR metabolomics,X23428.Concentration of VLDL Particles,PAPPA,Pappalysin-1,41913,0.000534656281897067,0.00483001839732084,-0.00893217977685178,0.0100014923406459,0.911860307275901
NMR metabolomics,X23428.Concentration of VLDL Particles,OPTC,Opticin,42070,0.000498277581281759,0.00461910446749512,-0.00855516717500868,0.00955172233757219,0.914097882776075
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTF,Ciliary neurotrophic factor,39586,-0.000377615742487038,0.00353257682106429,-0.00730146631177304,0.00654623482679896,0.914874019917103
NMR metabolomics,X23428.Concentration of VLDL Particles,NENF,Neudesin,39919,-0.00116195120003889,0.0114714618283848,-0.0236460163836731,0.0213221139835953,0.919321575568202
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD5,Sushi domain-containing protein 5,39695,-0.000354408531049003,0.00352449479974546,-0.0072624183385501,0.0065536012764521,0.91990487134201
NMR metabolomics,X23428.Concentration of VLDL Particles,SHD,SH2 domain-containing adapter protein D,39554,0.000820493306545612,0.00843082685406385,-0.0157039273274195,0.0173449139405108,0.922473560903273
NMR metabolomics,X23428.Concentration of VLDL Particles,IL9,Interleukin-9,39757,-0.000550257771843343,0.00573908402768121,-0.0117988624660985,0.0106983469224118,0.923618376693686
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.000243471645106842,0.00260073910767115,-0.00534092029614229,0.00485397700592861,0.92541564999023
NMR metabolomics,X23428.Concentration of VLDL Particles,PXDNL,Peroxidasin-like protein,39919,-0.000541318865546436,0.00583983012737815,-0.0119873859152076,0.0109047481841147,0.926148079568586
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRING1,SREBP regulating gene protein,39560,0.000582762030083489,0.00635349207316498,-0.0118700824333199,0.0130356064934869,0.92691971475568
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5A,Cytochrome b5,39560,0.000645505246978119,0.00728605822893485,-0.0136351688817342,0.0149261793756904,0.929405736731735
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN7,Septin-7,39757,0.000480728095218967,0.0054381886426669,-0.0101781216444082,0.0111395778348461,0.929561484994795
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.000433107886680757,0.00526980848688125,-0.00989571674760648,0.010761932520968,0.934499824265355
NMR metabolomics,X23428.Concentration of VLDL Particles,TAP1,Antigen peptide transporter 1,39757,0.000479989252999233,0.00596293318317613,-0.011207359786026,0.0121673382920244,0.935844623544593
NMR metabolomics,X23428.Concentration of VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.000280262963619996,0.00352187443243396,-0.00718313685119055,0.00662261092395056,0.936574246931496
NMR metabolomics,X23428.Concentration of VLDL Particles,TSLP,Thymic stromal lymphopoietin,41900,0.000482466450156066,0.00613445573508337,-0.0115410667906073,0.0125059996909195,0.937313300904265
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB2,Beta-crystallin B2,39929,0.000550997584009175,0.00714484861456533,-0.0134529057005389,0.0145549008685572,0.938530907665941
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGEA3,Melanoma-associated antigen 3,39757,0.000675188380479159,0.0088070500286928,-0.0165866296757587,0.017937006436717,0.938891794418727
NMR metabolomics,X23428.Concentration of VLDL Particles,IL33,Interleukin-33,41913,-0.000261775537615237,0.00401638173567076,-0.00813388373952993,0.00761033266429945,0.948034086787148
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC25A,M-phase inducer phosphatase 1,39560,-0.000266092264700972,0.00409969629907639,-0.00830149701089069,0.00776931248148875,0.948250536570949
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS2,Thrombospondin-2,42137,-0.000239850776917476,0.00393175986809502,-0.00794610011838372,0.00746639856454877,0.951357390311169
NMR metabolomics,X23428.Concentration of VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.00018826442167454,0.00308994152544094,-0.00624454981153878,0.0058680209681897,0.951417501635979
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM2,Neural cell adhesion molecule 2,42137,0.000164838802950962,0.00274238889661668,-0.00521024343441774,0.00553992104031966,0.952070711560932
NMR metabolomics,X23428.Concentration of VLDL Particles,EPB41L5,Band 4.1-like protein 5,39649,0.000365196676909053,0.00634826504316536,-0.0120774028076951,0.0128077961615132,0.954126434845836
NMR metabolomics,X23428.Concentration of VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.000205630751239066,0.00361608670271972,-0.00729316068856971,0.00688189918609158,0.954653333946791
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD9,COMM domain-containing protein 9,39919,-0.000228827482543453,0.00406836249950673,-0.00820281798157664,0.00774516301648973,0.955147149260113
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.000140475539121492,0.00256059062346649,-0.00487828208287283,0.00515923316111581,0.956250320240022
NMR metabolomics,X23428.Concentration of VLDL Particles,ANK2,Ankyrin-2,39575,0.000372232527525612,0.00714433651855363,-0.0136306670488395,0.0143751321038907,0.958448556491085
NMR metabolomics,X23428.Concentration of VLDL Particles,TFRC,Transferrin receptor protein 1,42200,0.000194953618570645,0.00381458858125631,-0.00728164000069173,0.00767154723783302,0.959240707856573
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD2,Leiomodin-2,39586,0.000303882542207552,0.00628638711374872,-0.0120174362007399,0.012625201285155,0.96144633398357
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17F,Interleukin-17F,41913,0.000324563078971108,0.00747252033872541,-0.0143215767849307,0.0149707029428729,0.965356052631848
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL6B,Myosin light chain 6B,39649,-0.000385166226084384,0.00931533073897797,-0.0186432144744812,0.0178728820223124,0.967019562639382
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA5,Annexin A5,41780,0.000124079727622823,0.0030913241462364,-0.00593491559900051,0.00618307505424616,0.967983673511522
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.000137445568237658,0.00348442330687889,-0.00696691524972028,0.00669202411324496,0.968535617640053
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG3,Secretogranin-3,42144,0.000133429763829386,0.00338613447972721,-0.00650339381643596,0.00677025334409473,0.968568278112613
NMR metabolomics,X23428.Concentration of VLDL Particles,CBX2,Chromobox protein homolog 2,39575,-0.000154468757992103,0.00403457647294456,-0.00806223864496344,0.00775330112897924,0.969460159005967
NMR metabolomics,X23428.Concentration of VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00013212839974976,0.00351540734637431,-0.00675806999914388,0.0070223267986434,0.970018839757296
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.000195165797886984,0.00540060050009507,-0.0107803427780733,0.0103900111822994,0.971173018256169
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTH3,Cytohesin-3,39560,-0.000230792226887712,0.00748129659292216,-0.0148941335490152,0.0144325490952397,0.975390342257376
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.000263652262453221,0.00936783149193449,-0.0180972974617384,0.0186246019866448,0.977547471798123
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,41913,8.9685017902203e-05,0.0031999046713495,-0.00618212813794281,0.00636149817374722,0.977640715366413
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00017953838101291,0.00697547437043634,-0.0134923913850423,0.0138514681470681,0.979466360461217
NMR metabolomics,X23428.Concentration of VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.000143414623338152,0.00649920177572821,-0.0125950208570891,0.0128818501037654,0.982395312346843
NMR metabolomics,X23428.Concentration of VLDL Particles,OMD,Osteomodulin,42185,8.83084202464352e-05,0.00417548064332636,-0.00809563364067323,0.0082722504811661,0.983126882423479
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO1,Alpha-enolase,42119,0.000110520012608987,0.00800698931753822,-0.0155831790497659,0.0158042190749839,0.988987398714127
NMR metabolomics,X23428.Concentration of VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,39990,-3.55124924085803e-05,0.00291269183894743,-0.00574438849674554,0.00567336351192838,0.990272384784503
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFD,Vascular endothelial growth factor D,42275,-4.4385771825142e-05,0.003928278225134,-0.00774381109308777,0.00765503954943749,0.990985027277519
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP8,Neutrophil collagenase,42224,-7.62670089854113e-05,0.00727854645570206,-0.0143422180621615,0.0141896840441906,0.991639808975794
NMR metabolomics,X23428.Concentration of VLDL Particles,TAGLN3,Transgelin-3,39560,-4.81087397115063e-05,0.00614238477688631,-0.0120871829024087,0.0119909654229857,0.993750969043939
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTN,Neuroplastin,41843,-4.29221950420343e-05,0.00796724604096736,-0.0156587244353381,0.015572880045254,0.995701633363595
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB2,Integrin beta-2,42079,1.28916692795427e-05,0.00292421311780967,-0.00571856604162741,0.00574434938018649,0.996482527309799
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-1.19101553996529e-05,0.00343401363848971,-0.00674257688683949,0.00671875657604018,0.997232773571689
